Sentence,class,file
Meta-analysis of the comparison  between CHADS 2 and CHA 2DS 2-VASc     Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com  of the CHADS 2 scores and the CHA 2DS 2-VASc scores.,Non-OADS,/arxiv_data1/oa_pdf/14/a1/jgc-10-03-258.PMC3796700.pdf
"Meta-analysis of the comparison  between CHADS 2 and CHA 2DS 2-VASc     Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com    Subgroup analysis: According to the result of the consi s- tency test, all the included studies were divided into  non-antic oagulant and anticoagulant subgroups.",Non-OADS,/arxiv_data1/oa_pdf/14/a1/jgc-10-03-258.PMC3796700.pdf
Meta-analysis of the comparison  between CHADS 2 and CHA 2DS 2-VASc     Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com    4  Discussion   The CHADS 2 score has be en widely used in evaluating  the risk of stroke in patients with AF since 2001.,Non-OADS,/arxiv_data1/oa_pdf/14/a1/jgc-10-03-258.PMC3796700.pdf
"Stata Tec hnical  Bulletin  (STB), 1998, 42:  16-22. http://onlinelibrary.wiley.",Non-OADS,/arxiv_data1/oa_pdf/14/a1/jgc-10-03-258.PMC3796700.pdf
"Meta-analysis of the comparison  between CHADS 2 and CHA 2DS 2-VASc     Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com  9  Poli D, Lip GY, Antonucci E, et al.",Non-OADS,/arxiv_data1/oa_pdf/14/a1/jgc-10-03-258.PMC3796700.pdf
268 Liu J. Diabetes and pneumonia mortality in seniors     Journal of Ge riatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com  Index (NDI).,Non-OADS,/arxiv_data1/oa_pdf/87/22/jgc-10-03-267.PMC3796701.pdf
Liu J. Diabetes and pneumonia mortality in seniors  269     http://www.jgc301.com; jgc@mail.sciencep.com  | Journal of Geriatric Cardiology   Table 2.,Non-OADS,/arxiv_data1/oa_pdf/87/22/jgc-10-03-267.PMC3796701.pdf
"270 Liu J. Diabetes and pneumonia mortality in seniors     Journal of Ge riatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com  tion,[20] were not associated with pneumonia mortality in  this study.",Non-OADS,/arxiv_data1/oa_pdf/87/22/jgc-10-03-267.PMC3796701.pdf
http://www.cdc.gov/nchs/nhanes/nh3data.htm.,OADS,/arxiv_data1/oa_pdf/87/22/jgc-10-03-267.PMC3796701.pdf
http://www.cdc.gov/nchs/data_access/data_   linkage/mortality/nhanes3_linkage.htm.,OADS,/arxiv_data1/oa_pdf/87/22/jgc-10-03-267.PMC3796701.pdf
Liu J. Diabetes and pneumonia mortality in seniors  271     http://www.jgc301.com; jgc@mail.sciencep.com  | Journal of Geriatric Cardiology   tients with community -acquired pneu monia: prediction of s e- verity and mortality.,Non-OADS,/arxiv_data1/oa_pdf/87/22/jgc-10-03-267.PMC3796701.pdf
" Journal of Geriatric Cardiology (201 3) 10: 272280   ©2013 JGC All rights reserved ; www.jgc301.com      http://www.jgc301.com; jgc@jgc301.com  | Journal of Geriatric Cardiology   Research Article     Open Access     Purification and functional assessment of smooth muscle cells derived  from mouse embryonic stem cells     Xiao -Xiang Tian, Jian Kang, Cheng -Hui Yan, Kai Xu, Jie Tao, Gui -Tang Yang, Ya -Ling Han   Department of Cardiology, Chi nese PLA Cardiovascular Research Institute, General Hospital of Shenyang Military Region, 83 Wenhua Road, Shenhe District,  Shenyang, Liaoning 110840, China     Abstract   Objective   To obtain a pure population of smooth muscle cells (SMC) derived from mouse e mbryonic stem cells (ESC) and further  assess their functions.",Non-OADS,/arxiv_data1/oa_pdf/45/a3/jgc-10-03-272.PMC3796702.pdf
Functional assessment of purified SMC from ESC   273     http://www.jgc301.com; jgc@mail .sciencep.com  | Journal of Geriatric Cardiology   tem where true SMC development and maturation are rec a- pitulated as in vivo  from a definite origin.,Non-OADS,/arxiv_data1/oa_pdf/45/a3/jgc-10-03-272.PMC3796702.pdf
Functional assessment of purified SMC from ESC     Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com     Figure 1 .,Non-OADS,/arxiv_data1/oa_pdf/45/a3/jgc-10-03-272.PMC3796702.pdf
Functional assessment of purified SMC from ESC   275     http://www.jgc301.com; jgc@mail .sciencep.com  | Journal of Geriatric Cardiology     fluorescence and in vivo  teratoma formation were used to  assess pluripotency of Tg -ESC.,OADS,/arxiv_data1/oa_pdf/45/a3/jgc-10-03-272.PMC3796702.pdf
Functional assessment of purified SMC from ESC     Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com  2.9  Proliferation assay   Proliferation of VSMC and P -SMC was assessed  by  counting  cell numbers  to plot growth curve .,OADS,/arxiv_data1/oa_pdf/45/a3/jgc-10-03-272.PMC3796702.pdf
Functional assessment of purified SMC from ESC   277     http://www.jgc301.com; jgc@mail .sciencep.com  | Journal of Geriatric Cardiology      Figure 2 .,Non-OADS,/arxiv_data1/oa_pdf/45/a3/jgc-10-03-272.PMC3796702.pdf
Functional assessment of purified SMC from ESC     Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com     Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/45/a3/jgc-10-03-272.PMC3796702.pdf
"Functional assessment of purified SMC from ESC   279     http://www.jgc301.com; jgc@mail .sciencep.com  | Journal of Geriatric Cardiology   ditional advantages as a differentiation marker due to its  high specificity, small size, and high efficiency.",Non-OADS,/arxiv_data1/oa_pdf/45/a3/jgc-10-03-272.PMC3796702.pdf
Functional assessment of purified SMC from ESC     Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com  contractility of purified smooth muscle cells derived from  embryonic stem cells.,Non-OADS,/arxiv_data1/oa_pdf/45/a3/jgc-10-03-272.PMC3796702.pdf
" Journal of Geriatric Cardiology (201 3) 10: 281285   ©2013 JGC All rights reserved ; www.jgc301.com      http://www.jgc301.com; jgc@jgc301.com  | Journal of Geriatric Cardiology   Research Article     Open Access     GRK 2 level in peripheral blood lymphocytes of elderly patients with acute  myocardial infarction      Wen-Qian Gao1, Chun -Guang Han2, Xiao -Chun Lu1, Yong -Xue Liu2, Hai -Peng Hui1, Hao Wang1  1The First Department of Geriatri c Cardiology, Chinese PLA General Hospital, Beijing 100853, China   2Beijing Institute of Radiation Medicine, Beijing, China      Abstract   Objective   To investigate the G protein -coupled receptor kinase  2 (GRK  2) level in peripheral blood lymphocytes with car diac fun c- tion in elderly patients with acute myocardial infarction.",Non-OADS,/arxiv_data1/oa_pdf/ae/82/jgc-10-03-281.PMC3796703.pdf
"Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com  2  Methods   2.1  Patients   This study included 40 patients aged 65 years or older  with acute STEMI  ( 24 h), and 40 age -matched patients  with unstable angina as a control group.",Non-OADS,/arxiv_data1/oa_pdf/ae/82/jgc-10-03-281.PMC3796703.pdf
283     http://www.jgc301.com; jgc@mail.sciencep.com  | Journal of Geriat ric Cardiology   Table 2.,Non-OADS,/arxiv_data1/oa_pdf/ae/82/jgc-10-03-281.PMC3796703.pdf
Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com  higher in patients with acute STEMI than in patients with  unstable angina.,Non-OADS,/arxiv_data1/oa_pdf/ae/82/jgc-10-03-281.PMC3796703.pdf
"285     http://www.jgc301.com; jgc@mail.sciencep.com  | Journal of Geriat ric Cardiology   14  Bonita RE, Raake P W, Otis NJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/ae/82/jgc-10-03-281.PMC3796703.pdf
" Journal of Geriatric Cardiology (201 3) 10: 286290   ©2013 JGC All rights reserved ; www.jgc301.com      http://www.jgc301.com; jgc@jgc301.com  | Journal of Geriatric Cardiology   Research Article     Open Access     Serum cystatin C concentration as an independent marker for hypertensive  left ventricular hypertrophy     Xin Li1*, Hang Zhu2*, Peng Li1, Qian X in2, Jie Liu2, Wei Z hang2, You -Hong Xing2, Hao Xue2  1Clinical Department of Me dicine, Chinese P LA General Hospital, Beijing 100853, China   2Department of Cardiology, Chinese P LA General Hospital, Beijing 100853, China     Abstract   Background  Serum cystatin C levels can be used to predict morbidity and mortality in patients with cardi ovascular disease.",Non-OADS,/arxiv_data1/oa_pdf/77/18/jgc-10-03-286.PMC3796704.pdf
"Cystatin C and hypertensive left ventricular hypertrophy  287     http://www.jgc301.com; jgc@mail.sciencep.com  | Journal of Geriatric Cardiology   sonal history of cardiovascular disease or periphera l artery  disease, and ather osclerotic risk factors, including diabetes,  hyperlipi demia, and smoking.",Non-OADS,/arxiv_data1/oa_pdf/77/18/jgc-10-03-286.PMC3796704.pdf
Cystatin C and hypertensive left ventricular hypertrophy     Journal  of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com  Table 1.,Non-OADS,/arxiv_data1/oa_pdf/77/18/jgc-10-03-286.PMC3796704.pdf
"Cystatin C and hypertensive left ventricular hypertrophy  289     http://www.jgc301.com; jgc@mail.sciencep.com  | Journal of Geriatric Cardiology   with hyperte nsive LVH, clinicians and geneticists have tried  to determine its underlying  mechanism and strategies for  early interve ntion.",Non-OADS,/arxiv_data1/oa_pdf/77/18/jgc-10-03-286.PMC3796704.pdf
"Cystatin C and hypertensive left ventricular hypertrophy     Journal  of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com  18  Briguori C, Visconti G, Rivera NV, et al.",Non-OADS,/arxiv_data1/oa_pdf/77/18/jgc-10-03-286.PMC3796704.pdf
" Journal of Geriatric Cardiology (201 3) 10: 291301   ©2013 JGC All rights reserved ; www.jgc301.com      http://www.jgc301.com; jgc@jgc301.com  | Journal of Geriatric Cardiology   Review     Open Access     Blood rheology and aging     Michael J. Simmonds1, Herbert J. Meiselman2, Oguz K. Baskurt3  1Heart Foundation Research Centre, Griffith Health Institute, Griffith University, Gold Coast, QLD  4222 , Australia   2Department of Physiology  and Biophysics, Keck School of Medicine, University of Southern California, Los Angeles, CA  9033 , USA   3Koc University School of Medicine, Istanbul, Turkey      Abstract   The flow properties of blood play significant roles in tissue perfusion by contributing to hydrod ynamic resistance in blood vessels.",Non-OADS,/arxiv_data1/oa_pdf/45/de/jgc-10-03-291.PMC3796705.pdf
Blood rheology and aging     Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com     Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/45/de/jgc-10-03-291.PMC3796705.pdf
Blood rheology and aging  293     http://www.jgc301.com; jgc@ma il.sciencep.com  | Journal of Geriatric Cardiology   3  Blood rheology and disease processes   There is a large collection of data related to alterations of  RBC mechanical properties and the flow behavior of blood  during disease processes.,Non-OADS,/arxiv_data1/oa_pdf/45/de/jgc-10-03-291.PMC3796705.pdf
Blood rheology and aging     Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com  RBC deformability may be actively regulated via the pho s- phorylation/dephosphorylation of various proteins contri b- uting to the membrane skeletal network and its interactions  with the RBC membrane .,Non-OADS,/arxiv_data1/oa_pdf/45/de/jgc-10-03-291.PMC3796705.pdf
Blood rheology and aging  295     http://www.jgc301.com; jgc@ma il.sciencep.com  | Journal of Geriatric Cardiology   among woman .,Non-OADS,/arxiv_data1/oa_pdf/45/de/jgc-10-03-291.PMC3796705.pdf
"Blood rheology and aging     Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com  associations given that simple postural changes and/or pe r- forming relatively mild exercise, such as walking, signif i- cantly influence hematocrit .",Non-OADS,/arxiv_data1/oa_pdf/45/de/jgc-10-03-291.PMC3796705.pdf
"Blood rheology and aging  297     http://www.jgc301.com; jgc@ma il.sciencep.com  | Journal of Geriatric Cardiology   deformability include altered sialic acid content and the  Na+-K+ ATPase activity of the cell membran e. While not  indicating causa lity, an interesting association between  sialic acid content and cell membrane rigidity has been o b- served, whereby the membrane bending modulus increased  linearly with reduced negative cell surface charge .",Non-OADS,/arxiv_data1/oa_pdf/45/de/jgc-10-03-291.PMC3796705.pdf
"Blood rheology and aging     Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com  stood, yet it seems quite logical that decreased plasma f i- brinogen co ncentration may explain, in part, these findings.",Non-OADS,/arxiv_data1/oa_pdf/45/de/jgc-10-03-291.PMC3796705.pdf
"Blood rheology and aging  299     http://www.jgc301.com; jgc@ma il.sciencep.com  | Journal of Geriatric Cardiology   man MR, Rampling  MW, et al, Eds;  IOS Press : Amsterdam,  the N etherlands , 2007 ; pp.",Non-OADS,/arxiv_data1/oa_pdf/45/de/jgc-10-03-291.PMC3796705.pdf
"Blood rheology and aging     Journal of Geriatric Cardiology  | jgc@jgc301.com; http://www.jgc301.com  54  Christy RM, Baskurt OK, Gass GC,  et al.",Non-OADS,/arxiv_data1/oa_pdf/45/de/jgc-10-03-291.PMC3796705.pdf
Blood rheology and aging  301     http://www.jgc301.com; jgc@ma il.sciencep.com  | Journal of Geriatric Cardiology   brinogen concentration in a general -population sa mple of  middle -aged men.,Non-OADS,/arxiv_data1/oa_pdf/45/de/jgc-10-03-291.PMC3796705.pdf
" Journal of Geriatric Cardiology (201 3) 10: 302304   ©2013 JGC All rights reserved ; www.jgc301.com      http://www.jgc301.com; jgc@jgc301.com  | Journal of Geriatric Cardiology   Case Report     Open Access     A successful team treatment for left main shock syndrome     Bin Que, Yu-Tong Cheng,  Hai Gao, Xiao -Tong Hou , Ran Dong , Nan  Li, Shao -Ping Nie   Beijing Anzhen Hospital of the Capital University of Medical Sciences, Beijing 100029,  China      Abstract   Acute myocardial infarction complicated by cardiogenic shock and left main coronary artery disease i s called left main shock syndrome.",Non-OADS,/arxiv_data1/oa_pdf/0f/02/jgc-10-03-302.PMC3796706.pdf
Treatment for left main shock syndrome  303     http://www.jgc301.com; jgc@mail.sciencep.com  | Journal of Geriatric Cardiology       Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/0f/02/jgc-10-03-302.PMC3796706.pdf
com; http://www.jgc301.com     Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/0f/02/jgc-10-03-302.PMC3796706.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e2/09/srep02945.PMC3796737.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2945 | DOI: 10.1038/srep02945 5",Non-OADS,/arxiv_data1/oa_pdf/e2/09/srep02945.PMC3796737.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e3/fb/srep02938.PMC3796738.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2938 | DOI: 10.1038/srep02938 7",Non-OADS,/arxiv_data1/oa_pdf/e3/fb/srep02938.PMC3796738.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/81/c8/srep02946.PMC3796739.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2946 | DOI: 10.1038/srep02946 4",Non-OADS,/arxiv_data1/oa_pdf/81/c8/srep02946.PMC3796739.pdf
"Genes belonging to miRNA families mir-1193, mir-134, mir-412, mir-485, mir-541, mir-654, mir-668 andmir-889 have been annotated only on the 11 strand in different species (see Supplementary Table 1 online for miRNA familiesbelonging to human C14MC and the miRNAVISA family key-word query at http://www.cbrc.kaust.edu.sa/mirnavisa/family.php).Taken together, this observation implies that miRNA families withgenes residing on imprinted genomic loci may define a subclass of themiRNA class that exhibits preferential strand-biased expression andtherefore genes in such subclasses may have similar but currentlyunknown transcriptional and epigenetic regulation mechanisms.These miRNA families show strict chromosome-specificity in differ-ent species as indicated in Figure 4 (hypothesis H5).",Non-OADS,/arxiv_data1/oa_pdf/84/69/srep02940.PMC3796740.pdf
at http://www.r-project.org/ 57.,Non-OADS,/arxiv_data1/oa_pdf/84/69/srep02940.PMC3796740.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/84/69/srep02940.PMC3796740.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2940 | DOI: 10.1038/srep02940 8",Non-OADS,/arxiv_data1/oa_pdf/84/69/srep02940.PMC3796740.pdf
"Biophysical Journal 76, 98–102, doi:http://dx.doi.",OADS,/arxiv_data1/oa_pdf/1b/af/srep02942.PMC3796741.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2942 | DOI: 10.1038/srep02942 7",Non-OADS,/arxiv_data1/oa_pdf/1b/af/srep02942.PMC3796741.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/4d/b7/srep02941.PMC3796742.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2941 | DOI: 10.1038/srep02941 10",Non-OADS,/arxiv_data1/oa_pdf/4d/b7/srep02941.PMC3796742.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ea/db/srep02950.PMC3796744.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2950 | DOI: 10.1038/srep02950 7",Non-OADS,/arxiv_data1/oa_pdf/ea/db/srep02950.PMC3796744.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/95/e0/srep02947.PMC3796745.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2947 | DOI: 10.1038/srep02947 5",Non-OADS,/arxiv_data1/oa_pdf/95/e0/srep02947.PMC3796745.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/9d/4f/srep02948.PMC3796746.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2948 | DOI: 10.1038/srep02948 6",Non-OADS,/arxiv_data1/oa_pdf/9d/4f/srep02948.PMC3796746.pdf
"This is an Open Access article distributed under  the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits non-commercial re-use,  distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/75/97/met019.PMC3796760.pdf
Details of the data accesspolicy for ALSPAC is available at: http://www.bristol.,OADS,/arxiv_data1/oa_pdf/dd/a9/jcpp0054-0591.PMC3796855.pdf
"Available from: http://www.sdqinfo.org/py /sdqinfo/c0.py [last accessed 10 September 2010] Goodman, R., & Scott, S. (1999).",Non-OADS,/arxiv_data1/oa_pdf/dd/a9/jcpp0054-0591.PMC3796855.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7f/d8/tacg-6-075.PMC3796859.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpThe Application of Clinical Genetics 2013:6 75–85The Application of Clinical Genetics Dove press submit your manuscript | www.dovepress.co m Dove press  75REVIEWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TACG.S5204 7Clinical impact of recent genetic discoveries   in osteoporosis Braxton D Mitchell Elizabeth A Streeten Department of Medicine and Program  for Personalized and Genomic  Medicine, University of Maryland  School of Medicine, and Geriatric  Research and Education Clinical  Center, Veterans Administration  Medical Center, Baltimore, MD, USA Correspondence: Braxton D Mitchell   University of Maryland School of  Medicine, 685 W Baltimore St, MSTF  302, Baltimore, MD 21201, USA   Tel +1 410 706 0161   Email bmitchel@medicine.umaryland.ed uAbstract:  Osteoporotic fracture carries an enormous public health burden in terms of mortality  and morbidity.",Non-OADS,/arxiv_data1/oa_pdf/7f/d8/tacg-6-075.PMC3796859.pdf
"The predictive ability was roughly  similar to (or, for hip or spine measurements, better than) that  of a one SD increase in blood pressure for stroke and better  than a one SD increase in serum cholesterol concentration  for cardiovascular disease.29 In a later meta-analysis, Johnell  et al reported that each SD decrease in BMD corresponded  approximately to a 2.9-fold increase in hip fracture risk.30 While these results illustrate the utility of DXA as a  screening tool, DXA does not have a high sensitivity at the  individual level for fracture prediction.31,32 Indeed, while the  lifetime risk of fracture in women and men over age 50 years  is estimated to be 50% and 30%, respectively,2 more than 50%  of women and 70% of men who experienced a fracture did not  meet DXA criteria for osteoporosis.33 Tools that assess bone  quality (eg, high resolution peripheral computed tomography)  improve fracture risk prediction over DXA but are not avail - able clinically.34 To improve fracture prediction, the FRAX®  tool ( http://www.shef.ac.uk/FRAX /) was developed in 2008  by the World Health Organization as an online calculator that integrates information from BMD and clinical risk factors  to calculate the 10-year probability of hip fracture and the  10-year probability of any major osteoporotic fracture (clini - cal spine, forearm, hip, or shoulder fracture).",Non-OADS,/arxiv_data1/oa_pdf/7f/d8/tacg-6-075.PMC3796859.pdf
"The Application of Clinical Genetics Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/the-application-of-clinical-genetics-journa lThe Application of Clinical Genetics is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings in  the field of human genetics.",Non-OADS,/arxiv_data1/oa_pdf/7f/d8/tacg-6-075.PMC3796859.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7f/d8/tacg-6-075.PMC3796859.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b8/71/prom-4-049.PMC3796868.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Related Outcome Measures 2013:4 49–54Patient Related Outcome Measures Dove press submit your manuscript | www.dovepress.co m Dove press  49ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/PROM.S5097 6Translation and validation of the Western   Ontario Osteoarthritis of the shoulder   (WOOs) index – the Danish version Jeppe V Rasmussen1 John Jakobsen2 Bo s Olsen1 stig Brorson1 1Department of Orthopedic surgery,   herlev University hospital, herlev,   Denmark; 2Department of Orthopedic  surgery, aalborg University hospital,   Thisted, Denmark correspondence: Jeppe V Rasmussen   herlev University hospital, Department  of Orthopedic surgery, herlev Ringvej  75, 2730 herlev, Denmark   Tel +45 40 56 18 59   Fax +45 44 88 30 33   email jevera01@heh.regionh.d kBackground and purpose:  The Western Ontario Osteoarthritis of the Shoulder (WOOS) index  is a patient-reported, disease-specific questionnaire for the measurement of the quality-of-life  in patients with osteoarthritis.",Non-OADS,/arxiv_data1/oa_pdf/b8/71/prom-4-049.PMC3796868.pdf
"Patient Related Outcome Measures Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-related-outcome-measures-journa lPatient Related Outcome Measures is an international, peer-reviewed,  open access journal focusing on treatment outcomes specifically  relevant to patients.",Non-OADS,/arxiv_data1/oa_pdf/b8/71/prom-4-049.PMC3796868.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/b8/71/prom-4-049.PMC3796868.pdf
Modified from  http://commons.wikimedia.org/wiki/Main_Page    1873-5294/13 $58.00+.00 © 2013 Bentham Science Publishers  Send Orders for Reprints to reprints@benthamscienc e.net,Non-OADS,/arxiv_data1/oa_pdf/95/64/CTMC-13-760.PMC3796894.pdf
(Accessed  Nov 6 at http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/95/64/CTMC-13-760.PMC3796894.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/4d/af/IJOrtho-47-443.PMC3796915.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/e7/98/IJOrtho-47-474.PMC3796920.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/e7/98/IJOrtho-47-474.PMC3796920.pdf
The application can be downloaded  from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/2d/f4/IJOrtho-47-487.PMC3796922.pdf
The application can be downloaded  from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/7f/c8/IJOrtho-47-500.PMC3796924.pdf
Available from: http://www.researchandmarkets.com/ reports/1877536/overview_of_orthopedic_joint_replacement_ market.pdf.,Non-OADS,/arxiv_data1/oa_pdf/98/4d/IJOrtho-47-505.PMC3796925.pdf
Available from: http://www.biomed.brown.edu/Courses/ BI108/BI108_2007_Groups/group 05/pages/sulzer.html.,Non-OADS,/arxiv_data1/oa_pdf/98/4d/IJOrtho-47-505.PMC3796925.pdf
Available from: http://www.rcseng.ac.uk/surgeons/research/ surgical-research/docs/An%20Investigation%20of%20the%20 Performance%20of%20the%203M%20Capital%20Hip%20 System%20Report%202001.pdf.,Non-OADS,/arxiv_data1/oa_pdf/98/4d/IJOrtho-47-505.PMC3796925.pdf
Available from: http://www.asrrecall.depuy.com/countries_list.,Non-OADS,/arxiv_data1/oa_pdf/98/4d/IJOrtho-47-505.PMC3796925.pdf
"Available from: http://www.aaos.org/research/ stats/patientstats.asp [Last accessed on 2013, September 6].",OADS,/arxiv_data1/oa_pdf/98/4d/IJOrtho-47-505.PMC3796925.pdf
Available from: http://www.nam.,Non-OADS,/arxiv_data1/oa_pdf/98/4d/IJOrtho-47-505.PMC3796925.pdf
Available from: http://www.aaos.,Non-OADS,/arxiv_data1/oa_pdf/98/4d/IJOrtho-47-505.PMC3796925.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution   Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial  re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/58/1d/djt213.PMC3797023.pdf
http://seer.cancer.gov/csr/1975_2010/ ;.,Non-OADS,/arxiv_data1/oa_pdf/58/1d/djt213.PMC3797023.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e7/f8/ndt-9-1539.PMC3797236.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2013:9 1539–1544Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1539Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S4240 4Spirituality in childhood cancer care Nádia Nara Rolim Lima1 vânia Barbosa do  Nascimento1 Sionara Melo Figueiredo   de Carvalho1 Modesto Leite Rolim Neto2 Marcial Moreno Moreira2 Aline Quental Brasil2 Francisco T elésforo  Celestino Junior2 Gislene Farias de Oliveira2 Alberto Olavo Advíncula  Reis3 1Health Sciences Postgraduate  Program, ABC Region Medical School,   Santo André, São Paulo, Brazil;   2Department of Medicine, Federal  University of Ceará, Barbalha, Ceará,   Brazil; 3Public Health Postgraduate  Program, University of São Paulo, São  Paulo, Brazil Correspondence: Modesto Leite Rolim  Neto   Faculty of Medicine, Federal University   of Ceará, Rua Divino Salvador,   S/N, Rosário, Barbalha, Ceará, Brazil   Tel +55 88 9691 1385   Fax +55 88 3572 7201   email modestorolim@yahoo.com.b rAbstract:  To deal with the suffering caused by childhood cancer, patients and their families  use different coping strategies, among which, spirituality appears a way of minimizing possible  damage.",Non-OADS,/arxiv_data1/oa_pdf/e7/f8/ndt-9-1539.PMC3797236.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/e7/f8/ndt-9-1539.PMC3797236.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e7/f8/ndt-9-1539.PMC3797236.pdf
Available  from: http://www.periodicos.capes.gov.br /.,Non-OADS,/arxiv_data1/oa_pdf/e7/f8/ndt-9-1539.PMC3797236.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9b/1c/dddt-7-1179.PMC3797237.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2013:7 1179–1186Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1179Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S5301 1Phase ii study of whole brain radiotherapy   with or without erlotinib in patients with multiple  brain metastases from lung adenocarcinoma hongqing Zhuang1–4 Zhiyong Yuan1–4 Jun Wang1–4 lujun Zhao1–4 Qingsong Pang1–4 Ping Wang1–4 1Department of radiotherapy, Tianjin  Medical University cancer institute  and hospital, 2national clinical  research center of cancer, 3Tianjin  Key laboratory of cancer Prevention  and Therapy, 4Tianjin lung cancer  center, Tianjin, People’s republic   of china correspondence: hongqing Zhuang;   Ping Wang   Tianjin Medical University cancer  institute and hospital, Department   of radiotherapy, huanhuxi road,  hexi District,Tianjin 300060, People’s   republic of china   Tel +86 222 334 1405   Fax +86 222 334 1405   email hongqingzhuang@163.c om;  wangping99999@yahoo.co mAbstract:  The aim of this paper is to explore the efficacy of whole brain radiotherapy (WBRT)  versus WBRT concurrent with erlotinib in patients with multiple brain metastases of lung  adenocarcinoma.",Non-OADS,/arxiv_data1/oa_pdf/9b/1c/dddt-7-1179.PMC3797237.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/9b/1c/dddt-7-1179.PMC3797237.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/1c/dddt-7-1179.PMC3797237.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/67/5f/ppa-7-1041.PMC3797238.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2013:7 1041–1045Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1041Methodologyopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/PPA.S5212 2“expiratory holding” approach in measuring   end-expiratory pulmonary artery wedge   pressure for mechanically ventilated patients Wanjie yang1 Xuefeng Zhao1 Qingguo Feng1 youzhong An2 Kai Wei1 Wei Wang1 Chang li1 Xiuling Cheng1 1Intensive Care Unit, the Fifth Central  hospital of tianjin, tianjin, People’s  Republic of China; 2Intensive Care  Unit, Peking University People’s  hospital, Beijing, People’s Republic   of China Correspondence: Wanjie yang   Intensive Care Unit, the Fifth Central  hospital of tianjin, tanggu district,  41 Zhejiang Road 41, 300450 tianjin,  People’s Republic of China   email wanjie_yang@163.co mObjective:  To accurately measure the end-expiratory pulmonary artery wedge pressure  (PAWP) with the “expiration holding” function on the ventilator and the “pulmonary artery  wedge  pressure review” software on the monitor.",Non-OADS,/arxiv_data1/oa_pdf/67/5f/ppa-7-1041.PMC3797238.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/67/5f/ppa-7-1041.PMC3797238.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/67/5f/ppa-7-1041.PMC3797238.pdf
"Available  from http://www.caccn.ca/en/pdfs/4A%20Hemodyn_waves%20(B%20 Morgan).pd f. Accessed September 25, 2013.",OADS,/arxiv_data1/oa_pdf/67/5f/ppa-7-1041.PMC3797238.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/32/b6/ott-6-1399.PMC3797239.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2013:6 1399–1416OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1399Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S3775 0The emerging and diverse roles of sirtuins   in cancer: a clinical perspective Hongfeng Yuan1 Leila Su2 wenY ong Chen1 1Department of Cancer Biology,  2Department of Molecular Medicine,  Beckman Research institute, City of  Hope, Duarte, CA, USA Correspondence: wenYong Chen   Department of Cancer Biology,   Beckman Research institute,   City of Hope, 1500 east Duarte Road,   Duarte, CA 91010, USA   Tel +1 626 301 8911   Fax +1 626 471 7193   email wechen@coh.or gAbstract:  Sirtuins are a highly conserved family of nicotinamide adenine dinucleotide  (NAD+)-dependent protein lysine modifying enzymes with deacetylase, adenosine diphosphate- ribosyltransferase and other deacylase activities.",Non-OADS,/arxiv_data1/oa_pdf/32/b6/ott-6-1399.PMC3797239.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/32/b6/ott-6-1399.PMC3797239.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/32/b6/ott-6-1399.PMC3797239.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/97/d7/ijnrd-6-193.PMC3797240.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nephrology and Renovascular Disease 2013:6 193–205International Journal of Nephrology and Renovascular Disease Dove press submit your manuscript | www.dovepress.co m Dove press  193RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJNRD.S3563 2Phosphate control in dialysis Adamasco Cupisti1 Maurizio Gallieni2 Maria Antonietta Rizzo2 Stefania Caria3 Mario Meola4 Piergiorgio Bolasco3 1Department of Clinical and  experimental Medicine, University  of Pisa, Pisa, Italy; 2Nephrology and  Dialysis Unit, San Carlo Borromeo  Hospital, Milan, Italy; 3Territorial  Department of Nephrology and  Dialysis, ASL Cagliari, Italy; 4Sant’Anna  School of Advanced Studies,   University of Pisa, Pisa, Italy Correspondence: Adamasco Cupisti   Department of Clinical and experimental   Medicine, University of Pisa,   via Roma 67, 56126, Pisa, Italy   Tel +39 50 997 291   Fax +39 50 997 287   email adamasco.cupisti@med.unipi.i tAbstract:  Prevention and correction of hyperphosphatemia is a major goal of chronic kidney  disease–mineral and bone disorder (CKD–MBD) management, achievable through avoidance  of a positive phosphate balance.",Non-OADS,/arxiv_data1/oa_pdf/97/d7/ijnrd-6-193.PMC3797240.pdf
"International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journa lThe International Journal of Nephrology and Renovascular Disease is  an international, peer-reviewed open-access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/97/d7/ijnrd-6-193.PMC3797240.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/97/d7/ijnrd-6-193.PMC3797240.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/33/5a/cmar-5-349.PMC3797241.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpCancer Management and Research 2013:5 349–356Cancer Management and Research Dove press submit your manuscript | www.dovepress.co m Dove press  349ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CMAR.S5214 7Prospective study evaluating the radiosensitizing  effect of reduced doses of temozolomide   in the treatment of egyptian patients   with glioblastoma multiforme May gaber hanan selim Tamer el-nahas Department of Clinical Oncology,   Cairo University, Cairo, egypt Correspondence: Tamer el-nahas   Department of Clinical Oncology,   Cairo University, 1 al saray street,   al Manial, Cairo, egypt   Fax +20 2 3347 7771   email elnahas@sphinxcure.co mPurpose:  In view of the documented toxicity of continuous daily radiosensitizer doses of   temozolomide concomitant with radiation in the treatment of glioblastoma multiforme, we  aimed to compare it with a different schedule of abbreviated radiosensitizer dosing.",Non-OADS,/arxiv_data1/oa_pdf/33/5a/cmar-5-349.PMC3797241.pdf
"Cancer Management and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/cancer-management-and-research-journa lCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of  preventative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/33/5a/cmar-5-349.PMC3797241.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/33/5a/cmar-5-349.PMC3797241.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/de/15/opth-7-1995.PMC3797242.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 1995–2001Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1995Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5012 0Comparison of enhanced depth imaging   and high-penetration optical coherence   tomography for imaging deep optic nerve   head and parapapillary structures atsuya Miki Yasushi ikuno Yukari Jo Kohji nishida Department of Ophthalmology,    Osaka University graduate school   of Medicine, Osaka, Japan Correspondence: atsuya Miki   Department of Ophthalmology,   Osaka University graduate school   of Medicine, room e7, 2-2 Yamadaoka,  suita, 565-0871, Japan   Tel +81 6 6879 3456   Fax +81 6 6879 3458   email a.miki.md@gmail.c omPurpose:  To evaluate and compare the abilities of enhanced depth imaging (EDI) and high- penetration optical coherence tomography (HP-OCT) to visualize the deep optic nerve head  (ONH) and deep parapapillary structures.",Non-OADS,/arxiv_data1/oa_pdf/de/15/opth-7-1995.PMC3797242.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/de/15/opth-7-1995.PMC3797242.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/de/15/opth-7-1995.PMC3797242.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/47/42/ppa-7-1007.PMC3797252.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2013:7 1007–1023Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1007OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S5129 9Determinants and consequences of insulin  initiation for type 2 diabetes in France: analysis   of the national health and Wellness survey gérard reach1 Véronique le Pautremat2 shaloo gupta3 1Department of endocrinology,   Diabetes, and Me tabolic Diseases,   Avicenne hospital AP hP, and eA  3412, crnh-idF , Paris 13 University,   sorbonnne Paris cité, Bobigny, France;   2Kantar health, Paris, France; 3Kantar  health, Princeton, nJ, UsA correspondence: gérard reach   service d’endocrinologie, Diabétologie,  Maladies Mé taboliques, hôpital Avicenne   APhP, 125 route de stalingrad,   93000 Bobigny, France   Tel +331 4895 5158   Fax +331 4895 5560   email gerard.reach@avc.aphp.f rBackground:  The aim of the study was to identify the intrinsic patient characteristics and  extrinsic environmental factors predicting prescription and use and, more specifically, early  initiation (up to 5 years of disease duration) of insulin for type 2 diabetes in France.",Non-OADS,/arxiv_data1/oa_pdf/47/42/ppa-7-1007.PMC3797252.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/47/42/ppa-7-1007.PMC3797252.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/47/42/ppa-7-1007.PMC3797252.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/.,Non-OADS,/arxiv_data1/oa_pdf/f3/54/ott-6-1385.PMC3797259.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2013:6 1385–1392OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1385Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S4776 4Fludarabine-based versus chOP-like regimens  with or without rituximab in patients with  previously untreated indolent lymphoma:   a retrospective analysis of safety and efficacy Xiao-xiao Xu1 Bei Yan2 Zhen-xing Wang3 Y ong Yu1 Xiao-xiong Wu2 Yi-zhuo Zhang1 1Department of hematology, Tianjin  Medical University cancer institute  and hospital, Tianjin Key laboratory  of cancer Prevention and Therapy,   Tianjin, 2Department of hematology,   First affiliated hospital of chinese  People’s liberation army general  hospital, Beijing, 3Department of  stomach Oncology, Tianjin Medical  University cancer institute and  hospital, Key laboratory of cancer  Prevention and Therapy, Tianjin,   People’s republic of china correspondence: Yizhuo Zhang   Department of hematology,   Tianjin Medical University cancer   institute and hospital, Tianjin Key  laboratory of cancer Prevention   and Therapy, Tianjin 300060,   People’s republic of china   Tel +86 22 2334 0123 2041   email yizhouzhang111@163.co mAbstract:  Fludarabine-based regimens and CHOP (doxorubicin, cyclophosphamide, vincristine,  prednisone)-like regimens with or without rituximab are the most common treatment modalities  for indolent lymphoma.",Non-OADS,/arxiv_data1/oa_pdf/f3/54/ott-6-1385.PMC3797259.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/f3/54/ott-6-1385.PMC3797259.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f3/54/ott-6-1385.PMC3797259.pdf
"The Korean Society for Radiation OncologyFluorodeoxyglucose positron-emission tomography  ratio in non-small cell lung cancer patients treated with  definitive radiotherapy Hyun-Cheol Kang, MD1, Hong-Gyun Wu, MD, PhD1,2,3, Tosol Yu, MD1,  Hak Jae Kim, MD, PhD1,2,3, Jin Chul Paeng, MD, PhD2,3,4 1Department of Radiation Oncology and 2Cancer Research Institute, Seoul National University College of Medicine, Seoul;  3Institute of Radiation Medicine, Medical Research Center, Seoul National University, Seoul;  4Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, KoreaRadiat Oncol J 2013;31(3):111-117 http://dx.doi.org/10.3857/roj.2013.31.3.111 pISSN 2234-1900 · eISSN 2234-3156  Original Article Purpose:  To determine whether the maximum standardized uptake value (SUV) of [18F] fluorodeoxyglucose uptake by positron  emission tomography (FDG PET) ratio of lymph node to primary tumor (mSUVR) could be a prognostic factor for node positive non- small cell lung cancer (NSCLC) patients treated with definitive radiotherapy (RT).",Non-OADS,/arxiv_data1/oa_pdf/f9/46/roj-31-111.PMC3797269.pdf
"ac.kr CC   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f9/46/roj-31-111.PMC3797269.pdf
"Hyun-Cheol Kang , et al 112 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.111  During the last decade, [18F]fluorodeoxyglucose positron  emission tomography (FDG PET), which is based on differences  in glucose metabolism between tumor and normal tissue, has  been incorporated into the cancer management process, for  staging [5-8], estimation of treatment response [9-14], and  delineation of RT targets [15] for NSCLC.",OADS,/arxiv_data1/oa_pdf/f9/46/roj-31-111.PMC3797269.pdf
"113FDG PET ratio prognostic in N+ www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.111The gross tumor volume (GTV) consisted of all known sites of  disease defined by CT with the visual aid of FDG PET or PET- CT scan data, without inclusion of elective nodal targets.",OADS,/arxiv_data1/oa_pdf/f9/46/roj-31-111.PMC3797269.pdf
"Hyun-Cheol Kang , et al 114 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.111CI, 5 to 17 months), respectively.",OADS,/arxiv_data1/oa_pdf/f9/46/roj-31-111.PMC3797269.pdf
"115FDG PET ratio prognostic in N+ www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.111node has a prognostic value, with adoption of the parameter  of maxSUV ratio between primary tumor and lymph node.",Non-OADS,/arxiv_data1/oa_pdf/f9/46/roj-31-111.PMC3797269.pdf
"Hyun-Cheol Kang , et al 116 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.111recurrence outside of the radiation field.",OADS,/arxiv_data1/oa_pdf/f9/46/roj-31-111.PMC3797269.pdf
117FDG PET ratio prognostic in N+ www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.111emission tomography in the lymph node staging of non-small  cell lung cancer patients.,Non-OADS,/arxiv_data1/oa_pdf/f9/46/roj-31-111.PMC3797269.pdf
"The Korean Society for Radiation OncologyNeoadjuvant intra-arterial chemotherapy combined with  radiotherapy and surgery in patients with advanced  maxillary sinus cancer Won Taek Kim, MD1, Jiho Nam, MD2, Yong Kan Ki, MD1, Ju Hye Lee, MD1, Dong Hyun Kim, MD1,  Dahl Park, PhD1, Kyu Sup Cho, MD3, Hwan Jung Roh, MD4, Dong Won Kim, MD, PhD1 1Department of Radiation Oncology, Biomedical Research Institute, Pusan National University Hospital, Pusan National  University School of Medicine, Busan; 2Department of Radiation Oncology, Pusan National University Yangsan Hospital,  Yangsan; 3Department of Otolaryngology, Biomedical Research Institute, Pusan National University Hospital,  Pusan National University School of Medicine, Busan; 4Department of Otolaryngology, Pusan National University  Yangsan Hospital, Pusan National University School of Medicine, Yangsan, KoreaRadiat Oncol J 2013;31(3):118-124 http://dx.doi.org/10.3857/roj.2013.31.3.118 pISSN 2234-1900 · eISSN 2234-3156  Original Article Purpose:  The optimal treatment of advanced maxillary sinus cancer has been challenging for several decades.",Non-OADS,/arxiv_data1/oa_pdf/ab/fb/roj-31-118.PMC3797270.pdf
"Tel: +82-55-360-3453, Fax: +82-55-360-2449, E-mail: jihonam@pusan.ac.kr CC   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ab/fb/roj-31-118.PMC3797270.pdf
119Combined therapy of maxillary sinus cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.118required to achieve complete resection of the tumor.,Non-OADS,/arxiv_data1/oa_pdf/ab/fb/roj-31-118.PMC3797270.pdf
"Won Taek Kim , et al 120 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.118Health Organization criteria, tumor response was evaluated  based on CT or magnetic resonance imaging (MRI) studies.",OADS,/arxiv_data1/oa_pdf/ab/fb/roj-31-118.PMC3797270.pdf
"121Combined therapy of maxillary sinus cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.118response plus partial response) of IAC was 55.5% (T3-63%  vs. T4-45%), and tumor down staging rate was 26% (31%  vs. 18%).",Non-OADS,/arxiv_data1/oa_pdf/ab/fb/roj-31-118.PMC3797270.pdf
"Won Taek Kim , et al 122 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.118  Most patients had shown varying degrees of late skin and  oral mucosa injury.",OADS,/arxiv_data1/oa_pdf/ab/fb/roj-31-118.PMC3797270.pdf
"123Combined therapy of maxillary sinus cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.118schedules (i.e., neoajuvant chemotherapy, concurrent  chemoradiotherapy, and neoadjuvant chemotherapy plus  concurrent chemoradiotherapy).",Non-OADS,/arxiv_data1/oa_pdf/ab/fb/roj-31-118.PMC3797270.pdf
"Won Taek Kim , et al 124 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.118safe and the rate of severe toxicity was comparable to the  initial treatment.",OADS,/arxiv_data1/oa_pdf/ab/fb/roj-31-118.PMC3797270.pdf
"The Korean Society for Radiation OncologyRole of radiotherapy for pancreatobiliary   neuroendocrine tumors Jeongshim Lee, MD, Jinhyun Choi, MD, Chihwan Choi, MD, Jinsil Seong, MD, PhD Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, KoreaRadiat Oncol J 2013;31(3):125-130 http://dx.doi.org/10.3857/roj.2013.31.3.125 pISSN 2234-1900 · eISSN 2234-3156  Original Article Purpose:  We investigated the role of radiotherapy (RT) for pancreatobiliary neuroendocrine tumors (PB-NETs).",Non-OADS,/arxiv_data1/oa_pdf/fd/96/roj-31-125.PMC3797271.pdf
"Tel: +82-2-2228-8116, Fax: +82-2-312-9033, E-mail:  JSSEONG@yuhs.ac  CC   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fd/96/roj-31-125.PMC3797271.pdf
"Jeongshim Lee , et al 126 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.125racil (5-FU) based agents [1,9].",OADS,/arxiv_data1/oa_pdf/fd/96/roj-31-125.PMC3797271.pdf
127Radiotherapy for pancreatobiliary NETs www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.125RT followed by surgery and 3 patients were treated with  surgery followed by postoperative RT.,Non-OADS,/arxiv_data1/oa_pdf/fd/96/roj-31-125.PMC3797271.pdf
"Jeongshim Lee , et al 128 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.125not locoregional failure, but distant metastasis.",OADS,/arxiv_data1/oa_pdf/fd/96/roj-31-125.PMC3797271.pdf
129Radiotherapy for pancreatobiliary NETs www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.125concurrent CRT.,Non-OADS,/arxiv_data1/oa_pdf/fd/96/roj-31-125.PMC3797271.pdf
"Jeongshim Lee , et al 130 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.125chemotherapy can be used as an effective treatment modality  in the management of advanced PB-NETs.",Non-OADS,/arxiv_data1/oa_pdf/fd/96/roj-31-125.PMC3797271.pdf
"The Korean Society for Radiation OncologyInvasion of the great vessels or atrium predicts worse  prognosis in thymic carcinoma Keun-Yong Eom, MD1, Hak Jae Kim, MD1, Hong-Gyun Wu, MD1,2,3,  Young Tae Kim, MD4, Dae Seog Heo, MD2,5, Young Whan Kim, MD5 1Department of Radiation Oncology and 2Cancer Research Institute, Seoul National University College of Medicine, Seoul;  3Institute of Radiation Medicine, Medical Research Center, Seoul National University, Seoul; Departments of  4Thoracic Surgery and 5Internal Medicine, Seoul National University College of Medicine, Seoul, KoreaRadiat Oncol J 2013;31(3):131-137 http://dx.doi.org/10.3857/roj.2013.31.3.131 pISSN 2234-1900 · eISSN 2234-3156  Original Article Purpose:  We evaluated treatment outcomes of thymic carcinomas to determine prognostic factors for survival.",Non-OADS,/arxiv_data1/oa_pdf/b2/e6/roj-31-131.PMC3797272.pdf
"Tel: +82-2-2072-3177, Fax: +82-2-742-2073, E-mail: wuhg@snu.ac.kr CC   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b2/e6/roj-31-131.PMC3797272.pdf
"Keun-Yong Eom , et al 132 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.131surrounding structures frequently and have early metastasis  to intrathoracic lymph nodes and distant organs.",OADS,/arxiv_data1/oa_pdf/b2/e6/roj-31-131.PMC3797272.pdf
133Prognostic factor for thymic carcinoma www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.131also performed when indicated.,Non-OADS,/arxiv_data1/oa_pdf/b2/e6/roj-31-131.PMC3797272.pdf
"Keun-Yong Eom , et al 134 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.131to 54 Gy), respectively.",OADS,/arxiv_data1/oa_pdf/b2/e6/roj-31-131.PMC3797272.pdf
"135Prognostic factor for thymic carcinoma www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.131or regional recurrence had developed infrequently, but failure  at distant sites exceeded three-fourths of all failures.",Non-OADS,/arxiv_data1/oa_pdf/b2/e6/roj-31-131.PMC3797272.pdf
"Keun-Yong Eom , et al 136 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.131Kondo and Monden [7], there was no difference of survival  between surgery only and surgery plus PORT in patients  with stage III and IV thymic carcinoma.",OADS,/arxiv_data1/oa_pdf/b2/e6/roj-31-131.PMC3797272.pdf
137Prognostic factor for thymic carcinoma www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.131limitation of the present study.,Non-OADS,/arxiv_data1/oa_pdf/b2/e6/roj-31-131.PMC3797272.pdf
"The Korean Society for Radiation OncologyTreatment results of breast cancer patients with  locoregional recurrence after mastectomy Yuri Jeong, MD1, Su Ssan Kim, MD, PhD1, Gyungyub Gong, MD, PhD2, Hee Jin Lee, MD2,  Sei Hyun Ahn, MD, PhD3, Byung Ho Son, MD, PhD3, Jong Won Lee, MD3, Eun Kyung Choi, MD, PhD1,  Sang-wook Lee, MD, PhD1, Ji Hyeon Joo, MD1, Seung Do Ahn, MD1 Departments of 1Radiation Oncology, 2Pathology, and 3Surgery, Asan Medical Center,  University of Ulsan College of Medicine, Seoul, KoreaRadiat Oncol J 2013;31(3):138-146 http://dx.doi.org/10.3857/roj.2013.31.3.138 pISSN 2234-1900 · eISSN 2234-3156  Original Article Purpose:  To analyze the results of locoregional and systemic therapy in the breast cancer patients with locoregional recurrence  (LRR) after mastectomy.",Non-OADS,/arxiv_data1/oa_pdf/6f/98/roj-31-138.PMC3797273.pdf
"Tel: +82-2-3010-5680, Fax: +82-2-3010-4427,  E-mail: watermountain@hanmail.net CC   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6f/98/roj-31-138.PMC3797273.pdf
"139Treatment results of locoregional recurrence after mastectomy www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.138strategies including locoregional therapy (wide excision and/or  radiotherapy) and/or systemic therapy (hormone therapy and/ or chemotherapy) can be considered depending on the site of  recur, operability, hormone receptor status, and other factors.",Non-OADS,/arxiv_data1/oa_pdf/6f/98/roj-31-138.PMC3797273.pdf
"Yuri Jeong , et al 140 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.138to 129 months (median, 30 months).",OADS,/arxiv_data1/oa_pdf/6f/98/roj-31-138.PMC3797273.pdf
"141Treatment results of locoregional recurrence after mastectomy www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.13841.8 months (mean, 25.1 months).",OADS,/arxiv_data1/oa_pdf/6f/98/roj-31-138.PMC3797273.pdf
"Yuri Jeong , et al 142 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.138  In multivariate analysis, the patients with regional recurrence  or recurrence in multiple sites showed trend to lower LRRFS  than patients with chest wall recurrence (hazard ratio [HR]  = 2.712, p = 0.066).",OADS,/arxiv_data1/oa_pdf/6f/98/roj-31-138.PMC3797273.pdf
"143Treatment results of locoregional recurrence after mastectomy www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.138significant for DFS (HR = 0.790, p = 0.497) (Table 3).",OADS,/arxiv_data1/oa_pdf/6f/98/roj-31-138.PMC3797273.pdf
"Yuri Jeong , et al 144 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.138studies [7,11-13,15,16].",OADS,/arxiv_data1/oa_pdf/6f/98/roj-31-138.PMC3797273.pdf
"145Treatment results of locoregional recurrence after mastectomy www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.138estrogen receptor, long disease-free interval (>12 months),  ≤3 tumor nodules, each ≤3 cm in diameter, tamoxifen group  showed significant improvement in DFS but no advantage in  OS.",OADS,/arxiv_data1/oa_pdf/6f/98/roj-31-138.PMC3797273.pdf
"Yuri Jeong , et al 146 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.13813.",OADS,/arxiv_data1/oa_pdf/6f/98/roj-31-138.PMC3797273.pdf
"The Korean Society for Radiation OncologyRole of salvage radiotherapy for regional lymph node  recurrence after radical surgery in advanced gastric cancer Byoung Hyuck Kim, MD1, Keun-Yong Eom, MD1, Jae-Sung Kim, MD1,  Hyung-Ho Kim, MD2, Do Joong Park, MD2 Departments of 1Radiation Oncology and 2General Surgery, Seoul National University Bundang Hospital, Seongnam, KoreaRadiat Oncol J 2013;31(3):147-154 http://dx.doi.org/10.3857/roj.2013.31.3.147 pISSN 2234-1900 · eISSN 2234-3156  Original Article Purpose:  To evaluate the role of salvage radiotherapy (RT) for the treatment of regional lymph node recurrence (RLNR) after  radical surgery in advanced gastric cancer.",Non-OADS,/arxiv_data1/oa_pdf/22/14/roj-31-147.PMC3797274.pdf
"Tel: +82-31-787-7652, Fax: +82-31-787-4019, E-mail:  978sarang@daum.net CC   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/22/14/roj-31-147.PMC3797274.pdf
"Byoung Hyuck Kim , et al 148 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.147lymphatic drainage pathways around the stomach make it  difficult to conduct complete LN dissection, which often results  in regional LN recurrence (RLNR) and contributes to further  risks for distant metastasis.",Non-OADS,/arxiv_data1/oa_pdf/22/14/roj-31-147.PMC3797274.pdf
149Salvage radiotherapy in gastric cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.147as a part of first salvage treatment option with or without  RT.,Non-OADS,/arxiv_data1/oa_pdf/22/14/roj-31-147.PMC3797274.pdf
"Byoung Hyuck Kim , et al 150 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.147did stable disease (SD), and 2 did progressive disease (PD).",OADS,/arxiv_data1/oa_pdf/22/14/roj-31-147.PMC3797274.pdf
151Salvage radiotherapy in gastric cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.147Table 3.,Non-OADS,/arxiv_data1/oa_pdf/22/14/roj-31-147.PMC3797274.pdf
"Byoung Hyuck Kim , et al 152 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.147PFS was 21 months in patients received RT and 5 months in  patients without RT (p < 0.001) (Fig.",OADS,/arxiv_data1/oa_pdf/22/14/roj-31-147.PMC3797274.pdf
153Salvage radiotherapy in gastric cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.147with LN recurrences after gastrectomy.,Non-OADS,/arxiv_data1/oa_pdf/22/14/roj-31-147.PMC3797274.pdf
"Byoung Hyuck Kim , et al 154 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.147References 1.",OADS,/arxiv_data1/oa_pdf/22/14/roj-31-147.PMC3797274.pdf
"The Korean Society for Radiation OncologyComparison between preoperative and postoperative  concurrent chemoradiotherapy for rectal cancer:   an institutional analysis Jeong Won Lee, MD1, Jong Hoon Lee, MD1, Jun-Gi Kim, MD2, Seong Taek Oh, MD2,  Hyuk Jun Chung2, Myung Ah Lee, MD3, Hoo Geun Chun, MD3, Song Mi Jeong, MD1,  Sei Chul Yoon, MD1, Hong Seok Jang, MD1 Departments of 1Radiation Oncology, 2Colorectal Surgery, and 3Medical Oncology, Seoul St. Mary’s Hospital,  The Catholic University of Korea College of Medicine, Seoul, KoreaRadiat Oncol J 2013;31(3):155-161 http://dx.doi.org/10.3857/roj.2013.31.3.155 pISSN 2234-1900 · eISSN 2234-3156  Original Article Purpose:  To evaluate the treatment outcomes of preoperative versus postoperative concurrent chemoradiotherapy (CRT) on  locally advanced rectal cancer.",Non-OADS,/arxiv_data1/oa_pdf/1c/9b/roj-31-155.PMC3797275.pdf
"Tel: +82-2-2258-1520, Fax:  +82-2-2258-1532, E-mail: hsjang11@catholic.ac.kr CC   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1c/9b/roj-31-155.PMC3797275.pdf
"Jeong Won Lee , et al 156 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.155of overall compliance, local control, and sphincter preservation  and to reduce the risk of toxicity [5].",Non-OADS,/arxiv_data1/oa_pdf/1c/9b/roj-31-155.PMC3797275.pdf
157Preoperative or postoperative chemoradiotherapy in rectal cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.155per oral was administered to 52.0% of the preoperative CRT  group and 68.3% of the postoperative CRT group following  completion of the adjuvant chemotherapy (p = 0.07).,Non-OADS,/arxiv_data1/oa_pdf/1c/9b/roj-31-155.PMC3797275.pdf
"Jeong Won Lee , et al 158 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.1553.",OADS,/arxiv_data1/oa_pdf/1c/9b/roj-31-155.PMC3797275.pdf
159Preoperative or postoperative chemoradiotherapy in rectal cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.155had acute grade 3 or higher toxicity.,Non-OADS,/arxiv_data1/oa_pdf/1c/9b/roj-31-155.PMC3797275.pdf
"Jeong Won Lee , et al 160 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.155by the difference of cancer stage distribution and relatively  small number of patients compared to previous studies.",OADS,/arxiv_data1/oa_pdf/1c/9b/roj-31-155.PMC3797275.pdf
161Preoperative or postoperative chemoradiotherapy in rectal cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.155with capecitabine for locally advanced rectal cancer.,Non-OADS,/arxiv_data1/oa_pdf/1c/9b/roj-31-155.PMC3797275.pdf
"The Korean Society for Radiation OncologyRole of adjuvant postoperative external beam radiotherapy  for well differentiated thyroid cancer Jeanny Kwon, MD1, Hong-Gyun Wu, MD, PhD1,2,3, Yeo-Kyu Youn, MD, PhD4, Kyu Eun Lee, MD, PhD4,  Kwang Hyun Kim, MD, PhD5, Do Joon Park, MD, PhD6  1Department of Radiation Oncology and 2Cancer Research Institute, Seoul National University College of Medicine, Seoul;  3Institute of Radiation Medicine, Medical Research Center, Seoul National University, Seoul; Departments of 4Surgery,  5Otolaryngology, and 6Internal Medicine, Seoul National University College of Medicine, Seoul, KoreaRadiat Oncol J 2013;31(3):162-170 http://dx.doi.org/10.3857/roj.2013.31.3.162 pISSN 2234-1900 · eISSN 2234-3156  Original Article Purpose:  To analyze the outcome of adjuvant postoperative external beam radiotherapy (EBRT) in well-differentiated thyroid  cancer (WDTC).",Non-OADS,/arxiv_data1/oa_pdf/0e/eb/roj-31-162.PMC3797276.pdf
"ac.kr CC   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0e/eb/roj-31-162.PMC3797276.pdf
163Post-op RT for differentiated thyroid cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.162cases.,Non-OADS,/arxiv_data1/oa_pdf/0e/eb/roj-31-162.PMC3797276.pdf
"Jeanny Kwon , et al 164 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.162and imaging studies.",OADS,/arxiv_data1/oa_pdf/0e/eb/roj-31-162.PMC3797276.pdf
165Post-op RT for differentiated thyroid cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.162Table 3.,Non-OADS,/arxiv_data1/oa_pdf/0e/eb/roj-31-162.PMC3797276.pdf
"Jeanny Kwon , et al 166 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.162Results 1.",OADS,/arxiv_data1/oa_pdf/0e/eb/roj-31-162.PMC3797276.pdf
"167Post-op RT for differentiated thyroid cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.162DM occurred in 2 patients, respectively.",Non-OADS,/arxiv_data1/oa_pdf/0e/eb/roj-31-162.PMC3797276.pdf
"Jeanny Kwon , et al 168 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.162that the LRFS at 5 years was 84% and confirmed the efficacy  of EBRT in reducing the risk of LRF to 0.35.",OADS,/arxiv_data1/oa_pdf/0e/eb/roj-31-162.PMC3797276.pdf
169Post-op RT for differentiated thyroid cancer www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.162(Table 4).,Non-OADS,/arxiv_data1/oa_pdf/0e/eb/roj-31-162.PMC3797276.pdf
"Jeanny Kwon , et al 170 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.162cases from the Surveillance, Epidemiology and End Results  (SEER) program 1973-1991.",OADS,/arxiv_data1/oa_pdf/0e/eb/roj-31-162.PMC3797276.pdf
"The Korean Society for Radiation OncologySorafenib-triggered radiation recall dermatitis with a  disseminated exanthematous reaction Dongryul Oh, MD1, Hee Chul Park, MD, PhD1, Ho Yeong Lim, MD, PhD2, Byung Chul Yoo, MD, PhD3 1Department of Radiation Oncology, 2Division of Hematology and Oncology, 3Department of Internal Medicine,  Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Radiat Oncol J 2013;31(3):171-174 http://dx.doi.org/10.3857/roj.2013.31.3.171 pISSN 2234-1900 · eISSN 2234-3156  Case Report Sorafenib is a multi-targeted kinase inhibitor, which is the current standard treatment for advanced hepatocellular carcinoma  (HCC).",Non-OADS,/arxiv_data1/oa_pdf/4e/ff/roj-31-171.PMC3797277.pdf
"Tel: +82-2-3410-2605, Fax: +82-2-3410-2619,  E-mail: rophc@skku.edu CC   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4e/ff/roj-31-171.PMC3797277.pdf
"Dongryul Oh , et al 172 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.171arterial enhancement and washout on segment 5.",OADS,/arxiv_data1/oa_pdf/4e/ff/roj-31-171.PMC3797277.pdf
173Sorafenib-triggered radiation recall dermatitis www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.171are frequently associated with RRD [9].,Non-OADS,/arxiv_data1/oa_pdf/4e/ff/roj-31-171.PMC3797277.pdf
"Dongryul Oh , et al 174 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.171between RT and subsequent exposure to the triggering drug  was 39.5 days, and time of onset of the ‘recalling’ skin reaction  ranged from a few minutes to 14 days (median, 3 days) with  intravenous drugs and from 3 days to 2 months (median, 8  days) with oral drugs.",Non-OADS,/arxiv_data1/oa_pdf/4e/ff/roj-31-171.PMC3797277.pdf
"Farkhad Manapov, MD, Maximilian Niyazi, MD, Minglun Li, MD Department of Radiation Oncology, University of Munich, GermanyRadiat Oncol J 2013;31(3):175-176 http://dx.doi.org/10.3857/roj.2013.31.3.175 pISSN 2234-1900 · eISSN 2234-3156  Letter to the Editor www.e-roj.orgEarly cisplatin-based concurrent chemoradiotherapy (CRT) is  a mainstay treatment in limited stage small-cell lung cancer  (LS SCLC; the Union for International Cancer Control stage I– III).",Non-OADS,/arxiv_data1/oa_pdf/5a/1e/roj-31-175.PMC3797278.pdf
"Tel: +49-89-70953770, Fax: +49-89-70956770, E-mail: farkhad.manapov@med.uni-muenchen.de CC   This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5a/1e/roj-31-175.PMC3797278.pdf
"Farkhad Manapov , et al 176 www.e-roj.org http://dx.doi.org/10.3857/roj.2013.31.3.175References 1.",Non-OADS,/arxiv_data1/oa_pdf/5a/1e/roj-31-175.PMC3797278.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e6/95/tcrm-9-377.PMC3797279.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2013:9 377–381Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  377ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S5098 1a 6-year experience of CPR outcomes   in an emergency department in Thailand Yuwares sittichanbuncha1 Thidathit Prachanukool1 Kittisak sawanyawisuth2,3 1emergency Medicine Department,   Faculty of Medicine, Ramathibodi  hospital, Mahidol University, Bangkok,   Thailand; 2Department of Medicine,   Faculty of Medicine, Khon Kaen  University, Khon Kaen, Thailand;   3Research and Diagnostic Center for  emerging infectious Diseases, Faculty  of Medicine, Khon Kaen University,   Khon Kaen, Thailand Correspondence: Kittisak sawanyawisuth   Department of Medicine, Faculty   of Medicine, Khon Kaen University,   123 Mitraparp Road, Khon Kaen,   40002, Thailand   Tel +66 43 363 664   Fax +66 43 348 399   email kittisak@kku.ac.t hPurpose:  Sudden cardiac arrest is a common emergency condition found in the emergency  department of the hospital.",Non-OADS,/arxiv_data1/oa_pdf/e6/95/tcrm-9-377.PMC3797279.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/e6/95/tcrm-9-377.PMC3797279.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e6/95/tcrm-9-377.PMC3797279.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d8/f1/idr-6-115.PMC3797280.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInfection and Drug Resistance 2013:6 115–123Infection and Drug Resistance Dove press submit your manuscript | www.dovepress.co m Dove press  115RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IDR.S3571 0whole-genome sequencing in bacteriology:   state of the art Michael J Dark  Department of Infectious Diseases  and Pathology and emerging  Pathogens Institute, University   of Florida, Gainesville, FL, USA Correspondence: Michael J Dark   Department of Infectious Diseases and  Pathology and emerging Pathogens  Institute, University of Florida,   PO Box 110880, Gainesville,   FL 32611-0880, USA   Tel (352)294-4138   Fax (352)392-9704   email darkmich@ufl.ed uAbstract:  Over the last ten years, genome sequencing capabilities have expanded exponentially.",Non-OADS,/arxiv_data1/oa_pdf/d8/f1/idr-6-115.PMC3797280.pdf
Adapted from  the NIH NHGRI Genome Sequencing Program website ( http://www.genome.gov/sequencingcosts /).,OADS,/arxiv_data1/oa_pdf/d8/f1/idr-6-115.PMC3797280.pdf
GnuBIO home page  2013; http://gnubio.com /.,Non-OADS,/arxiv_data1/oa_pdf/d8/f1/idr-6-115.PMC3797280.pdf
Oxford Nanopore Technologies  home page  2013; https://www.nanoporetech.com /.,Non-OADS,/arxiv_data1/oa_pdf/d8/f1/idr-6-115.PMC3797280.pdf
Sourceforge: Celera Assembler home page   2013; http://sourceforge.net/apps/mediawiki/wgs-assembler/index.,OADS,/arxiv_data1/oa_pdf/d8/f1/idr-6-115.PMC3797280.pdf
Sourceforge MIRA home page  2013; http://sourceforge.net/ apps/mediawiki/mira-assembler/index.php?titl e=Main_Page.,OADS,/arxiv_data1/oa_pdf/d8/f1/idr-6-115.PMC3797280.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/d8/f1/idr-6-115.PMC3797280.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/f1/idr-6-115.PMC3797280.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ac/e8/ndt-9-1521.PMC3797281.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2013:9 1521–1529Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1521Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S5191 0Lurasidone as a potential therapy for bipolar  disorder Y oung Sup woo Hee Ryung wang won-Myong Bahk Department of Psychiatry, Yeouido  St Mary’s Hospital, The Catholic  University of Korea, Seoul, Korea Correspondence: won-Myong Bahk   Department of Psychiatry, Yeouido  St Mary’s Hospital, The Catholic  University of Korea, #62, Yeouido-Dong,  Youngdeungpo-Gu, Seoul, Korea   Tel +82 237 791 250   Fax +82 278 065 77   email wmbahk@catholic.ac.k rAbstract:  Lurasidone is a benzisothiazol derivative and an atypical antipsychotic approved  by the US Food and Drug Administration for the acute treatment of adults with schizophrenia  (October 2010) and bipolar 1 depression (June 2013).",Non-OADS,/arxiv_data1/oa_pdf/ac/e8/ndt-9-1521.PMC3797281.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/ac/e8/ndt-9-1521.PMC3797281.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ac/e8/ndt-9-1521.PMC3797281.pdf
"Available from: http://www.nature.com/npp/ journal/v38/n1s/index.htm l. Accessed July 21, 2013.",OADS,/arxiv_data1/oa_pdf/ac/e8/ndt-9-1521.PMC3797281.pdf
Available from: http://www.nature.com/npp/journal/v38/n1s/index.,Non-OADS,/arxiv_data1/oa_pdf/ac/e8/ndt-9-1521.PMC3797281.pdf
"Available from: http://www.nature.com/npp/jour - nal/v38/n1s/index.htm l. Accessed July 21, 2013.",Non-OADS,/arxiv_data1/oa_pdf/ac/e8/ndt-9-1521.PMC3797281.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c7/af/ijn-8-3817.PMC3797282.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 3817–3831International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3817OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5100 2Photodynamic therapy with conventional   and Pegylated liposomal formulations of mThPc  (temoporfin): comparison of treatment efficacy  and distribution characteristics in vivo Vadzim reshetov1–3 henri-Pierre lassalle1,2 aurélie François1,2,4 Dominique Dumas5 sebastien hupont5 susanna gräfe6 Vasco Filipe7 Wim Jiskoot7 François guillemin1,2,4 Vladimir Zorin3 lina Bezdetnaya1,2,4 1Université de lorraine, centre de  recherche en automatique de Nancy,  campus sciences, Vandœuvre-lès- Nancy, France; 2centre National de  la Recherche Scientifique, Centre de  recherche en automatique de Nancy,  France; 3laboratory of Biophysics and  Biotechnology, Physics Faculty, Belarusian  state University, Minsk, Belarus; 4lorraine  cancer Institute, Vandoeuvre-lès-Nancy,  France; 5Université de lorraine, Plate  forme d’Imagerie et de Biophysique  cellulaire Plate Forme IBi sa d’Imagerie  et de Biophysique cellulaire de Nancy,  centre National de la recherche  Scientifique, Vandœuvre-lès-Nancy, France;  6Biolitec research gmbh, research and  Development, Jena, germany; 7Division  of Drug Delivery T echnology, leiden/ amsterdam center for Drug research,  leiden University, leiden, the Netherlands correspondence: Vadzim reshetov   laboratory of Biophysics and  Biotechnology, Physics Faculty,   Belarusian state University,  4 Nezavisimosti ave, 220030 Minsk,  Belarus/rUe Belmedpreparaty,   30 Fabritsius st, 220007 Minsk, Belarus   Tel +375 29 346 88 56   Fax +375 17 220 31 42   email vadim.reshetov@gmail.co mAbstract:  A major challenge in the application of a nanoparticle-based drug delivery system  for anticancer agents is the knowledge of the critical properties that influence their in vivo  behavior and the therapeutic performance of the drug.",Non-OADS,/arxiv_data1/oa_pdf/c7/af/ijn-8-3817.PMC3797282.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/c7/af/ijn-8-3817.PMC3797282.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c7/af/ijn-8-3817.PMC3797282.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3e/60/ndt-9-1531.PMC3797283.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2013:9 1531–1537Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1531OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S5203 0Detection of subclinical atherosclerosis   and diastolic dysfunction in patients   with schizophrenia cüneyt Ünsal1 Mustafa Oran2 hande Oktay T ureli3 seref alpsoy4 Sema Yeşilyurt5 Mehtap arslan6 Birol T opcu7 Osman Karakaya8 erhan Kurt6 1Department of Psychiatry, Namık  Kemal University, school of Medicine,   T ekirdag, T urkey; 2Department of  Internal Medicine, Namık Kemal  University, school of Medicine,   T ekirdag, T urkey; 3Department of  Cardiology, Bakırkoy Dr Sadi Konuk  education and research hospital,   istanbul, T urkey; 4Department of  Cardiology, Namık Kemal University,   school of Medicine, T ekirdag, T urkey;   5Department of Psychiatry, Bag ˘cılar  Training and research hospital,   istanbul, T urkey; 6Department of  Psychiatry, Bakirkoy Training and  research hospital for Psychiatry  Neurology and Neurosurgery,   istanbul, T urkey; 7Department of  Biostatistics, Namık Kemal University,   school of Medicine, T ekirdag, T urkey;   8Department of social service, Yalova  University, Faculty of economics and  administrative sciences, Yalova, T urkey correspondence: cüneyt Ünsal   Department of Psychiatry, school of  Medicine, Namik Kemal University,  Tekirdag 59100, Turkey   Tel +90 282 250 51 58   Fax +90 282 250 99 50   email drcunsal@gmail.co mBackground:  Patients with schizophrenia have a higher risk for cardiovascular diseases, which  is associated with early mortality compared with the nonschizophrenic population.",Non-OADS,/arxiv_data1/oa_pdf/3e/60/ndt-9-1531.PMC3797283.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/3e/60/ndt-9-1531.PMC3797283.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3e/60/ndt-9-1531.PMC3797283.pdf
"Retrieved September 20, 2000, from the World Wide Web: http://www.ama-assn.org .",Non-OADS,/arxiv_data1/oa_pdf/b4/bf/11606_2013_Article_2419.PMC3797347.pdf
"May 2012. http://www.uspreventiveservicestaskforce.org/ prostatecancerscreening.htm 17.Ransohoff DF, Collins MM, Fowler FJ.",Non-OADS,/arxiv_data1/oa_pdf/b4/bf/11606_2013_Article_2419.PMC3797347.pdf
References  1. http://www.cancer.org/cancer/prostatecancer/detailedguide/  prostate-cancer-key-statistics [accessed 7/9/13].,Non-OADS,/arxiv_data1/oa_pdf/cf/c0/JCB-5-21423.PMC3797407.pdf
Institute for Clinical and Economic Review; available at: http://www.icerreview.org/index.php?,Non-OADS,/arxiv_data1/oa_pdf/cf/c0/JCB-5-21423.PMC3797407.pdf
http://dx.doi.org/10.1016/  j.brachy.2013.08.003  13.,OADS,/arxiv_data1/oa_pdf/74/58/JCB-5-21484.PMC3797411.pdf
Retrieved from http://www.cdc.gov/ cancer/dcpc/data/men.htm.,OADS,/arxiv_data1/oa_pdf/8d/3f/JCB-5-21485.PMC3797412.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/cd/19/srep02957.PMC3797422.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2957 | DOI: 10.1038/srep02957 6",Non-OADS,/arxiv_data1/oa_pdf/cd/19/srep02957.PMC3797422.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2958 | DOI: 10.1038/srep02958 6",Non-OADS,/arxiv_data1/oa_pdf/97/cb/srep02958.PMC3797425.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/02/1f/srep02955.PMC3797427.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2955 | DOI: 10.1038/srep02955 7",Non-OADS,/arxiv_data1/oa_pdf/02/1f/srep02955.PMC3797427.pdf
is the mainly contributing authorof this paper.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/02/6a/srep02956.PMC3797430.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2956 | DOI: 10.1038/srep02956 7",Non-OADS,/arxiv_data1/oa_pdf/02/6a/srep02956.PMC3797430.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/5f/a9/srep02959.PMC3797431.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2959 | DOI: 10.1038/srep02959 6",Non-OADS,/arxiv_data1/oa_pdf/5f/a9/srep02959.PMC3797431.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/97/4c/srep02964.PMC3797433.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2964 | DOI: 10.1038/srep02964 6",Non-OADS,/arxiv_data1/oa_pdf/97/4c/srep02964.PMC3797433.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/63/9b/srep02960.PMC3797434.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2960 | DOI: `10.1038/srep02960 10",Non-OADS,/arxiv_data1/oa_pdf/63/9b/srep02960.PMC3797434.pdf
",http://w3.usf.edu/ FreeAssociation/ .. 33.",Non-OADS,/arxiv_data1/oa_pdf/ea/e3/srep02993.PMC3797436.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2993 | DOI: 10.1038/srep02993 8",Non-OADS,/arxiv_data1/oa_pdf/ea/e3/srep02993.PMC3797436.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2921 | DOI: 10.1038/srep02921 5",Non-OADS,/arxiv_data1/oa_pdf/d2/3b/srep02921.PMC3797541.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/95/12/dddt-7-1209.PMC3797606.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2013:7 1209–1222Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1209Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S3590 5Current and future G protein-coupled receptor  signaling targets for heart failure therapy Ashley Siryk-Bathgate Samalia Dabul Anastasios Lymperopoulos Laboratory for the Study of  Neurohormonal Control of  the Circulation, Department of  Pharmaceutical Sciences, Nova  Southeastern University College of  Pharmacy, Fort Lauderdale, FL, USA Correspondence: Anastasios  Lymperopoulos   Department of Pharmaceutical Sciences,   Nova Southeastern University College   of Pharmacy, 3200 S University Drive,   HPD (Terry) Building/Room 1338,   Fort Lauderdale, FL 33328, USA   Tel +1 954 262 1338   Fax +1 954 262 2278   email al806@nova.ed uAbstract:  Although there have been significant advances in the therapy of heart failure in  recent decades, such as the introduction of β-blockers and antagonists of the renin–angiotensin– aldosterone system, this devastating disease still carries tremendous morbidity and mortality  in the western world.",Non-OADS,/arxiv_data1/oa_pdf/95/12/dddt-7-1209.PMC3797606.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/95/12/dddt-7-1209.PMC3797606.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/95/12/dddt-7-1209.PMC3797606.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/70/42/ijn-8-3917.PMC3797607.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 3917–3925International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3917RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S5189 4Nanoscale bacteriophage biosensors beyond  phage display Jong-w ook Lee1 Jangwon Song1,2 Mintai P Hwang1 Kwan Hyi Lee1,2 1Center for Biomaterials, Biomedical  Research Institute, Korea Institute  of Science and T echnology, Seoul,   Korea; 2Department of Biomedical  engineering, University of Science and  T echnology, Seoul, Korea Correspondence: Kwan Hyi Lee   Center for Biomaterials, Biomedical   Research Institute, Korea Institute   of Science and Technology (KIST),   136-791, Hwarangno 14-gil 5   Seongbuk-gu, Seoul, Korea   Tel +82 2 958 6804   Fax +82 2 958 5308   email kwanhyi@kist.re.k rAbstract:  Bacteriophages are traditionally used for the development of phage display   technology.",Non-OADS,/arxiv_data1/oa_pdf/70/42/ijn-8-3917.PMC3797607.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/70/42/ijn-8-3917.PMC3797607.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/70/42/ijn-8-3917.PMC3797607.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/.,Non-OADS,/arxiv_data1/oa_pdf/db/35/ijn-8-3883.PMC3797608.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 3883–3886International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3883OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S4769 7Bioengineering in the oral cavity: our experience l catalfamo1 e Belli2 c Nava1 e Mici1 a calvo1 B D’alessandro1 Fs De Ponte1 1Unit of Maxillofacial surgery,   University of Messina, azienda  Ospedaliera Universitaria, Policlinico  g Martino, Messina, Italy; 2Unit of  Maxillofacial surgery, University rome  sapienza, azienda Ospedaliera sant  andrea, rome, Italy correspondence: luciano catalfamo   Policlinico g Martino, Via consolare  Valeria Nr.1, Messina, Italy 00100   Fax +399 0221 3222   email lc.lab@libero.i tBackground:  To date, there are no studies reported in the literature on the possible use of  bovine collagen, oxidized regenerated cellulose, or synthetic hyaluronic acid medications in  the oral cavity.",Non-OADS,/arxiv_data1/oa_pdf/db/35/ijn-8-3883.PMC3797608.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/db/35/ijn-8-3883.PMC3797608.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/db/35/ijn-8-3883.PMC3797608.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/dc/d6/dddt-7-1187.PMC3797609.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2013:7 1187–1193Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1187Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S2776 6Review of daclizumab and its therapeutic   potential in the treatment of relapsing–remitting   multiple sclerosis Jennifer Reardon1 Jai S Perumal1,2 1weill Cornell MS Center at Nyack  Hospital, Nyack Hospital, Nyack, NY,   USA; 2Department of Neurology, weill  Cornell Medical College, New Y ork,   NY, USA Correspondence: Jai S Perumal   weill Cornell Medical College,   1305 York Ave, 2nd floor,   New York, NY, USA 10021   Tel +1 646 962 5733   Fax +1 646 962 0390   email jsp9007@med.cornell.ed uAbstract:  Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central  nervous system.",Non-OADS,/arxiv_data1/oa_pdf/dc/d6/dddt-7-1187.PMC3797609.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/dc/d6/dddt-7-1187.PMC3797609.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/dc/d6/dddt-7-1187.PMC3797609.pdf
Available from: http://clinicaltrials.gov/ct2/ show/NCT0106440 1.,Non-OADS,/arxiv_data1/oa_pdf/dc/d6/dddt-7-1187.PMC3797609.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/21/d9/copd-8-493.PMC3797610.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2013:8 493–499International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  493OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S4960 9Development and validation of a model to predict  the risk of exacerbations in chronic obstructive  pulmonary disease loes CM Bertens1 Johannes B reitsma1 Karel gM Moons1 Yvonne van Mourik1 Jan Willem J lammers2 Berna Dl Broekhuizen1 arno W hoes1 Frans h rutten1 1Julius Center for health sciences  and Primary Care, 2Department of  Pulmonology, heart-lung Center,   University Medical Center Utrecht,   Utrecht, the netherlands Correspondence: loes CM Bertens   Julius Center for health sciences and  Primary Care, University Medical Center  Utrecht, PO Box 85060, stratenum  6.131, 3508 aB Utrecht, the netherlands   Tel +31 88 756 8375   Fax +31 88 756 9028   email l .c.m.bertens-2@umcutrecht.n lPurpose:  Prediction models for exacerbations in patients with chronic obstructive  pulmonary  disease (COPD) are scarce.",Non-OADS,/arxiv_data1/oa_pdf/21/d9/copd-8-493.PMC3797610.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/21/d9/copd-8-493.PMC3797610.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/21/d9/copd-8-493.PMC3797610.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/64/e9/cia-8-1377.PMC3797611.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2013:8 1377–1386Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1377OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5033 3Decreased functional capacity and   muscle strength in elderly women   with metabolic syndrome Denis Cesar leite Vieira1 ramires Alsamir Tibana1 Vitor Tajra1 Dahan da Cunha  nascimento1  Darlan lopes de Farias1 Alessandro de Oliveira  silva1 Tatiane gomes T eixeira1 romulo Maia Carlos  Fonseca2 ricardo Jacó de Oliveira2 Felipe Augusto dos santos  Mendes2 Wagner rodrigues Martins2 silvana schwerz Funghetto2 Margo gomes de Oliveira  Karnikowski2 James Wilfred n avalta3 Jonato Prestes1 1graduate Program on Physical  education, Catholic University of  Brasilia, Brasilia, Brazil; 2University  of Brasilia, UnB, Brasilia, Brazil;   3Department of Kinesiology and  nutrition sciences of the University  of nevada, las Vegas, nV, UsA Correspondence: Jonato Prestes   graduate Program on Physical education,  Catholic University of Brasilia, Brasilia,  Brazil, Qs 07, lote 01, ePTC – Bloco g,   71966-700, Aguas Claras,   Taguatinga, DF, Brazil   Tel +55 61 3356 9350   email jonatop@gmail.co mPurpose:  To compare the metabolic parameters, flexibility, muscle strength, functional  capacity, and lower limb muscle power of elderly women with and without the metabolic  syndrome (MetS).",Non-OADS,/arxiv_data1/oa_pdf/64/e9/cia-8-1377.PMC3797611.pdf
"The height of the vertical jump was calculated  using JUMPING PRO software (Sports Timing Systems,  http://www.sportstimingsystems.co.uk /) from the flight time  measured in each attempt.",OADS,/arxiv_data1/oa_pdf/64/e9/cia-8-1377.PMC3797611.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/64/e9/cia-8-1377.PMC3797611.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/64/e9/cia-8-1377.PMC3797611.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/.,Non-OADS,/arxiv_data1/oa_pdf/bc/09/dmso-6-379.PMC3797612.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013:6 379–388Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  379Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S5114 5Hepatic function and the cardiometabolic  syndrome Nicolas wiernsperger iNSeRM French institute of Health  and Medical Research, U1060,   National institute   of Applied Sciences, Lyon, University  of Lyon, villeurbanne, France Correspondence: Nicolas wiernsperger   CarMeN Laboratory iNSA, National  institute of Applied Sciences, University  of Lyon, iMBL, villeurbanne, F-69621  France   email remedes@orange.f rAbstract:  Despite skeletal muscle being considered by many as the source of insulin resistance,  physiology tells us that the liver is a central and cardinal regulator of glucose homeostasis.",Non-OADS,/arxiv_data1/oa_pdf/bc/09/dmso-6-379.PMC3797612.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/bc/09/dmso-6-379.PMC3797612.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/09/dmso-6-379.PMC3797612.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/90/20/cia-8-1387.PMC3797613.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2013:8 1387–1391Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1387OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5277 4Is the Chronic Kidney Disease epidemiology  Collaboration creatinine–cystatin C equation  useful for glomerular filtration rate estimation   in the elderly?,Non-OADS,/arxiv_data1/oa_pdf/90/20/cia-8-1387.PMC3797613.pdf
"laboratory methods GFR was measured by the 99mTc-DTPA renal dynamic  imaging method,6,7 as described previously.8 According  to the method developed by Ma et al,9 we determined the  minimum sample size to be 36 (95% confidence interval and  80% power), using Open Epi Version 2 ( http://www.openepi.",OADS,/arxiv_data1/oa_pdf/90/20/cia-8-1387.PMC3797613.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/90/20/cia-8-1387.PMC3797613.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/90/20/cia-8-1387.PMC3797613.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b5/10/btt-7-211.PMC3797614.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpBiologics: Targets and Therapy 2013:7 211–221Biologics: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  211Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BTT .S2509 5everolimus in the treatment of subependymal  giant cell astrocytomas, angiomyolipomas,   and pulmonary and skin lesions associated   with tuberous sclerosis complex David Neal Franz Department of Pediatrics, T uberous  Sclerosis Clinic, Cincinnati Children’s  Hospital Medical Center, Cincinnati,   OH, USA Correspondence: David Neal Franz   Department of Pediatrics, Tuberous  Sclerosis Clinic, Cincinnati Children’s  Hospital Medical Center, 3333 Burnet  Avenue, Cincinnati, OH 45229, USA   Tel +1 513 636 4222   Fax +1 513 636 1888   email d avid.franz@cchmc.or gAbstract:  Tuberous sclerosis complex (TSC) is an autosomal dominant genetic disorder caused  by inactivating mutations in either the TSC1  or TSC2  genes.",Non-OADS,/arxiv_data1/oa_pdf/b5/10/btt-7-211.PMC3797614.pdf
Avail - able from http://www.clinicaltrials.gov/ct2/show/NCT0078982 8.,Non-OADS,/arxiv_data1/oa_pdf/b5/10/btt-7-211.PMC3797614.pdf
"Biologics: Targets & Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/biologics-targets--therapy-journa lBiologics: Targets & Therapy is an international, peer-reviewed journal  focusing on the patho-physiological rationale for and clinical applica - tion of Biologic agents in the management of autoimmune diseases,  cancers or other pathologies where a molecular target can be identified.",Non-OADS,/arxiv_data1/oa_pdf/b5/10/btt-7-211.PMC3797614.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/b5/10/btt-7-211.PMC3797614.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/.,Non-OADS,/arxiv_data1/oa_pdf/fa/9b/cia-8-1365.PMC3797615.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2013:8 1365–1375Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1365OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S4682 6effectiveness of exercise and protein  supplementation intervention on body  composition, functional fitness, and oxidative  stress among elderly Malays with sarcopenia suzana shahar1 norshafarina shari  Kamaruddin2 Manal Badrasawi1 noor Ibrahim Mohamed  sakian3 Zahara Abd Manaf1 Zaitun Yassin4 leonard Joseph5 1Dietetic Programme, 2Biomedical  Programme, 3Occupational Therapy  Programme, school of healthcare  sciences, Universiti Kebangsaan  Malaysia, Jalan raja Muda Abdul  Aziz, Kuala lumpur, 4Department  of nutrition and Dietetics,   Faculty of Medicine and health  sciences, Universiti Putra Malaysia,   serdang, selangor, 5Department of  Physiotherapy, school of healthcare  sciences, Universiti Kebangsaan  Malaysia, Jalan raja Muda Abdul Aziz,   Kuala lumpur, Malaysia Correspondence: suzana shahar   Dietetic Programme,   school of healthcare sciences,   Universiti Kebangsaan Malaysia,   Jalan raja Muda Abdul Aziz,   50300 Kuala lumpur, Malaysia   email suzanas@medic.ukm.m yAbstract:  Sarcopenia, characterized as muscle loss that occurs with aging, is a major health  problem in an aging population, due to its implications on mobility, quality of life, and fall risk.",Non-OADS,/arxiv_data1/oa_pdf/fa/9b/cia-8-1365.PMC3797615.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/fa/9b/cia-8-1365.PMC3797615.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fa/9b/cia-8-1365.PMC3797615.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/.,Non-OADS,/arxiv_data1/oa_pdf/9f/ed/ijn-8-3855.PMC3797616.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 3855–3866International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3855OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S4774 9a novel application of maleimide for advanced  drug delivery: in vitro and in vivo evaluation   of maleimide-modified pH-sensitive liposomes Tianshu li shinji Takeoka Department of life science and  Medical Bioscience, graduate school  of advanced science and engineering,  Waseda University (TWIns),  shinjuku-ku, Tokyo, Japan correspondence: shinji Takeoka   Department of life science and   Medical Bioscience, graduate school   of advanced science and engineering,  Waseda University (TWIns),   shinjuku-ku, Tokyo 162-8480, Japan   Tel +81 3 5369 7324   Fax +81 3 5369 7324   email takeoka@waseda.j pAbstract:  Maleimide is a s table and easy-to-handle moiety that rapidly and covalently conjugates  thiol groups of cysteine residues in proteins or peptides.",Non-OADS,/arxiv_data1/oa_pdf/9f/ed/ijn-8-3855.PMC3797616.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/9f/ed/ijn-8-3855.PMC3797616.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9f/ed/ijn-8-3855.PMC3797616.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d3/8f/dddt-7-1201.PMC3797618.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2013:7 1201–1208Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1201Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S3944 9New developments in the combination treatment  of COPD: focus on umeclidinium/vilanterol Mario Cazzola1 Andrea Segreti1 Maria Gabriella Matera2 1Department of System Medicine,   University of Rome ‘T or vergata’,   Rome, italy; 2Department of  experimental Medicine, Second  University, Naples, italy Correspondence: Mario Cazzola   Unità di Farmacologia Clinica   Respiratoria, Dipartimento di Medicina  dei Sistemi, Università di Roma   ‘Tor vergata’, via Montpellier 1,   00133 Rome, italy   email mario.cazzola@uniroma2.i tAbstract:  An increasing body of evidence suggests that the long-acting muscarinic antagonist  (LAMA)/long-acting β2-agonist (LABA) combination appears to play an important role in  maximizing bronchodilation, with studies to date indicating that combining different classes of  bronchodilators may result in significantly greater improvements in lung function compared to  the use of a single drug, and that these combinations are well tolerated in patients with moderate- to-severe chronic obstructive pulmonary disease (COPD).",Non-OADS,/arxiv_data1/oa_pdf/d3/8f/dddt-7-1201.PMC3797618.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/d3/8f/dddt-7-1201.PMC3797618.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d3/8f/dddt-7-1201.PMC3797618.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b7/6b/clep-5-397.PMC3797619.pdf
Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpClinical Epidemiology 2013:5 397–405Clinical Epidemiology Dove press submit your manuscript | www.dovepress.co m Dove press  397Original rEsEarChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CLEP .S5050 5Does marriage protect against hospitalization  with pneumonia?,Non-OADS,/arxiv_data1/oa_pdf/b7/6b/clep-5-397.PMC3797619.pdf
Available from: http://www.sum.,Non-OADS,/arxiv_data1/oa_pdf/b7/6b/clep-5-397.PMC3797619.pdf
Available from: http://www.whocc.no/atc_ddd_index /.,OADS,/arxiv_data1/oa_pdf/b7/6b/clep-5-397.PMC3797619.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access  journal focusing on disease and drug epidemiology, identification of  risk factors and screening procedures to develop optimal preventative  initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/b7/6b/clep-5-397.PMC3797619.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/97/18/ijn-8-3867.PMC3797620.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 3867–3874International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3867OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5106 3New procedure to synthesize silver nanoparticles  and their interaction with local anesthetics aurora Mocanu1 roxana Diana Pasca1 gheorghe T omoaia2 corina garbo1 Petre T Frangopol1 Ossi horovitz1 Maria T omoaia-cotisel1 1chemical engineering Department,   Babes-Bolyai University, 2Orthopedic  Department, Iuliu hatieganu  University of Medicine and  Pharmacy, cluj-Napoca, romania correspondence: Maria Tomoaia-cotisel   chemical engineering Department,  Faculty of chemistry and chemical  engineering, Babes-Bolyai University,  11 arany János street, cluj-Napoca  400028, romania   Tel +40 264 593 833   Fax +40 264 590 818   email mcotisel@chem.ubbcluj.r oAbstract:  Silver nanoparticles (AgNPs) were prepared in aqueous colloid dispersions by the  reduction of Ag+ with glucose in alkaline medium.",Non-OADS,/arxiv_data1/oa_pdf/97/18/ijn-8-3867.PMC3797620.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/97/18/ijn-8-3867.PMC3797620.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/97/18/ijn-8-3867.PMC3797620.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ca/1e/ijn-8-3875.PMC3797621.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Nanomedicine 2013:8 3875–3882International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3875ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S5120 6Microwave-assisted synthesis of SnO2 nanorods  for oxygen gas sensing at room temperature Ameer Azam1 Sami S Habib1 Numan A Salah1 Faheem Ahmed2 1Centre of Nanotechnology, King  Abdulaziz University, Jeddah,    Saudi Arabia; 2School of Nano and   Advanced Materials Engineering,    Changwon National University,   Changwon, South Korea Correspondence: Ameer Azam   Centre of Nanotechnology,   King Abdulaziz University,   PO Box 80200, Jeddah 21589,   Saudi Arabia   Tel +966 53 118 5621   Fax +966 2 695 1566   Email azam222@rediffmail.co mAbstract:  High-quality single-crystalline SnO2 nanorods were synthesized using a microwave- assisted solution method.",Non-OADS,/arxiv_data1/oa_pdf/ca/1e/ijn-8-3875.PMC3797621.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/ca/1e/ijn-8-3875.PMC3797621.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ca/1e/ijn-8-3875.PMC3797621.pdf
"This is an Open Access article distributed unde r the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b5/a5/cvt170.PMC3797625.pdf
All analyses and quantiﬁcation of vessel parameterswere performed using ImageJ (v1.44 public domain software http://rsbweb.nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/b5/a5/cvt170.PMC3797625.pdf
"This is an Open Access article distributed unde r the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3d/e6/cvt187.PMC3797627.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9b/b8/ijwh-5-647.PMC3797631.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2013:5 647–655International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  647OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S4760 4Barriers to use of modern contraceptives among   women in an inner city area of Osogbo   metropolis, Osun state, nigeria eO asekun-Olarinmoye1 WO adebimpe1 JO Bamidele2 OO Odu2 IO asekun-Olarinmoye3 eO Ojofeitimi4 1Department of community Medicine,   Faculty of clinical sciences, Osun  state University, Osogbo, Osun state,   nigeria; 2Department of community  Medicine, Faculty of clinical sciences,   ekiti state University, ado-ekiti,   ekiti state, n igeria; 3Department of  community Health, school of Public  and allied Health, Babcock University,   Ilishan-remo, Ogun state, nigeria;   4Department of community Medicine,   Faculty of clinical sciences, ladoke  akintola University of T echnology,   Osogbo, Osun state, nigeria correspondence: eO asekun-Olarinmoye   Department of community Medicine,   college of Health sciences, Faculty of   clinical sciences, Osun state University,   PMB 4494, Osogbo, Osun state, nigeria   email gmjfunmilayo@gmail.co m; esther.",Non-OADS,/arxiv_data1/oa_pdf/9b/b8/ijwh-5-647.PMC3797631.pdf
Available from: http://www.prb.org/ Countries/Nigeria.aspx .,Non-OADS,/arxiv_data1/oa_pdf/9b/b8/ijwh-5-647.PMC3797631.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/9b/b8/ijwh-5-647.PMC3797631.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/b8/ijwh-5-647.PMC3797631.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b3/81/jmdh-6-391.PMC3797632.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Multidisciplinary Healthcare 2013:6 391–397Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  391Original researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JMDH.S5133 9Do structured arrangements for multidisciplinary  peer group supervision make a difference for  allied health professional outcomes?,Non-OADS,/arxiv_data1/oa_pdf/b3/81/jmdh-6-391.PMC3797632.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/b3/81/jmdh-6-391.PMC3797632.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/b3/81/jmdh-6-391.PMC3797632.pdf
"Available from: http://scottishmentoringnetwork.co.uk/assets/ downloads/resources/formal-v-informal-mentoring.pd f. Accessed   December 20, 2012.",Non-OADS,/arxiv_data1/oa_pdf/b3/81/jmdh-6-391.PMC3797632.pdf
"Available from: http://eprints.uwe.ac.uk/7465/1/SW_NQS W.  Accessed December 20, 2012.",Non-OADS,/arxiv_data1/oa_pdf/b3/81/jmdh-6-391.PMC3797632.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ca/04/ijnrd-6-223.PMC3797633.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nephrology and Renovascular Disease 2013:6 223–227International Journal of Nephrology and Renovascular Disease Dove press submit your manuscript | www.dovepress.co m Dove press  223ORIg INal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJNRD.S5290 5comparison of once daily versus twice   daily olmesartan in patients with chronic   kidney disease Yukinao sakai1 anna suzuki1 Koji Mugishima1 Yuichiro sumi1 Yusuke Otsuka1 T omoyuki Otsuka1 Dai Ohno1 Tsuneo Murasawa1 shuichi Tsuruoka2 1Department of Nephrology,   Nippon Medical school Musashikosugi  hospital, Kawasaki, Japan; 2Division  of Nephrology, Department of  Internal Medicine, graduate school  of Medicine, Nippon Medical school,  Tokyo, Japan correspondence: Yukinao sakai   Department of Nephrology, Nippon  Medical school Musashikosugi hospital,  1-396 Kosugi-cho, Nakahara-ku,   Kawasaki 211-8533, Japan   Tel +81 44 733 5181 ext 2205   Fax +81 44 711 8333   email y-sakai@nms.ac.j pBackground:  The effects of olmesartan (OLM) on blood pressure and kidney function in  Japanese patients with chronic kidney disease (CKD) were compared between 20 mg twice  daily (BID) and 40 mg once daily (QD) treatments.",Non-OADS,/arxiv_data1/oa_pdf/ca/04/ijnrd-6-223.PMC3797633.pdf
"International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journa lThe International Journal of Nephrology and Renovascular Disease is  an international, peer-reviewed open-access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/ca/04/ijnrd-6-223.PMC3797633.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ca/04/ijnrd-6-223.PMC3797633.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/05/9b/ijnrd-6-207.PMC3797634.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nephrology and Renovascular Disease 2013:6 207–214International Journal of Nephrology and Renovascular Disease Dove press submit your manuscript | www.dovepress.co m Dove press  207ORIg INal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJNRD.S5121 6Renoprotective effects of telmisartan   after unilateral renal ablation in rats T omohiro Matsuo Yasuyoshi Miyata Yuji sagara Y oshikazu higami shohei T obu Manabu Matsuo Mitsuru Noguchi Isao shimokawa hiroshi Kanetake hideki sakai Department of Nephro-Urology,   Department of Investigative Pathology,   Nagasaki University graduate school  of Biomedical sciences, Nagasaki,   Japan correspondence: Yasuyoshi Miyata   Department of Nephro-Urology,  Nagasaki University school of   Biomedical sciences, 1-7-1 sakamoto,   Nagasaki 852-8501, Japan   Tel +81 95 819 7340   Fax +81 95 819 7343   email int.doc.miya@m3.dion.ne.j pPurpose:  The renoprotective function of the angiotensin II type 1 receptor blocker (ARB) is  well-known in various studies, including the animal model of renal failure.",Non-OADS,/arxiv_data1/oa_pdf/05/9b/ijnrd-6-207.PMC3797634.pdf
"International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journa lThe International Journal of Nephrology and Renovascular Disease is  an international, peer-reviewed open-access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/05/9b/ijnrd-6-207.PMC3797634.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/05/9b/ijnrd-6-207.PMC3797634.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/28/5c/ndt-9-1565.PMC3797635.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2013:9 1565–1571Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1565Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S5231 1is quetiapine sui table for treatment of acute  schizophrenia with catatonic stupor?,Non-OADS,/arxiv_data1/oa_pdf/28/5c/ndt-9-1565.PMC3797635.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/28/5c/ndt-9-1565.PMC3797635.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/28/5c/ndt-9-1565.PMC3797635.pdf
"Published by Oxford University Press, on behalf of the Society of Systematic Biologists.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a8/05/syt054.PMC3797637.pdf
The open source implementation of ALE is available from https://github.com/ssolo/ALE.git.,OADS,/arxiv_data1/oa_pdf/a8/05/syt054.PMC3797637.pdf
"Cleaned alignments are available from the Dryad data repository at http://datadryad.org,doi:10.5061/dryad.pv6df.",OADS,/arxiv_data1/oa_pdf/a8/05/syt054.PMC3797637.pdf
"“Real” gene trees are available from the Dryad data repository at http://datadryad.org, doi:10.5061/dryad.pv6df.",OADS,/arxiv_data1/oa_pdf/a8/05/syt054.PMC3797637.pdf
"Simulated alignments are available from the Dryad data repository at http://datadryad.org,doi:10.5061/dryad.pv6df.",OADS,/arxiv_data1/oa_pdf/a8/05/syt054.PMC3797637.pdf
"ML reconciled trees are available from the Dryad data repository at http://datadryad.org,doi:10.5061/dryad.pv6df.",OADS,/arxiv_data1/oa_pdf/a8/05/syt054.PMC3797637.pdf
Our implementation of ALE is available from https://github.com/ssolo/ALE.git.,Non-OADS,/arxiv_data1/oa_pdf/a8/05/syt054.PMC3797637.pdf
"This is an open access article, published  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/2.5).",Non-OADS,/arxiv_data1/oa_pdf/a5/d9/JVR-04-013.PMC3797638.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided theoriginal work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/47/20/dkt217.PMC3797640.pdf
"http://www.fda.gov/ downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ UCM123686.pdf (7 November 2012, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/47/20/dkt217.PMC3797640.pdf
"http://www.aetna.com/cpb/medical/data/600_699/ 0650.html (6 December 2012, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/47/20/dkt217.PMC3797640.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7f/eb/ppa-7-1059.PMC3797646.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/7f/eb/ppa-7-1059.PMC3797646.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7f/eb/ppa-7-1059.PMC3797646.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8e/f8/ott-6-1417.PMC3797647.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2013:6 1417–1424OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1417Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5191 3Dynamin 3 : a new candidate tumor suppressor  gene in hepatocellular carcinoma detected   by triple combination array analysis Y oshikuni inokawa1 shuji nomoto1 Mitsuhiro hishida1 Masamichi hayashi1 Mitsuro Kanda1 Y oko nishikawa1 shin Takeda2 Michitaka Fujiwara1 Masahiko Koike1 hiroyuki sugimoto1 Tsutomu Fujii1 goro nakayama1 suguru Yamada1 chie Tanaka1 Daisuke Kobayashi1 Yasuhiro Kodera1 1gastroenterological surgery,    nagoya University graduate school   of Medicine, nagoya Japan;   2Department of surgery, nagoya  Medical center, nagoya, Japan correspondence: shuji nomoto   gastroenterological surgery,   nagoya University graduate school   of Medicine, 65 Tsurumai-cho,   showa-ku, nagoya 466-8550, Japan   Tel +81 52 744 2249   Fax +81 52 744 2255   email snomoto@med.nagoya-u.ac.j pBackground:  To identify genes associated with hepatocellular carcinoma (HCC) pathogenesis,  we developed a triple combination array strategy comprising methylation, gene expression, and  single nucleotide polymorphism (SNP) array analysis.",Non-OADS,/arxiv_data1/oa_pdf/8e/f8/ott-6-1417.PMC3797647.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/8e/f8/ott-6-1417.PMC3797647.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8e/f8/ott-6-1417.PMC3797647.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fa/3c/tcrm-9-383.PMC3797649.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2013:9 383–390Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  383Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S5014 5Obesity detection rate among primary school  students in the People’s Republic of China:   a meta-analysis Yue-long Jin* Ling-ling Ding* Ying-shui Yao Xiu-li Song Hui Tang Lian-ping He Yan Chen Faculty of epidemiology and Statistics,   School of Public Health, wannan  Medical College, Anhui, People’s  Republic of China *These authors contributed equally to  this work Correspondence: Ying-shui Yao   Faculty of epidemiology and Statistics,  School of Public Health, wannan Medical  College, 22 wenchang west Road,  Yijiang District, wuhu 241002, Anhui,  People’s Republic of China   Tel +86 055 3393 2651   Fax +86 055 3393 2651   email yingshuiyao@163.co mBackground:  Obesity has become a major public health problem worldwide.",Non-OADS,/arxiv_data1/oa_pdf/fa/3c/tcrm-9-383.PMC3797649.pdf
Available from: http://www.cdc.gov/ obesity/data/adult.html.,Non-OADS,/arxiv_data1/oa_pdf/fa/3c/tcrm-9-383.PMC3797649.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/fa/3c/tcrm-9-383.PMC3797649.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fa/3c/tcrm-9-383.PMC3797649.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2c/d4/ott-6-1425.PMC3797650.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2013:6 1425–1435OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1425Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S3467 8Targeting hedgehog signaling in cancer: research  and clinical developments Jingwu Xie Christopher M Bartels Scott w Barton Dongsheng Gu wells Center for Pediatric   Research, Division of Hematology   and Oncology, Department of   Pediatrics, indiana University Simon   Cancer Center, indiana University,    indianapolis, iN, USA Correspondence: Jingwu Xie   Cancer Research institute,   Room R4-327, 1040 w. walnut Street,  indianapolis, iN 46202, USA   T el +1 317 278 3999   Fax +1 317 274 8046   email jinxie@iu.ed uAbstract:  Since its first description in Drosophila  by Drs Nusslein-V olhard and Wieschaus  in 1980, hedgehog (Hh) signaling has been implicated in regulation of cell differentiation,  proliferation, tissue polarity, stem cell maintenance, and carcinogenesis.",Non-OADS,/arxiv_data1/oa_pdf/2c/d4/ott-6-1425.PMC3797650.pdf
"First, gene  expression analyses revealed elevated Hh target gene  expression in embryonic rhabdomyosarcomas.111 Second,  preliminary studies used forskolin or SMO inhibitor to  shrink tumors in mouse models.174 In addition, evidence for  Hh signaling in meningiomas and SCLC is quite clear, and  Table 1  A list of hedgehog signaling inhibitors in clinical trials (from http://clinicaltrials.go v)a Molecule Other names Phase Tumor types FDA approval Company GDC-0449 vismodegib/erivedge i/ii/iii BCCs and solid tumors BCCs Hoffmann-La Roche Ltd iPi-926 i/ii Solid tumors Infinity Pharmaceuticals, Inc. LDe225 i/ii Leukemia and solid tumors Novartis AG LeQ506 i Solid tumors Novartis AG PF-04449913 i/ii Leukemia and solid tumors Pfizer, Inc. TAK-441 i Solid tumors Millennium Pharmaceuticals, inc. BMS833923 XL-139 i/ii SCLC and solid tumors Bristol-Myers Squibb LY2940680 i/ii SCLC/advanced cancer eli Lilly and Company Notes:  aAll small molecules target smoothened molecule.",Non-OADS,/arxiv_data1/oa_pdf/2c/d4/ott-6-1425.PMC3797650.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/2c/d4/ott-6-1425.PMC3797650.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/d4/ott-6-1425.PMC3797650.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/77/4b/opth-7-2003.PMC3797651.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 2003–2006Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2003Case repO rtopen access to scientific and medical research Open access Full text article http: //dx.doi.org/10.2147/OPTH.S5119 6a case of presumed choroidal metastasis   from carcinoid tumor treated by photodynamic  therapy with verteporfin setsuko Kawakami Y oshihiro Wakabayashi Hiroshi Goto Department of Ophthalmology, tokyo  Medical University, tokyo, Japan Correspondence: setsuko Kawakami   Department of Ophthalmology, tokyo  Medical University, 6-7-1 Nishi-shinjuku,  shinjuku-ku, tokyo 160-0023, Japan   tel +81 3 3342 6111 ext 5880   Fax +81 3 3346 9170   email setsu@tokyo-med.ac.j pAbstract:  We report a case of metastatic choroidal carcinoid tumor with favorable outcome  after photodynamic therapy.",Non-OADS,/arxiv_data1/oa_pdf/77/4b/opth-7-2003.PMC3797651.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/77/4b/opth-7-2003.PMC3797651.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/77/4b/opth-7-2003.PMC3797651.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5b/c8/opth-7-1979.PMC3797652.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phClinical Ophthalmology 2013:7 1979–1985Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1979Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5292 2Comparative visual performance with monofocal  and multifocal intraocular lenses Kjell gunnar gundersen1,* richard Potvin2,* 1Privatsykehuset haugesund,   haugesund, norway; 2science   in Vision, Burleson, TX, Usa *These authors contributed equally to  this work Correspondence: Kjell gunnar  gundersen   Privatsykehuset haugesund,   haraldsgaten 139,   5527 haugesund, norway   email kggunder@gmail.co mBackground:  To compare near, intermediate, and distance vision, and quality of vision using  appropriate subjective questionnaires, when monofocal or apodized diffractive multifocal  intraocular lenses (IOLs) are binocularly implanted.",Non-OADS,/arxiv_data1/oa_pdf/5b/c8/opth-7-1979.PMC3797652.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/5b/c8/opth-7-1979.PMC3797652.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5b/c8/opth-7-1979.PMC3797652.pdf
"Available from: http://www.accessdata.fda.gov/cdrh_docs/pdf4/ p040020a.pd f. Accessed September 23, 2013.",OADS,/arxiv_data1/oa_pdf/5b/c8/opth-7-1979.PMC3797652.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/48/f7/ppa-7-1047.PMC3797653.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2013:7 1047–1057Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1047Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S5274 6Should treatment for depression be   based more on patient preference?,Non-OADS,/arxiv_data1/oa_pdf/48/f7/ppa-7-1047.PMC3797653.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/48/f7/ppa-7-1047.PMC3797653.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/48/f7/ppa-7-1047.PMC3797653.pdf
"INJ This is an Open Access article distributed under the terms of the Creative Commons Attri - bution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a6/a5/inj-17-107.PMC3797889.pdf
"The cerebral cortex plays a key role in memory, Original Article http://dx.doi.org/10.5213/inj.2013.17.3.107 pISSN 2093-4777 · eISSN 2093-6931",Non-OADS,/arxiv_data1/oa_pdf/a6/a5/inj-17-107.PMC3797889.pdf
"•  Music and Noise Influence Neurogenesis and Thickness  http://dx.doi.org/10.5213/inj.2013.17.3.107INJ attention, perceptual awareness, thought, language, and con - sciousness.",Non-OADS,/arxiv_data1/oa_pdf/a6/a5/inj-17-107.PMC3797889.pdf
•  Music and Noise Influence Neurogenesis and Thickness  http://dx.doi.org/10.5213/inj.2013.17.3.107INJ rahydrochloride (DAB) containing nickel chloride (40 mg/mL)  and 0.03% hydrogen peroxide for 5 minutes.,Non-OADS,/arxiv_data1/oa_pdf/a6/a5/inj-17-107.PMC3797889.pdf
"•  Music and Noise Influence Neurogenesis and Thickness  http://dx.doi.org/10.5213/inj.2013.17.3.107INJ dU-positive cells in somatosensory cortex layer VI was 140.56 ±   17.67 in the control group, 210.53 ± 35.48 in the music-applied  group, and 123.14 ± 27.51 in the noise-applied group.",OADS,/arxiv_data1/oa_pdf/a6/a5/inj-17-107.PMC3797889.pdf
"•  Music and Noise Influence Neurogenesis and Thickness  http://dx.doi.org/10.5213/inj.2013.17.3.107INJ Influence of Prenatal Music and Noise on Layer Thickness  in the Somatosensory Cortex of Rat Pups The thickness of somatosensory cortex layer I was 0.141 ± 0.006  mm in the control group, 0.129 ± 0.006 mm in the music-applied  group, and 0.103 ± 0.007 mm in the noise-applied group.",OADS,/arxiv_data1/oa_pdf/a6/a5/inj-17-107.PMC3797889.pdf
•  Music and Noise Influence Neurogenesis and Thickness  http://dx.doi.org/10.5213/inj.2013.17.3.107INJ of Korea Grant funded by the Korean Government (MEST)  (NRF-2010-0022895).,Non-OADS,/arxiv_data1/oa_pdf/a6/a5/inj-17-107.PMC3797889.pdf
•  Music and Noise Influence Neurogenesis and Thickness  http://dx.doi.org/10.5213/inj.2013.17.3.107INJ Neurosci 2008;33:10-6.,Non-OADS,/arxiv_data1/oa_pdf/a6/a5/inj-17-107.PMC3797889.pdf
"INJ This is an Open Access article distributed under the terms of the Creative Commons Attri - bution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1e/20/inj-17-114.PMC3797890.pdf
Two important groups of proteins in - volved in apoptotic cell death are the members of the Bcl-2  family [12] and a class of cysteine proteases known as caspases Original Article http://dx.doi.org/10.5213/inj.2013.17.3.114 pISSN 2093-4777 · eISSN 2093-6931,Non-OADS,/arxiv_data1/oa_pdf/1e/20/inj-17-114.PMC3797890.pdf
•  Stresses and Memory Impairment http://dx.doi.org/10.5213/inj.2013.17.3.114INJ [13].,Non-OADS,/arxiv_data1/oa_pdf/1e/20/inj-17-114.PMC3797890.pdf
•  Stresses and Memory Impairment http://dx.doi.org/10.5213/inj.2013.17.3.114INJ chemistry was conducted as previously described [22].,Non-OADS,/arxiv_data1/oa_pdf/1e/20/inj-17-114.PMC3797890.pdf
•  Stresses and Memory Impairment http://dx.doi.org/10.5213/inj.2013.17.3.114INJ dentate gyrus are presented in Fig.,Non-OADS,/arxiv_data1/oa_pdf/1e/20/inj-17-114.PMC3797890.pdf
•  Stresses and Memory Impairment http://dx.doi.org/10.5213/inj.2013.17.3.114INJ pressions of Bax and Bcl-2 in the hippocampus were increased  in all the stress groups compared to those in the normal group  (P < 0.05).,Non-OADS,/arxiv_data1/oa_pdf/1e/20/inj-17-114.PMC3797890.pdf
•  Stresses and Memory Impairment http://dx.doi.org/10.5213/inj.2013.17.3.114INJ nized as targets of glucocorticoids following stress exposure [2].,Non-OADS,/arxiv_data1/oa_pdf/1e/20/inj-17-114.PMC3797890.pdf
•  Stresses and Memory Impairment http://dx.doi.org/10.5213/inj.2013.17.3.114INJ 126:533-40.,Non-OADS,/arxiv_data1/oa_pdf/1e/20/inj-17-114.PMC3797890.pdf
"INJ This is an Open Access article distributed under the terms of the Creative Commons Attri - bution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f3/96/inj-17-121.PMC3797891.pdf
A successful  trial is followed by either transurethral resection of the prostate Original Article http://dx.doi.org/10.5213/inj.2013.17.3.121 pISSN 2093-4777 · eISSN 2093-6931,Non-OADS,/arxiv_data1/oa_pdf/f3/96/inj-17-121.PMC3797891.pdf
•  Factors Affecting Trial Without Catheter for First Spontaneous AUR http://dx.doi.org/10.5213/inj.2013.17.3.121INJ (TURP) or medical therapy with outpatient follow-up.,Non-OADS,/arxiv_data1/oa_pdf/f3/96/inj-17-121.PMC3797891.pdf
•  Factors Affecting Trial Without Catheter for First Spontaneous AUR http://dx.doi.org/10.5213/inj.2013.17.3.121INJ ous data were checked for skewness and kurtosis of the distri - bution.,OADS,/arxiv_data1/oa_pdf/f3/96/inj-17-121.PMC3797891.pdf
•  Factors Affecting Trial Without Catheter for First Spontaneous AUR http://dx.doi.org/10.5213/inj.2013.17.3.121INJ ative indication for TURP [1].,Non-OADS,/arxiv_data1/oa_pdf/f3/96/inj-17-121.PMC3797891.pdf
•  Factors Affecting Trial Without Catheter for First Spontaneous AUR http://dx.doi.org/10.5213/inj.2013.17.3.121INJ their limited value in predicting outcomes and recommend giv - ing the “benefit of the doubt” and offering TWOC regardless of  a large RV .,Non-OADS,/arxiv_data1/oa_pdf/f3/96/inj-17-121.PMC3797891.pdf
•  Factors Affecting Trial Without Catheter for First Spontaneous AUR http://dx.doi.org/10.5213/inj.2013.17.3.121INJ 8.,Non-OADS,/arxiv_data1/oa_pdf/f3/96/inj-17-121.PMC3797891.pdf
"INJ This is an Open Access article distributed under the terms of the Creative Commons Attri - bution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/74/ce/inj-17-127.PMC3797892.pdf
The aim was to carry out the first systematic study to com - pare the prevalence of symptoms of urinary bladder detrusor  dysfunction in a group of Lyme disease patients and a group of  matched controls.Original Article http://dx.doi.org/10.5213/inj.2013.17.3.127 pISSN 2093-4777 · eISSN 2093-6931,Non-OADS,/arxiv_data1/oa_pdf/74/ce/inj-17-127.PMC3797892.pdf
•  Detrusor Dysfunction in Lyme Disease http://dx.doi.org/10.5213/inj.2013.17.3.127INJ MATERIALS AND METHODS Subjects This study was cross-sectional and carried out in the Breakspear  neuroscience department.,OADS,/arxiv_data1/oa_pdf/74/ce/inj-17-127.PMC3797892.pdf
•  Detrusor Dysfunction in Lyme Disease http://dx.doi.org/10.5213/inj.2013.17.3.127INJ ease: review.,Non-OADS,/arxiv_data1/oa_pdf/74/ce/inj-17-127.PMC3797892.pdf
"INJ This is an Open Access article distributed under the terms of the Creative Commons Attri - bution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/72/96/inj-17-130.PMC3797893.pdf
"The cause of OAB is widely recognized to be multifactorial,  involving such areas as aging, urinary tract infection, urethral Original Article http://dx.doi.org/10.5213/inj.2013.17.3.130 pISSN 2093-4777 · eISSN 2093-6931",Non-OADS,/arxiv_data1/oa_pdf/72/96/inj-17-130.PMC3797893.pdf
"•  Physical Exercise Improves Voiding Functions http://dx.doi.org/10.5213/inj.2013.17.3.130INJ syndrome, pregnancy, diabetes mellitus, and obesity.",Non-OADS,/arxiv_data1/oa_pdf/72/96/inj-17-130.PMC3797893.pdf
"•  Physical Exercise Improves Voiding Functions http://dx.doi.org/10.5213/inj.2013.17.3.130INJ performed the exercises on a motorized treadmill and station - ary cycle for 40 minutes, respectively, and performed resistance  exercise for 20 minutes once per day for 52 weeks.",Non-OADS,/arxiv_data1/oa_pdf/72/96/inj-17-130.PMC3797893.pdf
"•  Physical Exercise Improves Voiding Functions http://dx.doi.org/10.5213/inj.2013.17.3.130INJ cling and treadmill exercise for 40 minutes, respectively, at an  intensity of approximately 50% of VO 2 peak (peak oxygen vol - ume) during this study.",Non-OADS,/arxiv_data1/oa_pdf/72/96/inj-17-130.PMC3797893.pdf
•  Physical Exercise Improves Voiding Functions http://dx.doi.org/10.5213/inj.2013.17.3.130INJ gree of obesity in the subjects.,Non-OADS,/arxiv_data1/oa_pdf/72/96/inj-17-130.PMC3797893.pdf
•  Physical Exercise Improves Voiding Functions http://dx.doi.org/10.5213/inj.2013.17.3.130INJ elderly women.,Non-OADS,/arxiv_data1/oa_pdf/72/96/inj-17-130.PMC3797893.pdf
"•  Physical Exercise Improves Voiding Functions http://dx.doi.org/10.5213/inj.2013.17.3.130INJ continence, usually with frequency and nocturia in the absence  of other pathologies.",Non-OADS,/arxiv_data1/oa_pdf/72/96/inj-17-130.PMC3797893.pdf
•  Physical Exercise Improves Voiding Functions http://dx.doi.org/10.5213/inj.2013.17.3.130INJ physical exercise may relieve the symptoms of OAB.,Non-OADS,/arxiv_data1/oa_pdf/72/96/inj-17-130.PMC3797893.pdf
•  Physical Exercise Improves Voiding Functions http://dx.doi.org/10.5213/inj.2013.17.3.130INJ bolic syndrome (from Studies of a Targeted Risk Reduction Inter - vention through Defined Exercise).,Non-OADS,/arxiv_data1/oa_pdf/72/96/inj-17-130.PMC3797893.pdf
"INJ This is an Open Access article distributed under the terms of the Creative Commons Attri - bution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c3/0b/inj-17-139.PMC3797894.pdf
The response related to desmopressin treatment is assessed Original Article http://dx.doi.org/10.5213/inj.2013.17.3.139 pISSN 2093-4777 · eISSN 2093-6931,Non-OADS,/arxiv_data1/oa_pdf/c3/0b/inj-17-139.PMC3797894.pdf
"140    www.einj.orgLee and Park  •  Efficacy of Salvage Interferential Electrical Stimulation Therapy http://dx.doi.org/10.5213/inj.2013.17.3.139INJ within 1 to 2 weeks, and when a response is shown, it is admin - istered for 3 months.",Non-OADS,/arxiv_data1/oa_pdf/c3/0b/inj-17-139.PMC3797894.pdf
"www.einj.org     141 Lee and Park  •  Efficacy of Salvage Interferential Electrical Stimulation Therapy http://dx.doi.org/10.5213/inj.2013.17.3.139INJ in 7 patients (70%); and no response (0–49% decrease), in 1 pa - tient (10%).",OADS,/arxiv_data1/oa_pdf/c3/0b/inj-17-139.PMC3797894.pdf
"142    www.einj.orgLee and Park  •  Efficacy of Salvage Interferential Electrical Stimulation Therapy http://dx.doi.org/10.5213/inj.2013.17.3.139INJ trally active medications such as imipramine, and prostaglan - din synthesis inhibitors and prostaglandin receptor antagonists  can be prescribed to decrease bladder overactivity.",Non-OADS,/arxiv_data1/oa_pdf/c3/0b/inj-17-139.PMC3797894.pdf
www.einj.org     143 Lee and Park  •  Efficacy of Salvage Interferential Electrical Stimulation Therapy http://dx.doi.org/10.5213/inj.2013.17.3.139INJ symptoms.,OADS,/arxiv_data1/oa_pdf/c3/0b/inj-17-139.PMC3797894.pdf
144    www.einj.orgLee and Park  •  Efficacy of Salvage Interferential Electrical Stimulation Therapy http://dx.doi.org/10.5213/inj.2013.17.3.139INJ standardization document from the International Children’s Con - tinence Society.,Non-OADS,/arxiv_data1/oa_pdf/c3/0b/inj-17-139.PMC3797894.pdf
"INJ This is an Open Access article distributed under the terms of the Creative Commons Attri - bution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/23/b5/inj-17-145.PMC3797895.pdf
If these symptoms are not Original Article http://dx.doi.org/10.5213/inj.2013.17.3.145 pISSN 2093-4777 · eISSN 2093-6931,Non-OADS,/arxiv_data1/oa_pdf/23/b5/inj-17-145.PMC3797895.pdf
"•  TVT and TVT-O for Overactive Bladder http://dx.doi.org/10.5213/inj.2013.17.3.145INJ resolved, patients may consider the surgery to be ineffective.",Non-OADS,/arxiv_data1/oa_pdf/23/b5/inj-17-145.PMC3797895.pdf
•  TVT and TVT-O for Overactive Bladder http://dx.doi.org/10.5213/inj.2013.17.3.145INJ group and from 5.1 ± 4.4 to 1.8 ± 3.0 in the TVT-O group.,OADS,/arxiv_data1/oa_pdf/23/b5/inj-17-145.PMC3797895.pdf
"•  TVT and TVT-O for Overactive Bladder http://dx.doi.org/10.5213/inj.2013.17.3.145INJ sodes, urgency grade, and maximum voided volume greatly  improved with TVT than with TVT-O.",Non-OADS,/arxiv_data1/oa_pdf/23/b5/inj-17-145.PMC3797895.pdf
"•  TVT and TVT-O for Overactive Bladder http://dx.doi.org/10.5213/inj.2013.17.3.145INJ open in the TOT and TVT-O treatments than in the TVT, and  that a larger angle at rest is significantly associated with recur - rent SUI [26].",Non-OADS,/arxiv_data1/oa_pdf/23/b5/inj-17-145.PMC3797895.pdf
•  TVT and TVT-O for Overactive Bladder http://dx.doi.org/10.5213/inj.2013.17.3.145INJ by their respective preference for OAB symptoms instead of  randomizing the patients.,Non-OADS,/arxiv_data1/oa_pdf/23/b5/inj-17-145.PMC3797895.pdf
•  TVT and TVT-O for Overactive Bladder http://dx.doi.org/10.5213/inj.2013.17.3.145INJ al.,OADS,/arxiv_data1/oa_pdf/23/b5/inj-17-145.PMC3797895.pdf
"INJ This is an Open Access article distributed under the terms of the Creative Commons Attri - bution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/44/05/inj-17-152.PMC3797896.pdf
"”  Jang Hwan Kim Department of Urology, Y onsei University College of Medicine E-mail: jkim@yuhs.acBook Review http://dx.doi.org/10.5213/inj.2013.17.3.152 pISSN 2093-4777 · eISSN 2093-6931",Non-OADS,/arxiv_data1/oa_pdf/44/05/inj-17-152.PMC3797896.pdf
"INJ This is an Open Access article distributed under the terms of the Creative Commons Attri - bution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/09/83/inj-17-97.PMC3797897.pdf
Int Neurourol J 2013;17:98-106.Editorial  http://dx.doi.org/10.5213/inj.2013.17.3.97 pISSN 2093-4777 · eISSN 2093-6931,Non-OADS,/arxiv_data1/oa_pdf/09/83/inj-17-97.PMC3797897.pdf
"INJ This is an Open Access article distributed under the terms of the Creative Commons Attri - bution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which  permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c7/b9/inj-17-98.PMC3797898.pdf
"For exam - ple, the EndoSure of Cardiomems, which is inserted into the  aorta to measure intrasac pressure during endovascular abdomi - nal aortic aneurysm repair and during endovascular thoracic Review Article http://dx.doi.org/10.5213/inj.2013.17.3.98 pISSN 2093-4777 · eISSN 2093-6931",Non-OADS,/arxiv_data1/oa_pdf/c7/b9/inj-17-98.PMC3797898.pdf
"www.einj.org     99 Joung  •  Development of Implantable Medical Devices  http://dx.doi.org/10.5213/inj.2013.17.3.98INJ aortic aneurysm repair, can detect intraoperative leaks of the  stent graft.",Non-OADS,/arxiv_data1/oa_pdf/c7/b9/inj-17-98.PMC3797898.pdf
"100    www.einj.orgJoung  •  Development of Implantable Medical Devices  http://dx.doi.org/10.5213/inj.2013.17.3.98INJ GENERAL THOUGHTS ON IMPLANTABLE  MEDICAL DEVICES The designing of an implantable medical device is initiated with  information gathering from three main participants: the patient,  the medical staff, and the engineer.",Non-OADS,/arxiv_data1/oa_pdf/c7/b9/inj-17-98.PMC3797898.pdf
www.einj.org     101 Joung  •  Development of Implantable Medical Devices  http://dx.doi.org/10.5213/inj.2013.17.3.98INJ surrounding environment immediately responds to the materi - al itself or to microorganisms on the surface of the device.,Non-OADS,/arxiv_data1/oa_pdf/c7/b9/inj-17-98.PMC3797898.pdf
"102    www.einj.orgJoung  •  Development of Implantable Medical Devices  http://dx.doi.org/10.5213/inj.2013.17.3.98INJ Structural Design of Implantable Devices and Delivery  Systems The human body is a complex system operated by mechanical,  chemical, and electrical mechanisms of numerous organs, tis - sues, and cells.",OADS,/arxiv_data1/oa_pdf/c7/b9/inj-17-98.PMC3797898.pdf
"www.einj.org     103 Joung  •  Development of Implantable Medical Devices  http://dx.doi.org/10.5213/inj.2013.17.3.98INJ to the external coil within range, the magnetic flux makes cur - rent flow through the inner coil and induces uniform electrical  voltage by rectification and regulation.",Non-OADS,/arxiv_data1/oa_pdf/c7/b9/inj-17-98.PMC3797898.pdf
104    www.einj.orgJoung  •  Development of Implantable Medical Devices  http://dx.doi.org/10.5213/inj.2013.17.3.98INJ tain the best device.,Non-OADS,/arxiv_data1/oa_pdf/c7/b9/inj-17-98.PMC3797898.pdf
Available from: http://www.iso.org/ iso/catalogue_detail?csnumber=36786.,Non-OADS,/arxiv_data1/oa_pdf/c7/b9/inj-17-98.PMC3797898.pdf
Available  from: http://www.fas.org/sgp/crs/misc/R42130.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c7/b9/inj-17-98.PMC3797898.pdf
www.einj.org     105 Joung  •  Development of Implantable Medical Devices  http://dx.doi.org/10.5213/inj.2013.17.3.98INJ 24.,Non-OADS,/arxiv_data1/oa_pdf/c7/b9/inj-17-98.PMC3797898.pdf
Available from:  http://www.intel.com/content/www/us/en/silicon-innovations/ standards-22-nanometers-technology-backgrounder.html.,Non-OADS,/arxiv_data1/oa_pdf/c7/b9/inj-17-98.PMC3797898.pdf
106    www.einj.orgJoung  •  Development of Implantable Medical Devices  http://dx.doi.org/10.5213/inj.2013.17.3.98INJ Med Implants 1991;1:89-106.,OADS,/arxiv_data1/oa_pdf/c7/b9/inj-17-98.PMC3797898.pdf
"Key Words :   International Digestive Endoscopy Network; Korean Society of Gastrointestinal Endoscopy;    Japan Gastrointestinal Endoscopy Society; Highlight; Clinical Endoscopy한 학교에 과가 2개인 경우 Departments of 1Aaa~ and 2Bbb~Open Access Received: July 20, 2013    Accepted:  July 30, 2013 Correspondence: Ki Baik Hahm  Digestive Disease Center, CHA Bundang Medical Center, CHA University, and CHA Cancer Prevention Research Center, CHA Cancer Institute, 59 Y atap-ro,  Bundang-gu, Seongnam 463-712, Korea Tel: +82-31-780-5220, Fax: +82-31-780-5219, E-mail: hahmkb@cha.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.5.425",Non-OADS,/arxiv_data1/oa_pdf/3f/74/ce-46-425.PMC3797920.pdf
"Key Words :  Forceps biopsy; Endoscopic resection; Histologic discrepancy; UlcerOpen Access Received: June 8, 2013    Revised: July 5, 2013 Accepted:  July 8, 2013 Correspondence: Chan Gyoo KimCenter for Gastric Cancer, National Cancer Center, 323 Ilsan-ro, Ilsandong- gu, Goyang 410-769, Korea Tel: +82-31-920-1620, Fax: +82-31-920-2798, E-mail: glse@chol.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.5.436 INTRODUCTION Endoscopic forceps biopsy is essential before planning an  endoscopic resection of gastric epithelial tumors.",Non-OADS,/arxiv_data1/oa_pdf/c9/ec/ce-46-436.PMC3797921.pdf
"Key Words :  Endosonography; Subepithelial masses; Endoscopic ultrasound-guided fine needle aspiration;    Endoscopic ultrasound-guided core needle biopsyOpen Access Received: June 9, 2013    Revised: August 2, 2013 Accepted:  August 2, 2013 Correspondence: Joo Ha HwangDivision of Gastroenterology and Hepatology, Department of Medicine, Uni- versity of Washington School of Medicine, 1959 NE Pacific St, Box 356424,  Seattle, W A, USATel: +1-206-685-2283, Fax: +1-206-598-4303 E-mail: jooha@u.washington.edu cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.5.441",Non-OADS,/arxiv_data1/oa_pdf/be/ea/ce-46-441.PMC3797922.pdf
"Key Words :  Microscopy, confocal; Gastric intestinal metaplasia; Barrett esophagus; DysplasiaOpen Access Received: June 10, 2013    Accepted:  July 4, 2013 Correspondence: Joo Ha Hwang Division of Gastroenterology, Department of Medicine, University of Wash-ington, School of Medicine, 1959 NE Pacific St, Box 356424, Seattle, W A, USA Tel: +1-206-685-2283, Fax: +1-206-221-3992 E-mail: jooha@u.washington.edu cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.5.445 INTRODUCTION The endoscopic use of confocal microscopy for in vivo  di- agnosis is a relatively new application of a previously ex vivo  technology.1 Probe catheters range in size from 0.9- to 2.5- mm allowing their use through any endoscope with a 10 Fr  working channel.",Non-OADS,/arxiv_data1/oa_pdf/cc/0a/ce-46-445.PMC3797923.pdf
"Key Words :  Stomach; Duodenum; Neuroendocrine tumors; Endoscopic treatmentOpen Access Received: June 18, 2013    Revised: June 28, 2013 Accepted:  July 1, 2013 Correspondence: Moo In ParkDepartment of Internal Medicine, Kosin University College of Medicine, 262  Gamcheon-ro, Seo-gu, Busan 602-702, Korea Tel: +82-51-990-6719, Fax: +82-51-990-3005 E-mail: mipark@ns.kosinmed.or.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.5.450 INTRODUCTION Neuroendocrine tumors (NETs) are defined as epithelial  neoplasms with predominant neuroendocrine differentiation,  arising throughout the body.",Non-OADS,/arxiv_data1/oa_pdf/fa/c2/ce-46-450.PMC3797924.pdf
"Key Words :  Endoscopic submucosal dissection; Hemorrhage; Prevention and control; HemostasisOpen Access Received: June 27, 2013    Accepted:  July 4, 2013 Correspondence: Sang Kil Lee Division of Gastroenterology, Department of Internal Medicine, Y onsei Insti-tute of Gastroenterology, Y onsei University College of Medicine, 50 Y onsei-ro,  Seodaemun-gu, Seoul 120-749, Korea Tel: +82-2-2228-1996, Fax: +82-2-393-6884, E-mail: sklee@yuhs.ac cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.5.456 INTRODUCTION Endoscopic submucosal dissection (ESD) was developed  for en bloc resections for all tumor sizes and locations.1 ESD  is an advanced technique with a long procedure time com- pared to endoscopic mucosal resection (EMR).2,3 In addition,  intraoperative bleeding is more frequent during ESD than during EMR.",Non-OADS,/arxiv_data1/oa_pdf/a9/4b/ce-46-456.PMC3797925.pdf
"Key Words :  Endoscopic submucosal dissection; Early gastric cancer; Extended indication; Long-term outcomeOpen Access Received: July 12, 2013    Revised: August 6, 2013 Accepted:  August 6, 2013 Correspondence: Hwoon-Y ong JungDepartment of Gastroenterology, Asan Digestive Disease Research Institute,  Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro  43-gil, Songpa-gu, Seoul 138-736, KoreaTel: +82-2-3010-3197, Fax: +82-2-476-0824, E-mail: hyjung@amc.seoul.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.5.463 INTRODUCTION Gastric cancer is the most common malignancy in Korea.",Non-OADS,/arxiv_data1/oa_pdf/56/10/ce-46-463.PMC3797926.pdf
"Key Words :  Colorectal neoplasms; Endoscopic submucosal dissection; Traction; GravitationOpen Access Received: June 8, 2013    Revised: July 8, 2013 Accepted:  July 18, 2013 Correspondence: Bo-In LeeDepartment of Internal Medicine, Incheon St. Mary’s Hospital, The Catholic  University of Korea College of Medicine, 56 Dongsu-ro, Bupyeong-gu, Incheon  403-720, KoreaTel: +82-32-280-5052, Fax: +82-32-280-5987, E-mail: gidoc4u@gmail.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.5.467 INTRODUCTION As a result of the development of endoscopic submucosal  dissection (ESD), the en bloc  resection of larger gastrointesti- nal neoplasms can be performed successfully.",Non-OADS,/arxiv_data1/oa_pdf/09/e2/ce-46-467.PMC3797927.pdf
DOI: http://dx.doi.org/10.1007/s00464-013-2887-6.,Non-OADS,/arxiv_data1/oa_pdf/09/e2/ce-46-467.PMC3797927.pdf
"Key Words :  Colorectal surgery; Dilatation; Endoscopy, gastrointestinalOpen Access Received: June 8, 2013    Revised: July 19, 2013 Accepted:  August 9, 2013 Correspondence: Seong Woo JeonDepartment of Internal Medicine, Kyungpook National University Hospital,  Kyungpook National University School of Medicine, 130 Dongdeok-ro, Jung- gu, Daegu 700-721, KoreaTel: +82-53-200-3517, Fax: +82-53-200-2077, E-mail: swjeon@knu.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.5.472 INTRODUCTION Benign colorectal strictures can develop after diverticulitis,  ischemic colitis, radiation colitis, or colonic resection.",Non-OADS,/arxiv_data1/oa_pdf/af/fe/ce-46-472.PMC3797928.pdf
"Key Words :  Gastrointestinal; Colonoscopy; HemorrageOpen Access Received: June 8, 2013    Revised: July 7, 2013 Accepted:  August 12, 2013 Correspondence: Byung Ik JangDepartment of Internal Medicine, Y eungnam University College of Medicine,  170 Hyeonchung-ro, Nam-gu, Daegu 705-717, Korea Tel: +82-53-620-3830, Fax: +82-53-654-8386, E-mail: jbi@med.yu.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.5.476",Non-OADS,/arxiv_data1/oa_pdf/bf/fb/ce-46-476.PMC3797929.pdf
"Key Words :  Double-balloon enteroscopy; Single-balloon enteroscopy; Spiral enteroscopyOpen Access Received:  June 16, 2013    Accepted:  June 25, 2013 Correspondence:  Jin-Oh Kim Institute of Digestive Research, Digestive Disease Center, Department of Inter - nal Medicine, Soonchunhyang University College of Medicine, 59 Daesagwan- ro, Y ongsan-gu, Seoul 140-743, Korea Tel: +82-2-709-9202, Fax: +82-2-709-9696, E-mail:  jokim@schmc.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.5.480",Non-OADS,/arxiv_data1/oa_pdf/87/4b/ce-46-480.PMC3797930.pdf
"Key Words :  Gastrointestinal tract; Hemorrhage; EmbolizationOpen Access Received: June 17, 2013    Accepted:  June 25, 2013 Correspondence: Ji Hoon Shin Depatment of Radiology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Korea Tel: +82-2-3010-4352, Fax: +82-2-476-0006, E-mail: jhshin@amc.seoul.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.5.486 INTRODUCTION In gastrointestinal (GI) bleeding, endoscopic diagnosis and  therapy is the initial treatment of choice as it is imperative to  determine whether bleeding is variceal or arterial, and endo-scopic treatments usually achieve primary hemostasis in the majority of patients.",Non-OADS,/arxiv_data1/oa_pdf/e9/10/ce-46-486.PMC3797931.pdf
"Key Words :  Endoscopic mucosal resection; Cap; Band ligationOpen Access Received: June 18, 2013    Revised: August 23, 2013 Accepted:  August 24, 2013 Correspondence: Seun Ja ParkDepartment of Internal Medicine, Kosin University Gospel Hospital, Kosin  University College of Medicine, 262 Gamcheon-ro, Seo-gu, Busan 602-702,  KoreaTel: +82-51-990-5061, Fax: +82-51-990-3046 E-mail: parksj@ns.kosinmed.or.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.5.492 INTRODUCTION Endoscopic mucosal resection (EMR) is an endoscopic al- ternative to surgical resection of mucosal and submucosal ne- oplastic lesions and intramucosal cancers.",Non-OADS,/arxiv_data1/oa_pdf/04/68/ce-46-492.PMC3797932.pdf
"Key Words :  Perforation; Colonoscopy; Surgical instruments; Endoscopy; ColonOpen Access Received:  June 26, 2013    Accepted:  July 2, 2013 Correspondence:  Jeong-Sik Byeon Division of Gastroenterology, Department of Internal Medicine, Asan Medi - cal Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil,  Songpa-gu, Seoul 138-736, Korea Tel: +82-2-3010-3905, Fax: +82-2-485-5782, E-mail:  jsbyeon@amc.seoul.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.5.495",Non-OADS,/arxiv_data1/oa_pdf/4f/4e/ce-46-495.PMC3797933.pdf
"Key Words :  Pancreatic pseudocyst; Metal stents; Plastic stents; Endoscopic ultrasound-guided pseudocyst drainage;    Endoscopic drainageOpen Access Received: May 8, 2013    Revised: June 30, 2013 Accepted:  July 17, 2013 Correspondence: Shyam VaradarajuluCenter for Interventional Endoscopy, Florida Hospital, 601 East Rollins St,  Orlando, FL 32803, USA Tel: +1-407-303-2570, Fax: +1-407-303-2585 E-mail: svaradarajulu@yahoo.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.5.500 INTRODUCTION Endoscopic treatment outcomes are directly related to the  type of pancreatic fluid collection (PFC) being treated; while  the treatment success for pancreatic pseudocysts is greater than 90%, it is at best 50% to 65% for walled-off pancreatic necrosis (WOPN).",Non-OADS,/arxiv_data1/oa_pdf/13/f4/ce-46-500.PMC3797934.pdf
DOI: http://dx.doi.org/10.1111/jgh.12328.,Non-OADS,/arxiv_data1/oa_pdf/13/f4/ce-46-500.PMC3797934.pdf
"Key Words :  Endoscopic ultrasound-guided biopsy; Endoscopic ultrasound-guided fine needle aspiration; Trucut biopsy; ProCore;     Flexible 19 GOpen Access Received:  May 8, 2013    Revised:  June 24, 2013 Accepted:  June 24, 2013 Correspondence:  Shyam Varadarajulu Center for Interventional Endoscopy, Florida Hospital, 601 East Rollins St,  Orlando, FL 32803, USA Tel: +1-407-303-2570, Fax: +1-407-303-2585,  E-mail:  svaradarajulu@yahoo.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.5.503",Non-OADS,/arxiv_data1/oa_pdf/ce/ab/ce-46-503.PMC3797935.pdf
"Key Words :  Endosonography; Pancreatic fluid collections; Pancreatic pseudocyst; Nonbulging pancreatic fluid collectionsOpen Access Received: June 1, 2013    Revised: July 25, 2013 Accepted:  August 1, 2013 Correspondence: Michel KahalehDivision of Gastroenterology and Hepatology, New Y ork Presbyterian Hospi- tal, Weill Cornell Medical College, 525 E 68th St, New Y ork, NY 10021, USA Tel: +1-646-962-4797, Fax: +1-646-962-4000, E-mail: mkahaleh@gmail.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.5.506",Non-OADS,/arxiv_data1/oa_pdf/87/43/ce-46-506.PMC3797936.pdf
"Key Words :  Bile ducts, extrahepatic; Biliary tract; Drug-eluting stents; Stents Open Access Received: June 4, 2013    Revised: June 28, 2013 Accepted:  June 29, 2013 Correspondence: Dae Hwan KangNational Research and Development Center for Hepatobiliary Cancer, Re- search Institute for Convergence of Biomedical Science and Technology, Pu- san National University Y angsan Hospital, Pusan National University School of Medicine, 20 Geumo-ro, Y angsan 626-787, Korea Tel: +82-55-360-3870, Fax: +82-55-360-3879, E-mail: sulsulpul@yahoo.co.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.5.515 INTRODUCTION Over the last 20 years since using biliary stents for palliative  treatment of malignant biliary obstruction, the indication of  biliary stents has expanded continuously to include various benign biliary diseases.",Non-OADS,/arxiv_data1/oa_pdf/94/23/ce-46-515.PMC3797937.pdf
"Key Words :  Cholangiopancreatography, endoscopic retrograde; Perforation; Duodenum; Therapeutics소화기내시경 46-5-19 / 재교 9.27 (디자인1팀  강은지) Open Access Received:  June 7, 2013    Accepted:  June 25, 2013 Correspondence:  Tae Hoon Lee Division of Gastroenterology, Department of Internal Medicine, Soonchun - hyang University Cheonan Hospital, Soonchunhyang University College of  Medicine, 31 Suncheonhyang 6-gil, Dongnam-gu, Cheonan 330-930, Korea Tel: +82-41-570-3662, Fax: +82-41-574-5762, E-mail:  thlee9@schmc.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.5.522",Non-OADS,/arxiv_data1/oa_pdf/3a/d9/ce-46-522.PMC3797938.pdf
"Key Words :  Percutaneous transhepatic cholangioscopy; Diagnostic role; Therapeutic roleOpen Access Received: June 9, 2013    Revised: August 12, 2013 Accepted:  August 21, 2013 Correspondence: Sung Koo LeeDivision of Gastroenterology, Department of Internal Medicine, Asan Medi- cal Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil,  Songpa-gu, Seoul 138-736, KoreaTel: +82-2-3010-3186, Fax: +82-2-3010-3186, E-mail: sklee@amc.seoul.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.5.529 INTRODUCTION Direct visualization of the biliary system has advantages for  the identification and treatment of intraductal lesions com- pared to indirect imaging of endoscopic retrograde cholangi - opancreatography (ERCP).",Non-OADS,/arxiv_data1/oa_pdf/73/a8/ce-46-529.PMC3797939.pdf
"Key Words :  Peroral cholangioscopy; Ultraslim endoscope; Bile duct diseasesOpen Access Received:  June 21, 2013    Accepted:  June 25, 2013 Correspondence:  Jong Ho Moon Digestive Disease Center, Soonchunhyang University Bucheon Hospital,  Soonchunhyang University School of Medicine, 170 Jomaru-ro, Wonmi-gu,  Bucheon 420-767, Korea Tel: +82-32-621-5094, Fax: +82-32-621-5080, E-mail:  jhmoon@schmc.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.5.537",Non-OADS,/arxiv_data1/oa_pdf/bd/9b/ce-46-537.PMC3797940.pdf
"Key Words :  Endosonography; Endoscopic ultrasound-guided fine needle aspiration; Pancreatic neoplasmsOpen Access Received:  June 27, 2013    Accepted:  July 3, 2013 Correspondence:  Eun Y oung Kim Department of Internal Medicine, Catholic University of Daegu School of  Medicine, 33 Duryugongwon-ro 17-gil, Nam-gu, Daegu 705-718, Korea Tel: +82-53-650-4092, Fax: +82-53-624-3281, E-mail:  kimey@cu.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.5.540",Non-OADS,/arxiv_data1/oa_pdf/56/b9/ce-46-540.PMC3797941.pdf
"Key Words :  Endosonography; Cholangiopancreatography, endoscopic retrograde; Endoscopic ultrasound guided biliary drainage;    Biliary strictureOpen Access Received: July 9, 2013    Revised: August 13, 2013 Accepted:  August 13, 2013 Correspondence: Michel KahalehDivision of Gastroenterology and Hepatology, New Y ork Presbyterian Hospi- tal, Weill Cornell Medical College, 525 E 68th St, New Y ork, NY 10021, USA Tel: +1-646-962-4797, Fax: +1-646-962-4000, E-mail: mkahaleh@gmail.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.5.543",Non-OADS,/arxiv_data1/oa_pdf/6a/4f/ce-46-543.PMC3797942.pdf
"Key Words :  Endosonography; Biopsy, fine-needle; Pancreatic cyst; Lesions; Pancreatic neoplasmsOpen Access Received: July 23, 2013    Revised: August 13, 2013 Accepted:  August 19, 2013 Correspondence: Michel KahalehDivision of Gastroenterology and Hepatology, New Y ork Presbyterian Hospi- tal, Weill Cornell Medical College, 525 E 68th St, New Y ork, NY 10021, USA Tel: +1-646-962-4797, Fax: +1-646-962-4000, E-mail: mkahaleh@gmail.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.5.552 INTRODUCTION Despite advancements in medical and surgical therapy in  the past few decades, pancreatic cancer continues to be a dev - astating disease with a dismal prognosis.",Non-OADS,/arxiv_data1/oa_pdf/5b/ab/ce-46-552.PMC3797943.pdf
Available from: http://seer.cancer.gov/csr/1975_2010/.,Non-OADS,/arxiv_data1/oa_pdf/5b/ab/ce-46-552.PMC3797943.pdf
"Key Words :  Lymphoma, B-cell, marginal zone; Mucosa-associated lymphoid tissue; Endosonography; DuodenumOpen Access Received:  August 18, 2012    Revised:  October 4, 2012 Accepted:  October 9, 2012 Correspondence:  Hyung Wook Kim Division of Gastroenterology, Department of Internal Medicine, Pusan National  University School of Medicine, 49 Busandaehak-ro, Yangsan 626-815, Korea Tel: +82-51-360-1535, Fax: +82-51-360-1536, E-mail:  mdkhwook@gmail.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.5.563",Non-OADS,/arxiv_data1/oa_pdf/98/94/ce-46-563.PMC3797944.pdf
"Key Words :  Stomach; Inverted hyperplastic polyp; Gastritis cystica profunda; AdenocarcinomaOpen Access Received: August 31, 2012    Revised: November 2, 2012 Accepted:  November 27, 2012 Correspondence: Jong Kyu ParkDepartment of Internal Medicine, Gangneung Asan Hospital, University of  Ulsan College of Medicine, 38 Bangdong-gil, Sacheon-myeon, Gangneung  210-711, KoreaTel: +82-33-610-3949, Fax: +82-33-610-4960, E-mail: saiah@naver.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.5.568",Non-OADS,/arxiv_data1/oa_pdf/27/85/ce-46-568.PMC3797945.pdf
"Key Words :  Peutz-Jeghers syndrome; Stomach neoplasms; Pancreatic neoplasmsOpen Access Received: September 20, 2012    Revised: November 30, 2012 Accepted:  December 5, 2012 Correspondence: Sung Pyo HongDepartment of Internal Medicine, CHA Bundang Medical Center, CHA Uni- versity, 59 Y atap-ro, Bundang-gu, Seongnam 463-712, Korea Tel: +82-31-780-5214, Fax: +82-31-780-5219, E-mail: sphong@cha.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.5.572 INTRODUCTION Hyperpigmented mucocutaneous macules are clues to the  suspicion of Peutz-Jeghers syndrome (PJS).",Non-OADS,/arxiv_data1/oa_pdf/92/a2/ce-46-572.PMC3797946.pdf
"Key Words :  Esophageal carcinoid tumor; Endosonography; Endoscopic mucosal resection Open Access Received:  September 24, 2012    Revised:  October 15, 2012 Accepted:  October 29, 2012 Correspondence:  Seun Ja Park Department of Internal Medicine, Kosin University College of Medicine, 262  Gamcheon-ro, Seo-gu, Busan 602-702, Korea Tel: +82-51-990-5209, Fax: +82-51-990-3005, E-mail:  parksj6406@yahoo.co.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.5.576",Non-OADS,/arxiv_data1/oa_pdf/6b/1d/ce-46-576.PMC3797947.pdf
"Key Words :  Amyloidosis; Gastric outlet obstructionOpen Access Received: September 28, 2012    Accepted:  December 26, 2012 Correspondence: Hyun Woong Lee Division of Gastroenterology, Department of Internal Medicine, Chung-Ang University College of Medicine, 84 Heukseok-ro, Dongjak-gu, Seoul 156-861,  Korea  Tel: +82-2-6299-1417, Fax: +82-2-6299-1137, E-mail: lhwdoc@hanmail.net  cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.5.579 INTRODUCTION The term amyloidosis refers to a group of disorders char - acterized by the extracellular accumulation of insoluble, fibril - lar proteins in various organs and tissues.1,2 The fibrils, com- posed of low-molecular-weight subunits of serum proteins,  may be recognized microscopically by their ability to bind to Congo red, resulting in a characteristic green birefringence under polarized light.",Non-OADS,/arxiv_data1/oa_pdf/ba/f7/ce-46-579.PMC3797948.pdf
"Key Words :  Somatostatinoma; Stomach metastasis; Endosonography; Neuroendocrine tumorsOpen Access Received: September 28, 2012    Revised: November 6, 2012 Accepted:  January 2, 2013 Correspondence: Varayu PrachayakulDivision of Gastroenterology, Department of Internal Medicine, Siriraj Hos- pital, Mahidol University Faculty of Medicine, 2 Prannok Rd, Bangkoknoi,  Bangkok 10700, Thailand Tel: +66-81-865-4646, Fax: +66-2-412-1088, E-mail: kaiyjr@gmail.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.5.582",Non-OADS,/arxiv_data1/oa_pdf/8c/54/ce-46-582.PMC3797949.pdf
"Key Words :  Lipoma; Colonoscopy; ColonOpen Access Received: September 4, 2012    Revised: October 6, 2012 Accepted:  October 11, 2012 Correspondence: Chang-Il KwonDigestive Disease Center, CHA Bundang Medical Center, CHA University, 59  Y atap-ro, Bundang-gu, Seongnam 463-712, Korea Tel: +82-31-780-5220, Fax: +82-31-780-5219, E-mail: endoscopy@cha.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.5.586 INTRODUCTION Colonic lipoma is the second most common, but very rare,  tumor after colon polyps.1 Although most cases are found in - cidentally in asymptomatic patients, some cases may present  with symptoms such as abdominal pain, diarrhea, intestinal obstruction and bleeding.",Non-OADS,/arxiv_data1/oa_pdf/26/f0/ce-46-586.PMC3797950.pdf
"Key Words :  Chronic intestinal pseudo-obstruction; Pregnancy; Colonoscopic decompression; Interstitial cells of CajalOpen Access Received:  September 4, 2012    Revised:  December 6, 2012 Accepted:  February 12, 2013 Correspondence:  Bo-In Lee Division of Gastroenterology, Department of Internal Medicine, Incheon St.  Mary’s Hospital, The Catholic University of Korea College of Medicine, 56  Dongsu-ro, Bupyeong-gu, Incheon 403-720, Korea Tel: +82-32-280-5051, Fax: +82-32-280-5082, E-mail:  gidoc4u@gmail.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.5.591",Non-OADS,/arxiv_data1/oa_pdf/33/6f/ce-46-591.PMC3797951.pdf
"Key Words :  Endosonography; Biopsy, fine-needle; LymphangiomaOpen Access Received: December 3, 2012    Revised: January 21, 2013 Accepted:  January 23, 2013 Correspondence: Tyler BlackDepartment of Internal Medicine, Duke University Medical Center, 2301 Er - win Rd, Durham, NC 27710, USATel: +1-334-714-4850, Fax: +1-919-681-6448, E-mail: tylerpblack@gmail.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2013.46.5.595",Non-OADS,/arxiv_data1/oa_pdf/51/ca/ce-46-595.PMC3797952.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d1/ef/srep02969.PMC3797983.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2969 | DOI: 10.1038/srep02969 4",Non-OADS,/arxiv_data1/oa_pdf/d1/ef/srep02969.PMC3797983.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/3f/07/srep02979.PMC3797984.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2979 | DOI: 10.1038/srep02979 8",Non-OADS,/arxiv_data1/oa_pdf/3f/07/srep02979.PMC3797984.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d2/b1/srep02975.PMC3797987.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2975 | DOI: 10.1038/srep02975 8",Non-OADS,/arxiv_data1/oa_pdf/d2/b1/srep02975.PMC3797987.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2970 | DOI: 10.1038/srep02970 7",Non-OADS,/arxiv_data1/oa_pdf/5f/d9/srep02970.PMC3797988.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/66/ff/srep02968.PMC3797989.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2968 | DOI: 10.1038/srep02968 4",Non-OADS,/arxiv_data1/oa_pdf/66/ff/srep02968.PMC3797989.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/63/13/srep02973.PMC3797990.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2973 | DOI: 10.1038/srep02973 8",Non-OADS,/arxiv_data1/oa_pdf/63/13/srep02973.PMC3797990.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ba/d1/srep02978.PMC3797991.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2978 | DOI: 10.1038/srep02978 8",Non-OADS,/arxiv_data1/oa_pdf/ba/d1/srep02978.PMC3797991.pdf
Travel and Tourism: Economic Impact (2012).URL http://www.wttc.org/site_media/uploads/downloads/world2012.pdf Accessed March 2013.,Non-OADS,/arxiv_data1/oa_pdf/f2/ad/srep02976.PMC3797992.pdf
wrote the manuscript.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/f2/ad/srep02976.PMC3797992.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2976 | DOI: 10.1038/srep02976 7",Non-OADS,/arxiv_data1/oa_pdf/f2/ad/srep02976.PMC3797992.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc- nd/3.0/ Appendix Appendix Ocriplasmin PI—UK and Ireland JETREAs.0.5 mg/0.2 ml concentrate for solution for injection (ocriplasmin) Prescribing Information (Refer to full Summary of Product Characteristics(SmPC) before prescribing) Presentation: Type I glass vial containing 0.2 ml concentrate for solution for injection.",Non-OADS,/arxiv_data1/oa_pdf/f7/ac/eye2013212a.PMC3797995.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2900 | DOI: 10.1038/srep02900 7",Non-OADS,/arxiv_data1/oa_pdf/40/b4/srep02900.PMC3798008.pdf
All authors reviewed the manuscript.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/fb/6c/srep02951.PMC3798042.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2951 | DOI: 10.1038/srep02951 6",Non-OADS,/arxiv_data1/oa_pdf/fb/6c/srep02951.PMC3798042.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a0/76/cmar-5-357.PMC3798099.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpCancer Management and Research 2013:5 357–365Cancer Management and Research Dove press submit your manuscript | www.dovepress.co m Dove press  357Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CMAR.S4932 1Benefit risk assessment and update on the use   of docetaxel in the management of breast cancer Scheryll Alken Catherine M Kelly Department of Medical Oncology,   Mater Misericordiae University  Hospital, Dublin, ireland Correspondence: Catherine M Kelly   Department of Medical Oncology,   Mater Misericordiae  University Hospital,   University College Dublin, eccles Street,   Dublin 7, ireland   Tel +353 803 2990   Fax +353 803 2404   email c atherine.kelly@ucd.i eAbstract:  The objective of this paper is to review the data supporting the use of docetaxel in  the treatment of breast cancer, focusing on pharmacokinetics, efficacy in adjuvant and metastatic  trials alone and in combination with chemotherapeutic and targeted agents, and the toxicity of  docetaxel in comparison to paclitaxel.",Non-OADS,/arxiv_data1/oa_pdf/a0/76/cmar-5-357.PMC3798099.pdf
"Cancer Management and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/cancer-management-and-research-journa lCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of  preventative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/a0/76/cmar-5-357.PMC3798099.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a0/76/cmar-5-357.PMC3798099.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1b/49/copd-8-461.PMC3798110.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2013:8 461–471International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  461RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S49392COPD management: role of symptom assessment  in routine clinical practice Thys van der Molen1,2 Marc Miravitlles3 Janwillem wH Kocks1,2 1Department of General Practice,   2GRIAC (Groningen Research  Institute for Asthma and COPD),   University of Groningen, University  Medical Center Groningen, Groningen,   The Netherlands; 3Pneumology  Department, Hospital Universitari  vall d’Hebron, Biomedical Research  Networking Centre in Respiratory  Diseases (CIBeReS), Barcelona, Spain Correspondence: Thys van der Molen   Department of General Practice,   University Medical Center Groningen,   Antonius Deusinglaan 1, PO 9700 AD,   Groningen, The Netherlands   Tel +315 0363 7478   email t.van.der.molen@med.umcg.n lAbstract:  Patients with chronic obstructive pulmonary disease (COPD) present with a variety  of symptoms that significantly impair health-related quality of life.",Non-OADS,/arxiv_data1/oa_pdf/1b/49/copd-8-461.PMC3798110.pdf
"Available from: http://www.goldcopd.co m.  Accessed July 25, 2013.",Non-OADS,/arxiv_data1/oa_pdf/1b/49/copd-8-461.PMC3798110.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/1b/49/copd-8-461.PMC3798110.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1b/49/copd-8-461.PMC3798110.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5c/aa/dddt-7-1195.PMC3798112.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2013:7 1195–1200Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1195Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S5082 8a comparative study of internal laser-assisted   and conventional liposuction: a look at   the influence of drugs and major surgery   on laboratory postoperative values Andrzej Feliks Przylipiak1 Elżbieta Galicka1 Magdalena Donejko1 Marek niczyporuk1 Jerzy Przylipiak2 1Department of aesthetic Medicine,   Faculty of Pharmacy, Medical  University of Białystok, Białystok,   Poland; 2Medical Office, Białystok,   Poland Correspondence: Andrzej Feliks  Przylipiak   Department of aesthetic Medicine,  Faculty of Pharmacy, Medical University  of Białystok, 15-267 Białystok, Poland   Tel +48 857485822   email medycynaestetyczna@umb.edu.p lBackground:  Liposuction is a type of aesthetic surgery that has been performed on humans  for decades.",Non-OADS,/arxiv_data1/oa_pdf/5c/aa/dddt-7-1195.PMC3798112.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/5c/aa/dddt-7-1195.PMC3798112.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5c/aa/dddt-7-1195.PMC3798112.pdf
fCambridge University Press 2012 The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/ >.,Non-OADS,/arxiv_data1/oa_pdf/4e/76/S0305000912000372a.PMC3798116.pdf
"A humorous example comes from Serge Sharoﬀ’s comment on the frequency list he derived from the Russian National Corpus (http://www.artint.ru/projects/frqlist/frqlist-en.php): As an example, the corpus contains a huge sequel to Tolkien’s The Lord of the Rings written by a Russian author (Nick Perumov).",Non-OADS,/arxiv_data1/oa_pdf/4e/76/S0305000912000372a.PMC3798116.pdf
"Similar points hold for mention of topical entities and concepts, for example as illustrated by the frequency of the lexical item sustainability over time (http://xkcd.com/1007/).VARIATION IN THE INPUT 1097",Non-OADS,/arxiv_data1/oa_pdf/4e/76/S0305000912000372a.PMC3798116.pdf
https://cmusphinx.svn.sourceforge.net/svnroot/cmusphinx/trunk/cmudict/ cmudict.0.7a).,OADS,/arxiv_data1/oa_pdf/4e/76/S0305000912000372a.PMC3798116.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/ >.,Non-OADS,/arxiv_data1/oa_pdf/d3/b3/S0305000912000414a.PMC3798120.pdf
Availableat: http://www.er.uqam.ca/nobel/r32764/Labelle/Acquisition.html.,Non-OADS,/arxiv_data1/oa_pdf/d3/b3/S0305000912000414a.PMC3798120.pdf
"Unpublished doctoral dissertation, University of Massachusetts, Amherst.Available at: http://scholarworks.umass.edu/dissertations/AAI9960783/.",Non-OADS,/arxiv_data1/oa_pdf/d3/b3/S0305000912000414a.PMC3798120.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1c/dd/ijn-8-3895.PMC3798145.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 3895–3905International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3895OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S4869 4local delivery of controlled-release simvastatin/ Plga/hap microspheres enhances bone repair I-chun Tai1–3 Yin-chih Fu3,4 chih-Kuang Wang3,5 Je-Ken chang3,4,6 Mei-ling ho1–3 1graduate Institute of Medicine,   2Department of Physiology,   3Orthopedic research center,   college of Medicine, 4Department  of Orthopedics, 5Department of  Medicinal and applied chemistry,   college of life science, Kaohsiung  Medical University, 6Department of  Orthopedics, Kaohsiung Municipal  Ta-T ung hospital, Kaohsiung, Taiwan correspondence: Mei-ling ho   Department of Physiology, Orthopedic  research center, college of Medicine,  Kaohsiung Medical University, 100 shih- chuan 1st road, Kaohsiung 807,   Taiwan   Tel +886 7312 1101 ext 2309   Fax +886 7323 4687   email homelin@cc.kmu.edu.t wAbstract:  Statins are used clinically for reduction of cholesterol synthesis to prevent  cardiovascular disease.",Non-OADS,/arxiv_data1/oa_pdf/1c/dd/ijn-8-3895.PMC3798145.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/1c/dd/ijn-8-3895.PMC3798145.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1c/dd/ijn-8-3895.PMC3798145.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/65/f2/dmso-6-393.PMC3798146.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013:6 393–401Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  393ShO rT repO rTopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S5115 1The effect of very low-calorie diets on renal   and hepatic outcomes: a systematic review Catherine rolland1 Alexandra Mavroeidi2 Kelly L Johnston3 John Broom1,3 1Centre for Obesity research and  epidemiology (CO re), Faculty of  health and Social Care, robert  Gordon University, Aberdeen,   Scotland, UK; 2School of Medical  Sciences, College of Life Sciences and  Medicine, University of Aberdeen,   Aberdeen, Scotland, UK; 3LighterLife  Ltd, harlow, essex, UK Correspondence: Catherine rolland   COre (Centre for Obesity research  and epidemiology), the robert Gordon  University, Aberdeen, AB251hG,  Scotland, UK   email ext.rolland1@rgu.ac.u kAbstract:  Very low-calorie diets (VLCDs) are an effective means by which to induce   clinically significant weight loss.",Non-OADS,/arxiv_data1/oa_pdf/65/f2/dmso-6-393.PMC3798146.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/65/f2/dmso-6-393.PMC3798146.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/65/f2/dmso-6-393.PMC3798146.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ff/83/ijn-8-3833.PMC3798147.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 3833–3842International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3833OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5099 1Mesoporous silica nanoparticles synthesized from  liquid crystal display manufacturing extracts as  a potential candidate for a drug delivery carrier:  evaluation of their safety and biocompatibility Yu-chih lin1 liang-Yi lin2 Ming-Yi gao3 Yi-Ping Fang3 1Department of environmental  engineering and health, Yuanpei  University, 2Institute of environmental  engineering, National chiao  T ung University, 3Department of  Biotechnology, Yuanpei University,   hsinchu, Taiwan correspondence: Yi-Ping Fang   Department of Biotechnology,   Yuanpei University, 306 Yuanpei st,   hsinchu, 30015, Taiwan   Tel +886 3 538 1183 ext 8150   Fax +886 3 610 2312   email ypfang@mail.ypu.edu.t wAbstract:  Mesoporous silica nanoparticles (MSNs) were synthesized as a promising drug  delivery carrier due to the large surface area and porous characteristics.",Non-OADS,/arxiv_data1/oa_pdf/ff/83/ijn-8-3833.PMC3798147.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/ff/83/ijn-8-3833.PMC3798147.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/83/ijn-8-3833.PMC3798147.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/47/9a/ijn-8-3955.PMC3798148.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 3955–3961International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3955OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5199 4adherence ability of Staphylococcus epidermidis    on prosthetic biomaterials: an in vitro study Takayuki shida1 hironobu Koseki1 Itaru Y oda1 hidehiko horiuchi1 hideyuki sakoda2 Makoto Osaki1 1Department of Orthopedic surgery,  graduate school of Medicine,  Nagasaki University, Nagasaki, Japan;  2Division of Medical Devices, National  Institute of health sciences, Tokyo,  Japan correspondence: hironobu Koseki   Department of Orthopedic surgery,  graduate school of Medicine,   Nagasaki University, 1-7-1, sakamoto,  Nagasaki 852-8501, Japan   Tel +81 95 819 7321   Fax +81 95 849 7325   email koseki@nagasaki-u.ac.j pAbstract:  Bacterial adhesion to the surface of biomaterials is an essential step in the   pathogenesis of implant-related infections.",Non-OADS,/arxiv_data1/oa_pdf/47/9a/ijn-8-3955.PMC3798148.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/47/9a/ijn-8-3955.PMC3798148.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/47/9a/ijn-8-3955.PMC3798148.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ee/9a/ijn-8-3927.PMC3798150.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 3927–3936International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3927OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S4859 7a novel preparation method for drug  nanocrystals and characterization by ultrasonic  spray-assisted electrostatic adsorption Bing gao1–3 Jun Wang2 Dunju Wang1,2 Ziqiang Zhu1,2 Zhiqiang Qiao2 guangcheng Yang2 Fude Nie2 1school of Material science and  engineering, southwest University  of science and T echnology, Mianyang,   People’s republic of china, 2Institute  of chemical Materials, china academy  of engineering Physics, Mianyang,   sichuan, People’s republic of china,   3si chuan research center of New  Materials, Mianyang, People’s republic  of china correspondence: guangcheng Yang;   Fude Nie   Institute of chemical Materials,   china academy of engineering   Physics, Mianyang, sichuan, 621900,   People’s republic of china   Tel +86 816 254 4436   Fax +86 816 254 4426   email ygcheng@hotmail.co m;   zgh-nfd@sohu.co mPurpose:  The purpose of this study was to develop a novel and continuous method for prepar - ing a nanosized particle of drug crystals and to characterize its properties.",Non-OADS,/arxiv_data1/oa_pdf/ee/9a/ijn-8-3927.PMC3798150.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/ee/9a/ijn-8-3927.PMC3798150.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ee/9a/ijn-8-3927.PMC3798150.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/92/4b/ijn-8-3907.PMC3798151.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 3907–3915International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3907OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S4755 1Targeting mirNa-based medicines   to cystic fibrosis airway epithelial cells   using nanotechnology Paul J McKiernan2 Orla Cunningham1,2 Catherine M Greene2 sally-ann cryan1,3 1School of Pharmacy, Royal College  of surgeons in Ireland, 2respiratory  Research Division, Department of  Medicine, royal college of surgeons in  Ireland Education and Research Centre,  Beaumont hospital, 3Trinity centre for  Bioengineering, Trinity College Dublin,  Dublin, Ireland correspondence: sally-ann cryan   School of Pharmacy, Royal College   of surgeons in Ireland, Y ork house,   Y ork St, Dublin 2, Ireland   T el +353 1402 2741   Fax +353 1402 2765   email scryan@rcsi.i eAbstract:  Cystic fibrosis (CF) is an inherited disorder characterized by chronic airway  inflammation.",Non-OADS,/arxiv_data1/oa_pdf/92/4b/ijn-8-3907.PMC3798151.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/92/4b/ijn-8-3907.PMC3798151.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/92/4b/ijn-8-3907.PMC3798151.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2a/9d/ijn-8-3887.PMC3798152.pdf
Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 3887–3894International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3887OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S4984 5Does the extracorporeal circulation worsen  anemia in hemodialysis patients?,Non-OADS,/arxiv_data1/oa_pdf/2a/9d/ijn-8-3887.PMC3798152.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/2a/9d/ijn-8-3887.PMC3798152.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2a/9d/ijn-8-3887.PMC3798152.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a5/6a/dmso-6-389.PMC3798155.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013:6 389–392Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  389Original reSearchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DMSO.S5184 3evaluation of the maximum beyond-use-date  stability of regular human insulin extemporaneously  prepared in 0.9% sodium chloride in a polyvinyl  chloride bag Megan a rocchio caryn D Belisle Bonnie c greenwood Michael c cotugno Paul M Szumita Department of Pharmacy, Brigham and  Women’s hospital, Boston, M a, USa correspondence: Paul M Szumita   Brigham and Women’s hospital,   Department of Pharmacy, 75 Francis St,  l2 Pharmacy administration, Boston,   Ma 02115, USa   Tel +1 617 732 7677   Fax +1 617 566 2396   email pszumita@partners.or gBackground:  Regular human insulin 100 units added to a sufficient quantity of 0.9% sodium  chloride, to yield a total volume of 100 mL within a polyvinylchloride bag, is accepted to be  stable for 24 hours due to physical denaturation and chemical modification.",Non-OADS,/arxiv_data1/oa_pdf/a5/6a/dmso-6-389.PMC3798155.pdf
"Available from: http://www.usp.org/usp-n f. Accessed on  August 11, 2013.",Non-OADS,/arxiv_data1/oa_pdf/a5/6a/dmso-6-389.PMC3798155.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/a5/6a/dmso-6-389.PMC3798155.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a5/6a/dmso-6-389.PMC3798155.pdf
"Available from: http://www.dynalabs.us/content/index.shtm l. Accessed  September 6, 2012.",Non-OADS,/arxiv_data1/oa_pdf/a5/6a/dmso-6-389.PMC3798155.pdf
URL: http://www.diabetesincontrol.com/articl es/54-feature/5614-.,Non-OADS,/arxiv_data1/oa_pdf/ce/1a/pharmpract-10-033.PMC3798160.pdf
Available at: http://www.scripintelligence.com/multimedia/archive/ 00000/BS1353_124a.pdf [Last accessed: 18 November 2011]  8.,Non-OADS,/arxiv_data1/oa_pdf/c5/66/pharmpract-10-003.PMC3798161.pdf
Available at:  http://www.farmaactueel.nl/beleidsstukken/rapport-in koopvoordelen-apotheekhoudenden-2009.pdf [Last accessed 18  November 2011]  9.,Non-OADS,/arxiv_data1/oa_pdf/c5/66/pharmpract-10-003.PMC3798161.pdf
Available at: http://www.sfk.nl/publicat ies/data_en_feiten.html [Last accessed: 18 November 2011]  10.,Non-OADS,/arxiv_data1/oa_pdf/c5/66/pharmpract-10-003.PMC3798161.pdf
Available at: http://www.sfk.nl/publicaties/data_en_f eiten.html [Last accessed: 21 November 2011].,OADS,/arxiv_data1/oa_pdf/c5/66/pharmpract-10-003.PMC3798161.pdf
Available at : http://whocc.goeg.at/ [Last accessed: 18 November 2011]  13.,Non-OADS,/arxiv_data1/oa_pdf/c5/66/pharmpract-10-003.PMC3798161.pdf
Available at:  http://www.aqf.edu.au/Portals/0/Documents/Handbook/AQF_Handbook_51-72.pdf.,Non-OADS,/arxiv_data1/oa_pdf/67/7b/pharmpract-10-052.PMC3798162.pdf
"http://www.pcbs.gov.ps/Portals/_PCBS/Downloads/book1842.pdf  (Accessed Nov 4, 2011.)",Non-OADS,/arxiv_data1/oa_pdf/77/31/pharmpract-10-017.PMC3798164.pdf
URL: http://publicationethics.org/files/u2/02B_P lagiarism_Published.pdf (accessed 29-Feb-2012)  3.,Non-OADS,/arxiv_data1/oa_pdf/0d/6e/pharmpract-10-001.PMC3798167.pdf
URL: http://www.icmje.org/publishi ng_4overlap.html (accessed 29-Feb-2012)  9.,Non-OADS,/arxiv_data1/oa_pdf/0d/6e/pharmpract-10-001.PMC3798167.pdf
"20.   https://online.epocrates.com (accessed May 8, 2011)  21.",Non-OADS,/arxiv_data1/oa_pdf/ff/35/pharmpract-10-009.PMC3798168.pdf
"44. http://medicine.iupui.edu/clinpharm/ddi s/table.asp  (accessed Nov 8, 2011)  45.",Non-OADS,/arxiv_data1/oa_pdf/ff/35/pharmpract-10-009.PMC3798168.pdf
Available at:  http://www.pharmainfo.net/reviews/risk-assessment-non-ste roidal-anti-inflammatory-drugs (Accessed on Aug 2011).,Non-OADS,/arxiv_data1/oa_pdf/2e/42/pharmpract-10-040.PMC3798169.pdf
Available at:  http://www.nice.org.uk/newsroom/features/measuringe ffectivenessandcosteffectivenesstheqaly.jsp (Accessed on  August 2011).,Non-OADS,/arxiv_data1/oa_pdf/2e/42/pharmpract-10-040.PMC3798169.pdf
Available at:  http://www.whoindia.org/LinkFiles/Commision_on_Mac roeconomic_and_Health_Bg_P2_Estimation_of_the_burden_of_ diarrhoeal_diseases_in_India.pdf  15.,Non-OADS,/arxiv_data1/oa_pdf/2e/42/pharmpract-10-040.PMC3798169.pdf
Available at:  http://ssmon.chb.kth.se/vol15/issue3/4_Thom as.pdf (Accessed on September 2011).,Non-OADS,/arxiv_data1/oa_pdf/2e/42/pharmpract-10-040.PMC3798169.pdf
New  York: Oxford University Press; 2006. http://files.dcp2.org/pdf/gbd/gbdfm.pdf (Accessed on Dec 2010)  19.,Non-OADS,/arxiv_data1/oa_pdf/2e/42/pharmpract-10-040.PMC3798169.pdf
Available at: http://www.who.int/evidence/bod (Accessed on Dec 2010).,OADS,/arxiv_data1/oa_pdf/2e/42/pharmpract-10-040.PMC3798169.pdf
"URL:  http://www.fda.gov/safety/medwatch/howtoreport/ucm053087.htm (Accessed July 27, 2012).",OADS,/arxiv_data1/oa_pdf/07/56/pharmpract-11-090.PMC3798170.pdf
(http://www.fda.gov/downloads/advisorycommittees/committees meetingmaterials/drugs/c ardiovascularandrenaldrugsad visorycommittee/ucm226009.pdf).,Non-OADS,/arxiv_data1/oa_pdf/07/56/pharmpract-11-090.PMC3798170.pdf
Available online at:  http://www.nao.org.uk/publications/0708/new_contra cts_for_general_prac.aspx (Accessed 23/10/2011).,Non-OADS,/arxiv_data1/oa_pdf/73/63/pharmpract-11-109.PMC3798171.pdf
Available online at:  http://www.psnc.org.uk/data/files/PharmacyContra ct/pharmacy_contract_summary_dec_2004.pdf (Accessed  23/10/2011).,Non-OADS,/arxiv_data1/oa_pdf/73/63/pharmpract-11-109.PMC3798171.pdf
Available on line at :  http://www.dh.gov.uk/en/Publicationsandstatistics/Pub lications/PublicationsPolicy AndGuidance/DH_083815 (Accessed  23/2/2012).,Non-OADS,/arxiv_data1/oa_pdf/73/63/pharmpract-11-109.PMC3798171.pdf
Available on line at:  http://www.pjonline.com/blog_entry/the_bus iness_of_pharmacy (Accessed 26/10/2011).,Non-OADS,/arxiv_data1/oa_pdf/73/63/pharmpract-11-109.PMC3798171.pdf
Available on line at:  http://www.psnc.org.uk/pages/advanced_servi ces_fundinghtml.html (Accessed 4/3/2012).,Non-OADS,/arxiv_data1/oa_pdf/73/63/pharmpract-11-109.PMC3798171.pdf
Availabl e on line at: http://www.pharmacyregulation.org/standards  (Accessed 15/03/2012).,Non-OADS,/arxiv_data1/oa_pdf/73/63/pharmpract-11-109.PMC3798171.pdf
Availabl e from: http://www.pharmacypgd.co.uk/system/gphcstandards.pdf  (Accessed 6/3/2012).,Non-OADS,/arxiv_data1/oa_pdf/73/63/pharmpract-11-109.PMC3798171.pdf
Available on line at: http://www.pprt.org.uk/Documents/TrustNews/The_effect_of_the_new_community_pharmacy_contract_on_the_commu nity_pharmacy_workforce.pdf (Accessed 1/3/2012).,Non-OADS,/arxiv_data1/oa_pdf/73/63/pharmpract-11-109.PMC3798171.pdf
Available from: http://www.llakes.org (Accessed 25  February 2012).,Non-OADS,/arxiv_data1/oa_pdf/73/63/pharmpract-11-109.PMC3798171.pdf
Available from:  http://www.msp.ac.uk/studying/postgraduate/cert -gen-pharm-pract/index.html (Accessed 25/2/2012).,Non-OADS,/arxiv_data1/oa_pdf/73/63/pharmpract-11-109.PMC3798171.pdf
Available  from:  http://www.who.int/medicines/publications /WHO_PSM_PAR_2006.5.pdf (Accessed 14/3/2012).,OADS,/arxiv_data1/oa_pdf/73/63/pharmpract-11-109.PMC3798171.pdf
Available from:  http://www.rpharms.com/pressreleases-pdfs/1445---rp s-lcf-document---final.pdf (Accessed 14/03/2012).,Non-OADS,/arxiv_data1/oa_pdf/73/63/pharmpract-11-109.PMC3798171.pdf
"Accessed at  http://ijahsp.nova.edu/articl es/vol6num2/pdf/Hardigan.pdf, December 14th 2011.",Non-OADS,/arxiv_data1/oa_pdf/96/b1/pharmpract-11-071.PMC3798172.pdf
"Accessed at  http://www.nber.org/papers/w11474, December 14th 2011.",Non-OADS,/arxiv_data1/oa_pdf/96/b1/pharmpract-11-071.PMC3798172.pdf
"Accessed at  http://www.biomedcentral.com/content/pdf/1472-6963-6-55.pdf, December 14th 2011.",Non-OADS,/arxiv_data1/oa_pdf/96/b1/pharmpract-11-071.PMC3798172.pdf
"Accessed at http://www.aacp.org/resources/research/pharmacymanpo wer/Documents/2009%20National%20Pharmacist%20Workfor ce%20Survey%20-%20FINAL%20REPORT.pdf, December 15th 2011.",Non-OADS,/arxiv_data1/oa_pdf/96/b1/pharmpract-11-071.PMC3798172.pdf
"Accessed  at http://www.medscape.com/viewarticle/521115, December 15th 2011.",Non-OADS,/arxiv_data1/oa_pdf/96/b1/pharmpract-11-071.PMC3798172.pdf
"Acce ssed at http://www.minneapolisfed.org/research/sr/sr386.pdf,  December 15th 2011.",Non-OADS,/arxiv_data1/oa_pdf/96/b1/pharmpract-11-071.PMC3798172.pdf
Promoting rational use of medicines: core  components [http://apps.who.int/medicinedocs/pdf/h3011e/h3011e.pdf  (Accessed 21/1/10)  3.,Non-OADS,/arxiv_data1/oa_pdf/6c/4f/pharmpract-11-066.PMC3798173.pdf
http://www.inrud.org /ICIUM/ConferenceMaterials/376-ibrahem-_a.pdf (Accessed  26/05/2012)  8.,Non-OADS,/arxiv_data1/oa_pdf/6c/4f/pharmpract-11-066.PMC3798173.pdf
Available at:  http://www.fip.org/www/uploads/database_file.,OADS,/arxiv_data1/oa_pdf/6c/4f/pharmpract-11-066.PMC3798173.pdf
http://www.unicef.org /infobycountry/ghana_statistics.html (Accessed 3/4/2010)  11.,Non-OADS,/arxiv_data1/oa_pdf/6c/4f/pharmpract-11-066.PMC3798173.pdf
Available at: http://www.ghana.gov.,Non-OADS,/arxiv_data1/oa_pdf/6c/4f/pharmpract-11-066.PMC3798173.pdf
Cairo; WHO: 2003.  http://www.emro.who.int/dsaf/dsa311.pdf (Accessed 4/4/2010)  13.,Non-OADS,/arxiv_data1/oa_pdf/6c/4f/pharmpract-11-066.PMC3798173.pdf
British National Formulary (B NF 60) [http://bnf.org/bnf/bnf/current/1008.htm (Accessed 3/4/2010)   15.,Non-OADS,/arxiv_data1/oa_pdf/6c/4f/pharmpract-11-066.PMC3798173.pdf
"Available at: http://www.acpe-accredit.org/pdf/ACPE_Revised_PharmD_Standar ds_Adopted_Jan152006.pdf (Accessed on May 2, 2011).",Non-OADS,/arxiv_data1/oa_pdf/6b/82/pharmpract-11-061.PMC3798176.pdf
"Available at https://www.aamc.org/download/183128/data/in ter-professional_education_current_rationale_resources.pdf  (Accessed Aug 30, 2011)  14.",Non-OADS,/arxiv_data1/oa_pdf/6b/82/pharmpract-11-061.PMC3798176.pdf
"Available at: http://www.acpe- accredit.org/pdf/S2007Guidelines2.0_ChangesIdentifiedInRed.pdf (Accessed on June 7, 2011).",OADS,/arxiv_data1/oa_pdf/6b/82/pharmpract-11-061.PMC3798176.pdf
"Available at: http://www.acpe-accredit.org/pdf/ACPE_Revised_PharmD_Standar ds_Adopted_Jan152006.pdf (Accessed on May 2, 2011).",Non-OADS,/arxiv_data1/oa_pdf/6b/82/pharmpract-11-061.PMC3798176.pdf
"Pharma cy support staff roles and definitions (updated May, 2009); 2009.  http://www.docstoc.com/docs/27981460/Pharmacy-support-staff-roles-and-definitions (Accessed 13 Mar 2013).",OADS,/arxiv_data1/oa_pdf/f7/75/pharmpract-11-118.PMC3798177.pdf
"Canberra: Commonwealth Department of Health and Aged  Care, 2001. http://pivotwest.org.au.titan.imagin8.co m/icms_docs/12623_What_is_DMMR_.pdf (Accessed 13 Mar 2013).",Non-OADS,/arxiv_data1/oa_pdf/f7/75/pharmpract-11-118.PMC3798177.pdf
"London: Pharmacy Practice Research Trust, 2007.  http://www.pprt.org/Documents/ResearchFunding/National_ev aluation_of_the_new_community_pharamcy_contract.pdf  (Accessed 17 Mar 2013).",Non-OADS,/arxiv_data1/oa_pdf/f7/75/pharmpract-11-118.PMC3798177.pdf
http://faculty.ksu.edu.sa/hisham/Documents/RPSGB_Files_/7 /LEBphsupconsultareas.pdf  (Accessed 13 Mar 2013).,Non-OADS,/arxiv_data1/oa_pdf/f7/75/pharmpract-11-118.PMC3798177.pdf
"Accessed at  http://ijahsp.nova.edu/articl es/vol6num2/pdf/Hardigan.pdf, December 14th 2011.",Non-OADS,/arxiv_data1/oa_pdf/2c/6b/pharmpract-11-081.PMC3798178.pdf
"Accessed at  http://www.nber.org/papers/w11474, December 14th 2011.",Non-OADS,/arxiv_data1/oa_pdf/2c/6b/pharmpract-11-081.PMC3798178.pdf
"Accessed at  http://www.biomedcentral.com/content/pdf/1472-6963-6-55.pdf, December 14th 2011.",Non-OADS,/arxiv_data1/oa_pdf/2c/6b/pharmpract-11-081.PMC3798178.pdf
"Accessed at http://www.aacp.org/resources/research/pharmacymanpo wer/Documents/2009%20National%20Pharmacist%20Workfor ce%20Survey%20-%20FINAL%20REPORT.pdf, December 15th 2011.",Non-OADS,/arxiv_data1/oa_pdf/2c/6b/pharmpract-11-081.PMC3798178.pdf
"Accessed  at http://www.medscape.com/viewarticle/521115, December 15th 2011.",Non-OADS,/arxiv_data1/oa_pdf/2c/6b/pharmpract-11-081.PMC3798178.pdf
"Acce ssed at http://www.minneapolisfed.org/research/sr/sr386.pdf,  December 15th 2011.",Non-OADS,/arxiv_data1/oa_pdf/2c/6b/pharmpract-11-081.PMC3798178.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1d/43/jmdh-6-399.PMC3798200.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Multidisciplinary Healthcare 2013:6 399–407Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  399Original researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JMDH.S4933 9Predicting intention to use voluntary HiV  counseling and testing services among health  professionals in Jimma, ethiopia, using the theory  of planned behavior Fira abamecha1 ameyu godesso2 eshetu girma3 1Department of nursing, Mizan-Tepi  University, Mizan, 2Department of  sociology, Jimma University, Jimma,   3Department of Health education and  Behavioral sciences, Jimma University,   Jimma, ethiopia correspondence: Fira abamecha   Department of nursing, Mizan-Tepi  University, P.O.",Non-OADS,/arxiv_data1/oa_pdf/1d/43/jmdh-6-399.PMC3798200.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/1d/43/jmdh-6-399.PMC3798200.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/1d/43/jmdh-6-399.PMC3798200.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f5/f9/opth-7-2011.PMC3798201.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 2011–2017Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2011Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5089 8improvement of visual acuity in diabetic   and nondiabetic patients after nd:Y ag   laser capsulotomy Muhammed Tayyab awan1,2 Muhammed anwar Khan3 saba al-Khairy1,4 samina Malik1,4 1Pak lab and Diagnostic Center,   Karachi, Pakistan; 2school of  Biomedical sciences, University  of Ulster, Coleraine, northern  ireland, UK; 3Department of Medical  education, King saud bin abdul- aziz University of health sciences,   riyadh, saudi arabia; 4Department of  Ophthalmology, Jinnah Post graduate  Medical Center, Karachi, Pakistan Correspondence: Muhammed Tayyab  awan   Pak lab and Diagnostic Center, 63-2/h,   Block 6, PeChs, Karachi 75100, Pakistan   Tel +92 333 850 8882   Fax +92 213 454 7222   email tayawan71@yahoo.co.u kPurpose:  The aim of the study reported here was to compare the improvement of visual acuity  (V A) of diabetic and nondiabetic patients after neodymium-doped yttrium-aluminum-garnet  (Nd:YAG) laser capsulotomy.",Non-OADS,/arxiv_data1/oa_pdf/f5/f9/opth-7-2011.PMC3798201.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/f5/f9/opth-7-2011.PMC3798201.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f5/f9/opth-7-2011.PMC3798201.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/19/46/opth-7-2007.PMC3798202.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 2007–2010Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2007Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5020 0Pattern of corneal pathologies in children seen  at Yaoundé gynaeco-Obstetric and Paediatric  hospital, Cameroon assumpta l Bella1,2 Viola a Dohvoma1 andré O eballe3 Oumarou abdouramani2 1Faculty of Medicine and Biomedical  sciences, University of Yaoundé i,   Yaoundé, 2Yaoundé gynaeco- Obstetric and Paediatric hospital,  Yaoundé, 3Faculty of Medicine and  Pharmaceutical sciences, University   of Douala, Douala, Cameroon Correspondence: Viola a Dohvoma   Ophthalmology Unit, Yaoundé   gynaeco-Obstetric and Paediatric  hospital, PO Box 4362 Yaoundé,  Cameroon   Tel +237 9973 5506   Fax +237 2223 7429   email andinv@gmail.co mPurpose:  To describe the different corneal pathologies and determine the prevalence of corneal  blindness amongst children aged 0–15 years, seen at the ophthalmology unit of a tertiary hospital  in Cameroon.",Non-OADS,/arxiv_data1/oa_pdf/19/46/opth-7-2007.PMC3798202.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/19/46/opth-7-2007.PMC3798202.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/19/46/opth-7-2007.PMC3798202.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5b/eb/prom-4-061.PMC3798203.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpPatient Related Outcome Measures 2013:4 61–73Patient Related Outcome Measures Dove press submit your manuscript | www.dovepress.co m Dove press  61Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PROM.S3139 2Optimal management of severe nausea and  vomiting in migraine: improving patient outcomes Miguel JA Láinez1,2 Ana García-Casado1 Francisco Gascón1 1Servicio de Neurología, Hospital  Clínico Universitario, valencia, Spain;   2 Departamento de Neurología,   Universidad Católica de valencia,   valencia, Spain Correspondence: Miguel JA Láinez   Servicio de Neurología, Hospital   Clínico Universitario, 17 Avinguda   Blasco ibáñez, valencia 46010, Spain   Tel +34 963 868 863   Fax +34 963 987 812   email jlaineza@meditex.e sAbstract:  Migraine is a common and potentially disabling disorder for patients, with  wide-reaching implications for health care services, society, and the economy.",Non-OADS,/arxiv_data1/oa_pdf/5b/eb/prom-4-061.PMC3798203.pdf
"Patient Related Outcome Measures Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-related-outcome-measures-journa lPatient Related Outcome Measures is an international, peer-reviewed,  open access journal focusing on treatment outcomes specifically  relevant to patients.",Non-OADS,/arxiv_data1/oa_pdf/5b/eb/prom-4-061.PMC3798203.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/5b/eb/prom-4-061.PMC3798203.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d9/89/opth-7-2019.PMC3798205.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 2019–2030Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2019Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S5011 9Keratoconus: current perspectives Jayesh vazirani Sayan Basu Cornea and Anterior Segment  Services, L v Prasad eye institute,   Hyderabad, india Correspondence: Sayan Basu   Sixth Floor, Lv Prasad eye institute,   Kallam Anji Reddy Campus,   Banjara Hills Road No 2,   Hyderabad, 500034, india   Tel +91 99 8947 9969   Fax +91 40 2354 8271   email sayanbasu@lvpei.or gAbstract:  Keratoconus is characterized by progressive corneal protrusion and thinning, leading  to irregular astigmatism and impairment in visual function.",Non-OADS,/arxiv_data1/oa_pdf/d9/89/opth-7-2019.PMC3798205.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/d9/89/opth-7-2019.PMC3798205.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d9/89/opth-7-2019.PMC3798205.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/49/8e/vhrm-9-599.PMC3798206.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpVascular Health and Risk Management 2013:9 599–615Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  599ORiginal ReseaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/VHRM.S4983 0cardiovascular outcomes during treatment   with dabigatran: comprehensive analysis   of individual subject data by treatment andreas clemens1 Mandy Fraessdorf2 Jeffrey Friedman3 1corporate Division Medicine,   Ta cardiovascular, 2Medical Data  services, Boehringer ingelheim  gmbH & co K g, ingelheim am Rhein,   germany; 3Boehringer ingelheim  Pharmaceuticals inc, Ridgefield,    cT, Usa correspondence: andreas clemens   Boehringer ingelheim Pharma   gmbH & co Kg, Bingerstrasse 173,   55216 ingelheim am Rhein, germany   Tel +49 613 2779 0606   Fax +49 613 2729 0606   email andreas.clemens@boehringer- ingelheim.co mBackground:  Dabigatran 150  mg twice daily was shown to be superior to warfarin in  preventing  stroke in subjects with nonvalvular atrial fibrillation (SPAF) in the RE-L Y (  Randomized   Evaluation of Long-term anticoagulation therapY) trial.",Non-OADS,/arxiv_data1/oa_pdf/49/8e/vhrm-9-599.PMC3798206.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/49/8e/vhrm-9-599.PMC3798206.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/49/8e/vhrm-9-599.PMC3798206.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9a/7d/opth-7-2031.PMC3798226.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Ophthalmology 2013:7 2031–2035Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2031Case repO rtopen access to scientific and medical research Open access Full text article http: //dx.doi.org/10.2147/OPTH.S5279 6scattered depressions with temporal  preponderance in visual field test coexisting  with optic disc temporal atrophy in cerebral  arteriovenous malformation Gokcen Gokce1 Nisa Cem Oren2 Osman Melih Ceylan3 tarkan Mumcuoglu3 Volkan Hurmeric3 1Sarıkamis Military Hospital,   Department of Ophthalmology,   2Department of Radiology, Kars,   3Gulhane Military Medical Academy,   Department of Ophthalmology,   Ankara, T urkey Correspondence: Gokcen Gokce   Sarıkamis Military Hospital, Department  of Ophthalmology, Osman Pasa Street,  36500, Sarikamis, Kars, Turkey   tel +90 504 927 620   Fax +90 474 413 6264   email drgokcengokce@gmail.co mAbstract:  In this article, the unusual association of optic disc temporal atrophy associated with  scattered depressions with temporal preponderance in visual field test resembling incomplete  bitemporal hemianopsia is reported.",Non-OADS,/arxiv_data1/oa_pdf/9a/7d/opth-7-2031.PMC3798226.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/9a/7d/opth-7-2031.PMC3798226.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9a/7d/opth-7-2031.PMC3798226.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9c/1b/ijnrd-6-215.PMC3798232.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nephrology and Renovascular Disease 2013:6 215–221International Journal of Nephrology and Renovascular Disease Dove press submit your manuscript | www.dovepress.co m Dove press  215ORIg INal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJNRD.S4678 8hemodialysis catheter implantation in the axillary  vein by ultrasound guidance versus palpation   or anatomical reference cesar a Restrepo Valencia1 carlos a Buitrago Villa1 Jose a chacon cardona2 1Internal Medicine, Nephrology,   2epidemiology, caldas University,   Manizales, colombia correspondence: cesar a Restrepo  Valencia   associate Professor, Universidad  de caldas, Department clinico,  Facultad de ciencias para la salud,  calle 25 Nro 48-57, Manizales,  caldas,  colombia   T el +57 6 873 3060 ext 31262   email caugustorv@une.net.c oBackground:  We compared the results of four different methods of hemodialysis catheter  insertion in the medial segment of the axillary vein: ultrasound guidance, palpation, anatomical  reference, and prior transient catheter.",Non-OADS,/arxiv_data1/oa_pdf/9c/1b/ijnrd-6-215.PMC3798232.pdf
"International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journa lThe International Journal of Nephrology and Renovascular Disease is  an international, peer-reviewed open-access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/9c/1b/ijnrd-6-215.PMC3798232.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9c/1b/ijnrd-6-215.PMC3798232.pdf
"Available from:  http://www.cari.org.au/DIAL YSIS_va_published/Insertion%20of%20 catheters.pd f. Accessed September 26, 2012.",Non-OADS,/arxiv_data1/oa_pdf/9c/1b/ijnrd-6-215.PMC3798232.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/01/e4/ndt-9-1573.PMC3798233.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2013:9 1573–1582Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1573Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S2811 7evidence for single nucleotide polymorphisms   and their association with bipolar disorder Aleksandra Szczepankiewicz1,2 1Laboratory of Molecular and Cell  Biology, 2Department of Psychiatric  Genetics, Poznan University of  Medical Sciences, Poznan, Poland Correspondence: Aleksandra  Szczepankiewicz   Laboratory of Molecular and Cell Biology,  Department of Psychiatric Genetics,  Poznan University of Medical Sciences,  27/33 Szpitalna St, 60-572 Poznan, Poland   Tel +48 61 849 1311   Fax +48 61 848 0111   email alszczep@ump.edu.p lAbstract:  Bipolar disorder (BD) is a complex disorder with a number of susceptibility genes  and environmental risk factors involved in its pathogenesis.",Non-OADS,/arxiv_data1/oa_pdf/01/e4/ndt-9-1573.PMC3798233.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/01/e4/ndt-9-1573.PMC3798233.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/01/e4/ndt-9-1573.PMC3798233.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/47/1f/opth-7-2037.PMC3798236.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Ophthalmology 2013:7 2037–2042Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2037Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5160 0a meta-analysis of studies on cosmetically   tinted soft contact lenses Marjorie J rah1 Jeffery schafer1 lening Zhang1 Osbert Chan2 lipika roy3 Joseph T Barr1 1Bausch & lomb incorporated,   rochester, nY, Usa; 2Bausch & lomb  incorporated, asia Pacific Medical  affairs, hong Kong; 3Bausch & lomb  incorporated, asia Pacific Medical  affairs, singapore, Malaysia Correspondence: Marjorie J rah   Bausch & lomb incorporated,  1400 north goodman st,   rochester, nY 14609, Usa   Tel +1 585 413 6397   Fax +1 585 338 0750   email m arjorie.",Non-OADS,/arxiv_data1/oa_pdf/47/1f/opth-7-2037.PMC3798236.pdf
Avail - able from: http://www.ipsos.com /.,Non-OADS,/arxiv_data1/oa_pdf/47/1f/opth-7-2037.PMC3798236.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/47/1f/opth-7-2037.PMC3798236.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/47/1f/opth-7-2037.PMC3798236.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/94/f3/opth-7-2043.PMC3798237.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 2043–2049Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2043Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S52260anatomic and functional outcomes   of 25-gauge vitrectomy for repair of eyes   with rhegmatogenous retinal detachment  complicated by proliferative vitreoretinopathy Chiharu iwahashi-shima Tatsuhiko sato hajime Bando T oshihide ikeda Kazuyuki emi Osaka rosai hospital Clinical  research Center for Occupational  sensory Organ Disability, sakai, Japan Correspondence: Tatsuhiko sato   Osaka rosai hospital Clinical research  Center for Occupational sensory Organ  Disability, 1179-3 nagasone-cho, Kita-ku,  sakai 591-8025, Japan   Tel +817 2252 3561   Fax +817 2258 8720   email t-satou@orh.go.j pBackground:  The purpose of this study was to evaluate the outcome of 25-gauge vitrec - tomy for repair of rhegmatogenous retinal detachment (RRD) complicated by proliferative  vitreoretinopathy (PVR).",Non-OADS,/arxiv_data1/oa_pdf/94/f3/opth-7-2043.PMC3798237.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/94/f3/opth-7-2043.PMC3798237.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/94/f3/opth-7-2043.PMC3798237.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ec/a7/opth-7-2051.PMC3798238.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 2051–2056Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2051Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S4891 4Meta-analysis of the ocular biocompatibility   of a new multipurpose lens care system William reindel Mohinder M Merchea Marjorie J rah lening Zhang Bausch & lomb incorporated,   rochester, nY, Usa Correspondence: Marjorie J rah   Bausch & lomb incorporated,  1400 north goodman st,   rochester, nY 14609, Usa   Tel +1 585 413 6397   Fax +1 585 338 0750   email m arjorie.",Non-OADS,/arxiv_data1/oa_pdf/ec/a7/opth-7-2051.PMC3798238.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/ec/a7/opth-7-2051.PMC3798238.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ec/a7/opth-7-2051.PMC3798238.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/36/70/ndt-9-1545.PMC3798239.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2013:9 1545–1552Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1545OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S5246 3reduced serum paraoxonase 1 (PON1)   activity in patients with schizophrenia   treated with olanzapine but not quetiapine cüneyt Ünsal1 Yakup albayrak1 Neslihan albayrak2 Murat Kulog ˘lu3 Kenji hashimoto4 1Department of Psychiatry, Namik  Kemal University, school of Medicine,  Tekirda , Turkey; 2Department of  cardiology, Kirklareli state hospital,  Kirklareli, Turkey; 3Department  of Psychiatry, akdeniz University  school of Medicine, antalya, Turkey;  4Division of clinical Neuroscience,  chiba University center for Forensic  Mental health, chiba, Japan correspondence: Yakup albayrak   Namik Kemal University, school of  Medicine, Department of Psychiatry,   Tunca Caddesi, Tekirdag ˘, 59100, Turkey   Tel +90 505 635 5434   Fax +90 282 250 9950   email dr.fuge@hotmail.co mBackground:  Second generation antipsychotics (SGAs) are currently the most prescribed drugs  in the treatment of schizophrenia.",Non-OADS,/arxiv_data1/oa_pdf/36/70/ndt-9-1545.PMC3798239.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/36/70/ndt-9-1545.PMC3798239.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/36/70/ndt-9-1545.PMC3798239.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/e4/5d/JCB_201307046.PMC3798243.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/e4/5d/JCB_201307046.PMC3798243.pdf
Online supplemental material  is available at http://www.jcb.org/cgi/content/full/jcb.201307046/DC1.,Non-OADS,/arxiv_data1/oa_pdf/e4/5d/JCB_201307046.PMC3798243.pdf
"140:3335– 3347. http://dx.doi.org/10.1242/dev.09501 8 Artavanis-Tsakonas, S., and M.A.",Non-OADS,/arxiv_data1/oa_pdf/e4/5d/JCB_201307046.PMC3798243.pdf
"http://dx.doi.org/10   .1016/S0070-2153(10)92001- 2 Bouras, T., B. Pal, F. Vaillant, G. Harburg, M.L.",OADS,/arxiv_data1/oa_pdf/e4/5d/JCB_201307046.PMC3798243.pdf
"http://dx.doi.org/10.1016/j.stem.2008.08.00 1 Fre, S., S.K.",OADS,/arxiv_data1/oa_pdf/e4/5d/JCB_201307046.PMC3798243.pdf
"http://dx.doi.org/10.1371/journal.pone.002578 5 Kent, S., J. Hutchinson, A. Balboni, A. Decastro, P. Cherukuri, and J. Direnzo.",Non-OADS,/arxiv_data1/oa_pdf/e4/5d/JCB_201307046.PMC3798243.pdf
"http://dx.doi.org/10.4161/   cc.10.18.1730 0Clonal expansion quantification To quantify the clonal expansion on Notch3-expressing cells, we developed  a protocol to remove the stroma surrounding the mammary gland by enzy - matic digestion and visualize the remaining intact mammary ducts through  compiled confocal z stacks.",Non-OADS,/arxiv_data1/oa_pdf/e4/5d/JCB_201307046.PMC3798243.pdf
"29:2013– 2023. http://dx.doi.org/10.1038/onc.2009.48 9 Van Keymeulen, A., A.S. Rocha, M. Ousset, B. Beck, G. Bouvencourt, J.",Non-OADS,/arxiv_data1/oa_pdf/e4/5d/JCB_201307046.PMC3798243.pdf
"http://dx.doi.org/10.1038/nature1057 3 Watson, C.J.",OADS,/arxiv_data1/oa_pdf/e4/5d/JCB_201307046.PMC3798243.pdf
"8:203. http://dx.doi.org/10.1186/bcr140 1 Williams, J.M., and C.W.",Non-OADS,/arxiv_data1/oa_pdf/e4/5d/JCB_201307046.PMC3798243.pdf
"http://dx.doi.org/10.1016/0012-1606(83)   90086- 6 Xu, K., J. Usary, P.C.",OADS,/arxiv_data1/oa_pdf/e4/5d/JCB_201307046.PMC3798243.pdf
"http://dx.doi.org/10.1016/j.ccr.2012.03.04 1 Yamaguchi, N., T. Oyama, E. Ito, H. Satoh, S. Azuma, M. Hayashi, K. Shimizu,  R. Honma, Y. Yanagisawa, A. Nishikawa, et al.",OADS,/arxiv_data1/oa_pdf/e4/5d/JCB_201307046.PMC3798243.pdf
"http://dx.doi   .org/10.1158/0008-5472.CAN-07-159 7Kiaris, H., K. Politi, L.M.",Non-OADS,/arxiv_data1/oa_pdf/e4/5d/JCB_201307046.PMC3798243.pdf
"http://dx.doi.org/10.1016/   S0002-9440(10)63333- 0 Kitamoto, T., and K. Hanaoka.",OADS,/arxiv_data1/oa_pdf/e4/5d/JCB_201307046.PMC3798243.pdf
"28:2205– 2216. http://dx.doi.org/10.1002/stem.54 7 Kuang, S., K. Kuroda, F. Le Grand, and M.A.",OADS,/arxiv_data1/oa_pdf/e4/5d/JCB_201307046.PMC3798243.pdf
"129:999– 1010. http://dx.doi.org/10.1016/j.cell.2007.03.04 4 Lessard, J., and G. Sauvageau.",OADS,/arxiv_data1/oa_pdf/e4/5d/JCB_201307046.PMC3798243.pdf
"http://dx.doi   .org/10.1038/nature0157 2 Molofsky, A.V., R. Pardal, T. Iwashita, I.K.",OADS,/arxiv_data1/oa_pdf/e4/5d/JCB_201307046.PMC3798243.pdf
"http://dx.doi.org/10.1038/   nature0206 0 Molyneux, G., F.C.",Non-OADS,/arxiv_data1/oa_pdf/e4/5d/JCB_201307046.PMC3798243.pdf
"http://dx.doi.org/10.1002/stem.77 5 Muzumdar, M.D., B. Tasic, K. Miyamichi, L. Li, and L. Luo.",OADS,/arxiv_data1/oa_pdf/e4/5d/JCB_201307046.PMC3798243.pdf
"8:207.  http://dx.doi.org/10.1186/bcr141 1 Park, I.K., D. Qian, M. Kiel, M.W.",OADS,/arxiv_data1/oa_pdf/e4/5d/JCB_201307046.PMC3798243.pdf
"http://dx.doi.org/10.1038/nature0158 7 Prat, A., and C.M.",OADS,/arxiv_data1/oa_pdf/e4/5d/JCB_201307046.PMC3798243.pdf
"http://dx.doi.org/10.1038/nm0809-84 2 Raafat, A., A.S. Goldhar, M. Klauzinska, K. Xu, I. Amirjazil, D. McCurdy, K.  Lashin, D. Salomon, B.K.",Non-OADS,/arxiv_data1/oa_pdf/e4/5d/JCB_201307046.PMC3798243.pdf
"http://dx.doi.org/10.1002/jcp.2252 6 Raouf, A., Y. Zhao, K. To, J. Stingl, A. Delaney, M. Barbara, N. Iscove, S.  Jones, S. McKinney, J. Emerman, et al.",OADS,/arxiv_data1/oa_pdf/e4/5d/JCB_201307046.PMC3798243.pdf
"http://dx.doi.org/10.1016/j.stem.2008   .05.01 8 Regan, J.L., H. Kendrick, F.A.",OADS,/arxiv_data1/oa_pdf/e4/5d/JCB_201307046.PMC3798243.pdf
"31:869– 883. http://dx.doi.org/10.1038/onc.2011.28 9 Šale, S., D. Lafkas, and S. Artavanis-Tsakonas.",Non-OADS,/arxiv_data1/oa_pdf/e4/5d/JCB_201307046.PMC3798243.pdf
"http://dx.doi.org/10.1038/ncb272 5 Sang, L., and H.A.",OADS,/arxiv_data1/oa_pdf/e4/5d/JCB_201307046.PMC3798243.pdf
"http://dx.doi.org/10.4161/cc.8.14.910 4 Shackleton, M., F. Vaillant, K.J.",Non-OADS,/arxiv_data1/oa_pdf/e4/5d/JCB_201307046.PMC3798243.pdf
"http://dx.doi.org/10.1038/nature0437 2 Shehata, M., A. Teschendorff, G. Sharp, N. Novcic, A. Russell, S. Avril, M. Prater,  P. Eirew, C. Caldas, C.J.",Non-OADS,/arxiv_data1/oa_pdf/e4/5d/JCB_201307046.PMC3798243.pdf
"http://dx.doi.org/10.1186/bcr333 4 Sleeman, K.E., H. Kendrick, D. Robertson, C.M.",Non-OADS,/arxiv_data1/oa_pdf/e4/5d/JCB_201307046.PMC3798243.pdf
"http://dx.doi.org/10.1002/1097-0029(20010115)   52:2<190::AID-JEMT1005>3.0.CO;2- O Speiser, J.J., C. Er şahin, and C. Osipo.",OADS,/arxiv_data1/oa_pdf/e4/5d/JCB_201307046.PMC3798243.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/7f/38/JCB_201306001.PMC3798244.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/7f/38/JCB_201306001.PMC3798244.pdf
"http://dx.doi.org/10.1016/j.cub.2012.01.04 1 Gadde, S., and R. Heald.",OADS,/arxiv_data1/oa_pdf/7f/38/JCB_201306001.PMC3798244.pdf
"http://dx.doi.org/10.1016/j.cub.2004.09.02 1 Goodwin, S.S., and R.D.",OADS,/arxiv_data1/oa_pdf/7f/38/JCB_201306001.PMC3798244.pdf
"http://dx.doi   .org/10.1016/j.cell.2010.09.02 2 Goshima, G., and J.M.",OADS,/arxiv_data1/oa_pdf/7f/38/JCB_201306001.PMC3798244.pdf
"http://dx.doi.org/10.1146/annurev-cellbio-   100109-10400 6 Goshima, G., and R.D.",OADS,/arxiv_data1/oa_pdf/7f/38/JCB_201306001.PMC3798244.pdf
"16:3896– 3907. http://dx.doi.org/10.1091/mbc.E05-02-011 8 Goshima, G., R. Wollman, S.S. Goodwin, N. Zhang, J.M.",Non-OADS,/arxiv_data1/oa_pdf/7f/38/JCB_201306001.PMC3798244.pdf
"http://dx.doi.org/   10.1126/science.114131 4 Hartigan, P.M. 1985.",Non-OADS,/arxiv_data1/oa_pdf/7f/38/JCB_201306001.PMC3798244.pdf
"http://dx.doi.org/10.1214/aos/117634657 7 Henikoff, S., K. Ahmad, J.S.",Non-OADS,/arxiv_data1/oa_pdf/7f/38/JCB_201306001.PMC3798244.pdf
"http://dx.doi   .org/10.1038/379270a 0 Kellogg, D.R., A. Kikuchi, T. Fujii-Nakata, C.W.",OADS,/arxiv_data1/oa_pdf/7f/38/JCB_201306001.PMC3798244.pdf
"http://dx.doi.org/10.1083/   jcb.130.3.66 1 Lele, T., S.R.",OADS,/arxiv_data1/oa_pdf/7f/38/JCB_201306001.PMC3798244.pdf
"http://dx.doi.org/10.1002/jcb.2099 7 Loughlin, R., R. Heald, and F. Nédélec.",OADS,/arxiv_data1/oa_pdf/7f/38/JCB_201306001.PMC3798244.pdf
"http://dx.doi.org/10.1083/jcb.20100607 6 Loughlin, R., J.D.",OADS,/arxiv_data1/oa_pdf/7f/38/JCB_201306001.PMC3798244.pdf
"http://dx.doi.org/10.1016/j.cell.2011.11.01 4 Mallavarapu, A., K. Sawin, and T. Mitchison.",OADS,/arxiv_data1/oa_pdf/7f/38/JCB_201306001.PMC3798244.pdf
"http://dx.doi.org/10   .1016/S0960-9822(00)80090- 1 McIntosh, J.R., M.I.",OADS,/arxiv_data1/oa_pdf/7f/38/JCB_201306001.PMC3798244.pdf
"http://dx.doi.org/10.1017/   S003358351200001 7 Parry, D.H., and P.H.",Non-OADS,/arxiv_data1/oa_pdf/7f/38/JCB_201306001.PMC3798244.pdf
"http://dx.doi.org/10.1016/S0960-9822(01)00204- 4 Phair, R.D., and T. Misteli.",OADS,/arxiv_data1/oa_pdf/7f/38/JCB_201306001.PMC3798244.pdf
"http://dx.doi.org/10.1038/3500707 7 Ris, H. 1943.",Non-OADS,/arxiv_data1/oa_pdf/7f/38/JCB_201306001.PMC3798244.pdf
"http://dx.doi.org/10.2307/153827 8 Rogers, G.C., S.L.",Non-OADS,/arxiv_data1/oa_pdf/7f/38/JCB_201306001.PMC3798244.pdf
"http://dx.doi.org/10.1038/nature0225 6 Rogers, S.L., G.C.",OADS,/arxiv_data1/oa_pdf/7f/38/JCB_201306001.PMC3798244.pdf
"http://dx.doi.org/10.1083/   jcb.20020203 2 Saunders, A.M., J.",OADS,/arxiv_data1/oa_pdf/7f/38/JCB_201306001.PMC3798244.pdf
"http://dx.doi.org/10.1016/j.cub.2007.05.00 1 Sharp, D.J., H.M. Brown, M. Kwon, G.C.",OADS,/arxiv_data1/oa_pdf/7f/38/JCB_201306001.PMC3798244.pdf
"http://dx.doi.org/10.1091/mbc.11.1.24 1 Stevenson, V.A., J. Kramer, J. Kuhn, and W.E.",OADS,/arxiv_data1/oa_pdf/7f/38/JCB_201306001.PMC3798244.pdf
"http://dx.doi.org/10.1038/3505057 9 Tao, L., A. Mogilner, G. Civelekoglu-Scholey, R. Wollman, J. Evans, H.  Stahlberg, and J.M.",Non-OADS,/arxiv_data1/oa_pdf/7f/38/JCB_201306001.PMC3798244.pdf
http://dx.doi.org/10.1016/j.cub.2006.09.06 4Online supplemental material Fig.,OADS,/arxiv_data1/oa_pdf/7f/38/JCB_201306001.PMC3798244.pdf
Online supplemental material is available at http://www.jcb.org/cgi/ content/full/jcb.201306001/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/7f/38/JCB_201306001.PMC3798244.pdf
Additional data are available in the  JCB DataViewer at http://dx.doi.org/10.1083/jcb.201306001.dv.,OADS,/arxiv_data1/oa_pdf/7f/38/JCB_201306001.PMC3798244.pdf
"4:1343. http://dx.doi.org/10.1038/ncomms234 8 Brugués, J., V. Nuzzo, E. Mazur, and D.J.",OADS,/arxiv_data1/oa_pdf/7f/38/JCB_201306001.PMC3798244.pdf
"149:554– 564. http://dx.doi.org/10.1016/j.cell.2012.03.02 7 Brust-Mascher, I., and J.M.",OADS,/arxiv_data1/oa_pdf/7f/38/JCB_201306001.PMC3798244.pdf
"http://dx.doi.org/10.1091/mbc.02-05-006 9 Brust-Mascher, I., G. Civelekoglu-Scholey, M. Kwon, A. Mogilner, and J.M.",Non-OADS,/arxiv_data1/oa_pdf/7f/38/JCB_201306001.PMC3798244.pdf
"http://dx.doi   .org/10.1091/mbc.E08-10-103 3 Burbank, K.S., T.J. Mitchison, and D.S.",OADS,/arxiv_data1/oa_pdf/7f/38/JCB_201306001.PMC3798244.pdf
"http://dx.doi.org/10   .1016/j.cub.2007.07.05 8 Cheerambathur, D.K., G. Civelekoglu-Scholey, I. Brust-Mascher, P. Sommi, A.  Mogilner, and J.M.",OADS,/arxiv_data1/oa_pdf/7f/38/JCB_201306001.PMC3798244.pdf
"http://dx.doi.org/10.1083/jcb.20061111 3 Civelekoglu-Scholey, G., L. Tao, I. Brust-Mascher, R. Wollman, and J.M.",Non-OADS,/arxiv_data1/oa_pdf/7f/38/JCB_201306001.PMC3798244.pdf
"http://dx.doi.org/10.1083/jcb.20090815 0 Cole, D.G., W.M.",Non-OADS,/arxiv_data1/oa_pdf/7f/38/JCB_201306001.PMC3798244.pdf
"6:8. http://dx.doi.org/10.1186/1747-1028-6- 8 Desai, A., S. Verma, T.J. Mitchison, and C.E.",Non-OADS,/arxiv_data1/oa_pdf/7f/38/JCB_201306001.PMC3798244.pdf
"http://dx.doi.org/10   .1016/S0092-8674(00)80960- 5 Drechsler, H., and A.D. McAinsh.",OADS,/arxiv_data1/oa_pdf/7f/38/JCB_201306001.PMC3798244.pdf
"2:120140. http://dx.doi.org/10.1098/rsob.12014 0 Dumont, S., and T.J. Mitchison.",Non-OADS,/arxiv_data1/oa_pdf/7f/38/JCB_201306001.PMC3798244.pdf
"19:1086– 1095. http://dx.doi.org/10.1016/j.cub.2009.05.05 6 Erban, R., J. Chapman, and P. Maini.",OADS,/arxiv_data1/oa_pdf/7f/38/JCB_201306001.PMC3798244.pdf
"Available at: http://arxiv.org/ abs/0704.1908 (accessed September 13, 2013).",Non-OADS,/arxiv_data1/oa_pdf/7f/38/JCB_201306001.PMC3798244.pdf
"http://dx.doi.org/10.1083/   jcb.20120401 9 van den Wildenberg, S.M., L. Tao, L.C.",Non-OADS,/arxiv_data1/oa_pdf/7f/38/JCB_201306001.PMC3798244.pdf
"http://dx.doi.org/10.1016/j.cub.2008.10.02 6 Varga, V., J. Helenius, K. Tanaka, A.A. Hyman, T.U.",OADS,/arxiv_data1/oa_pdf/7f/38/JCB_201306001.PMC3798244.pdf
"http://dx.doi.org/10.1038/ncb146 2 Vernì, F., M.P.",Non-OADS,/arxiv_data1/oa_pdf/7f/38/JCB_201306001.PMC3798244.pdf
"http://dx.doi.org/10.1016/j.cub.2004.08.05 4 Walczak, C.E., S. Cai, and A. Khodjakov.",OADS,/arxiv_data1/oa_pdf/7f/38/JCB_201306001.PMC3798244.pdf
67:715– 728. http://dx.doi.org/10.1002/cm.2048 2,Non-OADS,/arxiv_data1/oa_pdf/7f/38/JCB_201306001.PMC3798244.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
Online supplemental material is available at http://www.jcb.org/cgi/   content/full/jcb.201212024/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi.org/10.1083/jcb.111.3.80 7 Besschetnova, T.Y., B. Roy, and J.V.",OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi.org/10.1038/   3507508 3 Calvert, P.D., W.E.",Non-OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi.org/10.1085/jgp.20091032 2 Charpilienne, A., M. Nejmeddine, M. Berois, N. Parez, E. Neumann, E. Hewat,  G. Trugnan, and J. Cohen.",Non-OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi.org/10.1074/jbc   .M10193520 0 Chih, B., P. Liu, Y. Chinn, C. Chalouni, L.G.",Non-OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi.org/10.1038/ncb241 0 Chung, I., R. Akita, R. Vandlen, D. Toomre, J. Schlessinger, and I. Mellman.",Non-OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi.org/10.1038/   nature0882 7 Crank, J.",Non-OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi.org/10.1038/   sj.emboj.760035 0 Davis, L.I., and G. Blobel.",OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi.org/10.1016/   0092-8674(86)90784- 1 Davis, L.I., and G. Blobel.",OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi.org/10   .1038/ncb207 3 Dix, J.A., and A.S. Verkman.",OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
http://dx.doi.org/10.1146/   annurev.biophys.37.032807.12582 4,Non-OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"141:1208– 1219. http://dx.doi.org/10.1016/j.cell.2010.05.01 5 Joglekar, A.P., E.D.",OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi.org/10   .1016/S0091-679X(08)85007- 8 Kee, H.L., J.F.",OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi.org/10.1038/ncb245 0 Kirchhofer, A., J. Helma, K. Schmidthals, C. Frauer, S. Cui, A. Karcher, M.  Pellis, S. Muyldermans, C.S.",Non-OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi.org/10.1038/nsmb.172 7 Knibbs, R.N., I.J.",OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi.org/   10.1038/nmeth.142 8 Kutay, U., E. Izaurralde, F.R.",OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"16:1153– 1163. http://dx.doi.org/10.1093/emboj/16.6.115 3 Lin, Y.C., P. Niewiadomski, B. Lin, H. Nakamura, S.C. Phua, J. Jiao, A.  Levchenko, T. Inoue, R. Rohatgi, and T. Inoue.",Non-OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi.org/10.1038/nchembio.125 2 Luby-Phelps, K. 2000.",OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi.org/10.1016/S0074-7696(08)60527- 6 Marshall, W.F., H. Qin, M. Rodrigo Brenni, and J.L.",OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi   .org/10.1091/mbc.E04-07-058 6 Marshallsay, C., and R. Lührmann.",OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi.org/   10.1083/jcb.116.4.85 1 Mohr, D., S. Frey, T. Fischer, T. Güttler, and D. Görlich.",OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi.org/10.1038/emboj.2009.20 0 Moree, B., C.B.",Non-OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi.org/10.1083/jcb.20110607 9 Nachury, M.V ., E.S.",OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi.org/10.1146/annurev.cellbio.042308.11333 7 Nagata, Y., and M.M.",OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi.org/10.1016/   j.neuron.2005.03.02 3 Najafi, M., and P.D.",OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi.org/   10.1016/j.visres.2012.08.00 6 Najafi, M., N.A.",OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi.org/10   .1073/pnas.111510910 9 Nakada, C., K. Ritchie, Y .",OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi.org/10.1038/ncb100 9 Nehring, R.B., D. Richter, and W. Meyerhof.",Non-OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi.org/10   .1016/S0928-4257(00)00203- 5Elowitz, M.B., M.G.",OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi   .org/10.1074/jbc.270.23.1378 7 Engel, B.D., H. Ishikawa, K.A.",OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi.org/10.1083/jcb.104.2.18 9 Flanagan, J.J., R.K. Tweten, A.E.",OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi.org/   10.1021/bi900230 9 Follit, J.A., R.A. Tuft, K.E.",OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi   .org/10.1091/mbc.E06-02-013 3 Follit, J.A., L. Li, Y. Vucica, and G.J.",OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi.org/10.1083/jcb.20091009 6 Francis, S.S., J. Sfakianos, B.",Non-OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi.org/10   .1083/jcb.20100900 1 Gilliam, J.C., J.T.",OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi.org/10.1016/j.cell.2012.10.03 8 Gillingham, A.K., and S. Munro.",OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi.org/   10.1083/jcb.103.3.81 9 Händel, M., S. Schulz, A. Stanarius, M. Schreff, M. Erdtmann-Vourliotis, H.  Schmidt, G. Wolf, and V. Höllt.",OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi   .org/10.1016/S0306-4522(98)00354- 6 Hao, L., M. Thein, I. Brust-Mascher, G. Civelekoglu-Scholey, Y. Lu, S. Acar, B.  Prevo, S. Shaham, and J.M.",OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi.org/10.1038/ncb226 8 Harbury, P.B., T. Zhang, P.S.",OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi.org/10.1126/science.824877 9 Heuck, A.P., P.C.",OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi.org/10.1007/978-90-481-8622-8_2 0 Hoelz, A., E.W.",Non-OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi.org/10   .1146/annurev-biochem-060109-15103 0 Hu, Q., L. Milenkovic, H. Jin, M.P.",OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi.org/10.1126/science.119105 4 Ishikawa, H., and W.F.",OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi.org/10.1038/   nrm308 5 Jaqaman, K., H. Kuwata, N. Touret, R. Collins, W.S.",OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
http://dx.doi   .org/10.1016/j.cell.2011.06.04 9,OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi.org/10.1093/protein/1.2.10 7 Ocbina, P.J., J.T.",OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi.org/10.1038/ng.83 2 Olofsson, A., H. Hebert, and M. Thelestam.",OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi.org/10.1016/0014-5793(93)80050- 5 Pedersen, L.B., and J.L.",OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"85:23– 61. http://dx.doi.org/10.1016/S0070-2153(08)00802- 8 Reiter, J.F., O.E.",OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi   .org/10.1038/embor.2012.7 3 Ribbeck, K., and D. Görlich.",OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi.org/10.1093/emboj/21.11.266 4 Rosenzweig, D.H., K.S.",Non-OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi.org/10   .1523/JNEUROSCI.1421-07.200 7 Schulz, I.",OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi.org/10.1091/mbc.E10-03-026 9 Shepard, L.A., A.P.",Non-OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi.org/10.1021/bi981452 f Song, A.-H., D. Wang, G. Chen, Y. Li, J. Luo, S. Duan, and M.-M. Poo.",OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi.org/10.1016/j.cell.2009.01.01 6 Suzuki, K., K. Ritchie, E. Kajikawa, T. Fujiwara, and A. Kusumi.",OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi   .org/10.1242/jeb.02192 3 Tran, P.V., C.J.",OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"40:403– 410. http://dx.doi.org/10.1038/ng.10 5 Wang, Q., J. Pan, and W.J.",Non-OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi.org/10.1016/j.cell.2006.02.04 4 Winckler, B., P. Forscher, and I. Mellman.",OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
"http://dx.doi.org/10.1038/1780 6 Ye, F., D.K.",Non-OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
http://dx.doi.org/10.7554/eLife.0065 4,Non-OADS,/arxiv_data1/oa_pdf/69/1a/JCB_201212024.PMC3798247.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/e8/ea/JCB_201304188.PMC3798248.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/e8/ea/JCB_201304188.PMC3798248.pdf
Online supplemental material is available at http://www.jcb.org/   cgi/content/full/jcb.201304188/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/e8/ea/JCB_201304188.PMC3798248.pdf
"http://dx.doi.org/10.1038/nature0302 9 Langelier, C., U.K. von Schwedler, R.D.",OADS,/arxiv_data1/oa_pdf/e8/ea/JCB_201304188.PMC3798248.pdf
"http://dx.doi.org/10.1128/JVI.01049-0 6 Matsunaga, K., T. Saitoh, K. Tabata, H. Omori, T. Satoh, N. Kurotori, I. Maejima,  K. Shirahama-Noda, T. Ichimura, T. Isobe, et al.",OADS,/arxiv_data1/oa_pdf/e8/ea/JCB_201304188.PMC3798248.pdf
"http://dx.doi.org/10.1038/ncb184 6 Mizushima, N. 2010.",Non-OADS,/arxiv_data1/oa_pdf/e8/ea/JCB_201304188.PMC3798248.pdf
"http://dx.doi.org/10.1016/   j.ceb.2009.12.00 4 Mizushima, N., A. Kuma, Y .",OADS,/arxiv_data1/oa_pdf/e8/ea/JCB_201304188.PMC3798248.pdf
"http://dx.doi.org/   10.1242/jcs.0038 1 Mizushima, N., B. Levine, A.M. Cuervo, and D.J.",Non-OADS,/arxiv_data1/oa_pdf/e8/ea/JCB_201304188.PMC3798248.pdf
"http://dx.doi.org/10.1038/nature0663 9 Morita, S., T. Kojima, and T. Kitamura.",OADS,/arxiv_data1/oa_pdf/e8/ea/JCB_201304188.PMC3798248.pdf
"http://dx.doi.org/10.1038/sj.gt.330120 6 Newton, K., M.L.",OADS,/arxiv_data1/oa_pdf/e8/ea/JCB_201304188.PMC3798248.pdf
"http://dx.doi.org/10.1016/j.cell.2008.07.03 9 Nishimura, T., T. Kaizuka, K. Cadwell, M.H.",OADS,/arxiv_data1/oa_pdf/e8/ea/JCB_201304188.PMC3798248.pdf
http://dx.doi.org/   10.1038/embor.2013.,OADS,/arxiv_data1/oa_pdf/e8/ea/JCB_201304188.PMC3798248.pdf
12:530– 544. http://dx.doi.org/10.1111/j.1462-5822.2009.01415.,Non-OADS,/arxiv_data1/oa_pdf/e8/ea/JCB_201304188.PMC3798248.pdf
"http://dx.doi   .org/10.1074/jbc.M30426620 0 Saitoh, T., N. Fujita, M.H.",OADS,/arxiv_data1/oa_pdf/e8/ea/JCB_201304188.PMC3798248.pdf
"http://dx.doi.org/10.1038/nature0738 3 Saitoh, T., N. Fujita, T. Hayashi, K. Takahara, T. Satoh, H. Lee, K. Matsunaga,  S. Kageyama, H. Omori, T. Noda, et al.",OADS,/arxiv_data1/oa_pdf/e8/ea/JCB_201304188.PMC3798248.pdf
"http://dx.doi.org/10   .1073/pnas.091126710 6 Shahnazari, S., W.L.",Non-OADS,/arxiv_data1/oa_pdf/e8/ea/JCB_201304188.PMC3798248.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e8/ea/JCB_201304188.PMC3798248.pdf
"http://dx.doi.org/10   .1016/j.febslet.2010.02.00 1 Thurston, T.L., G. Ryzhakov, S. Bloor, N. von Muhlinen, and F. Randow.",OADS,/arxiv_data1/oa_pdf/e8/ea/JCB_201304188.PMC3798248.pdf
"http://dx.doi.org/10.1038/   nature1074 4 Tokunaga, F., S. Sakata, Y. Saeki, Y. Satomi, T. Kirisako, K. Kamei, T.  Nakagawa, M. Kato, S. Murata, S. Yamaoka, et al.",OADS,/arxiv_data1/oa_pdf/e8/ea/JCB_201304188.PMC3798248.pdf
"http://dx.doi.org/10.1038/ncb182 1 van Wijk, S.J., E. Fiskin, M. Putyrski, F. Pampaloni, J. Hou, P. Wild, T.  Kensche, H.E.",Non-OADS,/arxiv_data1/oa_pdf/e8/ea/JCB_201304188.PMC3798248.pdf
"http://dx.doi   .org/10.1016/j.molcel.2012.06.01 7References Birmingham, C.L., and J.H.",OADS,/arxiv_data1/oa_pdf/e8/ea/JCB_201304188.PMC3798248.pdf
"http://dx.doi   .org/10.1083/jcb.124.5.67 7 Dupont, N., S. Lacas-Gervais, J. Bertout, I. Paz, B. Freche, G.T.",OADS,/arxiv_data1/oa_pdf/e8/ea/JCB_201304188.PMC3798248.pdf
"http://dx.doi.org/10.1016/j.chom.2009.07.00 5 Durocher, Y ., S. Perret, and A. Kamen.",OADS,/arxiv_data1/oa_pdf/e8/ea/JCB_201304188.PMC3798248.pdf
"http://dx.doi   .org/10.1093/nar/30.2.e 9 Fujita, N., M. Hayashi-Nishino, H. Fukumoto, H. Omori, A. Yamamoto, T.  Noda, and T. Yoshimori.",OADS,/arxiv_data1/oa_pdf/e8/ea/JCB_201304188.PMC3798248.pdf
"http://dx.doi.org/10.1091/mbc.E08-03-031 2 Fujita, N., T. Itoh, H. Omori, M. Fukuda, T. Noda, and T. Yoshimori.",OADS,/arxiv_data1/oa_pdf/e8/ea/JCB_201304188.PMC3798248.pdf
"http://dx.doi.org/   10.1091/mbc.E07-12-125 7 Fujita, N., T. Saitoh, S. Kageyama, S. Akira, T. Noda, and T. Yoshimori.",OADS,/arxiv_data1/oa_pdf/e8/ea/JCB_201304188.PMC3798248.pdf
"http://dx.doi.org/10.1074/   jbc.M109.03767 1 Fujita, N., and T. Yoshimori.",OADS,/arxiv_data1/oa_pdf/e8/ea/JCB_201304188.PMC3798248.pdf
"http://dx.doi.org/   10.1016/j.ceb.2011.03.00 3 Hara, T., and N. Mizushima.",OADS,/arxiv_data1/oa_pdf/e8/ea/JCB_201304188.PMC3798248.pdf
"http://dx.doi.org/10.4161/auto.5.1.718 0 Hofmann, R.M., and C.M.",Non-OADS,/arxiv_data1/oa_pdf/e8/ea/JCB_201304188.PMC3798248.pdf
"http://dx.doi.org/10   .1016/S0092-8674(00)80575- 9 Huett, A., R.J. Heath, J.",OADS,/arxiv_data1/oa_pdf/e8/ea/JCB_201304188.PMC3798248.pdf
"http://dx.doi   .org/10.1016/j.chom.2012.10.01 9 Itakura, E., and N. Mizushima.",OADS,/arxiv_data1/oa_pdf/e8/ea/JCB_201304188.PMC3798248.pdf
"http://dx.doi.org/10.4161/auto.6.6.1270 9 Itakura, E., C. Kishi-Itakura, I. Koyama-Honda, and N. Mizushima.",OADS,/arxiv_data1/oa_pdf/e8/ea/JCB_201304188.PMC3798248.pdf
"http://dx.doi.org/10.1242/jcs.09411 0 Itoh, T., N. Fujita, E. Kanno, A. Yamamoto, T. Yoshimori, and M. Fukuda.",OADS,/arxiv_data1/oa_pdf/e8/ea/JCB_201304188.PMC3798248.pdf
"http://dx.doi.org/10.1091/mbc.E07-12-123 1 Iwai, K., and F. Tokunaga.",OADS,/arxiv_data1/oa_pdf/e8/ea/JCB_201304188.PMC3798248.pdf
"http://dx.doi   .org/10.1038/embor.2009.14 4 Kageyama, S., H. Omori, T. Saitoh, T. Sone, J.L.",OADS,/arxiv_data1/oa_pdf/e8/ea/JCB_201304188.PMC3798248.pdf
"http://dx.doi   .org/10.1091/mbc.E10-11-089 3 Katzmann, D.J., M. Babst, and S.D.",OADS,/arxiv_data1/oa_pdf/e8/ea/JCB_201304188.PMC3798248.pdf
"http://dx.doi.org/10.1016/S0076-6879(08)03601- X Kobayashi, S., T. Kojidani, H. Osakada, A. Yamamoto, T. Yoshimori, Y.  Hiraoka, and T. Haraguchi.",OADS,/arxiv_data1/oa_pdf/e8/ea/JCB_201304188.PMC3798248.pdf
"http://dx.doi.org/10.4161/auto.6.1.1032 4 Kuma, A., M. Hatano, M. Matsui, A. Yamamoto, H. Nakaya, T. Yoshimori, Y.  Ohsumi, T. Tokuhisa, and N. Mizushima.",OADS,/arxiv_data1/oa_pdf/e8/ea/JCB_201304188.PMC3798248.pdf
"http://dx.doi.org/10.1126/science.120540 5 Yamamoto, M., T. Okamoto, K. Takeda, S. Sato, H. Sanjo, S. Uematsu, T.  Saitoh, N. Yamamoto, H. Sakurai, K.J.",OADS,/arxiv_data1/oa_pdf/e8/ea/JCB_201304188.PMC3798248.pdf
"http://dx.doi.org/10.1038/ni136 7 Yang, Y., J. Kitagaki, R.M.",OADS,/arxiv_data1/oa_pdf/e8/ea/JCB_201304188.PMC3798248.pdf
"http://dx.doi.org/10.1158/0008- 5472.CAN-07-056 8 Yoshikawa, Y., M. Ogawa, T. Hain, M. Yoshida, M. Fukumatsu, M. Kim, H.  Mimuro, I. Nakagawa, T. Yanagawa, T. Ishii, et al.",OADS,/arxiv_data1/oa_pdf/e8/ea/JCB_201304188.PMC3798248.pdf
"http://dx.doi.org/10.1038/ncb196 7 Youle, R.J., and D.P.",OADS,/arxiv_data1/oa_pdf/e8/ea/JCB_201304188.PMC3798248.pdf
"http://dx.doi.org/10.1038/nrm302 8 Zheng, Y.T., S. Shahnazari, A. Brech, T. Lamark, T. Johansen, and J.H.",Non-OADS,/arxiv_data1/oa_pdf/e8/ea/JCB_201304188.PMC3798248.pdf
http://dx.doi.org/10   .4049/jimmunol.090044 1,Non-OADS,/arxiv_data1/oa_pdf/e8/ea/JCB_201304188.PMC3798248.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
Online supplemental material is available at  http://www.jcb.org/cgi/content/full/jcb.201305022/DC1.,Non-OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi   .org/10.1016/j.cub.2009.04.02 4 Almonacid, M., S. Celton-Morizur, J.L.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi   .org/10.1016/j.cub.2011.02.00 3 Alsop, G.B., W. Chen, M. Foss, K.-F. Tseng, and D. Zhang.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1371/ journal.pone.000489 2 Arai, R., and I. Mabuchi.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1002/(SICI)1097-0061   (199807)14:10<943::AID-YEA292>3.0.CO;2- Y Balasubramanian, M.K., E. Bi, and M. Glotzer.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1016/j.cub.2004.09.02 2 Barr, F.A., and U. Gruneberg.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1016/j.cell.2007.11.01 1 Bi, E., P. Maddox, D.J.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"239:883– 888. http://dx.doi.org/10.1126/science.327728 3 Buttery, S.M., S. Yoshida, and D. Pellman.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1091/mbc   .E06-09-082 0 Buttery, S.M., K. Kono, E. Stokasimov, and D. Pellman.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1091/mbc   .E12-05-039 5 Cao, L.G., and Y.L.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"162:851– 862. http://dx.doi.org/10.1083/jcb.20030501 2 Castrillon, D.H., and S.A. Wasserman.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1128/MCB.24.24.10621-10635.200 4the edges of the colonies were imaged, whereas the entire colony was im - aged for the double mutants.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1016/j.ceb.2005   .12.01 1 Kovar, D.R., and T.D.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1073/   pnas.040590210 1 Kovar, D.R., J.R. Kuhn, A.L.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi   .org/10.1083/jcb.20021107 8 Kovar, D.R., V. Sirotkin, and M. Lord.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi   .org/10.1016/j.tcb.2010.11.00 1 Laporte, D., R. Zhao, and J.-Q.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1016/j.semcdb.2010.08.00 4 Laporte, D., V.C.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1083/jcb.20100817 1 Lee, I.-J., and J.-Q.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1242/jcs.10257 4 Lee, E., E.A.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1002/(SICI)1097-0169(1998)39:2<122:: AID-CM3>3.0.CO;2- 8 Lee, I.-J., V.C.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1002/cm.2105 2 Li, F., and H.N.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1091/ mbc.E11-07-063 1 Maiti, S., A. Michelot, C. Gould, L. Blanchoin, O. Sokolova, and B.L.",Non-OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1002/cm.2103 3 Martin, S.G., and F. Chang.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1016/   j.cub.2006.04.04 0 Martin, S.G., S.A. Rincón, R. Basu, P. Pérez, and F. Chang.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1091/mbc.E07-02-009 4 Moseley, J.B., I. Sagot, A.L.",Non-OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1091/mbc.E03-08-062 1 Neidt, E.M., B.J.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1074/jbc.M80420120 0 Ojkic, N., and D. Vavylonis.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"105:048102. http://dx.doi.org/10.1103/   PhysRevLett.105.04810 2 Padmanabhan, A., K. Bakka, M. Sevugan, N.I.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1016/j.cub.2011.01.05 9 Paoletti, A., and F. Chang.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi   .org/10.1091/mbc.11.8.275 7 Pelham, R.J., and F. Chang.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1038/   nature0099 9 Petersen, J., O. Nielsen, R. Egel, and I.M.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1083/   jcb.141.5.121 7 Pollard, T.D., and J.-Q.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1038/   nrm283 4 Pring, M., M. Evangelista, C. Boone, C. Yang, and S.H.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1021/bi026520 jChang, F., A. Woollard, and P. Nurse.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10   .1083/jcb.137.1.16 9 Chen, W., M. Foss, K.-F. Tseng, and D. Zhang.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1371/journal.pbio.006020 9 Chen, H., C.-C. Kuo, H. Kang, A.S. Howell, T.R.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1091/mbc   .E12-05-040 0 Chen, Q., S. Nag, and T.D.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi   .org/10.1016/j.jsb.2011.10.00 5 Chesarone, M., C.J.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10   .1016/j.devcel.2008.12.00 1 Coffman, V.C., and J.-Q.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1091/mbc.E09-05-042 8 Coffman, V.C., P. Wu, M.R.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1083/   jcb.20110607 8 Courtemanche, N., and T.D.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1074/jbc.M111.32295 8 Eisenmann, K.M., E.S.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/   10.1016/j.cub.2007.03.02 4 Evangelista, M., D. Pruyne, D.C. Amberg, C. Boone, and A. Bretscher.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10   .1038/ncb71 8 Feierbach, B., and F. Chang.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10   .1016/S1369-5274(01)00273- 9 Feierbach, B., and F. Chang.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1016/S0960-9822(01)00525- 5 Gao, L., and A. Bretscher.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi   .org/10.1091/mbc.E09-03-019 4 Gorelik, R., C. Yang, V. Kameswaran, R. Dominguez, and T. Svitkina.",Non-OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi   .org/10.1091/mbc.E10-03-025 6 Hachet, O., and V. Simanis.",Non-OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1101/gad.169720 8 Huang, Y., H. Yan, and M.K.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1083/jcb.20080615 1 Huang, J., Y. Huang, H. Yu, D. Subramanian, A. Padmanabhan, R. Thadani,  Y. Tao, X. Tang, R. Wedlich-Soldner, and M.K.",Non-OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi   .org/10.1083/jcb.20120904 4 Huckaba, T.M., T. Lipkin, and L.A. Pon.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1083/jcb.20060915 5 Kamasaki, T., R. Arai, M. Osumi, and I. Mabuchi.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1038/ncb129 5 Karpova, T.S., J.G.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
http://dx.doi.org/10   .1083/jcb.142.6.150 1,Non-OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1126/science.115108 6 Wang, H., and D. Vavylonis.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1371/ journal.pone.000407 8 Wang, J., S.P.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
http://dx.doi   .org/10.1111/j.1600-0854.2009.00893.,Non-OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1016/S0962-8924(97)01217- 8 Watanabe, S., Y. Ando, S. Yasuda, H. Hosoya, N. Watanabe, T. Ishizaki, and S.  Narumiya.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1091/mbc.E07-10-108 6 White, J.G., and G.G.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1016/0022-5193   (83)90342- 9 Wu, J.-Q., and T.D.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1126/   science.111323 0 Wu, J.-Q., J. Bähler, and J.R. Pringle.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1091/mbc.12.4.106 1 Wu, J.-Q., J.R. Kuhn, D.R.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1016/   S1534-5807(03)00324- 1 Wu, J.-Q., V. Sirotkin, D.R.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10   .1083/jcb.20060203 2 Wu, J.-Q., C.D.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1016/   S0091-679X(08)00609- 2 Xu, Y., J.B. Moseley, I. Sagot, F. Poy, D. Pellman, B.L.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1016/   S0092-8674(04)00210- 7 Yang, F., L.G.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi   .org/10.1038/nbt1096-124 6 Y onetani, A., and F. Chang.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1016/j.cub.2010.01.06 1 Yonetani, A., R.J. Lustig, J.B. Moseley, T. Takeda, B.L.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1091/mbc   .E07-07-073 1 Zacharias, D.A., J.D.",Non-OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1126/science.106853 9 Zhou, M., and Y.-L. Wang.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"19:318– 326. http://dx.doi.org/10.1091/mbc.E07-08-078 3Pruyne, D., M. Evangelista, C. Yang, E. Bi, S. Zigmond, A. Bretscher, and C.  Boone.",Non-OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1126/science   .107230 9 Pruyne, D., L. Gao, E. Bi, and A. Bretscher.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1091/mbc.E04-04-029 6 Quinlan, M.E., S. Hilgert, A. Bedrossian, R.D.",Non-OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1083/jcb   .20070619 6 Ramalingam, N., H. Zhao, D. Breitsprecher, P. Lappalainen, J. Faix, and M.  Schleicher.",Non-OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1016/   j.ejcb.2010.06.00 1 Riedl, J., A.H. Crevenna, K. Kessenbrock, J.H.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi   .org/10.1038/nmeth.122 0 Roberts-Galbraith, R.H., and K.L.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1091/mbc.E12-07-053 5 Scott, B.J., E.M. Neidt, and D.R.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1091/mbc.E11-06-049 2 Sohrmann, M., C. Fankhauser, C. Brodbeck, and V. Simanis.",Non-OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1101/   gad.10.21.270 7 Spudich, J.A., and S. Watt.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1534/genetics.113.14971 6 Takeya, R., K. Taniguchi, S. Narumiya, and H. Sumimoto.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
http://dx.doi.org/10.1038/emboj.2008.,OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1016/j.cub   .2008.02.00 5 Tolliday, N., M. Pitcher, and R. Li.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1091/mbc.E02-09-055 8 Tominaga, T., E. Sahai, P. Chardin, F. McCormick, S.A. Courtneidge, and A.S.  Alberts.",Non-OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10   .1016/S1097-2765(00)80399- 8 Vallen, E.A., J. Caviston, and E. Bi.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1091/mbc.11.2.59 3 van der Honing, H.S., L.S.",Non-OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
"http://dx.doi.org/10.1002/   cm.2053 4 Vavylonis, D., D.R.",OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
http://dx.doi.org/10.1016/j.molcel.2006.01.01 6,OADS,/arxiv_data1/oa_pdf/09/f0/JCB_201305022.PMC3798249.pdf
http://dx.doi.org/10.1083/jcb.201307110/DC1) now  show a high frequency of nonrandom template segrega - tion during differentiation of embryonic stem cells using  rigorous experimentation and implicate the methyltrans - ferase Dnmt3 as a key regulator of this process.,OADS,/arxiv_data1/oa_pdf/2c/a3/JCB_201308110.PMC3798250.pdf
"It has  been often argued that the probability of labeled strands of all  46 (in humans) or 40 (in mice) chromosomes being segregated  to one cell would be extremely low (246 or 240) and that any  observation of an asymmetric DNA labeling pattern even at a Nonrandom template segregation: A way to break  the symmetry of stem cells Yukiko M. Yamashita1,2 1Life Sciences Institute and 2Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, MI 48109 © 2013 Yamashita  This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/2c/a3/JCB_201308110.PMC3798250.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/2c/a3/JCB_201308110.PMC3798250.pdf
"http://dx.doi.org/10.1126/science.112051 9 Cairns, J.",Non-OADS,/arxiv_data1/oa_pdf/2c/a3/JCB_201308110.PMC3798250.pdf
"http://dx.doi.org/10.1038/255197a 0 Elabd, C., W. Cousin, R.Y.",Non-OADS,/arxiv_data1/oa_pdf/2c/a3/JCB_201308110.PMC3798250.pdf
"http://dx.doi.org/10.1038/nmeth.220 6 Lansdorp, P.M. 2007.",Non-OADS,/arxiv_data1/oa_pdf/2c/a3/JCB_201308110.PMC3798250.pdf
"http://dx.doi.org/10.1016/j.cell.2007.06.01 7 Lark, K.G.",OADS,/arxiv_data1/oa_pdf/2c/a3/JCB_201308110.PMC3798250.pdf
http://dx.doi.org/10.1016/   j.semcdb.2013.05.01 0.,OADS,/arxiv_data1/oa_pdf/2c/a3/JCB_201308110.PMC3798250.pdf
"http://dx.doi.org/10.1016/0092-   8674(78)90274- X Rando, T.A.",OADS,/arxiv_data1/oa_pdf/2c/a3/JCB_201308110.PMC3798250.pdf
"http://dx.doi.org/10.1016/j.cell.2007   .06.01 9 Sauer, S., S.S. Burkett, M. Lewandoski, and A.J.",OADS,/arxiv_data1/oa_pdf/2c/a3/JCB_201308110.PMC3798250.pdf
"http://dx.doi.org/10   .1007/s10577-013-9358- 8 Tajbakhsh, S., and C. Gonzalez.",Non-OADS,/arxiv_data1/oa_pdf/2c/a3/JCB_201308110.PMC3798250.pdf
"http://dx.doi.org/10.1038/nrm278 4 Yadlapalli, S., and Y.M.",OADS,/arxiv_data1/oa_pdf/2c/a3/JCB_201308110.PMC3798250.pdf
"498:251– 254. http://dx.doi.org/10.1038/nature1210 6avoidance of DNA mutation, one would wonder whether all   the chromosomes should follow NRTS or whether NRTS of  only a subset of chromosomes might suffice.",Non-OADS,/arxiv_data1/oa_pdf/2c/a3/JCB_201308110.PMC3798250.pdf
"Thus, MAD2L2 helps to en - sure a robustly bistable switch between APC/CCDC20 and  APC/CCDH1 during the metaphase-to-anaphase transition,  thereby contributing to mitotic fidelity.Sequestration of CDH1 by MAD2L2 prevents  premature APC/C activation prior to anaphase onset Tamar Listovsky and Julian E. Sale Medical Research Council Laboratory of Molecular Biology, Cambridge Biomedical Campus, Cambridge CB2 0QH, England, UK © 2013 Listovsky and Sale  This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
Online  supplemental material is available at http://www.jcb.org/cgi/content/full/ jcb.201302060/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
Additional data are available in the JCB DataViewer  at http://dx.doi.org/10.1083/jcb.201302060.dv.,OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"144:139– 151. http://dx.doi.org/10.1016/0042-6822(85)90312- 5 Bhat, A., P.L.",OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"http://dx.doi.org/10.1093/nar/gks144 2 Chao, W.C., K. Kulkarni, Z. Zhang, E.H. Kong, and D. Barford.",OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"http://dx.doi   .org/10.1038/nature1089 6 Chen, J., and G. Fang.",OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"http://dx.doi.org/10.1101/gad   .89870 1 Ciosk, R., W. Zachariae, C. Michaelis, A. Shevchenko, M. Mann, and K.  Nasmyth.",Non-OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)81211- 8 Cohen-Fix, O., J.M.",OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"http://dx.doi.org/10.1101/gad.10.24.308 1 Dial, J.M., E.V.",OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
http://dx.doi.org/10.1074/jbc.M60658920 0with PBS + 0.25% Triton X-100 and incubated for 10 min on ice.,Non-OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"http://dx.doi   .org/10.1371/journal.pone.000702 0 Medendorp, K., L. Vreede, J.J. van Groningen, L. Hetterschijt, L. Brugmans,  P.A.",OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"http://dx.doi   .org/10.1371/journal.pone.001512 8 Musacchio, A., and E.D.",OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"http://dx.doi.org/   10.1038/nrm216 3 Nelson, J.R., C.W.",OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"http://dx.doi   .org/10.1128/MCB.25.14.6103-6111.200 5 Pfleger, C.M., and M.W.",OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"http://dx.doi.org/10.1101/   gad.89790 1 Pines, J.",Non-OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"http://dx.doi.org/10.1038/nrm313 2 Prinz, S., E.S.",Non-OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"http://dx.doi.org/10.1016/   S0960-9822(98)70298- 2 Rape, M., and M.W.",OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"432:588– 595. http://dx.doi.org/10.1038/nature0302 3 Reber, A., C.F.",Non-OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"http://dx.doi.org/10.1242/dev.0248 8 Reimann, J.D., B.E.",OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"http://dx.doi.org/10.1101/   gad.94570 1 Sale, J.E.",OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"http://dx.doi.org/10.1101/csh - perspect.a01270 8 Schwab, M., A.S. Lutum, and W. Seufert.",OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"http://dx.doi.org/10.1016/   S0092-8674(00)80529- 2 Shirayama, M., W. Zachariae, R. Ciosk, and K. Nasmyth.",OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"http://dx.doi.org/10.1093/emboj/17.5.133 6 Shirayama, M., A. Tóth, M. Gálová, and K. Nasmyth.",OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"http://dx.doi.org/10.1038/4608 0 Shteinberg, M., Y. Protopopov, T. Listovsky, M. Brandeis, and A. Hershko.",Non-OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"http://dx.doi.org/10.1093/emboj/cdg16 1 Simpson-Lavy, K.J., Y.S.",Non-OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"http://dx.doi.org/10.1042/   BST038007 8 Sonoda, E., T. Okada, G.Y.",OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"http://dx.doi   .org/10.1093/emboj/cdg30 8 Stewart, S., and G. Fang.",OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
http://dx.doi.org/10.1158/0008-5472.,Non-OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"http://dx.doi.org/10.1038/nrm227 6Enquist-Newman, M., M. Sullivan, and D.O.",OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"http://dx.doi.org/10.1016/   j.molcel.2008.04.00 4 Fenech, M., M. Kirsch-Volders, A.T. Natarajan, J. Surralles, J.W.",OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"http://dx.doi.org/10.1016/j.cub.2008.09.05 8 Foe, I.T., S.A. Foster, S.K.",OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"http://dx.doi   .org/10.1016/j.cub.2011.09.05 1 Glotzer, M., A.W.",OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"http://dx.doi.org/10.1038/   349132a 0 Gutierrez, G.J., T. Tsuji, M. Chen, W. Jiang, and Z.A.",OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"http://dx.doi.org/10.1038/ncb207 1 Hagting, A., N. Den Elzen, H.C. Vodermaier, I.C.",OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"http://dx.doi   .org/10.1083/jcb.20011100 1 Hégarat, N., E. Smith, G. Nayak, S. Takeda, P.A.",OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"http://dx.doi.org/10.1083/jcb.20110505 8 Howell, B.J., B. Moree, E.M. Farrar, S. Stewart, G. Fang, and E.D.",OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"http://dx.doi.org/10.1016/j.cub.2004.05.05 3 Hsu, J.Y., J.D.",OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"http://dx.doi.org/10.1038/   ncb78 5 Jaspersen, S.L., J.F.",OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"http://dx.doi.org/10.1016/   S0960-9822(99)80111- 0 Kramer, E.R., N. Scheuringer, A.V.",OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"http://dx.doi.org/10.1091/mbc.11.5.155 5 Lawrence, C.W., G. Das, and R.B.",Non-OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"http://dx.doi.org/10.1007/BF0038331 6 Lee, J., J.A.",OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"http://dx.doi.org/10.4161/cc.9.9.1151 9 Lim, H.H., P.Y.",Non-OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"http://dx.doi.org/10.1016/S0960-9822   (98)70088- 0 Lindon, C., and J. Pines.",OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"164:233– 241. http://dx.doi.org/10.1083/jcb.20030903 5 Listovsky, T., A. Zor, A. Laronne, and M. Brandeis.",Non-OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"http://dx.doi.org/10.1006/excr.1999.478 8 Listovsky, T., Y.S.",OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"http://dx.doi.org/10.1038/   sj.emboj.760014 9 Lorca, T., A. Castro, A.M. Martinez, S. Vigneron, N. Morin, S. Sigrist, C.  Lehner, M. Dorée, and J.C. Labbé.",Non-OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"http://dx.doi.org/10.1093/emboj/17.13.356 5 Margottin-Goguet, F., J.Y.",Non-OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"http://dx.doi.org/10.1126/science.278.5337.46 0 Visintin, R., K. Craig, E.S.",OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"http://dx.doi.org/10.1016/   S1097-2765(00)80286- 5 Wäsch, R., and F.R.",OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"http://dx.doi   .org/10.1038/nature0085 6 Waters, L.S., and G.C.",OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"http://dx.doi.org/   10.1073/ pnas.051016710 3 Zachariae, W., M. Schwab, K. Nasmyth, and W. Seufert.",Non-OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
"http://dx.doi.org/10.1126/   science.282.5394.172 1 Zur, A., and M. Brandeis.",OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
http://dx.doi.org/10.1093/emboj/20.4.79 2,Non-OADS,/arxiv_data1/oa_pdf/6a/16/JCB_201302060.PMC3798251.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/35/d8/JCB_201307110.PMC3798252.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/35/d8/JCB_201307110.PMC3798252.pdf
"Cell numbers were determined at the indicated  times after initial plating, and population doubling times were determined  using an online doubling time calculator ( http://www.doubling-time.com/   compute.ph p).",OADS,/arxiv_data1/oa_pdf/35/d8/JCB_201307110.PMC3798252.pdf
"http://dx.doi.org/10.1038/255197a 0 Chen, T., Y. Ueda, J.E.",OADS,/arxiv_data1/oa_pdf/35/d8/JCB_201307110.PMC3798252.pdf
"http://dx.doi   .org/10.1371/journal.pbio.005010 2 Escobar, M., P. Nicolas, F. Sangar, S. Laurent-Chabalier, P. Clair, D. Joubert,  P. Jay, and C. Legraverend.",Non-OADS,/arxiv_data1/oa_pdf/35/d8/JCB_201307110.PMC3798252.pdf
"2:258. http://dx.doi.org/10.1038/ncomms126 0 Falconer, E., E.A.",OADS,/arxiv_data1/oa_pdf/35/d8/JCB_201307110.PMC3798252.pdf
"9:305. http://dx.doi   .org/10.1186/1476-4598-9-30 5 Huh, Y .H., and J.L.",Non-OADS,/arxiv_data1/oa_pdf/35/d8/JCB_201307110.PMC3798252.pdf
"http://dx.doi.org/10.1002/stem.70 7 Itskovitz-Eldor, J., M. Schuldiner, D. Karsenti, A. Eden, O. Yanuka, M. Amit,  H. Soreq, and N. Benvenisty.",Non-OADS,/arxiv_data1/oa_pdf/35/d8/JCB_201307110.PMC3798252.pdf
"http://dx.doi.org/   10.1128/MCB.24.20.8862-8871.200 4 Karpowicz, P., C. Morshead, A. Kam, E. Jervis, J. Ramunas, V. Cheng, and D.  van der Kooy.",Non-OADS,/arxiv_data1/oa_pdf/35/d8/JCB_201307110.PMC3798252.pdf
"170:721– 732. http://dx.doi.org/10.1083/jcb.20050207 3 Karpowicz, P., M. Pellikka, E. Chea, D. Godt, U. Tepass, and D. van der  Kooy.",OADS,/arxiv_data1/oa_pdf/35/d8/JCB_201307110.PMC3798252.pdf
"http://dx.doi   .org/10.1016/j.ejcb.2009.03.00 1 Kiel, M.J., S. He, R. Ashkenazi, S.N.",OADS,/arxiv_data1/oa_pdf/35/d8/JCB_201307110.PMC3798252.pdf
"http://dx.doi.org/10.1038/nature0611 5 King, F.W., C. Ritner, W. Liszewski, H.C.K.",Non-OADS,/arxiv_data1/oa_pdf/35/d8/JCB_201307110.PMC3798252.pdf
"http://dx.doi.org/10.1089/scd.2009.001 2 Klar, A.J.",OADS,/arxiv_data1/oa_pdf/35/d8/JCB_201307110.PMC3798252.pdf
"http://dx.doi.org/10.1038/326466a 0 Klar, A.J.",OADS,/arxiv_data1/oa_pdf/35/d8/JCB_201307110.PMC3798252.pdf
"http://dx.doi.org/10.1016/0168-9525(94)90055- 8 Knoblich, J.A.",OADS,/arxiv_data1/oa_pdf/35/d8/JCB_201307110.PMC3798252.pdf
"http://dx.doi.org/10.1016/j.cell.2008.02.00 7 Lansdorp, P.M. 2007.",OADS,/arxiv_data1/oa_pdf/35/d8/JCB_201307110.PMC3798252.pdf
"http://dx.doi.org/10.1016/j.cell.2007.06.01 7 Lark, K.G.",OADS,/arxiv_data1/oa_pdf/35/d8/JCB_201307110.PMC3798252.pdf
http://dx.doi.org/10.1016/0092-8674(92)90611- Fused at 1 µg/ml for CldU staining and at 5 µg/ml for BrdU staining.,OADS,/arxiv_data1/oa_pdf/35/d8/JCB_201307110.PMC3798252.pdf
Online supplemental material is avail - able at http://www.jcb.org/cgi/content/full/jcb.201307110/DC1.,Non-OADS,/arxiv_data1/oa_pdf/35/d8/JCB_201307110.PMC3798252.pdf
"http://dx.doi.org/10.1126/science.112051 9 Boyd, S.M., M.L.",OADS,/arxiv_data1/oa_pdf/35/d8/JCB_201307110.PMC3798252.pdf
http://dx.doi.org/10.1038/nature0886 8,Non-OADS,/arxiv_data1/oa_pdf/35/d8/JCB_201307110.PMC3798252.pdf
"http://dx.doi.org/10.1038/nature1073 4 Tsumura, A., T. Hayakawa, Y .",OADS,/arxiv_data1/oa_pdf/35/d8/JCB_201307110.PMC3798252.pdf
http://dx.doi.org/10.1111/j.1365-2443.2006.00984.,Non-OADS,/arxiv_data1/oa_pdf/35/d8/JCB_201307110.PMC3798252.pdf
"http://dx.doi   .org/10.1038/emboj.2008.7 2 Watanabe, K., M. Ueno, D. Kamiya, A. Nishiyama, M. Matsumura, T. Wataya,  J.B. Takahashi, S. Nishikawa, S.-I.",OADS,/arxiv_data1/oa_pdf/35/d8/JCB_201307110.PMC3798252.pdf
"http://dx.doi.org/   10.1038/nbt131 0 Wobus, A.M., K. Guan, H.T.",OADS,/arxiv_data1/oa_pdf/35/d8/JCB_201307110.PMC3798252.pdf
"498:251– 254. http://dx.doi.org/10.1038/nature1210 6 Yamashita, Y.M., A.P.",Non-OADS,/arxiv_data1/oa_pdf/35/d8/JCB_201307110.PMC3798252.pdf
"http://dx.doi.org/10.1126/science.113491 0Liberi, G., and M. Foiani.",Non-OADS,/arxiv_data1/oa_pdf/35/d8/JCB_201307110.PMC3798252.pdf
"http://dx.doi.org/10.1038/cr.2010.7 3 Ludwig, T.E., V .",Non-OADS,/arxiv_data1/oa_pdf/35/d8/JCB_201307110.PMC3798252.pdf
"http://dx.doi.org/10.1038/nmeth90 2 Lyko, F., and R. Brown.",OADS,/arxiv_data1/oa_pdf/35/d8/JCB_201307110.PMC3798252.pdf
"97:1498– 1506. http://dx.doi.org/10.1093/jnci/dji31 1 Meselson, M., and F.W.",OADS,/arxiv_data1/oa_pdf/35/d8/JCB_201307110.PMC3798252.pdf
"http://dx.doi.org/10   .1073/pnas.44.7.67 1 Nagy, A., J. Rossant, R. Nagy, W. Abramow-Newerly, and J.C. Roder.",OADS,/arxiv_data1/oa_pdf/35/d8/JCB_201307110.PMC3798252.pdf
"http://dx.doi.org/10.1038/sj.onc.120854 0 Okano, M., D.W. Bell, D.A.",OADS,/arxiv_data1/oa_pdf/35/d8/JCB_201307110.PMC3798252.pdf
"http://dx.doi.org/10.1016/S0092-8674   (00)81656- 6 Pal, R., S. Totey, M.K.",OADS,/arxiv_data1/oa_pdf/35/d8/JCB_201307110.PMC3798252.pdf
"http://dx.doi.org/10.3181/0901-RM-3 8 Panning, B., and R. Jaenisch.",OADS,/arxiv_data1/oa_pdf/35/d8/JCB_201307110.PMC3798252.pdf
"http://dx.doi.org/10.1016/   0092-8674(78)90274- X Quyn, A.J., P.L.",OADS,/arxiv_data1/oa_pdf/35/d8/JCB_201307110.PMC3798252.pdf
"http://dx.doi.org/10.1016/j.stem.2009.12   .007 Rando, T.A.",OADS,/arxiv_data1/oa_pdf/35/d8/JCB_201307110.PMC3798252.pdf
"http://dx.doi.org/10.1016/j.cell.2007.06.01 9 Rocheteau, P., B. Gayraud-Morel, I. Siegl-Cachedenier, M.A.",OADS,/arxiv_data1/oa_pdf/35/d8/JCB_201307110.PMC3798252.pdf
"http://dx.doi.org/10.1016/j.cell.2011.11.04 9 Rosenberger, R.F., and M. Kessel.",OADS,/arxiv_data1/oa_pdf/35/d8/JCB_201307110.PMC3798252.pdf
"http://dx.doi.org/10   .1371/journal.pbio.004041 7 Sakaue, M., H. Ohta, Y .",OADS,/arxiv_data1/oa_pdf/35/d8/JCB_201307110.PMC3798252.pdf
"http://dx.doi.org/10.1016/j.cub.2010.06.05 0 Sauer, S., S.S. Burkett, M. Lewandoski, and A.J.",OADS,/arxiv_data1/oa_pdf/35/d8/JCB_201307110.PMC3798252.pdf
"http://dx.doi.org/   10.1007/s10577-013-9358- 8 Schepers, A.G., R. Vries, M. van den Born, M. van de Wetering, and H. Clevers.",Non-OADS,/arxiv_data1/oa_pdf/35/d8/JCB_201307110.PMC3798252.pdf
"http://dx.doi.org/10.1038/ncb142 5 Smith, G.H.",Non-OADS,/arxiv_data1/oa_pdf/35/d8/JCB_201307110.PMC3798252.pdf
"http://dx.doi.org/10.1242/dev.0160 9 Sotiropoulou, P.A., A. Candi, and C. Blanpain.",Non-OADS,/arxiv_data1/oa_pdf/35/d8/JCB_201307110.PMC3798252.pdf
http://dx.doi.org/10   .1634/stemcells.2008-063 4,Non-OADS,/arxiv_data1/oa_pdf/35/d8/JCB_201307110.PMC3798252.pdf
"1  149–164 www.jcb.org/cgi/doi/10.1083/jcb.201303145 JCB 149Correspondence to Junjie Chen: jchen8@mdanderson.org Abbreviations used in this paper: FBL, fibrillarin; GO, Gene Ontology; IP, immuno­ precipitation; IR, ionizing radiation; PML, promyelocytic leukemia; qRT ­PCR, quan ­ titative RT ­PCR; SMN, survival of motor neuron; snRNP, small nuclear RNP.Complete screen data http://jcb-dataviewer.rupress.org/jcb/browse/6852/S152 Introduction The nucleus is enclosed by a double-membrane structure termed  the nuclear envelope, which serves as a physical barrier to sepa - rate nuclear contents from the cytoplasm.",Non-OADS,/arxiv_data1/oa_pdf/16/82/JCB_201303145.PMC3798253.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub ­ lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/16/82/JCB_201303145.PMC3798253.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by ­nc­sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/16/82/JCB_201303145.PMC3798253.pdf
Online supplemental material is avail ­ able at http://www.jcb.org/cgi/content/full/jcb.201303145/DC1.,Non-OADS,/arxiv_data1/oa_pdf/16/82/JCB_201303145.PMC3798253.pdf
Addi ­ tional data are available in the JCB DataViewer at http://dx.doi.org/10   .1083/jcb.201303145.dv.,OADS,/arxiv_data1/oa_pdf/16/82/JCB_201303145.PMC3798253.pdf
"http://dx.doi.org/   10.1002/wrna.113 9 Mahmoudi, S., S. Henriksson, I. Weibrecht, S. Smith, O. Söderberg, S.  Strömblad, K.G.",OADS,/arxiv_data1/oa_pdf/16/82/JCB_201303145.PMC3798253.pdf
"http://dx.doi   .org/10.1371/journal.pbio.100052 1 Makarov, E.M., O.V.",OADS,/arxiv_data1/oa_pdf/16/82/JCB_201303145.PMC3798253.pdf
"http://dx.doi.org/10.1126/science.107778 3 Matter, N., P. Herrlich, and H. König.",OADS,/arxiv_data1/oa_pdf/16/82/JCB_201303145.PMC3798253.pdf
"http://dx.doi   .org/10.1128/MCB.00467-0 8 Narayanan, U., T. Achsel, R. Lührmann, and A.G. Matera.",Non-OADS,/arxiv_data1/oa_pdf/16/82/JCB_201303145.PMC3798253.pdf
"http://dx.doi.org/10.1016/j.molcel.2004.09.02 4 Prasanth, K.V., S.G. Prasanth, Z. Xuan, S. Hearn, S.M.",OADS,/arxiv_data1/oa_pdf/16/82/JCB_201303145.PMC3798253.pdf
"http://dx.doi.org/   10.1016/j.cell.2005.08.03 3 Saitoh, N., C.S.",OADS,/arxiv_data1/oa_pdf/16/82/JCB_201303145.PMC3798253.pdf
"http://dx.doi.org/10.1091/mbc.E04-03-025 3 Sasaki, Y.T., T. Ideue, M. Sano, T. Mituyama, and T. Hirose.",OADS,/arxiv_data1/oa_pdf/16/82/JCB_201303145.PMC3798253.pdf
"http://dx.doi   .org/10.1073/pnas.080789910 6 Scherl, A., Y. Couté, C. Déon, A. Callé, K. Kindbeiter, J.C. Sanchez, A. Greco,  D. Hochstrasser, and J.J. Diaz.",Non-OADS,/arxiv_data1/oa_pdf/16/82/JCB_201303145.PMC3798253.pdf
"http://dx.doi   .org/10.1091/mbc.E02-05-027 1 Schulz, S., G. Chachami, L. Kozaczkiewicz, U.",Non-OADS,/arxiv_data1/oa_pdf/16/82/JCB_201303145.PMC3798253.pdf
"http://dx.doi   .org/10.1038/embor.2012.12 5 Spector, D.L.",OADS,/arxiv_data1/oa_pdf/16/82/JCB_201303145.PMC3798253.pdf
"http://dx.doi.org/10.1016/j.cell.2006.11.02 6 Spector, D.L., G. Lark, and S. Huang.",OADS,/arxiv_data1/oa_pdf/16/82/JCB_201303145.PMC3798253.pdf
"3:555– 569. http://dx.doi.org/10.1091/mbc.3.5.55 5 Strzelecka, M., A.C. Oates, and K.M.",Non-OADS,/arxiv_data1/oa_pdf/16/82/JCB_201303145.PMC3798253.pdf
"http://dx.doi.org/   10.1101/gr.087775.10 8 Sutherland, H.G., G.K. Mumford, K. Newton, L.V.",Non-OADS,/arxiv_data1/oa_pdf/16/82/JCB_201303145.PMC3798253.pdf
"http://dx.doi.org/10.1093/hmg/10.18.199 5 Thiry, M., T. Cheutin, F. Lamaye, N. Thelen, U.T.",Non-OADS,/arxiv_data1/oa_pdf/16/82/JCB_201303145.PMC3798253.pdf
"http://dx.doi.org/10.1091/ mbc.E08-02-018 4 Toyota, C.G., M.D.",Non-OADS,/arxiv_data1/oa_pdf/16/82/JCB_201303145.PMC3798253.pdf
"http://dx.doi.org/10.1007/s00412-009-0249- x Tucker, K.E., M.T.",Non-OADS,/arxiv_data1/oa_pdf/16/82/JCB_201303145.PMC3798253.pdf
"http://dx.doi.org/   10.1128/MCB.05266-1 1 Ahmad, Y ., F.M.",Non-OADS,/arxiv_data1/oa_pdf/16/82/JCB_201303145.PMC3798253.pdf
"http://dx.doi.org/10.1093/nar/gkn80 4 Andersen, J.S., C.E.",OADS,/arxiv_data1/oa_pdf/16/82/JCB_201303145.PMC3798253.pdf
"http://dx.doi.org/10.1016/S0960-9822(01)   00650- 9 Bessonov, S., M. Anokhina, A. Krasauskas, M.M.",OADS,/arxiv_data1/oa_pdf/16/82/JCB_201303145.PMC3798253.pdf
"http://dx.doi.org/10.1261/rna.245621 0 Bond, C.S., and A.H. Fox.",OADS,/arxiv_data1/oa_pdf/16/82/JCB_201303145.PMC3798253.pdf
"http://dx.doi.org/10.1083/   jcb.20090611 3 Chen, H.K., C.Y .",OADS,/arxiv_data1/oa_pdf/16/82/JCB_201303145.PMC3798253.pdf
"http://dx.doi   .org/10.1016/j.molcel.2009.06.02 7 Clemson, C.M., J.N.",OADS,/arxiv_data1/oa_pdf/16/82/JCB_201303145.PMC3798253.pdf
"http://dx.doi.org/10.1016/j.molcel.2009.01.02 6 Coady, T.H., and C.L.",OADS,/arxiv_data1/oa_pdf/16/82/JCB_201303145.PMC3798253.pdf
"http://dx.doi.org/   10.1002/wrna.7 6 De Belle, I., J.X.",Non-OADS,/arxiv_data1/oa_pdf/16/82/JCB_201303145.PMC3798253.pdf
"http://dx.doi.org/10.1074/jbc.M21050220 0 Girard, C., H. Neel, E. Bertrand, and R. Bordonné.",Non-OADS,/arxiv_data1/oa_pdf/16/82/JCB_201303145.PMC3798253.pdf
"http://dx.doi.org/10.1093/nar/gkl37 4 Hayano, T., M. Yanagida, Y. Yamauchi, T. Shinkawa, T. Isobe, and N.  Takahashi.",OADS,/arxiv_data1/oa_pdf/16/82/JCB_201303145.PMC3798253.pdf
"http://dx.doi.org/10.1074/jbc   .M30430420 0 Kaiser, T.E., R.V .",Non-OADS,/arxiv_data1/oa_pdf/16/82/JCB_201303145.PMC3798253.pdf
"http://dx.doi.org/10.1126/science   .116521 6 Kiss, T. 2004.",Non-OADS,/arxiv_data1/oa_pdf/16/82/JCB_201303145.PMC3798253.pdf
"http://dx.doi.org/10.1242/jcs.0148 7 Lallemand-Breitenbach, V., and H. de Thé.",Non-OADS,/arxiv_data1/oa_pdf/16/82/JCB_201303145.PMC3798253.pdf
"http://dx.doi.org/10.1101/   cshperspect.a00066 1 Lemm, I., C. Girard, A.N.",OADS,/arxiv_data1/oa_pdf/16/82/JCB_201303145.PMC3798253.pdf
"http://dx.doi   .org/10.1091/mbc.E06-03-024 7 Leung, A.K., L. Trinkle-Mulcahy, Y.W.",Non-OADS,/arxiv_data1/oa_pdf/16/82/JCB_201303145.PMC3798253.pdf
http://dx.doi.org/10.1093/nar/gkj00 4,Non-OADS,/arxiv_data1/oa_pdf/16/82/JCB_201303145.PMC3798253.pdf
"http://dx.doi.org/10.1083/jcb.20010408 3 Van Damme, E., K. Laukens, T.H.",OADS,/arxiv_data1/oa_pdf/16/82/JCB_201303145.PMC3798253.pdf
"http://dx.doi.org/10.7150/ijbs.6.5 1 Venteicher, A.S., and S.E.",OADS,/arxiv_data1/oa_pdf/16/82/JCB_201303145.PMC3798253.pdf
"http://dx.doi.org/10.4161/cc.8.9.828 8 Whittom, A.A., H. Xu, and M.D.",OADS,/arxiv_data1/oa_pdf/16/82/JCB_201303145.PMC3798253.pdf
"http://dx.doi.org/10.1007/s00018-008-7587- 3 Xu, H., R.S.",Non-OADS,/arxiv_data1/oa_pdf/16/82/JCB_201303145.PMC3798253.pdf
"http://dx.doi.org/10.1007/s00412-005-0003- y Zhu, Y., R.L.",OADS,/arxiv_data1/oa_pdf/16/82/JCB_201303145.PMC3798253.pdf
http://dx.doi.org/10.1091/mbc.E03-07-052 5=,Non-OADS,/arxiv_data1/oa_pdf/16/82/JCB_201303145.PMC3798253.pdf
"Recent progress has detailed the molecular  mechanisms of this metabolic phenotype and has offered  insight into new metabolic pathways that may be involved  in stem cell homeostasis.Nutrient-sensing pathways and metabolic regulation  in stem cells Joshua D. Ochocki1 and M. Celeste Simon1,2,3 1Abramson Family Cancer Research Institute, 2Department of Cell and Developmental Biology, Perelman School of Medicine at the University of Pennsylvania,   Philadelphia, PA 19104 3Howard Hughes Medical Institute, Philadelphia, PA 19104 © 2013 Ochocki and Simon  This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1038/nature0773 3 Easley, C.A.t., A. Ben-Yehudah, C.J.",Non-OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi   .org/10.1089/cell.2010.001 1 Edgar, A.J.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"3:18. http://dx.doi.org/10.1186/1471-2156-3-1 8 Eliasson, P., M. Rehn, P. Hammar, P. Larsson, O. Sirenko, L.A. Flippin, J.  Cammenga, and J.I.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1016/j.exphem.2010.01.00 5 Ellingson, W.J., D.G.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1007/s12015-009-9058- 0 Firth, J.D., B.L.",Non-OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/   10.1074/jbc.270.49.2908 3 Folmes, C.D., T.J. Nelson, A. Martinez-Fernandez, D.K.",Non-OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi   .org/10.1016/j.cmet.2011.06.01 1 Forristal, C.E., D.R.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1371/journal   .pone.006250 7 Gan, B., J. Hu, S. Jiang, Y. Liu, E. Sahin, L. Zhuang, E. Fletcher-Sananikone, S.  Colla, Y.A.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1038/nature0959 5 Gekas, C., F. Dieterlen-Lièvre, S.H.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1387/ijdb.103070c g Gnaiger, E. 2001.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1016/S0034-5687(01)00307- 3 Gordan, J.D., C.B.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1016/j.ccr.2007.07.00 6 Gross, D.N., A.P.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi   .org/10.1038/onc.2008.2 5 Guppy, M., E. Greiner, and K. Brand.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
http://dx.doi.org/10.1111/ j.1432-1033.1993.tb17637.,Non-OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1038/nature0957 2 Haigis, M.C., and D.A.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10   .1146/annurev.pathol.4.110807.09225 0 Hedrick, S.M., R. Hess Michelini, A.L.",Non-OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1038/nri327 8 Hemminki, A., D. Markie, I. Tomlinson, E. Avizienyte, S. Roth, A. Loukola,  G. Bignell, W. Warren, M. Aminoff, P. Höglund, et al.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1038/3443 2 Ho, P.J., M.L.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1182/blood-2009-   11-25087 8 Alexander, P.B., J. Wang, and S.L.",Non-OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.2174/09298671280166113 0 Balaban, R.S.",Non-OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1002/jcp.2077 6 Bernhardt, W.M., U. Gottmann, F. Doyon, B. Buchholz, V .",Non-OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi   .org/10.1038/ng.100 9 Chaudhari, P., Z. Ye, and Y.Y.",Non-OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1084/jem.2008129 7 Chen, C., Y. Liu, Y. Liu, and P. Zheng.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/   10.1172/JCI4387 3 Cho, Y.M., S. Kwon, Y.K.",Non-OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1016/j.bbrc.2006.08.02 0 Contreras, C.M., S. Gurumurthy, J.M.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1158/0008- 5472.CAN-07-501 4 Covello, K.L., J. Kehler, H. Yu, J.D.",Non-OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
http://dx.doi.org/10.1101/gad.139990 6,Non-OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/   10.1016/j.cmet.2011.03.00 9 Lin, S.-J., and L. Guarente.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1016/S0955-0674(03)00006- 1 Losman, J.A., R.E.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/   10.1126/science.123167 7 Lu, C., P.S.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1038/nature1086 0 Lützner, N., J. De-Castro Arce, and F. Rösl.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1371/journal   .pone.003259 0 Magee, J.A., T. Ikenoue, D. Nakada, J.Y.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1016/j.stem.2012.05.02 6 Majmundar, A.J., N. Skuli, R.C.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1128/MCB.05857-1 1 Matsui, K., S. Ezoe, K. Oritani, M. Shibata, M. Tokunaga, N. Fujita, A. Tanimura,  T. Sudo, H. Tanaka, M.W.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"418:811– 817. http://dx.doi.org/10.1016/j.bbrc.2012.01.10 9 Mazumdar, J., V. Dondeti, and M.C.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
http://dx.doi   .org/10.1111/j.1582-4934.2009.00963.,Non-OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi   .org/10.1038/ncb210 2 Miyamoto, K., K.Y.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1016/j.stem.2007.02.00 1 Murakami, M., T. Ichisaka, M. Maeda, N. Oshiro, K. Hara, F. Edenhofer, H.  Kiyama, K. Yonezawa, and S. Yamanaka.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1128/MCB.24   .15.6710-6718.200 4 Nakada, D., T.L.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"468:653– 658. http://dx.doi.org/10.1038/nature0957 1 Oh, W.J., and E. Jacinto.",Non-OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.4161/cc.10.14.1658 6 Panopoulos, A.D., O. Yanes, S. Ruiz, Y.S.",Non-OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-07-516 9 Peserico, A., F. Chiacchiera, V. Grossi, A. Matrone, D. Latorre, M. Simonatto,  A. Fusella, J.G.",Non-OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi   .org/10.1007/s00018-012-1244- 6 Prigione, A., B. Fauler, R. Lurz, H. Lehrach, and J. Adjaye.",Non-OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1074/jbc   .M110.21628 3 Sasaki, M., C.B.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1038/nature1132 3decline, in senescent human fetal mesenchymal stem cells.",Non-OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1089/ars.2012.469 2 Hsu, Y.C., and E. Fuchs.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1038/nrm327 2 Huang, H., and D.J.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1016/j.bbamcr.2011.01.00 7 Inoki, K., Y. Li, T. Zhu, J. Wu, and K.L.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1038/ncb83 9 Ito, K., A. Hirao, F. Arai, K. Takubo, S. Matsuoka, K. Miyamoto, M. Ohmura,  K. Naka, K. Hosokawa, Y. Ikeda, and T. Suda.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1038/nm138 8 Ito, K., A. Carracedo, D. Weiss, F. Arai, U. Ala, D.E.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1038/nm.288 2 Jan, M., T.M.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1126/scitranslmed.300431 5 Jang, Y .Y ., and S.J.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1182/blood-2007   -05-08775 9 Jenne, D.E., H. Reimann, J. Nezu, W. Friedel, S. Loff, R. Jeschke, O. Müller,  W. Back, and M. Zimmer.",Non-OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"467:338– 342. http://dx.doi.org/10.1038/nature0936 7 Kalaitzidis, D., S.M.",Non-OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1016/j.stem.2012.06.00 9 Kim, J.W., I. Tchernyshyov, G.L.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"3:177– 185. http://dx.doi.org/10.1016/j.cmet.2006.02.00 2 Kim, J., and K.-L. Guan.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1146/annurev-   biochem-062209-09441 4 Knobloch, M., S.M.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1038/   nature1168 9 Kops, G.J., T.B.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1038/nature0103 6 Krock, B., N. Skuli, and M.C.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1016/j.cmet.2010.12.01 5 Lee, I., A. Hendrix, J. Kim, J. Yoshimoto, and Y.J.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi   .org/10.1371/journal.pone.004472 0 Lee, J.Y., D. Nakada, O.H.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi   .org/10.1016/j.stem.2010.09.01 5 Lee, J.Y., Y.R.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
http://dx.doi.org/10.1111/j.1749-6632.2012.06725.,Non-OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/   10.1016/j.ceb.2012.01.00 5 Li, T.S., and E. Marbán.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1002/stem.53 2 Li, Y., S. Xu, M.M.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1074/jbc.M80051720 0 Yalcin, S., D. Marinkovic, S.K.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1038/emboj.2010.29 2 Yanes, O., J. Clark, D.M.",Non-OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1038/nchembio.36 4 Yecies, J.L., and B.D.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi   .org/10.1158/0008-5472.CAN-10-415 8 Yilmaz, O.H., R. Valdez, B.K.",Non-OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi   .org/10.1038/nature0470 3 Yilmaz, O.H., P. Katajisto, D.W. Lamming, Y. Gültekin, K.E.",Non-OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1016/   j.stem.2012.11.02 2 Zhang, J., J.C. Grindley, T. Yin, S. Jayasinghe, X.C.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1038/nature0474 7 Zhang, J., I. Khvorostov, J.S.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1038/emboj.2011.40 1 Zhou, J., P. Su, L. Wang, J. Chen, M. Zimmermann, O. Genbacev, O. Afonja,  M.C.",Non-OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi   .org/10.1007/978-1-61779-430-8_2 3Shyh-Chang, N., J.W.",Non-OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10   .1126/science.122660 3 Simsek, T., F. Kocabas, J. Zheng, R.J. Deberardinis, A.I.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10   .1016/j.stem.2010.07.01 1 Slack, C., A. Foley, and L. Partridge.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1371/journal   .pone.004769 9 Stenesen, D., J.M.",Non-OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1016/j.cmet.2012.12.00 6 Stojkovic, P., M. Lako, R. Stewart, S. Przyborski, L. Armstrong, J. Evans,  A. Murdoch, T. Strachan, and M. Stojkovic.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi   .org/10.1634/stemcells.2004-013 7 Takubo, K., N. Goda, W. Yamada, H. Iriuchishima, E. Ikeda, Y. Kubota, H. Shima,  R.S.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1016/j.stem.2010.06.02 0 Takubo, K., G. Nagamatsu, C.I.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"12:49– 61. http://dx.doi.org/10.1016/j.stem.2012.10.01 1 Thomson, J.A., J. Itskovitz-Eldor, S.S. Shapiro, M.A.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi   .org/10.1126/science.282.5391.114 5 Tothova, Z., R. Kollipara, B.J.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1016/   j.cell.2007.01.00 3 Vacanti, N.M., and C.M.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"1830:2361– 2369. http://dx.doi.org/10.1016/j.bbagen.2012.08.00 7 Vander Heiden, M.G., L.C.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1126/science.116080 9 Varum, S., A.S. Rodrigues, M.B.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1371/journal.pone.002091 4 Vazin, T., and W.J.",Non-OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1126/science.123476 9 Wang, G., H. Zhang, Y. Zhao, J. Li, J. Cai, P. Wang, S. Meng, J. Feng, C.  Miao, M. Ding, et al.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/   10.1016/j.bbrc.2005.03.05 8 Wang, J., P. Alexander, L. Wu, R. Hammer, O. Cleaver, and S.L.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1126/science.117328 8 Ward, P.S., J. Patel, D.R.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/10.1016/j.ccr.2010.01.02 0 Ward, P.S., J.R. Cross, C. Lu, O. Weigert, O. Abel-Wahab, R.L.",OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
"http://dx.doi.org/   10.1038/onc.2011.41 6 Warr, M.R., M. Binnewies, J. Flach, D. Reynaud, T. Garg, R. Malhotra, J.  Debnath, and E. Passegué.",Non-OADS,/arxiv_data1/oa_pdf/31/dd/JCB_201303110.PMC3798256.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1038/nrn237 3 Colón­Ramos, D.A., M.A.",Non-OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1126/science.114376 2 Coyle, I.P., Y .­H.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1016/S0896­6273(04)00016­ 9 Cuitino, L., J.A.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1038/nn180 8 de Wit, J., E. Sylwestrak, M.L.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1016/j.neuron.2009.12.01 9 Ding, M., D. Chao, G. Wang, and K. Shen.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"317:947– 951. http://dx.doi.org/10.1126/science.114572 7 Eroglu, C., N.J. Allen, M.W.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1016/j.cell.2009.09.02 5 Etherton, M.R., C.A.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/   10.1016/j.cub.2012.07.06 3 Garrett, A.M., and J.A.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.2818­09.200 9 Glass, D.J., D.C. Bowen, T.N.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1016/S0092­8674   (00)81252­ 0 Goda, Y ., and G.W.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1016/S0896­ 6273   (03)00608 ­1 Gómez­Casati, M.E., J.C. Murtie, C. Rio, K. Stankovic, M.C.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1073/   pnas.100893810 7 Goodwin, P.R., J.M.",Non-OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"32:8158– 8172. http://dx.doi.org/10.1523/JNEUROSCI.0251­12.201 2 Graf, E.R., X. Zhang, S.X.",Non-OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1016/j.cell   .2004.11.03 5 Graf, E.R., Y. Kang, A.M. Hauner, and A.M. Craig.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10   .1523/JNEUROSCI.1253­05.200 6 Graf, E.R., R.W.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1016/j.neuron.2009.11.00 2 Guan, H., and P.F.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1093/   cercor/bhq01 6 Henriquez, J.P., A. Webb, M. Bence, H. Bildsoe, M. Sahores, S.M.",Non-OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1074/jbc.M110.17630 5 Astigarraga, S., K. Hofmeyer, R. Farajian, and J.E.",Non-OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.1862­10.201 0 Baas, P.W., J.S.",Non-OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
http://dx.doi.org/   10.1111/j.1600­0854.2006.00392.,Non-OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1016/   j.neuron.2010.05.02 0 Bednarek, E., and P. Caroni.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1016/j.neuron.2011.02.03 4 Bloom, O., E. Evergren, N. Tomilin, O. Kjaerulff, P. Löw, L. Brodin, V.A.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"161:737– 747. http://dx.doi.org/10.1083/jcb.20021214 0 Blundell, J., K. Tabuchi, M.F.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
http://dx.doi.org/10.1111/j.1601­ 183X.2008.00455.,Non-OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.4517­09.201 0 Budnik, V. 1996.",Non-OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi   .org/10.1016/S0959­4388(96)80038­ 9 Cheadle, L., and T. Biederer.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1083/jcb.20120504 1 Chen, K., E.O.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1371/journal.pone.001111 5 Chia, P.H., M.R.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1038/nn.299 1 Chia, P.H., M.R.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1016/   j.mcn.2013.03.00 4 Chih, B., H. Engelman, and P. Scheiffele.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1016/j.neuron.2006.06.00 5 Christopherson, K.S., E.M. Ullian, C.C.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1016/   j.cell.2004.12.02 0 Chubykin, A.A., D. Atasoy, M.R.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"54:919– 931. http://dx.doi.org/10.1016/j.neuron.2007.05.02 9 Ciani, L., K.A.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
http://dx.doi.org/10   .1073/pnas.101813210 8,Non-OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi   .org/10.1016/j.cell.2008.10.00 2 Klassen, M.P., and K. Shen.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"130:704– 716. http://dx.doi.org/10.1016/j.cell.2007.06.04 6 Klassen, M.P., Y.E.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1016/j.neuron.2010.04.03 3 Ko, J., M.V.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1016/j.neuron.2009.12.01 2 Ko, J., G.J.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1083/jcb.20110107 2 Kohda, K., W. Kakegawa, S. Matsuda, R. Nakagami, N. Kakiya, and M. Yuzaki.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
25:1357– 1362. http://dx.doi.org/10.1111/j.1460­9568.2007.05412.,Non-OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1074/jbc.M112.34266 7 Korkut, C., B. Ataman, P. Ramachandran, J. Ashley, R. Barria, N. Gherbesi,  and V. Budnik.",Non-OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10   .1016/j.cell.2009.07.05 1 Kucukdereli, H., N.J. Allen, A.T. Lee, A. Feng, M.I.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi   .org/10.1073/pnas.110497710 8 Kurihara, H., K. Hashimoto, M. Kano, C. Takayama, K. Sakimura, M. Mishina,  Y. Inoue, and M. Watanabe.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1074/jbc.M109.06112 7 Ledda, F., G. Paratcha, T. Sandoval­Guzmán, and C.F.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10   .1038/nn185 5 Lee, S.H., and M. Sheng.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1016/S0959­4388(99)   00046­ X Li, J., J. Ashley, V. Budnik, and M.A.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1523/JNEUROSCI   .6343­10.201 1 Liao, E.H., W. Hung, B. Abrams, and M. Zhen.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"430:345– 350. http://dx.doi.org/10.1038/nature0264 7 Linhoff, M.W., J. Laurén, R.M.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1016/j.neuron.2009.01.01 7 Liu, J.S., C.R.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1016/j.molcel.2012.06.02 5 Liu, K.S.Y ., M. Siebert, S. Mertel, E. Knoche, S. Wegener, C. Wichmann, T.  Matkovic, K. Muhammad, H. Depner, C. Mettke, et al.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1126/science.121299 1 Lucido, A.L., F. Suarez Sanchez, P. Thostrup, A.V.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"8:1534– 1541. http://dx.doi.org/10.1038/nn157 6 Hong, W., T.J. Mosca, and L. Luo.",Non-OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/   10.1038/nature1092 6 Hotulainen, P., and C.C.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi   .org/10.1083/jcb.20100300 8 Huang, C.F., and G. Banker.",Non-OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
http://dx.doi.org/10.1111/j.1460­9568.2007.05361.,Non-OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi   .org/10.1523/JNEUROSCI.4473­08.200 9 Inaki, M., S. Yoshikawa, J.B. Thomas, H. Aburatani, and A.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1016/j.cub.2007.08.01 3 Jedlicka, P., M. Hoon, T. Papadopoulos, A. Vlachos, R. Winkels, A. Poulopoulos,  H. Betz, T. Deller, N. Brose, F. Varoqueaux, and S.W.",Non-OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1093/cercor/bhq10 0 Jensen, M., F.J. Hoerndli, P.J.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10   .1016/j.cell.2011.12.03 8 Jin, Y., and C.C.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1146/ annurev.cellbio.23.090506.12341 7 Jing, L., J.L.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/   10.1016/j.neuron.2008.12.02 5 Johnson, E.L. III, R.D.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1371/journal.pbio.100019 3 Joo, J.Y., S.J.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi   .org/10.1016/j.bbrc.2011.02.10 8 Kaeser, P.S., L. Deng, A.E.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1016/   j.neuron.2009.09.01 9 Kakegawa, W., T. Miyazaki, K. Emi, K. Matsuda, K. Kohda, J. Motohashi, M.  Mishina, S. Kawahara, M. Watanabe, and M. Yuzaki.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"28:1460– 1468. http://dx.doi.org/10.1523/JNEUROSCI.2553­07.200 8 Kakegawa, W., T. Miyazaki, K. Kohda, K. Matsuda, K. Emi, J. Motohashi,  M. Watanabe, and M. Yuzaki.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi   .org/10.1523/JNEUROSCI.6013­08.200 9 Kang, Y., X. Zhang, F. Dobie, H. Wu, and A.M. Craig.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1074/jbc.M70395720 0 Kashiwabuchi, N., K. Ikeda, K. Araki, T. Hirano, K. Shibuki, C. Takayama, Y.  Inoue, T. Kutsuwada, T. Yagi, Y. Kang, et al.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi   .org/10.1016/0092­8674(95)90334­ 8 Kim, S.H., and T.A.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1016/   j.neuron.2010.08.00 3 Kim, S.H., and T.A.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
http://dx.doi.org/10.1523/JNEUROSCI.4288­12.201 3,Non-OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1083/   jcb.20060703 6 Pielage, J., V. Bulat, J.B. Zuchero, R.D.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"69:1114– 1131. http://dx.doi.org/10.1016/j.neuron.2011.02.00 7 Poon, V .Y ., M.P.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1038/nature0729 1 Poulopoulos, A., G. Aramuni, G. Meyer, T. Soykan, M. Hoon, T. Papadopoulos,  M. Zhang, I. Paarmann, C. Fuchs, K. Harvey, et al.",Non-OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10   .1016/j.neuron.2009.08.02 3 Prange, O., T.P.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"2:7. http://dx.doi.org/10.1186/1749­8104­2­ 7 Sanes, J.R., and M. Yamagata.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1146/annurev   .cellbio.24.110707.17540 2 Sankaranarayanan, S., P.P.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1038/nn100 2 Scheiffele, P., J.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1016/S0092­8674(00)80877­ 6 Schubert, V., and C.G.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1242/   jcs.0333 7 Seeger, M.A., and S.E.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1074/jbc.M109.06824 7 Shapira, M., R.G.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"38:237– 252. http://dx.doi.org/10.1016/S0896­6273(03)00207­ 1 Silva, J.P., V.G.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi   .org/10.1073/pnas.101943410 8 Soler­Llavina, G.J., M.V.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi   .org/10.1073/pnas.111402810 8 Spangler, S.A., S.K.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1083/   jcb.20130101 1 Stan, A., K.N.",Non-OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1101/gad.193409.11 2 Stepanova, T., J. Slemmer, C.C.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1016/j.cell.2007.10.03 6 Stigloher, C., H. Zhan, M. Zhen, J. Richmond, and J.L.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/   10.1523/JNEUROSCI.1381­09.200 9 Maas, C., V .I.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.0195­12.201 2 Macaskill, A.F., J.E.",Non-OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/   10.1016/j.neuron.2009.01.03 0 Maniar, T.A., M. Kaplan, G.J.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1038/nn.297 0 Matsuda, K., and M. Yuzaki.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
http://dx.doi.org/10.1111/ j.1460­9568.2011.07638.,Non-OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1126/science.118515 2 McAllister, A.K.",Non-OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1146/annurev.neuro.29.051605   .11283 0 Missler, M., W. Zhang, A. Rohlmann, G. Kattenstroth, R.E.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi   .org/10.1038/nature0175 5 Miura, E., T. Iijima, M. Yuzaki, and M. Watanabe.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
http://dx.doi.org/10.1111/j.1460 ­9568.2006.04950.,Non-OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1038/nature1092 3 Mukherjee, K., X. Yang, S.H.",Non-OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1016/j.cell.2004.12.01 7 Nam, C.I., and L. Chen.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi   .org/10.1016/j.cell.2010.04.01 1 Owald, D., W. Fouquet, M. Schmidt, C. Wichmann, S. Mertel, H. Depner, F.  Christiansen, C. Zube, C. Quentin, J. Körner, et al.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1083/jcb.20090805 5 Owald, D., O. Khorramshahi, V.K.",Non-OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1038/nn.318 3 Patel, M.R., and K. Shen.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1126/   science.116902 5 Patel, M.R., E.K.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi   .org/10.1038/nn180 6 Peixoto, R.T., P.A.",Non-OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1016/j.neuron   .2012.07.00 6 Pielage, J., R.D.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
http://dx.doi.org/10   .1016/j.cub.2005.04.03 0,OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1038/nn.245 9 Yan, D., Z. Wu, A.D. Chisholm, and Y. Jin.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1016/j   .cell.2009.06.02 3 Yan, J., D.L.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.7554/eLife.0013 3 Yasumura, M., T. Yoshida, S.J.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
http://dx.doi.org/10.1111/j.1471­4159.2011.07631.,Non-OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.4637 ­11.201 2 Yumoto, N., N. Kim, and S.J.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"489:438– 442. http://dx.doi.org/10.1038/nature1134 8 Zhai, R.G., H. Vardinon­Friedman, C. Cases­Langhoff, B. Becker, E.D.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1016/S0896­6273(01)00185­ 4 Zhang, W., and D.L.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1002/jnr.1031 3 Zhang, W., A. Rohlmann, V .",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10   .1523/JNEUROSCI.0497­05.200 5 Zhang, B., S. Luo, Q. Wang, T. Suzuki, W.C. Xiong, and L. Mei.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1016/j   .neuron.2008.10.00 6 Zhang, B., C. Liang, R. Bates, Y. Yin, W.C. Xiong, and L. Mei.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"5:7. http://dx.doi.org/10.1186/1756­6606­5­ 7 Zhao, L., D. Wang, Q. Wang, A.A. Rodal, and Y.Q.",Non-OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10   .1371/journal.pgen.100345 0 Zhen, M., and Y. Jin.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
http://dx.doi   .org/10.1083/jcb.146.5.113 3SYD­2/liprin and UNC­10/RIM­dependent interactions.,OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.6164­10.201 1 Stone, M.C., F. Roegiers, and M.M.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1091/mbc.E07­10­107 9 Sun, M., G. Xing, L. Yuan, G. Gan, D. Knight, S.I.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.3854­10.201 1 Sun, Y., and S.X.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi   .org/10.1523/JNEUROSCI.2359­11.201 1 Takahashi, H., K. Katayama, K. Sohya, H. Miyamoto, T. Prasad, Y. Matsumoto,  M. Ota, H. Yasuda, T. Tsumoto, J. Aruga, and A.M. Craig.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi   .org/10.1523/JNEUROSCI.4740­04.200 5 Taru, H., and Y .",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1523/JNEUROSCI   .0002­11.201 1 Uemura, T., S. Kakizawa, M. Yamasaki, K. Sakimura, M. Watanabe, M. Iino,  and M. Mishina.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.2680­07.200 7 Uemura, T., S.J.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1016/   j.cell.2010.04.03 5 Waites, C.L., A.M. Craig, and C.C.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1146/ annurev.neuro.27.070203.14433 6 Waites, C.L., S.A. Leal ­Ortiz, T.F.M.",Non-OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.1835 ­11.201 1 Waites, C.L., S.A. Leal­Ortiz, N. Okerlund, H. Dalke, A. Fejtová, W.D.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1038/emboj.2013.2 7 Wan, H.I., A. DiAntonio, R.D.",Non-OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1016/S0896­6273(00)81166­ 6 Wang, J., N.J. Ruan, L. Qian, W.L.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1074/jbc.M70993920 0 Wang, X., and T.L.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1016/j.cell.2008.11.04 6 Wang, X., B. Hu, A. Zieba, N.G.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/   10.1523/JNEUROSCI.1255­09.200 9 Wentzel, C., J.E.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
"http://dx.doi.org/10.1016/j.neuron.2013.05.01 0 Wittenmayer, N., C. Körber, H. Liu, T. Kremer, F. Varoqueaux, E.R.",OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
http://dx.doi.org/   10.1016/j.neuron.2013.04.03 5,OADS,/arxiv_data1/oa_pdf/fb/23/JCB_201307020.PMC3798257.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
Online supplemental material is avail - able at http://www.jcb.org/cgi/content/full/jcb.201305159/DC1.,Non-OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi.org/10.1083/jcb.20040905 5 Bednar, J., R.A. Horowitz, S.A. Grigoryev, L.M.",Non-OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi.org/10.1002/bies.95014010 3 Carrero, G., E. Crawford, M.J. Hendzel, and G. de Vries.",Non-OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi.org/10.1016/   j.bulm.2004.02.00 5 Carrero, G., E. Crawford, J. Th’ng, G. de Vries, and M.J. Hendzel.",OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi.org/10.1016/S0076-6879(03)75026- 5 Carruthers, L.M., J. Bednar, C.L.",OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi.org/10.1021/bi981684 e Caterino, T.L., H. Fang, and J.J. Hayes.",Non-OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi   .org/10.1128/MCB.05145-1 1 Chadee, D.N., W.R. Taylor, R.A. Hurta, C.D.",Non-OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi   .org/10.1074/jbc.270.34.2009 8 Chadee, D.N., C.D.",Non-OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"272:8113– 8116. http://dx.doi.org/10.1074/jbc.272.13.811 3 Clark, D.J., C.S.",Non-OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi.org/10.1016/0076-   6879(92)11020- J Dou, Y ., and M.A.",OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"103:263.  http://dx.doi.org/10.1016/S0092-8674(00)00118- 5 Dou, Y ., C.A.",OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi   .org/10.1038/380544a 0 Lu, K.P., G. Finn, T.H.",OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi   .org/10.1038/nchembio.2007.3 5 Lu, M.J., S.S. Mpoke, C.A.",Non-OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi   .org/10.1091/mbc.6.8.107 7 Lu, P.J., X.Z.",OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi.org/10.1126/science.283.5406.132 5 Misteli, T., A. Gunjan, R. Hock, M. Bustin, and D.T.",OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi.org/10.1038/3504861 0 Moreno, S., and P. Nurse.",Non-OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi.org/10.1016/0092-8674(90)90463- O Müller, W.G., D. Walker, G.L.",OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi.org/   10.1083/jcb.20001106 9 Panyim, S., and R. Chalkley.",Non-OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi   .org/10.1016/0003-9861(69)90042- 3 Parseghian, M.H., and B.A.",OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi   .org/10.1139/o01-09 9 Paulson, J.R., J.S.",OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi.org/10.1371/journal.pone.001027 2 Raghuram, N., G. Carrero, J. Th’ng, and M.J. Hendzel.",Non-OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi   .org/10.1139/O08-12 7 Raghuram, N., G. Carrero, T.J. Stasevich, J.G.",Non-OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi.org/10.1021/bi100296 z Robinett, C.C., A.",OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi.org/10.1083/   jcb.135.6.168 5 Robinson, P.J., and D. Rhodes.",Non-OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi.org/10.1016/j.sbi.2006.05.00 7 Roque, A., I. Iloro, I. Ponte, J.L.",OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi.org/10.1074/jbc.M50563620 0 Roque, A., I. Ponte, and P. Suau.",OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi   .org/10.1093/nar/gkn44 0 Roth, S.Y., and C.D.",OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi.org/10.1074/jbc.M50895720 0 Stasevich, T.J., F. Mueller, D.T.",OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
http://dx.doi.org/10   .1038/emboj.2010.2 4by mimicking H1 removal.,OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi.org/   10.1016/S1097-2765(00)80215- 4 Dou, Y ., J. Bowen, Y .",OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi.org/10.1083/jcb   .20020213 1 Ericsson, C., U. Grossbach, B. Björkroth, and B. Daneholt.",OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi   .org/10.1016/0092-8674(90)90717- S Fang, H., D.J.",OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi.org/10.1093/nar/gkr86 6 Fujimori, F., K. Takahashi, C. Uchida, and T. Uchida.",OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi.org/   10.1006/bbrc.1999.173 6 Hansen, J.C. 2002.",OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi.org/10.1074/jbc.R50002220 0 Hendzel, M.J., M.A.",OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi.org/10.1074/jbc   .M40007020 0 Hennig, L., C. Christner, M. Kipping, B. Schelbert, K.P.",Non-OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"37:5953– 5960. http://dx.doi.org/10.1021/bi973162 p Herrera, R.E., F. Chen, and R.A. Weinberg.",Non-OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi.org/   10.1073/pnas.93.21.1151 0 Hohmann, P. 1983.",Non-OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"57:81– 92. http://dx.doi.org/10.1007/BF0022352 6 Hu, Y., I. Kireev, M. Plutz, N. Ashourian, and A.S. Belmont.",Non-OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi.org/   10.1083/jcb.20080919 6 Janicki, S.M., T. Tsukamoto, S.E.",OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi.org/10.1016/S0092-   8674(04)00171- 0 Kinoshita, E., E. Kinoshita-Kikuta, M. Matsubara, S. Yamada, H. Nakamura,  Y. Shiro, Y. Aoki, K. Okita, and T. Koike.",OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi   .org/10.1002/pmic.20080024 3 Kinoshita, E., E. Kinoshita-Kikuta, and T. Koike.",OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi.org/10.1038/nprot.2009.15 4 Koop, R., L. Di Croce, and M. Beato.",Non-OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi.org/10.1093/emboj/cdg05 2 Kruithof, M., F.T.",OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"16:534– 540. http://dx.doi.org/10.1038/nsmb.159 0 Lamy, F., R. Lecocq, and J.E.",OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
http://dx.doi.org/10.1111/j.1432-1033.1977.tb11347.,Non-OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi.org/10.1038/3504860 3 Li, G., R. Margueron, G. Hu, D. Stokes, Y.H.",Non-OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi.org/   10.1016/j.molcel.2010.01.04 2 Liou, Y.C., A. Ryo, H.K.",OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi.org/   10.1006/meth.1999.087 7 Steger, M., O. Murina, D. Hühn, L.P. Ferretti, R. Walser, K. Hänggi, L.  Lafranchi, C. Neugebauer, S. Paliwal, P. Janscak, et al.",OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi   .org/10.1016/j.molcel.2013.03.02 3 Stukenberg, P.T., and M.W.",OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi   .org/10.1016/S1097-2765(01)00245- 3 Swank, R.A., J.P. Th’ng, X.W.",OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"36:13761– 13768. http://dx.doi.org/10.1021/bi971436 3 Talasz, H., W. Helliger, B. Puschendorf, and H. Lindner.",Non-OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi.org/10.1021/bi951914 e Tatara, Y., T. Terakawa, and T. Uchida.",OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi.org/10.1271/bbb.10058 0 Taylor, W.R., D.N.",Non-OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi.org/10   .1016/0014-5793(95)01314- 8 Th’ng, J.P., X.W.",OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi.org/10.1074/jbc   .M50162720 0 Thoma, F., and T. Koller.",OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi.org/10.1016/0092-8674(77)90188- X Thoma, F., T. Koller, and A. Klug.",OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi.org/10.1083/   jcb.83.2.40 3 Tsukamoto, T., N. Hashiguchi, S.M.",OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi.org/10.1038/3504651 0 Tumbar, T., G. Sudlow, and A.S. Belmont.",Non-OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi.org/10.1083/jcb.145.7.134 1 Vicent, G.P., A.S. Nacht, J. Font-Mateu, G. Castellano, L. Gaveglia, C. Ballaré,  and M. Beato.",Non-OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi.org/10.1101/gad.62181 1 Xu, Y.X., and J.L.",OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi   .org/10.1101/gad.159280 7 Zheng, Y., S. John, J.J. Pesavento, J.R. Schultz-Norton, R.L.",Non-OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
"http://dx.doi   .org/10.1083/jcb.20100114 8 Zhou, X.Z., O. Kops, A. Werner, P.J.",OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
http://dx.doi.org/10.1016/S1097-2765(05)00083- 3,OADS,/arxiv_data1/oa_pdf/be/79/JCB_201305159.PMC3798258.pdf
©2013 by Anais Brasileiros de DermatologiaCONTINUING MEDICAL EDUCATION DOI: http://dx.doi.org/10.1590/abd1806-4841.20132463 Abstract: Paracoccidioidomycosis is an acute - to chronic systemic mycosis caused by fungi of the genus Paracoccidioides.,Non-OADS,/arxiv_data1/oa_pdf/72/bb/abd-88-05-0700.PMC3798345.pdf
s Cytokine detection for the diagnosis of chromium allergy * Detecção de citocinas no diagnóstico de pacientes alérgicos ao cromo DOI: http://dx.doi.org/10.1590/abd1806-4841.20132164 Abstract: BACKGROUND : Patch testing remains the gold standard method for the identification of the etiologic agent of allergic contact dermatitis.,Non-OADS,/arxiv_data1/oa_pdf/c1/7e/abd-88-05-0719.PMC3798347.pdf
"2013;88(5):726-30. s Differences in age and topographic distribution of the  different histological subtypes of basal cell carcinoma, Taubaté (SP), Brazil* Diferenças na idade e distribuição topográfica dos diferentes subtipos  histológicos de carcinoma basocelular, Taubaté (SP), Brasil Flávia Regina Ferreira1Bruna da Costa Pevide2Rafaela Fabri Rodrigues2 Luiz Fernando Costa Nascimento3Marcia Lanzoni de Alvarenga Lira4 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132145 Abstract: BACKGROUND : Basal cell carcinoma is the most common form of cancer in humans.",Non-OADS,/arxiv_data1/oa_pdf/00/ad/abd-88-05-0726.PMC3798348.pdf
2013;88(5):732-8.732s Comparative study of actinic keratosis treatment with 3% diclofenac sodium and 5% 5-fluorouracil* Estudo comparativo do tratamento de ceratoses actínicas com diclofenaco  sódico 3% e 5-fluorouracil 5%  Majoriê Mergen Segatto1 Vera Bauer Silveira3Sérgio Ivan Torres Dornelles2 Gabriela de Oliveira Frantz4 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132083 Abstract: BACKGROUND : Actinic keratosis is a frequent lesion which occurs in sunlight exposed areas.,Non-OADS,/arxiv_data1/oa_pdf/ab/b1/abd-88-05-0732.PMC3798349.pdf
Manifestações cutâneas em indivíduos infectados ou com doenças 739s Comparative study of the prevalence of sepsis in patients  admitted to dermatology and internal medicine wards* Estudo comparativo da prevalência de sepse em pacientes internados nas enfermarias de dermatologia e de clínica médica  Luiz Maurício Costa Almeida1Michelle dos Santos Diniz2Lorena dos Santos Diniz3 Jackson Machado-Pinto4Francisco Chagas Lima Silva5 DOI: http://dx.doi.org/10.1590/abd1806-4841.20131912 Abstract: BACKGROUND : Sepsis is a common cause of morbidity and mortality among hospitalized patients.,Non-OADS,/arxiv_data1/oa_pdf/6c/80/abd-88-05-0739.PMC3798350.pdf
2013;88(5):748-53. s American cutaneous leishmaniasis: epidemiological profile of patients treated in Londrina from 1998 to 2009* Leishmaniose tegumentar americana: perfil epidemiológico dos pacientes  atendidos no município de Londrina entre 1998 e 2009  Rubens Pontello Junior1Airton dos Santos Gon2Alessandra Ogama3 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132168 Abstract: BACKGROUND : American cutaneous leishmaniasis is a dermatozoonosis of compulsory notification with relevant morbidity.,Non-OADS,/arxiv_data1/oa_pdf/15/56/abd-88-05-0748.PMC3798351.pdf
"Disponível em:http://portal.saude.gov.br/portal/arquivos/pdf/casos_conf_lta.pdf Vale ECS, Furtado T. Tegumentary leishmaniasis in Brazil: a historical review related to 3. the origin, expansion and etiology.",Non-OADS,/arxiv_data1/oa_pdf/15/56/abd-88-05-0748.PMC3798351.pdf
"Disponível em:http://portal.saude.gov.br/portal/arquivos/pdf/manu_leishman.pdfSilveira TGV, Teodoro U, Lonardoni MVC, Guilherme ALF , Toledo MJO, Ramos M, et al.",Non-OADS,/arxiv_data1/oa_pdf/15/56/abd-88-05-0748.PMC3798351.pdf
s755INVESTIGATION Prognosis of patients with systemic lupus erythematosus  and discoid lesions* Prognóstico de pacientes com lúpus eritematoso sistêmico e lesões discóides   Thelma Larocca Skare1 Emilio Weingraber2Bárbara Stadler2 Diogo F. De Paula2 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132042 Abstract:  BACKGROUND : It has been observed that patients with systemic lupus erythematosus and discoid lesions have a milder systemic disease.,Non-OADS,/arxiv_data1/oa_pdf/37/d7/abd-88-05-0755.PMC3798352.pdf
2013;88(5):760-3. s760INVESTIGATION Psoriasis: correlation between severity index (PASI) and  quality of life index (DLQI) in patients assessed before  and after systemic treatment* Psoríase: correlação entre gravidade clínica (PASI) e qualidade de vida (DLQI)  em pacientes avaliados antes e depois de tratamento sistêmico   Maria Flávia Pereira da Silva1 Luciane Donida Bartoli Miot3Maria Rita Parise Fortes2 Silvio Alencar Marques4 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132052 Abstract: BACKGROUND : Psoriasis is a chronic inflammatory disease of the skin that affects patients of all ages and both genders.,Non-OADS,/arxiv_data1/oa_pdf/87/8f/abd-88-05-0760.PMC3798353.pdf
"2013;88(5):764-74. s764REVIEW Update on therapy for superficial mycoses:  review article part I * Atualização terapêutica das micoses superficiais: artigo de revisão parte I Maria Fernanda Reis Gavazzoni Dias1 Fred Bernardes-Filho2 Regina Casz Schechtman4Maria Victória Pinto Quaresma-Santos2 Adriana Gutstein da Fonseca Amorim3 David Rubem Azulay5 DOI: http://dx.doi.org/10.1590/abd1806-4841.20131996 Abstract: Superficial fungal infections of the hair, skin and nails are a major cause of morbidity in the world.",Non-OADS,/arxiv_data1/oa_pdf/54/59/abd-88-05-0764.PMC3798354.pdf
"2013;88(5):775-86. sREVIEW775 Cutaneous field cancerization: clinical, histopathological  and therapeutic aspects* Campo de cancerização cutâneo: implicações clínicas, histopatológicas  e terapêuticas   DOI: http://dx.doi.org/10.1590/abd1806-4841.20132300 Abstract: The concept of ""field cancerization"" was first introduced by Slaughter in 1953 when studying the pres- ence of histologically abnormal tissue surrounding oral squamous cell carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/7b/52/abd-88-05-0775.PMC3798355.pdf
"2013;88(5):787-92. sREVIEW787 Understanding the type 1 reactional state for early diagnosis and treatment: a way to avoid disability in leprosy* Compreender melhor o estado reacional tipo 1 para o diagnóstico e tratamento precoces: uma forma de se evitar as incapacidades na hanseníase   DOI: http://dx.doi.org/10.1590/abd1806-4841.20132004 Abstract: A type 1 reaction or reversal reaction is expressed clinically by inflammatory exacerbation of the skin lesions and nerve trunks, consequently leading to sensory and motor alterations.",Non-OADS,/arxiv_data1/oa_pdf/23/5f/abd-88-05-0787.PMC3798356.pdf
"Disponível em: http://www.saude.es.gov.br/down-load/portaria_3125_hanseniase_2010.pdf MAILING ADDRESS : José Augusto da Costa NeryRua Otávio Corrêa, 378 - Urca.",Non-OADS,/arxiv_data1/oa_pdf/23/5f/abd-88-05-0787.PMC3798356.pdf
"2013;88(5):793-5. sDERMATOPATHOLOGY793 Atrophic dermatofibroma* Dermatofibroma atrófico  Amanda Nascimento C. de  Macedo Mota1Violeta Duarte Tortelly1 Daniel Lago Obadia2Roberto Souto da Silva2 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132234 Abstract: Dermatofibroma is a benign fibrohistiocytic tumor, common and easily diagnosed when classical clini- copathologic features are present.",Non-OADS,/arxiv_data1/oa_pdf/c0/60/abd-88-05-0793.PMC3798357.pdf
"796sCASEREPORT Erosive pustular dermatosis of the scalp successfully treated with oral prednisone and topical tacrolimus* Dermatose pustular erosiva do couro cabeludo tratada com sucesso com  prednisona oral e tacrolimus tópico  Mariana Ribas Zahdi1Gabriela Bestani Seidel2 Vanessa Cristina Soares2Camila Fernanda Novak Pinheiro de Freitas1 Fabiane Andrade Mulinari-Brenner3 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132109 Abstract: Erosive pustular dermatosis of the scalp is a rare inflammatory disorder of the scalp, affecting elderly patients after local trauma and leading to scarring or cicatricial alopecia.",Non-OADS,/arxiv_data1/oa_pdf/7c/20/abd-88-05-0796.PMC3798358.pdf
2013;88(5):799-802. s799CASEREPORT Chronic graft-versus-host disease: clinical presentation of multiple lesions of lichenoid and atrophic pattern* Doença enxerto contra hospedeiro crônica: apresentação clínica com  inúmeras lesões de padrão liquenóide e de caráter atrófico  Luiza Vasconcelos1Érica Cristina Vieira1Eliana Maria Minicucci2 Ana Gabriela Salvio3Mair Pedro de Souza4Mariangela Esther Alencar Marques5 Silvio Alencar Marques6 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132128 Abstract: Graft-versus-host disease is observed mainly in recipients of hematopoietic cell transplantation and is expressed by cutaneous or systemic signals and symptoms.,Non-OADS,/arxiv_data1/oa_pdf/b9/60/abd-88-05-0799.PMC3798359.pdf
"803sCASEREPORT Pigmented eccrine poroma: report of an atypical case  with the use of dermoscopy* Poroma écrino pigmentado: relato de caso atípico com descrição da dermoscopia  Fabiana Carvalho de Almeida1 Ângela Cristina Rapela Medeiros3Silvana Maria de Morais Cavalcanti2 Márcia Almeida Galvão Teixeira2 DOI: http://dx.doi.org/10.1590/abd1806-4841.20131255 Abstract: Poromas are uncommon benign neoplasms originating from the terminal ductal portion of the sweat glands, mainly characterized by  skin-colored or pink pa pules or nodules, usually on the extremities.",Non-OADS,/arxiv_data1/oa_pdf/20/1b/abd-88-05-0803.PMC3798360.pdf
2013;88(5):807-10.807sCASEREPORT Case report of cutaneous histiocytic sarcoma: diagnostic and therapeutic dilemmas* Relato de um caso de sarcoma histiocítico cutâneo: dilemas  diagnósticos e terapêuticos  Flávia Trevisan1Celia Antonia Xavier2Clovis Antonio Lopes Pinto3 Fernanda Gomes Cattete1Fabíola Schauffler Stock1Marcella Ledo Martins1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132070 Abstract: Histiocytic sarcoma is a rare hematologic malignant neoplasia originating from histiocytic or dendritic cell clones.,Non-OADS,/arxiv_data1/oa_pdf/56/8d/abd-88-05-0807.PMC3798361.pdf
"2013;88(5):811-3.811sCASEREPORT Non-cultured melanocyte/keratinocyte transplantation for the treatment of stable vitiligo on the face: report of two cases* Transplante de suspensão celular de melanócitos/queratinócitos para o  tratamento de vitiligo estável na face: relato de dois casos   Mariana Gontijo Ramos1Daniel Gontijo Ramos2Gabriel Gontijo3 Camila Gontijo Ramos4Tania Nely Rocha5Rafael Henrique Rocha6 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132054 Abstract: There are many alternatives to treat vitiligo, including surgical procedures, which are recommended for patients resistant to other therapies.",Non-OADS,/arxiv_data1/oa_pdf/34/78/abd-88-05-0811.PMC3798362.pdf
2013;88(5):814-6. s Folliculitis decalvans: the use of dermatoscopy as an  auxiliary tool in clinical diagnosis* Foliculite decalvante: o uso da dermatoscopia como ferramenta  auxiliar no diagnóstico clínico   Mariana Rocha Fabris1Clarisse Pereira Melo2Daniel Fernandes Melo3 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132129 Abstract: Folliculitis decalvans is an inflammatory presentation of cicatrizing alopecia characterized by inflam- matory perifollicular papules and pustules.,Non-OADS,/arxiv_data1/oa_pdf/27/08/abd-88-05-0814.PMC3798363.pdf
2013;88(5):817-9.Dermoscopy examination of petechial lesions in a patient with Dermatitis Herpetiformis* Exame dermatoscópico de lesões petequiais num paciente com  Dermatite Herpetiforme  Paulo Ricardo Criado1Nilton Gioia Di Chiacchio2Leopoldo Duailibe Nogueira Santos2 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132089 Abstract: An uncommon skin manifestation of Dermatitis Herpetiformis is palmar and plantar purpura.,Non-OADS,/arxiv_data1/oa_pdf/13/5e/abd-88-05-0817.PMC3798364.pdf
2013;88(5):820-2.Ectopic cutaneous Schistosomiasis* Esquistossomose cutânea ectópica  Thiago Jeunon de Sousa Vargas1 Maria de Lourdes Palermo F. N. Moraes3 Maria Auxiliadora Jeunon Sousa5Raquel Lopes2 Karen Grace Pena de Azevedo4 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132105 Abstract: The authors report a case of ectopic cutaneous schistosomiasis in a 35 year-old female who presented clustered reddish macules and papules on the left buttock.,Non-OADS,/arxiv_data1/oa_pdf/ae/4a/abd-88-05-0820.PMC3798365.pdf
"Available from:http://www.derm101.com.Nunes FC, Costa MCE, Filhote MIF , Sharapinn M. Perfil Epidemiológico da esquis- 3. tossomose mansônica no bairro Alto da Boa Vista, no Rio de Janeiro.Epidemiological profile o mansonic schistosomiasis at Alto da Boa Vista neighbor-hood in Rio de Janeiro.",Non-OADS,/arxiv_data1/oa_pdf/ae/4a/abd-88-05-0820.PMC3798365.pdf
"DOI: http://dx.doi.org/10.1590/abd1806-4841.20132258 FIGURE 1 : Erythematous brownish plaque surroundedby a raised erythematous redborder with some erosions F IGURE 3 : Nummular erythe- matous lesions scattered onthe legs (a)in close detail dis- playing a scaling border (b)F IGURE 2 : A pathological infiltration of the epidermis by large-sized cells, single or arranged in clusters and dermal fibrosis containing these cells onH&E 10x (a).",Non-OADS,/arxiv_data1/oa_pdf/34/66/abd-88-05-0824.PMC3798366.pdf
"DOI: http://dx.doi.org/10.1590/abd1806-4841.20132430 FIGURE 1: Burrows and honey-colored crusting in the palms  with marked scaling and scratching lesions in the abdomen FIGURE 2: Dermoscopy (Dermalite Pro II, magnification 10x)  of a burrow  FIGURE 3: Mite identified by light microscopy (100x amplification) in skin scrapings of a burrow (after 10% KOH)",Non-OADS,/arxiv_data1/oa_pdf/33/03/abd-88-05-0826.PMC3798367.pdf
"DOI: http://dx.doi.org/10.1590/abd1806-4841.20132311 FIGURE 1: Isolated erythematous plaquewith focal desqua-mation, erosions,and grossly polycy-clic featuresF IGURE 2:  Intraepidermalinfiltrate of largecells with clearcytoplasm andpleomorphicnuclei, eitherloosely scatteredor in small nests(H&E × 200) FIGURE 3:  Immunohistochemical stainingfor cytokeratin 7demonstratingnotorious page-toid spread (CK7× 100) breast ultrasound and thoraco-abdomino-pelvic com- puterized tomography detected no changes.",Non-OADS,/arxiv_data1/oa_pdf/c4/f4/abd-88-05-0828.PMC3798368.pdf
"FIGURE 1: Flat, smooth-surfaced normochromic papules on  the upper gumFIGURE 2: Keratotic papules with a central depression located  on the wrist  FIGURE 3: Keratotic papules on the lateral area of the foot and medial malleolus, some are normochromic and others slightly eryt-hematous, resembling flat wartsDOI: http://dx.doi.org/10.1590/abd1806-4841.20132045 Anatomopathological exam of a facial papule showed unspecific alterations and the shoulder lesionanalysis resulted in sclerotic fibroma.",Non-OADS,/arxiv_data1/oa_pdf/5a/fe/abd-88-05-0832.PMC3798369.pdf
"He had antecedents of: pneu- FIGURE 1: Multiple scarified keratotic papules on the lower third of the rightleg and top of the right foot  F IGURE 2: Alopecic area with lichenifica- tion and scarification on the surface ofthe left temporal-occipital region  F IGURE 3: Prominent front and broad nose base with multiple papules, some with umbilicatedand other with keratotic surfaces  DOI: http://dx.doi.org/10.1590/abd1806-4841.20132112 monia, otitis and recurrent diarrhea since four months of age.",Non-OADS,/arxiv_data1/oa_pdf/29/74/abd-88-05-0836.PMC3798370.pdf
"Available from:http://www.ncbi.nlm.nih.gov/books/NBK25507.Venkata C, Ghafoor S, Venkateshiah SV.",Non-OADS,/arxiv_data1/oa_pdf/29/74/abd-88-05-0836.PMC3798370.pdf
Guibas1Michael Makris2Catherine Chliva2 Stamatios Gregoriou3Dimitris Rigopoulos4 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132072 Abstract: Atopic Dermatitis has long been a controversial entity in regard its relationship to food allergy.,Non-OADS,/arxiv_data1/oa_pdf/21/d7/abd-88-05-0839.PMC3798371.pdf
2013;88(5):842-3.Pyschodermatology: a trip through history* Psicodermatologia: uma viagem pela história   Katlein França1Anna Chacon2Jennifer Ledon3 Jessica Savas3Keyvan Nouri4 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132059 Abstract: The interaction between the mind and diseases of the skin has been the study focus for many researchers worldwide.,Non-OADS,/arxiv_data1/oa_pdf/11/f1/abd-88-05-0842.PMC3798372.pdf
©2013 by Anais Brasileiros de Dermatologia s844COMMUNICATION DOI: http://dx.doi.org/10.1590/abd1806-4841.20131970 Abstract: Conservative treatment of penile squamous cell carcinoma has been advocated as a method of choice for tumours at early stages.,Non-OADS,/arxiv_data1/oa_pdf/e9/e4/abd-88-05-0844.PMC3798373.pdf
"©2013 by Anais Brasileiros de Dermatologia s847COMMUNICATION DOI: http://dx.doi.org/10.1590/abd1806-4841.20131932 Abstract: Onychomycosis is a common disease, accounting for up to 50% of all ungual pathologies.",Non-OADS,/arxiv_data1/oa_pdf/1b/f2/abd-88-05-0847.PMC3798374.pdf
©2013 by Anais Brasileiros de Dermatologia s850ICONOGRAPHY DOI: http://dx.doi.org/10.1590/abd1806-4841.20132821 Abstract: Crack cocaine addiction is a public health problem in Brazil.,Non-OADS,/arxiv_data1/oa_pdf/c5/53/abd-88-05-0850.PMC3798375.pdf
"Disponível em: 2. http://pt.wikipedia.org/wiki/CrackAfonso L, Mohammad T, Thatai D. Crack whips the heart: a review of the cardiovas- 3. cular toxicity of cocaine.",Non-OADS,/arxiv_data1/oa_pdf/c5/53/abd-88-05-0850.PMC3798375.pdf
©2013 by Anais Brasileiros de DermatologiaComments regarding the article: Case for diagnosis: Abrikossoff  Tumor: unusual location* Comentários sobre o artigo “Caso para diagnóstico - Tumor de Abrikossoff:  localização não usual”    Oswaldo Delfini Filho1 DOI: http://dx.doi.org/10.1590/abd1806-4841.20132935 An Bras Dermatol.,Non-OADS,/arxiv_data1/oa_pdf/66/a4/abd-88-05-0853.PMC3798376.pdf
"2002 Jun;120(6):714-20; discussion 829-30, http://dx.doi.org/10.1001/archopht.120.6.714.",Non-OADS,/arxiv_data1/oa_pdf/08/1f/cln-68-10-1318.PMC3798551.pdf
"2003;135(3):314-20, http://dx.doi.org/10.1016/S0002-9394(02)01980-3.",Non-OADS,/arxiv_data1/oa_pdf/08/1f/cln-68-10-1318.PMC3798551.pdf
"2005;123(2):186-92, http://dx.doi.org/10.1001/archopht.",Non-OADS,/arxiv_data1/oa_pdf/08/1f/cln-68-10-1318.PMC3798551.pdf
"1998;22(1):31-5, http://dx.doi.org/10.1023/A:1006051725115.",Non-OADS,/arxiv_data1/oa_pdf/08/1f/cln-68-10-1318.PMC3798551.pdf
"1994;112(11):1437-45, http://dx.doi.org/10.1001/archopht.",Non-OADS,/arxiv_data1/oa_pdf/08/1f/cln-68-10-1318.PMC3798551.pdf
"2000;78(1):37-44, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/08/1f/cln-68-10-1318.PMC3798551.pdf
"1994;112(11):1446-54, http://dx.doi.org/10.1001/ archopht.1994.01090230060021.",Non-OADS,/arxiv_data1/oa_pdf/08/1f/cln-68-10-1318.PMC3798551.pdf
"2010;150(4):575-80, http://dx.doi.org/10.1016/j.ajo.",OADS,/arxiv_data1/oa_pdf/08/1f/cln-68-10-1318.PMC3798551.pdf
"2007;70(5):910-17, http://dx.doi.org/10.1590/S0004-27492007000600005.",Non-OADS,/arxiv_data1/oa_pdf/08/1f/cln-68-10-1318.PMC3798551.pdf
"2008;71(1):18-21, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/08/1f/cln-68-10-1318.PMC3798551.pdf
"2007;115(12):1753-6, http://dx.doi.org/10.1289/ehp.10363.",Non-OADS,/arxiv_data1/oa_pdf/08/1f/cln-68-10-1318.PMC3798551.pdf
"2004;111(12):2186-92, http://dx.doi.org/10.1016/ j.ophtha.2004.06.023.",Non-OADS,/arxiv_data1/oa_pdf/08/1f/cln-68-10-1318.PMC3798551.pdf
"2002;216(3):175-9, http://dx.doi.org/10.1159/000059624.",Non-OADS,/arxiv_data1/oa_pdf/08/1f/cln-68-10-1318.PMC3798551.pdf
"2000;28(2):113-7, http://dx.doi.org/10.1046/j.1442-9071.2000.00237.x.",Non-OADS,/arxiv_data1/oa_pdf/08/1f/cln-68-10-1318.PMC3798551.pdf
"2003;34(12):1563-74, http://dx.doi.org/10.1016/S0891-5849(03) 00185-0.",Non-OADS,/arxiv_data1/oa_pdf/16/d6/cln-68-10-1358.PMC3798552.pdf
"3):S233-6, http://dx.doi.org/10.1097/01.ASN.0000077408.",Non-OADS,/arxiv_data1/oa_pdf/16/d6/cln-68-10-1358.PMC3798552.pdf
"1991;10(5):339-52, http://dx.doi.org/10.1016/0891-5849(91)90040-A.",Non-OADS,/arxiv_data1/oa_pdf/16/d6/cln-68-10-1358.PMC3798552.pdf
"2005;32(1-2):70-5, http://dx.doi.org/10.1111/j.",Non-OADS,/arxiv_data1/oa_pdf/16/d6/cln-68-10-1358.PMC3798552.pdf
"2003;329(1-2):23-38, http://dx.doi.org/10.1016/S0009-8981(03)00003-2.",Non-OADS,/arxiv_data1/oa_pdf/16/d6/cln-68-10-1358.PMC3798552.pdf
"2005;19(5):369-75, http://dx.doi.org/10.1002/ptr.1628.",Non-OADS,/arxiv_data1/oa_pdf/16/d6/cln-68-10-1358.PMC3798552.pdf
"2002;35(4):351-6, http://dx.doi.org/10.1016/S0963-9969(01)00129-6.",Non-OADS,/arxiv_data1/oa_pdf/16/d6/cln-68-10-1358.PMC3798552.pdf
"2007;21:601-9, http://dx.doi.org/10.1111/ j.1472-8206.2007.00525.x.",Non-OADS,/arxiv_data1/oa_pdf/16/d6/cln-68-10-1358.PMC3798552.pdf
"2008;59(5):319-27, http://dx.doi.org/10.1016/j.etp.2007.",OADS,/arxiv_data1/oa_pdf/16/d6/cln-68-10-1358.PMC3798552.pdf
"1963;100:119-30, http://dx.doi.org/10.1016/0003- 9861(63)90042-0.",Non-OADS,/arxiv_data1/oa_pdf/16/d6/cln-68-10-1358.PMC3798552.pdf
"1976;72(1-2):248-54, http://dx.doi.org/10.1016/ 0003-2697(76)90527-3.",Non-OADS,/arxiv_data1/oa_pdf/16/d6/cln-68-10-1358.PMC3798552.pdf
"1987;161(2):559-66, http://dx.doi.org/10.1016/0003-2697(87)90489-1.Effect of roselle against oxidative stress Mohamed J et al.CLINICS 2013;68(10):1358-1363 1362",Non-OADS,/arxiv_data1/oa_pdf/16/d6/cln-68-10-1358.PMC3798552.pdf
"1997;272(33):20313-6, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/16/d6/cln-68-10-1358.PMC3798552.pdf
"2008;173(2):97-104, http://dx.doi.org/10.1016/j.cbi.2008.03.008.",OADS,/arxiv_data1/oa_pdf/16/d6/cln-68-10-1358.PMC3798552.pdf
"1997;45:3362-7, http://dx.doi.org/10.1021/jf970234a.",Non-OADS,/arxiv_data1/oa_pdf/16/d6/cln-68-10-1358.PMC3798552.pdf
"2000;29(1):51-60, http://dx.doi.org/10.1016/ S0891-5849(00)00329-4.CLINICS 2013;68(10):1358-1363 Effect of roselle against oxidative stress Mohamed J et al.",OADS,/arxiv_data1/oa_pdf/16/d6/cln-68-10-1358.PMC3798552.pdf
The allele frequencies were estimated by the gene counting method using the GENEPOP online version 4.0.10 (http://genepop.curtin.edu.au) (22).,OADS,/arxiv_data1/oa_pdf/a2/b9/cln-68-10-1325.PMC3798553.pdf
"2008;12(3):713-26, xi, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/a2/b9/cln-68-10-1325.PMC3798553.pdf
"1998;12(6):509-18, http://dx.doi.org/10.1046/j.1365-2036.1998.00328.x.",Non-OADS,/arxiv_data1/oa_pdf/a2/b9/cln-68-10-1325.PMC3798553.pdf
"1999;180(2):262-7, http://dx.doi.org/10.1086/3148 59.",Non-OADS,/arxiv_data1/oa_pdf/a2/b9/cln-68-10-1325.PMC3798553.pdf
"2001;44(6):379-82, http://dx.doi.org/10.1159/000050075.",Non-OADS,/arxiv_data1/oa_pdf/a2/b9/cln-68-10-1325.PMC3798553.pdf
"2004;313(4):1079-85, http://dx.doi.org/ 10.1016/j.bbrc.2003.12.045.6 .",Non-OADS,/arxiv_data1/oa_pdf/a2/b9/cln-68-10-1325.PMC3798553.pdf
"2000;18:143-64, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/a2/b9/cln-68-10-1325.PMC3798553.pdf
"2009;461(7262):399-401, http://dx.doi.org/10.1038/ nature08309.",Non-OADS,/arxiv_data1/oa_pdf/a2/b9/cln-68-10-1325.PMC3798553.pdf
"2009;41(10):1105-9, http://dx.doi.org/10.1038/ng.449.",Non-OADS,/arxiv_data1/oa_pdf/a2/b9/cln-68-10-1325.PMC3798553.pdf
"2009;461(7265):798-801, http://dx.doi.org/10.1038/nature08463.",Non-OADS,/arxiv_data1/oa_pdf/a2/b9/cln-68-10-1325.PMC3798553.pdf
"2003;4(6):411-9, http://dx.doi.org/10.1038/sj.gene.6363984.",Non-OADS,/arxiv_data1/oa_pdf/a2/b9/cln-68-10-1325.PMC3798553.pdf
"2004;68(Pt 2):139-53, http://dx.doi.org/10.1046/j.1529-8817.2003.00084.x.",Non-OADS,/arxiv_data1/oa_pdf/a2/b9/cln-68-10-1325.PMC3798553.pdf
"2007;176(3):1823-33, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/a2/b9/cln-68-10-1325.PMC3798553.pdf
"2000;18:143-64, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/a2/b9/cln-68-10-1325.PMC3798553.pdf
"2009;39(9):850-5, http://dx.doi.org/10.1111/j.1872-034X.2009.00529.",Non-OADS,/arxiv_data1/oa_pdf/a2/b9/cln-68-10-1325.PMC3798553.pdf
"2005;21(13):2933-42, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/a2/b9/cln-68-10-1325.PMC3798553.pdf
"2004, http://www.asha.org/docs/html/TR2004-00001.html.",OADS,/arxiv_data1/oa_pdf/94/ba/cln-68-10-1364.PMC3798554.pdf
"2012;56(4):420-32, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/94/5f/cln-68-10-1305.PMC3798610.pdf
"2010;110(2):570-80, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/94/5f/cln-68-10-1305.PMC3798610.pdf
"2010;110(5):1433-9, http://dx.doi.org/10.1213/ANE.0b013e3181d58052.",Non-OADS,/arxiv_data1/oa_pdf/94/5f/cln-68-10-1305.PMC3798610.pdf
"2006;50(1):14-8, http://dx.doi.org/10.1111/j.1399- 6576.2006.00905.x.",Non-OADS,/arxiv_data1/oa_pdf/94/5f/cln-68-10-1305.PMC3798610.pdf
"2003;99(2):314-23, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/94/5f/cln-68-10-1305.PMC3798610.pdf
"2004;59(3):216-21, http://dx.doi.org/10.1111/j.1365-2044.",Non-OADS,/arxiv_data1/oa_pdf/94/5f/cln-68-10-1305.PMC3798610.pdf
"2003;69(3):132-7, http://dx.doi.org/10.1159/000072665.",Non-OADS,/arxiv_data1/oa_pdf/94/5f/cln-68-10-1305.PMC3798610.pdf
"2003;58(10):951-6, http://dx.doi.org/10.1046/j.1365-2044.",Non-OADS,/arxiv_data1/oa_pdf/94/5f/cln-68-10-1305.PMC3798610.pdf
"2008;20(7):496-500, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/94/5f/cln-68-10-1305.PMC3798610.pdf
"2008;46(2):66-70, http://dx.doi.org/10.1016/ S1875-4597(08)60028-4.",Non-OADS,/arxiv_data1/oa_pdf/94/5f/cln-68-10-1305.PMC3798610.pdf
"2001;93(4):947-53, http://dx.doi.org/10.1097/00000539-200110000-00029.",Non-OADS,/arxiv_data1/oa_pdf/94/5f/cln-68-10-1305.PMC3798610.pdf
"1998;42(10):1192-8, http://dx.doi.org/10.1111/j.1399-6576.1998.tb05276.x.",Non-OADS,/arxiv_data1/oa_pdf/94/5f/cln-68-10-1305.PMC3798610.pdf
"2005;102(3):562-5, http://dx.doi.org/10.1097/ 00000542-200503000-00014.",Non-OADS,/arxiv_data1/oa_pdf/94/5f/cln-68-10-1305.PMC3798610.pdf
"2005;101(3):688-96, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/94/5f/cln-68-10-1305.PMC3798610.pdf
"2010;104(2):175-82, http://dx.doi.org/10.1093/bja/aep374.",Non-OADS,/arxiv_data1/oa_pdf/94/5f/cln-68-10-1305.PMC3798610.pdf
"2007;99(3):353-8, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/94/5f/cln-68-10-1305.PMC3798610.pdf
"2006;96(6):779-85, http://dx.doi.org/ 10.1093/bja/ael092.",Non-OADS,/arxiv_data1/oa_pdf/94/5f/cln-68-10-1305.PMC3798610.pdf
"2010;54(9):1111-6, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/94/5f/cln-68-10-1305.PMC3798610.pdf
"2002;96(2):306- 12, http://dx.doi.org/10.1097/00000542-200202000-00014.Desflurane awakening blood concentration Lin TC et al.CLINICS 2013;68(10):1305-1311 1310",Non-OADS,/arxiv_data1/oa_pdf/94/5f/cln-68-10-1305.PMC3798610.pdf
"2003;99(5):1062-5, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/94/5f/cln-68-10-1305.PMC3798610.pdf
"2005;49(2):243-7, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/94/5f/cln-68-10-1305.PMC3798610.pdf
"2007;117(3):557-67, http://dx.doi.org/10.1172/ JCI31139.",Non-OADS,/arxiv_data1/oa_pdf/a5/26/cln-68-10-1350.PMC3798612.pdf
"2012;8:42-54, http://dx.doi.org/10.1038/nrrheum.2011.149.3.",Non-OADS,/arxiv_data1/oa_pdf/a5/26/cln-68-10-1350.PMC3798612.pdf
"2013;80(1):23-8, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/a5/26/cln-68-10-1350.PMC3798612.pdf
"2012;13(1):173-9, http://dx.doi.org/10.2174/138920112798868566.",Non-OADS,/arxiv_data1/oa_pdf/a5/26/cln-68-10-1350.PMC3798612.pdf
"2006;107(1):25-31, http://dx.doi.org/10.1016/j.jep.2006.01.022.",OADS,/arxiv_data1/oa_pdf/a5/26/cln-68-10-1350.PMC3798612.pdf
"2012;33(5):1011-20, http://dx.doi.org/10.1007/s10072-011-0880-1.",Non-OADS,/arxiv_data1/oa_pdf/a5/26/cln-68-10-1350.PMC3798612.pdf
"2009;13(5):909-25, http://dx.doi.org/10.1111/j.",Non-OADS,/arxiv_data1/oa_pdf/a5/26/cln-68-10-1350.PMC3798612.pdf
"1980; 23(5):581-90, http://dx.doi.org/10.1002/art.1780230510.",Non-OADS,/arxiv_data1/oa_pdf/a5/26/cln-68-10-1350.PMC3798612.pdf
"2012;37(4):395- 403, http://dx.doi.org/10.1111/j.1365-2230.2011.04254.x.",Non-OADS,/arxiv_data1/oa_pdf/a5/26/cln-68-10-1350.PMC3798612.pdf
"2005;39(4):519-25, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/a5/26/cln-68-10-1350.PMC3798612.pdf
"2008;3(6):1101-8, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/a5/26/cln-68-10-1350.PMC3798612.pdf
"2002;137(1-2):2-10, http://dx.doi.org/10.1006/ jsbi.2002.4450.",Non-OADS,/arxiv_data1/oa_pdf/a5/26/cln-68-10-1350.PMC3798612.pdf
"1995;19(9):735-41, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/a5/26/cln-68-10-1350.PMC3798612.pdf
"2011;63(6):502-3, http://dx.doi.org/ 10.1016/j.phrs.2011.01.011.",OADS,/arxiv_data1/oa_pdf/a5/26/cln-68-10-1350.PMC3798612.pdf
"2005;24(2):111-6, http://dx.doi.org/10.1007/s10067-004-0987-3.",Non-OADS,/arxiv_data1/oa_pdf/a5/26/cln-68-10-1350.PMC3798612.pdf
"2012;35(3):1138-43, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/a5/26/cln-68-10-1350.PMC3798612.pdf
"1998;19(11):499-501, http://dx.doi.org/10.1016/ S0167-5699(98)01322-X.",Non-OADS,/arxiv_data1/oa_pdf/a5/26/cln-68-10-1350.PMC3798612.pdf
"2005;95(9):1088-91, http://dx.doi.org/10.1016/j.amjcard.",OADS,/arxiv_data1/oa_pdf/6b/ee/cln-68-10-1333.PMC3798672.pdf
"2002;106(13):1627-33, http://dx.doi.org/10.1161/01.CIR.",Non-OADS,/arxiv_data1/oa_pdf/6b/ee/cln-68-10-1333.PMC3798672.pdf
"1987;9(4):763-8, http://dx.doi.org/10.1016/S0735- 1097(87)80230-9.",Non-OADS,/arxiv_data1/oa_pdf/6b/ee/cln-68-10-1333.PMC3798672.pdf
"2001;38(2):409- 14, http://dx.doi.org/10.1016/S0735-1097(01)01349-3.",Non-OADS,/arxiv_data1/oa_pdf/6b/ee/cln-68-10-1333.PMC3798672.pdf
"2003;41(10):1672-8, http://dx.doi.org/10.1016/S0735-1097(03)00312-7.",Non-OADS,/arxiv_data1/oa_pdf/6b/ee/cln-68-10-1333.PMC3798672.pdf
"2004;17(2):168-72, http://dx.doi.org/10.1016/j.echo.2003.10.021 7.",OADS,/arxiv_data1/oa_pdf/6b/ee/cln-68-10-1333.PMC3798672.pdf
"2004;17(10):1021-9, http://dx.doi.org/10.1016/j.echo.2004.",OADS,/arxiv_data1/oa_pdf/6b/ee/cln-68-10-1333.PMC3798672.pdf
"2004;17(6):630-3, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/6b/ee/cln-68-10-1333.PMC3798672.pdf
"2008;21(11):1244-50, http://dx.doi.org/10.1016/ j.echo.2008.08.010.",OADS,/arxiv_data1/oa_pdf/6b/ee/cln-68-10-1333.PMC3798672.pdf
"2006;47(4):789-93, http://dx.doi.org/10.1016/j.jacc.2005.10.040.",OADS,/arxiv_data1/oa_pdf/6b/ee/cln-68-10-1333.PMC3798672.pdf
"2005;112(15):2364-72, http://dx.doi.org/10.1161/CIRCULATIONAHA.104.481283.",Non-OADS,/arxiv_data1/oa_pdf/6b/ee/cln-68-10-1333.PMC3798672.pdf
"2004;44(4):878-86, http://dx.doi.org/10.1016/j.jacc.2004.05.050.",OADS,/arxiv_data1/oa_pdf/6b/ee/cln-68-10-1333.PMC3798672.pdf
"1998;19(2):273-81, http://dx.doi.org/10.1053/euhj.1997.0617.",Non-OADS,/arxiv_data1/oa_pdf/6b/ee/cln-68-10-1333.PMC3798672.pdf
"2001;142(2):301-8, http://dx.doi.org/10.1067/mhj.2001.116960.",Non-OADS,/arxiv_data1/oa_pdf/6b/ee/cln-68-10-1333.PMC3798672.pdf
"2006;47(4):721-5, http://dx.doi.org/10.1016/j.jacc.2005.10.042.",OADS,/arxiv_data1/oa_pdf/6b/ee/cln-68-10-1333.PMC3798672.pdf
"2008;1(1):44-53, http://dx.doi.org/10.1016/j.jcin.2007.11.003.",OADS,/arxiv_data1/oa_pdf/6b/ee/cln-68-10-1333.PMC3798672.pdf
"2010;160(1):179-87, http://dx.doi.org/10.1016/j.ahj.2010.04.015.",OADS,/arxiv_data1/oa_pdf/6b/ee/cln-68-10-1333.PMC3798672.pdf
"1984;4(1):72-9, http://dx.doi.org/10.1016/S0735-1097(84)80321-6.",Non-OADS,/arxiv_data1/oa_pdf/6b/ee/cln-68-10-1333.PMC3798672.pdf
"1985;71(2):297-307, http://dx.doi.org/ 10.1161/01.CIR.71.2.297.",Non-OADS,/arxiv_data1/oa_pdf/6b/ee/cln-68-10-1333.PMC3798672.pdf
"2002;106(24):3037-43, http://dx.doi.org/10.1161/01.CIR.0000041432.80615.",Non-OADS,/arxiv_data1/oa_pdf/6b/ee/cln-68-10-1333.PMC3798672.pdf
"2000;102(9):1014-9, http://dx.doi.org/10.1161/01.CIR.102.9.",Non-OADS,/arxiv_data1/oa_pdf/6b/ee/cln-68-10-1333.PMC3798672.pdf
"1999;281(14):1291-7, http://dx.doi.org/10.1001/jama.281.14.1291.",Non-OADS,/arxiv_data1/oa_pdf/6b/ee/cln-68-10-1333.PMC3798672.pdf
"2006;3(1):45-51, http://dx.doi.org/10.3132/dvdr.2006.006.CLINICS 2013;68(10):1333-1337 Echocardiographic studies in patients with CTO Erdogan E et al.",Non-OADS,/arxiv_data1/oa_pdf/6b/ee/cln-68-10-1333.PMC3798672.pdf
"2000;14(6):579-87, http://dx.doi.org/10.1023/A:1007890126061.",Non-OADS,/arxiv_data1/oa_pdf/e7/02/cln-68-10-1344.PMC3798673.pdf
"2000;35(3):569-82, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e7/02/cln-68-10-1344.PMC3798673.pdf
"2010;48(3):558-63, http://dx.doi.org/10.1016/j.yjmcc.2009.",OADS,/arxiv_data1/oa_pdf/e7/02/cln-68-10-1344.PMC3798673.pdf
"2010;48(3):504-11, http://dx.doi.org/10.1016/j.yjmcc.2009.07.015.",OADS,/arxiv_data1/oa_pdf/e7/02/cln-68-10-1344.PMC3798673.pdf
"2012;92(2):635-88, http://dx.doi.org/10.1152/ physrev.00008.2011.",Non-OADS,/arxiv_data1/oa_pdf/e7/02/cln-68-10-1344.PMC3798673.pdf
"2007;13(8):962-9, http://dx.doi.org/ 10.1038/nm1619.",Non-OADS,/arxiv_data1/oa_pdf/e7/02/cln-68-10-1344.PMC3798673.pdf
"2008;205(2):295-303, http://dx.doi.org/10.1084/jem.",Non-OADS,/arxiv_data1/oa_pdf/e7/02/cln-68-10-1344.PMC3798673.pdf
"2005;18(12):1440-63, http://dx.doi.org/10.1016/ j.echo.2005.10.005.",OADS,/arxiv_data1/oa_pdf/e7/02/cln-68-10-1344.PMC3798673.pdf
"2010;26(3):395- 402, http://dx.doi.org/10.1159/000320563.",Non-OADS,/arxiv_data1/oa_pdf/e7/02/cln-68-10-1344.PMC3798673.pdf
"2009;93(4):434-40, http://dx.doi.org/10.1590/S0066-782X2009001000018.Table 4 - Levels of myocardial periostin and collagen types I and III.",Non-OADS,/arxiv_data1/oa_pdf/e7/02/cln-68-10-1344.PMC3798673.pdf
"2000;95(3):208-14, http://dx.doi.org/10.1007/s003950050183.",Non-OADS,/arxiv_data1/oa_pdf/e7/02/cln-68-10-1344.PMC3798673.pdf
"2009;105(10):934-47, http://dx.doi.org/10.1161/CIRCRESAHA.109.201400.",Non-OADS,/arxiv_data1/oa_pdf/e7/02/cln-68-10-1344.PMC3798673.pdf
"2009;3(3- 4):275-86, http://dx.doi.org/10.1007/s12079-009-0063-5.CLINICS 2013;68(10):1344-1349 Periostin post-infarction Minicucci MF et al.",Non-OADS,/arxiv_data1/oa_pdf/e7/02/cln-68-10-1344.PMC3798673.pdf
"2013;68(6):846-50, http://dx.doi.org/10.6061/ clinics/2013(06)20.",Non-OADS,/arxiv_data1/oa_pdf/33/b5/cln-68-10-1380.PMC3798674.pdf
"2001;6(2):159-65, http://dx.doi.org/10.1111/j.1542-474X.2001.tb00101.x.",Non-OADS,/arxiv_data1/oa_pdf/33/b5/cln-68-10-1380.PMC3798674.pdf
"1998;135(5 Pt 1):733-8, http://dx.doi.org/10.1016/S0002-8703(98)70030- 4.",Non-OADS,/arxiv_data1/oa_pdf/33/b5/cln-68-10-1380.PMC3798674.pdf
"2006;14(80):1378-82, http://dx.doi.org/10.1038/oby.2006.156.",Non-OADS,/arxiv_data1/oa_pdf/33/b5/cln-68-10-1380.PMC3798674.pdf
"2002;7(3):222-7, http://dx.doi.org/10.1111/j.1542-474X.2002.tb00167.x.",Non-OADS,/arxiv_data1/oa_pdf/33/b5/cln-68-10-1380.PMC3798674.pdf
"2010;65(11):1067-71, http://dx.doi.org/10.1590/S1807-59322010001100001.",Non-OADS,/arxiv_data1/oa_pdf/33/b5/cln-68-10-1380.PMC3798674.pdf
"2012;35(5):544-52, http://dx.doi.org/10.1111/j.1540-8159.2012.03355.x.",Non-OADS,/arxiv_data1/oa_pdf/33/b5/cln-68-10-1380.PMC3798674.pdf
2013 Jun 20. http://dx.doi.org/10.1002/clc.22163.,Non-OADS,/arxiv_data1/oa_pdf/33/b5/cln-68-10-1380.PMC3798674.pdf
"2009;26(7):779-84, http://dx.doi.org/10.1111/j.1540-8175.",Non-OADS,/arxiv_data1/oa_pdf/33/b5/cln-68-10-1380.PMC3798674.pdf
"2010;14(3):183-92, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/19/e7/cln-68-10-1293.PMC3798690.pdf
"2010;21(3):457-66, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/19/e7/cln-68-10-1293.PMC3798690.pdf
"2000;46(6):306-10, http://dx.doi.org/10.1159/ 000022182.",Non-OADS,/arxiv_data1/oa_pdf/19/e7/cln-68-10-1293.PMC3798690.pdf
"1991;46(3):69-76, http://dx.doi.org/10.1093/geronj/46.3.M69.",Non-OADS,/arxiv_data1/oa_pdf/19/e7/cln-68-10-1293.PMC3798690.pdf
"2009;55(3):259-68, http://dx.doi.org/10.1159/000172832.",Non-OADS,/arxiv_data1/oa_pdf/19/e7/cln-68-10-1293.PMC3798690.pdf
"1994;23(5):371-7, http://dx.doi.org/10.1093/ageing/23.5.371.",Non-OADS,/arxiv_data1/oa_pdf/19/e7/cln-68-10-1293.PMC3798690.pdf
"2005;16(8):1004-10, http://dx.doi.org/10.1007/s00198-004-1791-2.",Non-OADS,/arxiv_data1/oa_pdf/19/e7/cln-68-10-1293.PMC3798690.pdf
"2010;21(7):1237-45, http://dx.doi.org/10.1007/s00198-009-1064-1.",Non-OADS,/arxiv_data1/oa_pdf/19/e7/cln-68-10-1293.PMC3798690.pdf
"2007;62(6):652-7, http://dx.doi.org/10.1093/gerona/62.6.652.",Non-OADS,/arxiv_data1/oa_pdf/19/e7/cln-68-10-1293.PMC3798690.pdf
"2011;22(1):85-90, http://dx.doi.org/10.1007/s00198-010-1265-7.",Non-OADS,/arxiv_data1/oa_pdf/19/e7/cln-68-10-1293.PMC3798690.pdf
"2009;150(10):681-7, http://dx.doi.org/10.7326/0003-4819-150-10-200905 190-00005.",Non-OADS,/arxiv_data1/oa_pdf/19/e7/cln-68-10-1293.PMC3798690.pdf
"2011;70(4):379-82, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/19/e7/cln-68-10-1293.PMC3798690.pdf
"2007;40(11):2477-82, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/19/e7/cln-68-10-1293.PMC3798690.pdf
"2010;21(9):1487-91, http://dx.doi.org/ 10.1007/s00198-009-1117-5.",Non-OADS,/arxiv_data1/oa_pdf/19/e7/cln-68-10-1293.PMC3798690.pdf
"2009;4(1-2):25-9, http://dx.doi.org/10.1007/s11657-009-0023-y.",Non-OADS,/arxiv_data1/oa_pdf/19/e7/cln-68-10-1293.PMC3798690.pdf
"2009;31(10):496-502, http://dx.doi.org/10.1590/ S0100-72032009001000005.",Non-OADS,/arxiv_data1/oa_pdf/19/e7/cln-68-10-1293.PMC3798690.pdf
"2013;24(7):2007-13, http://dx.doi.org/10.1007/s00198-013-2285-x.",Non-OADS,/arxiv_data1/oa_pdf/19/e7/cln-68-10-1293.PMC3798690.pdf
"2003;18(2):101-8, http://dx.doi.org/10.1016/S0966-6362(02)00200-X.",Non-OADS,/arxiv_data1/oa_pdf/19/e7/cln-68-10-1293.PMC3798690.pdf
"2007;22(3):297-304, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/19/e7/cln-68-10-1293.PMC3798690.pdf
"2003;18(2):343-51, http://dx.doi.org/ 10.1359/jbmr.2003.18.2.343.",Non-OADS,/arxiv_data1/oa_pdf/19/e7/cln-68-10-1293.PMC3798690.pdf
"2006;17(5):656-63, http://dx.doi.org/10.1007/s00198-005-0030 -9.",Non-OADS,/arxiv_data1/oa_pdf/19/e7/cln-68-10-1293.PMC3798690.pdf
"2010;25(2):362-8., http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/19/e7/cln-68-10-1293.PMC3798690.pdf
"2006;12(11 Pt 1):3233-7, http://dx.doi.org/10.1158/1078-0432.CCR-06-0456.",Non-OADS,/arxiv_data1/oa_pdf/89/c8/cln-68-10-1371.PMC3798691.pdf
"2012;30(8):1597-610, http://dx.doi.org/10.1002/stem.1157.",Non-OADS,/arxiv_data1/oa_pdf/89/c8/cln-68-10-1371.PMC3798691.pdf
"2010;116(20):4103-15, http://dx.doi.org/10.1182/blood-2010- 01-262790.",Non-OADS,/arxiv_data1/oa_pdf/89/c8/cln-68-10-1371.PMC3798691.pdf
"2012;19(4):273-9, http://dx.doi.org/10.1097/MOH.0b013e328353c6bf.8.",Non-OADS,/arxiv_data1/oa_pdf/89/c8/cln-68-10-1371.PMC3798691.pdf
"2005;106(9):3142-9, http://dx.doi.org/10.1182/ blood-2004-10-4057.",Non-OADS,/arxiv_data1/oa_pdf/89/c8/cln-68-10-1371.PMC3798691.pdf
"2011;117(16):4253-61, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/89/c8/cln-68-10-1371.PMC3798691.pdf
"2011;117(20):5350-61, http://dx.doi.org/10.1182/blood- 2011-01-333476.",Non-OADS,/arxiv_data1/oa_pdf/89/c8/cln-68-10-1371.PMC3798691.pdf
"2011;118(6):1504-15, http://dx.doi.org/10.1182/blood-2010-06-288910.",Non-OADS,/arxiv_data1/oa_pdf/89/c8/cln-68-10-1371.PMC3798691.pdf
"2009;114(5):937-51, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/89/c8/cln-68-10-1371.PMC3798691.pdf
"2001;25(4):402-8, http://dx.doi.org/10.1006/meth.2001.1262.",Non-OADS,/arxiv_data1/oa_pdf/89/c8/cln-68-10-1371.PMC3798691.pdf
"2012;40(4):307-17 e3, http://dx.doi.org/10.1016/j.exphem.2011.11.010.",OADS,/arxiv_data1/oa_pdf/89/c8/cln-68-10-1371.PMC3798691.pdf
"2011;317(18):2616-29, http://dx.doi.org/10.1016/j.yexcr.2011.08.007.",OADS,/arxiv_data1/oa_pdf/89/c8/cln-68-10-1371.PMC3798691.pdf
"2004;103(6):2325-31, http://dx.doi.org/10.1182/ blood-2003-09-3287.",Non-OADS,/arxiv_data1/oa_pdf/89/c8/cln-68-10-1371.PMC3798691.pdf
"2003;34(2):148-50, http://dx.doi.org/10.1038/ng1156.CLINICS 2013;68(10):1371-1375 PTK2 and PTPN11 in Myelodysplastic Syndromes Lazarini M et al.",Non-OADS,/arxiv_data1/oa_pdf/89/c8/cln-68-10-1371.PMC3798691.pdf
"2008;62:71-92, http://dx.doi.org/10.1146/annurev.micro.62.",Non-OADS,/arxiv_data1/oa_pdf/c0/f6/cln-68-10-1299.PMC3798712.pdf
"2011;11:106, http://dx.doi.org/10.1186/1471-2334-11-106.",Non-OADS,/arxiv_data1/oa_pdf/c0/f6/cln-68-10-1299.PMC3798712.pdf
"2002;2:33- 42, http://dx.doi.org/10.1016/S1473-3099(01)00171-2.",OADS,/arxiv_data1/oa_pdf/c0/f6/cln-68-10-1299.PMC3798712.pdf
"2009;155(1):34-8, http://dx.doi.org/10.1016/j.jviromet.2008.09.023.",OADS,/arxiv_data1/oa_pdf/c0/f6/cln-68-10-1299.PMC3798712.pdf
"2011;16(8):936-48, http://dx.doi.org/10.1111/j.1365-3156.2011.",Non-OADS,/arxiv_data1/oa_pdf/c0/f6/cln-68-10-1299.PMC3798712.pdf
"2007;18(8):605-12, http://dx.doi.org/10.1080/09537100701426604.",Non-OADS,/arxiv_data1/oa_pdf/c0/f6/cln-68-10-1299.PMC3798712.pdf
"2010;50(8):1135-43, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c0/f6/cln-68-10-1299.PMC3798712.pdf
"2006;6(5):297-302, http://dx.doi.org/10.1016/S1473-3099(06) 70465-0.",OADS,/arxiv_data1/oa_pdf/c0/f6/cln-68-10-1299.PMC3798712.pdf
"2012;32(S1):33-8, http://dx.doi.org/10.1179/2046904712Z.00000000052.Classifications of dengue cases in Brazil Lima FR et al.CLINICS 2013;68(10):1299-1304 1304",Non-OADS,/arxiv_data1/oa_pdf/c0/f6/cln-68-10-1299.PMC3798712.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fe/9d/ket219.PMC3798713.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e9/03/ket262.PMC3798714.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d2/bd/ket265.PMC3798715.pdf
"2000. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp (1 December 2012, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/d2/bd/ket265.PMC3798715.pdf
"1In Norway, a steady decline in daily smoking has been observed since the mid-1990s and today17% of the adult population smoke on a daily or occasional basis (http://www.ssb.no/royk/).",Non-OADS,/arxiv_data1/oa_pdf/3c/06/ejhg201326a.PMC3798835.pdf
Data from Statistics Norway (http://www.ssb.no/royk/) show that around 8% of the adult population use snus on a daily or occasional basis.,OADS,/arxiv_data1/oa_pdf/3c/06/ejhg201326a.PMC3798835.pdf
"3 Global Initiative for Chronic Obstructive Lung Disease: Global strategy for the diagnosis, management, and prevention of COPD: updated 2010. http://www.goldcopd.",Non-OADS,/arxiv_data1/oa_pdf/3c/06/ejhg201326a.PMC3798835.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/CHRNA5 gene polymorphism and nicotine dependence ME Gabrielsen et al 1299 European Journal of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/3c/06/ejhg201326a.PMC3798835.pdf
"MATERIALS AND METHODS This article is the output from a Best Practice meeting on deafness caused by mutations at the DFNB1 locus, organised by the European Molecular Genetics Quality Network (EMQN; http://www.emqn.org.uk).",Non-OADS,/arxiv_data1/oa_pdf/42/0a/ejhg201383a.PMC3798855.pdf
T esting should only be performedin laboratories that are accredited according to ISO15189 or the equivalent (see the Organisation for Economic Cooperation and Development (OECD) Guidelines (http://www.oecd.org/science/biotechnologypolicies/38839788.pdf).,Non-OADS,/arxiv_data1/oa_pdf/42/0a/ejhg201383a.PMC3798855.pdf
The meeting was advertised on the EMQN and EuroGentest websites (http://www.eurogentest.org); it was organised by the EMQN team responsible for the DFNB1 EQA scheme and attended by 15 clinical and scientiﬁc experts named in the Acknowledgements.,Non-OADS,/arxiv_data1/oa_pdf/42/0a/ejhg201383a.PMC3798855.pdf
"Guidelines already exist, for example, those of the OECD (http://www.oecd.org/science/biotech- nologypolicies/38839788.pdf), the Swiss Society of Medical Genetics(http://www.sgmg.ch), and the UK Clinical Molecular Genetics Society (www.cmgs.org); however, the following relates speciﬁcally to deafness caused by mutations at the DFNB1 locus.",Non-OADS,/arxiv_data1/oa_pdf/42/0a/ejhg201383a.PMC3798855.pdf
(http://www.hgvs.org/mutnomen/).,Non-OADS,/arxiv_data1/oa_pdf/42/0a/ejhg201383a.PMC3798855.pdf
"There is considerable difﬁculty, however, in using HGVS for the well-known deletions including those found in the GJB6 gene (http://www.hgvs.org/mutnomen/uncertain.html#exondel).",Non-OADS,/arxiv_data1/oa_pdf/42/0a/ejhg201383a.PMC3798855.pdf
"In laboratory reports, an interpretation should be made as to thepredicted functional effect of the variant, following the guidelines ofthe Clinical Molecular Genetics Society (http://cmgs.org/).",Non-OADS,/arxiv_data1/oa_pdf/42/0a/ejhg201383a.PMC3798855.pdf
"London .The dataset contains about 5% samples of human trips by Tube in London, which were captured by Oyster cards during a week in November 2009 (availableonline at http://www.tfl.gov.uk/businessandpartners/syndication/).",OADS,/arxiv_data1/oa_pdf/c4/29/srep02983.PMC3798880.pdf
Chicago .The dataset used here comes from the household travel tracker survey in Chicago Metropolitan areas conducted by Chicago Metropolitan Agency for Planning from January 2007 to February 2008 (available online at http://www.cmap.,OADS,/arxiv_data1/oa_pdf/c4/29/srep02983.PMC3798880.pdf
"Los angeles .The Post-Census Regional Household Travel Survey, sponsored by the Southern California Association of Governments in 2001, was aimed to investigatehuman travel behavior in the Los Angeles region of California (available online athttp://www.scag.ca.gov/travelsurvey/).",Non-OADS,/arxiv_data1/oa_pdf/c4/29/srep02983.PMC3798880.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.How to cite this article: Liang, X., Zhao, J.C., Dong, L. & Xu, K. Unraveling the origin of exponential law in intra-urban human mobility.",Non-OADS,/arxiv_data1/oa_pdf/c4/29/srep02983.PMC3798880.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2983 | DOI: 10.1038/srep02983 7",Non-OADS,/arxiv_data1/oa_pdf/c4/29/srep02983.PMC3798880.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/99/0c/srep02986.PMC3798881.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2986 | DOI: 10.1038/srep02986 6",Non-OADS,/arxiv_data1/oa_pdf/99/0c/srep02986.PMC3798881.pdf
"Determination of the characteristic limits (decision threshold, detection limit and limits of the confidence interval) for measurements of ionizing radiation — Fundamentals and application, ,https://www.iso.org/obp/ui/#iso:std:iso:11929:ed-1:v1:en .",Non-OADS,/arxiv_data1/oa_pdf/e2/c4/srep02988.PMC3798882.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2988 | DOI: 10.1038/srep02988 5",Non-OADS,/arxiv_data1/oa_pdf/e2/c4/srep02988.PMC3798882.pdf
http://www.osdd.net.,Non-OADS,/arxiv_data1/oa_pdf/fd/9f/srep02987.PMC3798883.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/fd/9f/srep02987.PMC3798883.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2987 | DOI: 10.1038/srep02987 7",Non-OADS,/arxiv_data1/oa_pdf/fd/9f/srep02987.PMC3798883.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/aa/79/srep02982.PMC3798884.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2982 | DOI: 10.1038/srep02982 5",Non-OADS,/arxiv_data1/oa_pdf/aa/79/srep02982.PMC3798884.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/9f/db/srep02980.PMC3798885.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2980 | DOI: 10.1038/srep02980 9",Non-OADS,/arxiv_data1/oa_pdf/9f/db/srep02980.PMC3798885.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/db/bf/srep02381.PMC3798886.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2381 | DOI: 10.1038/srep02381 6",Non-OADS,/arxiv_data1/oa_pdf/db/bf/srep02381.PMC3798886.pdf
org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Natural history of breast cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.471 2043,Non-OADS,/arxiv_data1/oa_pdf/9f/20/bjc2013471a.PMC3798948.pdf
"http://ncrndev.org.uk/downloads/MiscDocs/NCRI_NCRN_Decade_Web.pdf Seow H-Y, Whelan P, Levine MN, Cowan K, Lysakoswki B, Kowasleski B, Snider A, Xu RY, Arnold A (2012) Funding oncology clinical trials: are Cooperative Group trials sustainable?",Non-OADS,/arxiv_data1/oa_pdf/96/1b/bjc2013495a.PMC3798949.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)LOX in tumour endothelium BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.535 2247,Non-OADS,/arxiv_data1/oa_pdf/9c/de/bjc2013535a.PMC3798951.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)EpCAM signalling in gastric cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.536 2227,Non-OADS,/arxiv_data1/oa_pdf/cd/fc/bjc2013536a.PMC3798952.pdf
"Prostate cancer is the second most common cancer diagnosed in men globally, accounting for 13.6% of all cancer cases in men worldwide (http://globocan.iarc.fr) in 2008.",Non-OADS,/arxiv_data1/oa_pdf/61/8a/bjc2013537a.PMC3798953.pdf
"In the United States, the National Cancer Institute (NCI) estimates that 241 740 men will have been diagnosed with and 28 170 men will have died of cancer of the prostate during 2012 (http://seer.cancer.gov).",Non-OADS,/arxiv_data1/oa_pdf/61/8a/bjc2013537a.PMC3798953.pdf
org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)EL102 pre-clinical anti-prostate cancer activity BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.537 2141,Non-OADS,/arxiv_data1/oa_pdf/61/8a/bjc2013537a.PMC3798953.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER HOTAIR exhibits oncogenic activity in ESCC 2278 www.bjcancer.com | DOI:10.1038/bjc.2013.548,Non-OADS,/arxiv_data1/oa_pdf/9b/47/bjc2013548a.PMC3798955.pdf
Animal experiments were performed according to protocols approved by the National Animal Research Authority in compliance with the European Convention of the Protection of Vertebrates Used for Scientific Purposes (approval ID1499 and 3275; http://www.fdu.no/).,Non-OADS,/arxiv_data1/oa_pdf/8d/b1/bjc2013549a.PMC3798956.pdf
"The functional annotation tool of DAVID (Database for Annotation, Visualization and Integrated Discovery, http://david.abcc.ncifcrf.- gov/home.jsp) was used for functional enrichment analysis of the gene lists, using the DAVID default population background for Homo sapiens .",OADS,/arxiv_data1/oa_pdf/8d/b1/bjc2013549a.PMC3798956.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Phenotype profiling of osteosarcoma cell lines 2236 www.bjcancer.com | DOI:10.1038/bjc.2013.549,Non-OADS,/arxiv_data1/oa_pdf/8d/b1/bjc2013549a.PMC3798956.pdf
"Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Immune responses, senescence and survival in CRC 2216 www.bjcancer.com | DOI:10.1038/bjc.2013.556",Non-OADS,/arxiv_data1/oa_pdf/12/9d/bjc2013556a.PMC3798960.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER PICT1 inTP53 wild-type gastric cancer 2206 www.bjcancer.com | DOI:10.1038/bjc.2013.561,Non-OADS,/arxiv_data1/oa_pdf/48/2e/bjc2013561a.PMC3798961.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER MiR-100/99a in acute lymphoblastic leukaemia 2198 www.bjcancer.com | DOI:10.1038/bjc.2013.562,Non-OADS,/arxiv_data1/oa_pdf/ae/c5/bjc2013562a.PMC3798962.pdf
National Cancer Intelligence Network (2011) National Cancer Data Repository http://www.ncin.org.uk/collecting_and_using_data/national_cancer_data_repository/default.aspx.,Non-OADS,/arxiv_data1/oa_pdf/9b/07/bjc2013569a.PMC3798965.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Emergency Presentation 2034 www.bjcancer.com | DOI:10.1038/bjc.2013.569,Non-OADS,/arxiv_data1/oa_pdf/9b/07/bjc2013569a.PMC3798965.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Lymph node in oral cavity cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.570 2095,Non-OADS,/arxiv_data1/oa_pdf/db/69/bjc2013570a.PMC3798966.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER BCG immunotherapy in STn/S6Tþbladder tumours 2114 www.bjcancer.com | DOI:10.1038/bjc.2013.571,Non-OADS,/arxiv_data1/oa_pdf/97/9c/bjc2013571a.PMC3798967.pdf
Available http://www.hqip.org.uk/assets/NCAPOP-Library/Lung-Cancer-NHS-IC-AUDIT-2011.pdf.,Non-OADS,/arxiv_data1/oa_pdf/64/f3/bjc2013572a.PMC3798968.pdf
Available http://www.nice.org.uk/nicemedia/live/13465/54202/54202.pdf.,Non-OADS,/arxiv_data1/oa_pdf/64/f3/bjc2013572a.PMC3798968.pdf
Available http://www.ons.gov.uk/ons/dcp171778_247385.pdf [Accessed 13 December 2011].,Non-OADS,/arxiv_data1/oa_pdf/64/f3/bjc2013572a.PMC3798968.pdf
Available at http://www.ons.gov.uk/ons/rel/cancer-unit/cancer-survival/2005-2009–followed-up-to-2010/summary-cancer-survival-2005-2009–followed-up-to-2010.html.,Non-OADS,/arxiv_data1/oa_pdf/64/f3/bjc2013572a.PMC3798968.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Lung cancer survival in England BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.572 2065,Non-OADS,/arxiv_data1/oa_pdf/64/f3/bjc2013572a.PMC3798968.pdf
"We included 71 PTC cases, diagnosed in the UkrAm cohort between 1998 and 2008 at the Laboratory of Morphology of Endocrine System of the Institute of Endocrinology and Metabolism (IEM, Kiev, Ukraine), that had tumour and/or normal tissue RNA specimens in the CTB (http://www.chernobyltissuebank.com/).",Non-OADS,/arxiv_data1/oa_pdf/36/18/bjc2013574a.PMC3798970.pdf
"Detailed operating procedures for the collection, documenta- tion, and processing of frozen tumour and normal thyroid tissue specimens are available from the CTB website (http://www.chernobyl- tissuebank.com/) and were developed jointly with the Laboratory of Morphology of Endocrine System of the IEM and the Wales Cancer Bank.",Non-OADS,/arxiv_data1/oa_pdf/36/18/bjc2013574a.PMC3798970.pdf
Full details of RNA extraction can be obtained from the CTB website (http://www.chernobyltissuebank.com/).,Non-OADS,/arxiv_data1/oa_pdf/36/18/bjc2013574a.PMC3798970.pdf
pathway software (http://www.pantherdb.org/) that group genes with similar biological function based on their annotation.,OADS,/arxiv_data1/oa_pdf/36/18/bjc2013574a.PMC3798970.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER I-131 dose and gene expression 2294 www.bjcancer.com | DOI:10.1038/bjc.2013.574,Non-OADS,/arxiv_data1/oa_pdf/36/18/bjc2013574a.PMC3798970.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)ERCC1 is prognostic in head and neck cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.576 2105,Non-OADS,/arxiv_data1/oa_pdf/df/6f/bjc2013576a.PMC3798971.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Combination immunotherapy with EGFR inhibitors 2166 www.bjcancer.com | DOI:10.1038/bjc.2013.577,Non-OADS,/arxiv_data1/oa_pdf/0e/c0/bjc2013577a.PMC3798972.pdf
"For cluster and gene ontology (GO) analyses, we used the Cytoscapeplatform for network analysis (www.cytoscape.org), using the plug- ins CluterONE version 0.91 (http://chianti.ucsd.edu/cyto_web/ plugins/) for the clustering of proteins and BINGO version 2.44 (http://www.psb.ugent.be/cbd/papers/BiNGO/) for the analysis of GO annotations of biological processes associated with our obtained protein networks.",OADS,/arxiv_data1/oa_pdf/2e/fc/bjc2013578a.PMC3798973.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER EPHA2 as receptor for targeted drug delivery to OS 2154 www.bjcancer.com | DOI:10.1038/bjc.2013.578,Non-OADS,/arxiv_data1/oa_pdf/2e/fc/bjc2013578a.PMC3798973.pdf
"Densitometry of bands were determined using the public domain ImageJ (version 1.38) from the National Institute of Health available on the Internet at http://rsbweb.nih.gov/ij.GGH, TS and DHFR enzyme activity assays.",OADS,/arxiv_data1/oa_pdf/14/26/bjc2013579a.PMC3798974.pdf
"Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Folate, GGH and cancer chemosensitivity 2188 www.bjcancer.com | DOI:10.1038/bjc.2013.579",Non-OADS,/arxiv_data1/oa_pdf/14/26/bjc2013579a.PMC3798974.pdf
Prostate cancer is the leading male cancer in the United Kingdom and a principal cause of cancer-related mortality (http://www.info.,Non-OADS,/arxiv_data1/oa_pdf/0e/51/bjc2013589a.PMC3798976.pdf
The specific criteria are defined in the UK National Institute for Clinical Excellence guidelines (due to be updated in the next year) (http://www.guidance.nice.org.uk/ CG58/Guidance/pdf/English).,Non-OADS,/arxiv_data1/oa_pdf/0e/51/bjc2013589a.PMC3798976.pdf
"Report by the Controller and Audito r General, http://www.nao.org.",Non-OADS,/arxiv_data1/oa_pdf/0e/51/bjc2013589a.PMC3798976.pdf
Available at http://www.nao.org.uk/wp-content/uploads/2010/11/1011568.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0e/51/bjc2013589a.PMC3798976.pdf
Available  from:  https://www.scsadiagnostics.com/home     25.,Non-OADS,/arxiv_data1/oa_pdf/40/34/JRI-14-120.PMC3799268.pdf
2007 Jun [cited 2012 Dec];  Available from: http://www.mariestopes.org.uk/  documents/UK%20Abortion%20Statistics%20200 6.pdf    17.,OADS,/arxiv_data1/oa_pdf/89/08/JRI-14-143.PMC3799272.pdf
Available  from: http://www.ncbi.nlm.nih.gov/pmc/    2.,Non-OADS,/arxiv_data1/oa_pdf/90/6d/JRI-14-95.PMC3799274.pdf
3Corresponding author E-mail pare@andromeda.rutgers.eduArticle is online at http://www.learnmem.org/cgi/doi/10.,Non-OADS,/arxiv_data1/oa_pdf/bb/f9/HauflerLM031799.PMC3799415.pdf
It is also noteworthythat neuroimaging studies associating the hippocampus with scene construction identify not only the hippocampus but also a number of other brain regions belonging to an extended 10Corresponding author E-mail lsquire@ucsd.eduArticle is online at http://www.learnmem.org/cgi/doi/10.,Non-OADS,/arxiv_data1/oa_pdf/9e/35/KimLM031633.PMC3799416.pdf
(Gold and Squire 7Corresponding author E-mail lsquire@ucsd.eduArticle is online at http://www.learnmem.org/cgi/doi/10.,Non-OADS,/arxiv_data1/oa_pdf/cb/b3/KnutsonLM032490.PMC3799417.pdf
"2000; Chudasama and Robbins 2004), as 1Corresponding author E-mail matzel@rci.rutgers.eduArticle is online at http://www.learnmem.org/cgi/doi/10.",Non-OADS,/arxiv_data1/oa_pdf/4f/23/WassLM031971.PMC3799419.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d9/ef/gkt640.PMC3799425.pdf
"For VIGS target regions, two unique stretchesof 250–350 nt for each N. tabacum sequence were selected, which returned only a single hit on submission to siRNAScan (http://bioinfo2.noble.org/RNAiScan.htm).",OADS,/arxiv_data1/oa_pdf/d9/ef/gkt640.PMC3799425.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/64/af/gkt648.PMC3799427.pdf
"Non-synonymous single-nucleotide mutations in the hTERT gene occur at /C245% frequency; 44 different non- synonymous mutations have been identiﬁed in the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu) as of January 2013, and this number will grow quicklyas the cost of genome sequencing continues to plummet.",Non-OADS,/arxiv_data1/oa_pdf/04/57/gkt653.PMC3799428.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/04/57/gkt653.PMC3799428.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d0/5f/gkt662.PMC3799432.pdf
protein-fold recognition server (http://www.sbg.bio.ic.ac.,Non-OADS,/arxiv_data1/oa_pdf/d0/5f/gkt662.PMC3799432.pdf
"Interestingly, a squamous cell lung cancer sample in the Catalogue of Somatic Mutations in Cancer database possesses a W948L missense mutation within the ﬁrst BAHdomain of BAF180 (the mutation data were obtained fromthe Sanger Institute Catalogue Of Somatic Mutations In Cancer web site, http://www.sanger.ac.uk/cosmic) (44).",Non-OADS,/arxiv_data1/oa_pdf/d0/5f/gkt662.PMC3799432.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a2/60/gkt663.PMC3799433.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ca/19/gkt670.PMC3799437.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/07/ea/gkt673.PMC3799439.pdf
There are >100 structur- ally distinct ribonucleosides that have been identiﬁed in allthree domains of life (http://rna-mdb.cas.albany.edu/ RNAmods/ (2).,OADS,/arxiv_data1/oa_pdf/90/7b/gkt679.PMC3799443.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/90/7b/gkt679.PMC3799443.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c7/95/gkt681.PMC3799444.pdf
"The different conformations of the studied residues, motifs and domains in the X family polymerases were analysed with the software MacPymol (http://delsci.com/macpymol/).",OADS,/arxiv_data1/oa_pdf/c7/95/gkt681.PMC3799444.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6e/9d/gkt685.PMC3799445.pdf
"We downloaded the following ﬁles from http://test.mirz.unibas.ch/smirnaWeb/geneBio/ smiRNA/temp/10544043421949953483/samples in the fol- lowing subfolders (October, 2011): AGO1: /230/mapped_sequences, /230/genome_mappings AGO2: /238/mapped_sequences, /238/genome_mappingsAGO3: /239/mapped_sequences, /239/genome_mappings AGO4: /240/mapped_sequences, /240/genome_mappings The numbers of mononucleotide repeats bound by Ago proteins are listed in Supplementary Table S2.",OADS,/arxiv_data1/oa_pdf/6e/9d/gkt685.PMC3799445.pdf
"The list of housekeeping genes was downloadedfrom http://www.compugen.co.il/supp_info/Housekeeping_ genes.html (October, 2011).",OADS,/arxiv_data1/oa_pdf/6e/9d/gkt685.PMC3799445.pdf
"The list of tissue-speciﬁc genes was downloaded from http://bioinfo.wilmer.jhu.edu/tiger/ download/ref2tissue-Table.txt (October, 2011).",OADS,/arxiv_data1/oa_pdf/6e/9d/gkt685.PMC3799445.pdf
"Nobel Media AB 2013. http://www.nobelprize.org (23 July 2013, datelast accessed).",Non-OADS,/arxiv_data1/oa_pdf/6e/9d/gkt685.PMC3799445.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c1/09/gkt691.PMC3799448.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/20/24/gkt695.PMC3799450.pdf
"Telomerase puriﬁcation For telomerase overexpression, Human Embyronic Kidney (HEK) 293E cells were grown in suspensionculture and transiently transfected with pcDNA6-ZZ- 3xFLAG-hTERT and pBS-U1-hTR at the Protein Expression Core Facility of EPFL (http://pecf.epﬂ.ch/).",Non-OADS,/arxiv_data1/oa_pdf/20/24/gkt695.PMC3799450.pdf
RNA chromatin immunoprecipitations RNA chromatin immunoprecipitations (RNA-ChIP) assays were performed as described (http://www.protocol-online.org/cgi-bin/prot/view_cache.cgi?ID=3241)with minor modiﬁcations.,OADS,/arxiv_data1/oa_pdf/20/24/gkt695.PMC3799450.pdf
"ACKNOWLEDGEMENTS The authors thank Claus Azzalin, Sascha Feuerhahn and Antonio Porro for discussion and Sarah Turnheer and David Hacker from the protein expression core facilityat EPFL (http://pecf.epﬂ.ch/) for the expression of telomerase.",Non-OADS,/arxiv_data1/oa_pdf/20/24/gkt695.PMC3799450.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/74/ab/gkt706.PMC3799453.pdf
CEAS Web-based CEAS analysis (http://ceas.cbi.pku.edu.cn/ index.html) was performed on a publicly available PRChIP–Chip data set (http://cistrome.org/NR_Cistrome/Cistrome.html).,OADS,/arxiv_data1/oa_pdf/74/ab/gkt706.PMC3799453.pdf
"To determine the role of STAT5 in coregulating phospho-Ser81 PR-B-dependent transcription, we analyzed a publicly available (http://cistrome.org/Cistrome/ Cistrome_Project.html) PR chromatin immunoprecip-itation ChIP–chip data set for the presence of STAT5 binding sites within or nearby PR binding sites.",OADS,/arxiv_data1/oa_pdf/74/ab/gkt706.PMC3799453.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c8/d5/gkt710.PMC3799454.pdf
Scanned images were quantiﬁed using Image J (http://rsbweb.nih.gov/ij).,OADS,/arxiv_data1/oa_pdf/c8/d5/gkt710.PMC3799454.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ba/2e/gkt723.PMC3799457.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6b/66/gkt745.PMC3799458.pdf
"All predicted chromatin structures in this work, the source code and web service of this method are availableat http://ibi.hzau.edu.cn/3dmodel/.",OADS,/arxiv_data1/oa_pdf/6b/66/gkt745.PMC3799458.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c4/68/gkt753.PMC3799459.pdf
"Availability and implementation: Source code, binaries for Linux and MacOSX, and an interactive web server are available at http://swissmodel.expasy.org/lddt Contact: torsten.schwede@unibas.ch Supplementary information : Supplementary data are available at Bioinformatics online.",OADS,/arxiv_data1/oa_pdf/87/99/btt473.PMC3799472.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/87/99/btt473.PMC3799472.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/99/fb/btt489.PMC3799481.pdf
"A server performing piET calculations is available atour site: http://mammoth.bcm.tmc.edu/uet.ACKNOWLEDGEMENT The authors thank Panagiotis Katsonis, Andreas M. Lisewskiand Ilya Novikov for helpful discussion.",Non-OADS,/arxiv_data1/oa_pdf/99/fb/btt489.PMC3799481.pdf
"SUPPLEMENTARY MATERIAL Supplementary material is linked to the online version of the paper at http://www.nature.com/jid REFERENCES Akiyama T, Tominaga M, Davoodi A et al.",Non-OADS,/arxiv_data1/oa_pdf/a7/17/jid2013194a.PMC3800262.pdf
Tech Corner IASP Newsletter; availabel at: http://www.iasp-pain.org/AM/Template.cfm?,Non-OADS,/arxiv_data1/oa_pdf/a7/17/jid2013194a.PMC3800262.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/9a/45/IJNM-28-105.PMC3800303.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/9a/45/IJNM-28-105.PMC3800303.pdf
The application can be downloaded  from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/9c/3a/IJNM-28-108.PMC3800304.pdf
The application can be downloaded  from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/22/dc/IJNM-28-119.PMC3800308.pdf
Available from: http://www.rertr.anl.,Non-OADS,/arxiv_data1/oa_pdf/9d/6b/IJNM-28-70.PMC3800314.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/01/7c/IJNM-28-99.PMC3800320.pdf
Available from: http://www.isaweb.in.,Non-OADS,/arxiv_data1/oa_pdf/36/bc/IJA-57-334.PMC3800322.pdf
Available from: http://www.medin.nic.in.,Non-OADS,/arxiv_data1/oa_pdf/36/bc/IJA-57-334.PMC3800322.pdf
Available from: http://www.webmd.com/parenting/rectal-ear-oral-and-axillary-temperature-comparison [Accessed on 2012 Dec 1].,Non-OADS,/arxiv_data1/oa_pdf/b6/01/IJA-57-377.PMC3800330.pdf
Available from: http://www.ebmedicine.net.,Non-OADS,/arxiv_data1/oa_pdf/b6/01/IJA-57-377.PMC3800330.pdf
"Source of Support:  Nil, Conflict of Interest:  None declared Conference Calendar Details Name of the conference: 2nd OFISACON 2013 Date: 14th and 15th September 2013 Venue: Giridhar Eye Institute, Cochin, Kerala, India Organising Secretary:  Dr. Pushpa Susan Isaac Contact: +91 98472 66933 E-mail: ofisacon2013@gmail.com Name of the conference: KISACON 2013 – Karnataka State Conference - 2013 Date: 13th to 15th September 2013 Venue: Raja Rajeswari Medical College, Bangalore, Karnataka, IndiaOrganising Secretary:  Dr. Rangalakshmi Contact: +91 99867 97987 E-mail: kisacon2013@gmail.com Name of the conference: RFISA - 2013 - The 19 th Annual Conference of Railway  Forum of ISA Date: 21st and 22nd September 2013 Venue: Mysore, Karnataka, IndiaOrganising Secretary:  Dr. P R Anitha Contact: +91 97316 67507 E-mail: drrani22@yahoo.com Name of the conference: WISACON - RAJISCON - 2013 Date: 27 th to 29th September 2013 Venue: Department of Anaesthesiology, RNT Medical College, Udaipur,  Rajasthan, India Organising Secretary:  Dr. Lalit Kumar Raiger Contact: +91 94143 52823 E-mail: drlalitkumar@hotmail.com Name of the conference: North Zone Conference - 14th NZISACON 2013 Date: 27th to 29th September 2013 Venue: Department of Anaesthesia & Critical Care MMIMSR, Mullana, Ambala,  Haryana, India Organising Secretary:  Dr. J R Thakur Contact: +91 80599 31422E-mail: organizingsecretary@nzisacon2013.orgWebsite: http://www.nzisacon2013.com Name of the conference: East Zone Conference, ISAJAC – 2013, 23 rd Joint Annual  Conference & 34  Annual State Conferene of ISA West Bengal State Branch Date: 27th and 28th September 2013 Venue: Tata Medical Centre, B. M. Birla Heart Research Centre, Eastern  Command Hospital & IPGMER, Kolkata, West Bengal, India.",Non-OADS,/arxiv_data1/oa_pdf/8b/52/IJA-57-381.PMC3800331.pdf
"Organising Secretary:  Dr. Subir Banerjee Contact: +91 98302 76975 E-mail: drsubirbanerjee@gmail.com Name of the conference: 6th National Conference AOA 2013 Date: 4th to 6th October 2013 Venue: Dr. TMA Pai International Conventional Centre, Mangalore, Karnataka, India Organising Secretary:  Dr. Jesni Joseph Manissery Contact: +91 93423 25084 E-mail: aoa2013mangalore@gmail.com Website: http://www.aoa2013mangalore.com Name of the conference: ISAAPCON - 2013 Date: 25th to 27th October 2013 Venue: Mamatha Medical College, Khammam Organising Secretary:  Dr. Badam Kishan Rao Contact: +91 98661 81161 E-mail: kishanraobadam@yahoo.co.inName of the conference: 37th Annual State Conference - Kerala Date: 25th to 27th October 2013 Venue: Shifta Convention Centre, Malappuram, Kerala, India Organising Secretary:  Dr. Mohamed Abdul Nazar Contact: +91 09400 627481E-mail: ekmanazar@gmail.com Name of the conference: BJSAC 2013 Date: 26 th and 27th October 2013 Venue: Katihar Medical College Organising Secretary:  Dr. Ashutosh Kumar Jha Contact: +91 94312 28657E-mail: bjsac2013@gmail.com Name of the conference: ICA CON - 2013 Date: 23 rd and 24th November 2013 Venue: Bhopal Memorial Hospital & Research Centre Organising Secretary:  Dr. Anurag Yadava Contact: +91 94250 12102E-mail: icacon2013@gmail.com Name of the conference: 61 st Annual National Conference of the Indian  Society of Anaesthesiologists, ISACON 2013 Date: 26th to 29th December 2013 Venue: Gauhati Medical College, Assam, Inida Organising Secretary:  Dr. Rajib Kr.",Non-OADS,/arxiv_data1/oa_pdf/8b/52/IJA-57-381.PMC3800331.pdf
Available from: http://www.pedsanesthesia.org/meetings/2005winter/man/2005%20P22_Kang.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e4/c1/IJA-57-387.PMC3800332.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/e4/c1/IJA-57-387.PMC3800332.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/b5/2f/IJA-57-397.PMC3800335.pdf
"Source of Support:  Nil, Conflict of Interest:  None declared Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.",Non-OADS,/arxiv_data1/oa_pdf/64/ed/IJA-57-401.PMC3800336.pdf
"National Institute for Health and Clinical Excellence, The Management of Hip Fracture in Adults, National Institute for Health and Clinical Excellence, 2011, http://www.nice.org.uk/cg124.",Non-OADS,/arxiv_data1/oa_pdf/42/f7/IJA-57-408.PMC3800339.pdf
British  Orthopaedic Association; 2008. http://www.boa.ac.uk/LIB/LIBPUB/Documents/BOAST%201%20-%20Hip%20Fracture%20in%20 the%20Older%20Person%20Version%20 1%20-%202008.pdf.,Non-OADS,/arxiv_data1/oa_pdf/42/f7/IJA-57-408.PMC3800339.pdf
"National Institute for Health and Clinical Excellence, The Management of Hip Fracture in Adults, National Institute for Health and Clinical Excellence, 2011, http://www.nice.org.uk/cg124.",Non-OADS,/arxiv_data1/oa_pdf/b5/82/IJA-57-410.PMC3800340.pdf
British  Orthopaedic Association; 2008. http://www.boa.ac.uk/LIB/LIBPUB/Documents/BOAST%201%20-%20Hip%20Fracture%20in%20 the%20Older%20Person%20Version%20 1%20-%202008.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b5/82/IJA-57-410.PMC3800340.pdf
Available from: http://www.health.vic.gov.au/clinrisk [Last accessed on 2013 Mar 20].,Non-OADS,/arxiv_data1/oa_pdf/a7/a0/IJA-57-422.PMC3800346.pdf
Available  from: http://www.ha.org.hk/haho/ho/psrm/SESUE _Annual_ Report_2011.pdf [Last accessed on 2013 Mar 20].,OADS,/arxiv_data1/oa_pdf/a7/a0/IJA-57-422.PMC3800346.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/7a/76/NJMS-4-40.PMC3800383.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/7a/76/NJMS-4-40.PMC3800383.pdf
The application can be downloaded  from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/a9/51/NJMS-4-87.PMC3800393.pdf
The application can be downloaded  from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/98/22/NJMS-4-90.PMC3800394.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/51/80/NJMS-4-94.PMC3800395.pdf
"4: 323-326 pISSN 2005-9159  eISSN 2093-0569http://dx.doi.org/10.3344/kjp.2013.26.4.323 |E d i t o r i a l| A New Approach to Neuroplasty Department of Anesthesiology and Pain Medicine, University of Ulsan College of Medicine,  Asan Medical Center, Seoul, Korea Jin Woo Shin, MD Received August 29, 2013.",Non-OADS,/arxiv_data1/oa_pdf/70/a1/kjpain-26-323.PMC3800703.pdf
4: 327-335 pISSN 2005-9159  eISSN 2093-0569http://dx.doi.org/10.3344/kjp.2013.26.4.327 | Review Article | Should We Start Treating Chronic Low Back Pain with  Antibiotics Rather than with Pain Medications?,Non-OADS,/arxiv_data1/oa_pdf/7e/44/kjpain-26-327.PMC3800704.pdf
4: 336-346 pISSN 2005-9159  eISSN 2093-0569http://dx.doi.org/10.3344/kjp.2013.26.4.336 | Review Article | Role of Catheter ’s Position for Final Results  in Intrathecal Drug Delivery.,Non-OADS,/arxiv_data1/oa_pdf/49/f4/kjpain-26-336.PMC3800705.pdf
"4: 347-355 pISSN 2005-9159  eISSN 2093-0569http://dx.doi.org/10.3344/kjp.2013.26.4.347 | Review Article | An Insight Into Neurophysiology of Pulpal Pain:  Facts and Hypotheses Departments of Conservative Dentistry & Endodontics, *Orthodontics & Dentofacial Othopaedics,  Hitkarni Dental College & Hospital, Jabalpur, †Department of Conservative Dentistry & Endodontics,  V .S Dental College & Hospital, Bangalore, India Niharika Jain, MDS, Abhishek Gupta, MDS*, and Meena N., MDS† Pain and pain control are important to the dental profession because the general perception of the public  is that dental treatment and pain go hand in hand.",Non-OADS,/arxiv_data1/oa_pdf/e5/94/kjpain-26-347.PMC3800706.pdf
"4: 356-360 pISSN 2005-9159  eISSN 2093-0569http://dx.doi.org/10.3344/kjp.2013.26.4.356 | Original Article | The Effect of Urinary Trypsin Inhibitor Against  Neuropathic Pain in Rat Models Department of Anesthesiology and Pain Medicine, Chosun University School of Medicine,   *Medical School, Chonnam National University, Gwangju, Korea Ki Tae Jung, MD, Hyun Young Lee, MD, Myung Ha Yoon, MD*, and Ky ung Joon Lim, MD Background:  Nerve injury sometimes leads to chronic neuropathic pain associated with neuroinflammation in the nervous  system.",Non-OADS,/arxiv_data1/oa_pdf/07/05/kjpain-26-356.PMC3800707.pdf
"4: 361-367 pISSN 2005-9159  eISSN 2093-0569http://dx.doi.org/10.3344/kjp.2013.26.4.361 | Original Article | The Analgesic Effect of Nefopam with Fentanyl  at the End of Laparoscopic Cholecystectomy D e p a r t m e n t  o f  A n e s t h e s i o l o g y  a n d  P a i n  M e d i c i n e ,  S c h o o l  o f  M e d i c i n e ,  W o n k w a n g  U n i v e r s i t y ,  I k s a n ,  K o r e a Ju Hwan Lee, MD, Jae Hong Kim, MD, and Yong Kwan Cheong, MD Background:  Nefopam is a centrally acting analgesic that is used to control pain.",Non-OADS,/arxiv_data1/oa_pdf/6e/1a/kjpain-26-361.PMC3800708.pdf
"4: 368-373 pISSN 2005-9159  eISSN 2093-0569http://dx.doi.org/10.3344/kjp.2013.26.4.368 | Original Article | Bertolotti Syndrome: A Diagnostic and  Management Dilemma for Pain Physicians Departments of Anesthesia, *Nuclear Medicine,  Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India Anuj Jain, MD, Anil Agarwal, MD, Suruchi Jain, MD*, and Chetna Shamshery, MD Background:  Bertolotti’s syndrome (BS), a form of lumbago in lumbosacral transitional vertebrae, is an important cause  of low back pain in young patients.",Non-OADS,/arxiv_data1/oa_pdf/f1/44/kjpain-26-368.PMC3800709.pdf
"4: 374-378 pISSN 2005-9159  eISSN 2093-0569http://dx.doi.org/10.3344/kjp.2013.26.4.374 | Original Article | The Effect of Ultrasound-guided TAPB on Pain Management  after Total Abdominal Hysterectomy Department of Anesthesiology and Pain Medicine, Amiralmomenin Hospital,  *Anesthesiology and Pain Department, Rasoul-Akram Hospital,  †Genycology Department, Rasoul-Akram Hospital, ‡Minimally Invasive Surgery Research Centre,  T ehran University of Medical Sciences, T ehran, Islamic Republic of Iran  Helen Gharaei, MD, FIPP , Farnad Imani, MD*, Fariba Almasi, MD†, and Massoud Solimani, MD‡ Background: Incisional pain is particularly troublesome after hysterectomy.",Non-OADS,/arxiv_data1/oa_pdf/ac/7b/kjpain-26-374.PMC3800710.pdf
"4: 379-386 pISSN 2005-9159  eISSN 2093-0569http://dx.doi.org/10.3344/kjp.2013.26.4.379 | Original Article | Intrathecal Meperidine Plus Lidocaine for Prevention of  Shivering during Cesarean Section Departments of Anaeasthesiology, *Student Research Committee, Jahrom University of Medical Sciences, Jahrom,  †Department of Obstetrics and Gynecology, Shiraz University of Medical Sciences, Shiraz, Iran Ahmad Rastegarian, MD, Mohamed Amin Ghobadifar, MD*,  Hossein Kargar, MD*, and Zahra Mosallanezhad, MD† Background:  Shivering related to spinal anesthesia may interfere wi th monitoring and is uncomfortable.",Non-OADS,/arxiv_data1/oa_pdf/7a/0d/kjpain-26-379.PMC3800711.pdf
"4: 387-391 pISSN 2005-9159  eISSN 2093-0569http://dx.doi.org/10.3344/kjp.2013.26.4.387 |C a s e  R e p o r t| Diagnosis of Iliotibial Band Friction Syndrome and  Ultrasound Guided Steroid Injection  Department of Anesthesiology and Pain Medicine, Keimyung University School of Medicine, Daegu, Korea J i  H e e  H o n g ,  M D ,  a n d  J i  S u b  K i m ,  M D A 64-year-old woman visited our pain clinic with the pain of right lateral side of thigh for one year.",Non-OADS,/arxiv_data1/oa_pdf/43/cd/kjpain-26-387.PMC3800712.pdf
"4: 392-395 pISSN 2005-9159  eISSN 2093-0569http://dx.doi.org/10.3344/kjp.2013.26.4.392 |C a s e  R e p o r t| Approach for Epiduroscopic Laser Neural Decompression  in Case of the Sacral Canal Stenosis Department of Anesthesiology and Pain Medicine, Konyang University Hospital, Daejeon, Korea Dae Hyun Jo, MD, Hun Ju Yang, MD, and Jae Jung Kim, MD E p i d u r o s c o p y  i s  v e r y  u s e f u l  i n  t h e  t r e a t m e n t  o f  n o t  o n l y  l o w  b a c k  p a i n  c a u s e d  b y  f a i l e d  b a c k  s u r g e r y   syndrome, epidural scar or herniated disc but also by chronic refractory low back pain which does not respond  to interventional conservative treatment including fluoroscopically-directed epidural steroid injections and  percutaneous adhesiolysis.",Non-OADS,/arxiv_data1/oa_pdf/23/1e/kjpain-26-392.PMC3800713.pdf
"4: 396-400 pISSN 2005-9159  eISSN 2093-0569http://dx.doi.org/10.3344/kjp.2013.26.4.396 | Brief Report | Computed Tomography (CT) Simulated Fluoroscopy-Guided  Transdiscal Approach in Transcrural Celiac Plexus Block Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Yu Gyeong Kong, MD, Jin Woo Shin , MD, Jeong Gill Leem, MD, and Jeong Hun Suh, MD Conventional transcrural CPB via the “walking off” th e vertebra technique may injure vital organs while  attempting to proximally spread injectate around the celiac plexus.",Non-OADS,/arxiv_data1/oa_pdf/c1/d1/kjpain-26-396.PMC3800714.pdf
"4: 401-405 pISSN 2005-9159  eISSN 2093-0569http://dx.doi.org/10.3344/kjp.2013.26.4.401 | Brief Report | Percutaneous T2 and T3 Radiofrequency Sympathectomy  for Complex Regional Pain Syndrome Secondary  to Brachial Plexus Injury: A Case Series Department of Anesthesiology , Kuching Specialist Hospital, Sarawak, *Department of Medicine, Sarawak  General Hospital, Sarawak, †Department of Anesthesiology, University Science Malaysia Hospital,  Kelantan, Malaysia, ‡The Pain Specialist' Clinic, Mt.",Non-OADS,/arxiv_data1/oa_pdf/97/50/kjpain-26-401.PMC3800715.pdf
"4: 406 pISSN 2005-9159  eISSN 2093-0569http://dx.doi.org/10.3344/kjp.2013.26.4.406 | Letters to Editor | Postoperative Orthostatic Intolerance and Gender Differences Department of Anesthesia and Pain Medicine, Pusan National University School of Medicine, Yangsan, Korea Sang Wook Shin, MD Received September 13, 2013.",Non-OADS,/arxiv_data1/oa_pdf/27/92/kjpain-26-406.PMC3800716.pdf
"4: 407-408 pISSN 2005-9159  eISSN 2093-0569http://dx.doi.org/10.3344/kjp.2013.26.4.407 | Letters to Editor | A Simple Working Classification Proposed for Orofacial  Pain (OFP) Commonly Encountered in Dental Practice Department of Dentistry, Government Taluk Head Quarters Hospital, Nilambur, India  Thorakkal Shamim, MDS Received June 11, 2013.",Non-OADS,/arxiv_data1/oa_pdf/75/0e/kjpain-26-407.PMC3800717.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION  Breast cancer is the most common cancer among women  worldwide [1] and the second most common cancer in Korean  women [2].",Non-OADS,/arxiv_data1/oa_pdf/e9/e6/jbc-16-245.PMC3800720.pdf
"In this article, we review the studies conducted The Korean Hereditary Breast Cancer Study: Review and Future Perspectives Eunyoung Kang, Sung-Won Kim Department of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, KoreaREVIEW ARTICLEJ Breast Cancer 2013 September; 16(3): 245-253  http://dx.doi.org/10.4048/jbc.2013.16.3.245 Most studies related to BRCA  mutations have been performed in  Western populations, and only a few small studies have been  conducted in Korean populations.",Non-OADS,/arxiv_data1/oa_pdf/e9/e6/jbc-16-245.PMC3800720.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.245through the KOHBRA Study over the past 6 years and describe  the future perspectives of the study.,Non-OADS,/arxiv_data1/oa_pdf/e9/e6/jbc-16-245.PMC3800720.pdf
"Review of the KOHBRA Study247 http://dx.doi.org/10.4048/jbc.2013.16.3.245  http://ejbc.krThirty-three and 35 distinct BRCA1  and BRCA2  mutations  were identified in the interim analysis of 831 patients with fa - milial or nonfamilial breast cancer in the KOHBRA Study co - hort, respectively [10].",Non-OADS,/arxiv_data1/oa_pdf/e9/e6/jbc-16-245.PMC3800720.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.245tions of this study included the small number of cases, the  high proportion of probands, the short follow-up period, and  the large CIs.",OADS,/arxiv_data1/oa_pdf/e9/e6/jbc-16-245.PMC3800720.pdf
Review of the KOHBRA Study249 http://dx.doi.org/10.4048/jbc.2013.16.3.245  http://ejbc.krpopulation.,Non-OADS,/arxiv_data1/oa_pdf/e9/e6/jbc-16-245.PMC3800720.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.245second- or third-degree relatives occurred significantly less  frequently, with only 31.3% of participants sharing their re - sults with these family members.",Non-OADS,/arxiv_data1/oa_pdf/e9/e6/jbc-16-245.PMC3800720.pdf
Review of the KOHBRA Study251 http://dx.doi.org/10.4048/jbc.2013.16.3.245  http://ejbc.krsimilar to those of Western populations.,Non-OADS,/arxiv_data1/oa_pdf/e9/e6/jbc-16-245.PMC3800720.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.245tification of the breast cancer susceptibility gene BRCA2.,Non-OADS,/arxiv_data1/oa_pdf/e9/e6/jbc-16-245.PMC3800720.pdf
http://www.nccn.org.,Non-OADS,/arxiv_data1/oa_pdf/e9/e6/jbc-16-245.PMC3800720.pdf
Review of the KOHBRA Study253 http://dx.doi.org/10.4048/jbc.2013.16.3.245  http://ejbc.krlactic mastectomy of asymptomatic BRCA2 mutation carrier: a case re - port.,Non-OADS,/arxiv_data1/oa_pdf/e9/e6/jbc-16-245.PMC3800720.pdf
Epub 2013  Mar 16. http://dx.doi.org/10.1007/s10689-013-9625-z.,Non-OADS,/arxiv_data1/oa_pdf/e9/e6/jbc-16-245.PMC3800720.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Hematological malignancies include lymphoid, myeloid,  and histiocytic/dendritic neoplasms as defined in the most re - cent World Health Organization classification, updated in  2008 [1].",Non-OADS,/arxiv_data1/oa_pdf/17/be/jbc-16-254.PMC3800721.pdf
"The American College  of Radiology recommends an average glandular dose of ≤ 3  mGy for standard screening mammography, and thus, the ef -Lymphoma Affecting the Breast: A Pictorial Review of Multimodal Imaging  Findings Euddeum Shim*, Sung Eun Song*, Bo Kyoung Seo, Y oung-Sik Kim1, Gil Soo Son2 Departments of Radiology, 1Pathology, and 2General Surgery, Korea University Ansan Hospital, Ansan, Korea REVIEW ARTICLEJ Breast Cancer 2013 September; 16(3): 254-265  http://dx.doi.org/10.4048/jbc.2013.16.3.254 Hematological malignancies rarely affect the breast, and the ma - jority of those that do are lymphomas.",Non-OADS,/arxiv_data1/oa_pdf/17/be/jbc-16-254.PMC3800721.pdf
"Imaging of Breast  lymphoma 255 http://dx.doi.org/10.4048/jbc.2013.16.3.254  http://ejbc.krfective radiation dose should be 6 mGy or less for routine,  two-view mammography [6].",Non-OADS,/arxiv_data1/oa_pdf/17/be/jbc-16-254.PMC3800721.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.254Table 1.,Non-OADS,/arxiv_data1/oa_pdf/17/be/jbc-16-254.PMC3800721.pdf
"Imaging of Breast  lymphoma 257 http://dx.doi.org/10.4048/jbc.2013.16.3.254  http://ejbc.krcluding chemotherapy, radiation, bone marrow transplanta - tion, and surgery may be effective in some cases, and ultravio - let light therapy or electron beam radiation is effective for T- cell lymphoma with skin involvement.",Non-OADS,/arxiv_data1/oa_pdf/17/be/jbc-16-254.PMC3800721.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.254Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/17/be/jbc-16-254.PMC3800721.pdf
"Imaging of Breast  lymphoma 259 http://dx.doi.org/10.4048/jbc.2013.16.3.254  http://ejbc.krUS is often more informative (Figures 4, 5), as breast lympho - ma usually appears as a hypoechoic solid mass with circum - scribed or indistinct margins (Figures 1-4) [28,29,33-36].",Non-OADS,/arxiv_data1/oa_pdf/17/be/jbc-16-254.PMC3800721.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.254techniques than mammography for the evaluation of enlarg - ing lymph nodes (Figures 4-6), and CT may be useful for the  evaluation of intrathoracic and extrathoracic lymphadenopa - thy and involvement of the chest wall or lung in lymphoma  patients (Figure 4).",Non-OADS,/arxiv_data1/oa_pdf/17/be/jbc-16-254.PMC3800721.pdf
"Imaging of Breast  lymphoma 261 http://dx.doi.org/10.4048/jbc.2013.16.3.254  http://ejbc.krhas indistinct margins or is spiculated, characteristics that are  somewhat different from those of breast lymphoma.",Non-OADS,/arxiv_data1/oa_pdf/17/be/jbc-16-254.PMC3800721.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.254extremely rare and dilated ducts or fistulas are never associated  with breast lymphoma.,Non-OADS,/arxiv_data1/oa_pdf/17/be/jbc-16-254.PMC3800721.pdf
Imaging of Breast  lymphoma 263 http://dx.doi.org/10.4048/jbc.2013.16.3.254  http://ejbc.krsulting in radiologically similar features.,Non-OADS,/arxiv_data1/oa_pdf/17/be/jbc-16-254.PMC3800721.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.254lymph node on radiological examination.,OADS,/arxiv_data1/oa_pdf/17/be/jbc-16-254.PMC3800721.pdf
http://www.lymphoma.org/atf/cf/%7B0363   CDD6-51B5-427B-BE48-E6AF871ACEC9%7D/T-CELL%20LYM - PHOMAS.PDF .,Non-OADS,/arxiv_data1/oa_pdf/17/be/jbc-16-254.PMC3800721.pdf
Imaging of Breast  lymphoma 265 http://dx.doi.org/10.4048/jbc.2013.16.3.254  http://ejbc.krcell lymphoma: Consortium for Improving Survival of Lymphoma  (CISL) study.,Non-OADS,/arxiv_data1/oa_pdf/17/be/jbc-16-254.PMC3800721.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Radiotherapy (RT) is an important treatment modality in  breast cancer management.",Non-OADS,/arxiv_data1/oa_pdf/c7/a8/jbc-16-266.PMC3800722.pdf
"How -Association of Human Epidermal Growth Factor Receptor 2 with  Radiotherapy Resistance in Patients with T1N0M0 Breast Cancer Hyun-Ah Kim, Eun-Kyu Kim, Min-Soo Kim, Jong-Han Yu1, Mi-Ri Lee2, Hae Kyung Lee3, Y oung-Jin Suh4, Woo Chul Noh,  Korean Breast Cancer Society Department of Surgery, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul; 1Department of Surgery, Asan Medical  Center, University of Ulsan College of Medicine, Seoul; 2Department of Surgery, Dong-A University Medical Center, Busan; 3Department of General Surgery,  Cheil General Hospital & Women’s Healthcare Center, Seoul; 4Department of Surgery, St. Vincent’s Hospital, The Catholic University of Korea College of  Medicine, Suwon, KoreaORIGINAL ARTICLEJ Breast Cancer 2013 September; 16(3): 266-273  http://dx.doi.org/10.4048/jbc.2013.16.3.266 Purpose:  Preclinical studies have shown that human epidermal  growth factor receptor 2 (HER2) status is associated with resis - tance to radiotherapy (RT).",Non-OADS,/arxiv_data1/oa_pdf/c7/a8/jbc-16-266.PMC3800722.pdf
"HER2 and Radiotherapy Resistance267 http://dx.doi.org/10.4048/jbc.2013.16.3.266  http://ejbc.krever, few clinical studies on this subject have been reported.",Non-OADS,/arxiv_data1/oa_pdf/c7/a8/jbc-16-266.PMC3800722.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.266National Cancer Incidence Database (KNCID), and the com - pleteness of the KNCID for 2009 was 97.2%, as determined by  the Ajiki method [20].",OADS,/arxiv_data1/oa_pdf/c7/a8/jbc-16-266.PMC3800722.pdf
HER2 and Radiotherapy Resistance269 http://dx.doi.org/10.4048/jbc.2013.16.3.266  http://ejbc.krhigher frequency of treatment with adjuvant chemotherapy  than the HER2(+)/RT(+) group.,Non-OADS,/arxiv_data1/oa_pdf/c7/a8/jbc-16-266.PMC3800722.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.266In addition, an age of ≥ 50 years at diagnosis (HR, 1.410; 95%  CI, 1.044–1.904; p= 0.025) and HR(+) status (HR, 0.351; 95%  CI, 0.260–0.472; p< 0.001) retained statistical significance as Figure 2.",Non-OADS,/arxiv_data1/oa_pdf/c7/a8/jbc-16-266.PMC3800722.pdf
HER2 and Radiotherapy Resistance271 http://dx.doi.org/10.4048/jbc.2013.16.3.266  http://ejbc.krformed for this group.,Non-OADS,/arxiv_data1/oa_pdf/c7/a8/jbc-16-266.PMC3800722.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.266ent populations.,Non-OADS,/arxiv_data1/oa_pdf/c7/a8/jbc-16-266.PMC3800722.pdf
HER2 and Radiotherapy Resistance273 http://dx.doi.org/10.4048/jbc.2013.16.3.266  http://ejbc.krpy in addition to adjuvant systemic therapy: long-term results from the  Danish Breast Cancer Cooperative Group DBCG 82 b and c random - ized studies.,Non-OADS,/arxiv_data1/oa_pdf/c7/a8/jbc-16-266.PMC3800722.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION For patients with locally advanced breast cancer (LABC),  even after mastectomy and systemic therapy, the possibility of  occult disease cannot be excluded.",Non-OADS,/arxiv_data1/oa_pdf/29/25/jbc-16-274.PMC3800723.pdf
"The Ki-67 index, a marker of cell Prognostic Value of the Nodal Ratio and Ki-67 Expression in Breast Cancer  Patients Treated with Postmastectomy Radiotherapy Tae Ryool Koo, Keun Y ong Eom, Eun Y oung Kang1, Yu Jung Kim1, Sung Won Kim1, Jee Hyun Kim1, Jae Sung Kim,   In Ah Kim Department of Radiation Oncology, Seoul National University College of Medicine, Seoul; 1Breast Care Center, Seoul National University Bundang Hospital,  Seongnam, KoreaORIGINAL ARTICLEJ Breast Cancer 2013 September; 16(3): 274-284  http://dx.doi.org/10.4048/jbc.2013.16.3.274 Purpose:  This pilot study aimed to evaluate prognostic factors of  postmastectomy radiotherapy (PMRT) for breast cancer patients  undergoing systemic therapy in either preoperative or postopera - tive setting.",Non-OADS,/arxiv_data1/oa_pdf/29/25/jbc-16-274.PMC3800723.pdf
"Nodal ratio and Ki-67 in postmastectomy radiotherapy275 http://dx.doi.org/10.4048/jbc.2013.16.3.274  http://ejbc.krproliferation, is likewise a marker of a specific intrinsic sub - type [11,12] and is also associated with breast cancer recur - rence and death [13-16].",Non-OADS,/arxiv_data1/oa_pdf/29/25/jbc-16-274.PMC3800723.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.274ed according to the seventh edition of the AJCC cancer stag - ing system [4].,Non-OADS,/arxiv_data1/oa_pdf/29/25/jbc-16-274.PMC3800723.pdf
"Nodal ratio and Ki-67 in postmastectomy radiotherapy277 http://dx.doi.org/10.4048/jbc.2013.16.3.274  http://ejbc.krSPSS version 18.0 (SPSS, Chicago, USA) was used for statisti - cal analyses.",OADS,/arxiv_data1/oa_pdf/29/25/jbc-16-274.PMC3800723.pdf
"The maximal chi-square method in the R program version  2.13.0 (R Development Core Team, Vienna, Austria; available  from http://www.R-project.org) was used to obtain the opti - mal cut-off value of the NR, which was 0.2.",OADS,/arxiv_data1/oa_pdf/29/25/jbc-16-274.PMC3800723.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.274or negative HR status.,Non-OADS,/arxiv_data1/oa_pdf/29/25/jbc-16-274.PMC3800723.pdf
"Nodal ratio and Ki-67 in postmastectomy radiotherapy279 http://dx.doi.org/10.4048/jbc.2013.16.3.274  http://ejbc.krWith respect to the type of initial disease relapse, LRR oc - curred in 4 patients (PST subgroup, 4), DM in 14 patients  (non-PST subgroup, 7; PST subgroup, 7), and both LRR and  DM in 10 patients (non-PST subgroup, 3; PST subgroup, 7).",Non-OADS,/arxiv_data1/oa_pdf/29/25/jbc-16-274.PMC3800723.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.274Univariate analysis Univariate analysis revealed that patients with a NR of > 0.2  had a significantly lower DMFS ( p= 0.003), DFS ( p= 0.006),  and OS ( p= 0.032) than those with a NR of ≤ 0.2.",Non-OADS,/arxiv_data1/oa_pdf/29/25/jbc-16-274.PMC3800723.pdf
Nodal ratio and Ki-67 in postmastectomy radiotherapy281 http://dx.doi.org/10.4048/jbc.2013.16.3.274  http://ejbc.kr6 patients in the high-risk group had died at the time of the  last follow-up.,Non-OADS,/arxiv_data1/oa_pdf/29/25/jbc-16-274.PMC3800723.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.274more patients could have a lower N stage as a result of chemo - therapy.,Non-OADS,/arxiv_data1/oa_pdf/29/25/jbc-16-274.PMC3800723.pdf
"Nodal ratio and Ki-67 in postmastectomy radiotherapy283 http://dx.doi.org/10.4048/jbc.2013.16.3.274  http://ejbc.krhowever, the high-risk group tended to have a worse progno - sis than the low-risk group ( p= 0.067), and the intermediate- risk group showed no association.",Non-OADS,/arxiv_data1/oa_pdf/29/25/jbc-16-274.PMC3800723.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.274my irradiation limited to patients with four or more positive nodes, as  recommended in international consensus reports?",Non-OADS,/arxiv_data1/oa_pdf/29/25/jbc-16-274.PMC3800723.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION The frequency of sister chromatid exchanges (SCEs), the  occurrence of micronuclei, and the proliferation rate index  (PRI) in peripheral blood lymphocytes are cytogenetic mark - ers of chromosome instability that have been implicated in the  development of many tumors [1-4].",Non-OADS,/arxiv_data1/oa_pdf/e1/4d/jbc-16-285.PMC3800724.pdf
"We also wished to establish whether Cytogenetic Finding of Breast Cancer Cases and in Their First-Degree  Relatives Dilek Aşcı Çelik, Pınar Aslan Koşar, Nurten Özçelik, Erol Eroğlu1 Department of Medical Biology and Genetic, Süleyman Demirel University School of Medicine, and 1Department of General Surgery, Süleyman Demirel  University Medical Faculty, Isparta, TurkeyORIGINAL ARTICLEJ Breast Cancer 2013 September; 16(3): 285-290  http://dx.doi.org/10.4048/jbc.2013.16.3.285 Purpose:  The aim of this study was to evaluate and compare the  rate of sister chromatid exchange (SCE), the occurrence of   micronuclei, and the lymphocyte proliferation rate index (PRI) in  patients with breast cancer, their first-degree relatives, and  healthy volunteers.",Non-OADS,/arxiv_data1/oa_pdf/e1/4d/jbc-16-285.PMC3800724.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.285there was an association between DNA damage and the level  of specific tumor markers.,OADS,/arxiv_data1/oa_pdf/e1/4d/jbc-16-285.PMC3800724.pdf
"Breast Cancer and Cytogenetic Finding 287 http://dx.doi.org/10.4048/jbc.2013.16.3.285  http://ejbc.krInc., San Diego, USA).",Non-OADS,/arxiv_data1/oa_pdf/e1/4d/jbc-16-285.PMC3800724.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.285DISCUSSION In the present study, the levels of spontaneous DNA dam - age in lymphocytes of treatment-naïve breast cancer patients,  their first-degree relatives, and healthy control subjects were  examined.",OADS,/arxiv_data1/oa_pdf/e1/4d/jbc-16-285.PMC3800724.pdf
"Breast Cancer and Cytogenetic Finding 289 http://dx.doi.org/10.4048/jbc.2013.16.3.285  http://ejbc.krpared to the control subjects (3.9 ± 0.4) ( p< 0.001 and p=  0.001, respectively).",Non-OADS,/arxiv_data1/oa_pdf/e1/4d/jbc-16-285.PMC3800724.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.285of the uterine cervix.,Non-OADS,/arxiv_data1/oa_pdf/e1/4d/jbc-16-285.PMC3800724.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Breast cancer has high morbidity and mortality rates, and is  a serious threat to the health of women worldwide [1].",Non-OADS,/arxiv_data1/oa_pdf/02/c9/jbc-16-291.PMC3800725.pdf
"Cells  from patients with FA are particularly sensitive to DNA inter ­ strand cross­link­inducing agents such as MMC and diepoxy ­Silencing of Fanconi Anemia Complementation Group F Exhibits Potent  Chemosensitization of Mitomycin C Activity in Breast Cancer Cells Jiankun Yu1,*, Lin Zhao1,*, Y anlin Li1, Na Li1, Miao He1, Xuefeng Bai1, Zhaojin Yu1, Zhihong Zheng2, Xiaoyi Mi2,   Enhua Wang2, Minjie Wei1,2 1Department of Pharmacology and 2Institute of Pathology and Pathophysiology, China Medical University, Shenyang, ChinaORIGINAL ARTICLEJ Breast Cancer 2013 September; 16(3): 291-299  http://dx.doi.org/10.4048/jbc.2013.16.3.291 Purpose:  Fanconi anemia complementation group F (FANCF) is a  key factor to maintaining the function of Fanconi anaemia/BRCA  (FA/BRCA) pathway, a DNA-damage response pathway.",Non-OADS,/arxiv_data1/oa_pdf/02/c9/jbc-16-291.PMC3800725.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.291butane [7].,Non-OADS,/arxiv_data1/oa_pdf/02/c9/jbc-16-291.PMC3800725.pdf
"FANCF and Mitomycin C Sensitivity 293 http://dx.doi.org/10.4048/jbc.2013.16.3.291  http://ejbc.krthen transfected with control shRNA or FANCF shRNA for  48 hours, followed by treatment with MMC at different con ­ centrations (0.01, 0.25, 2.5, 5, 10, 20, or 40 μM) for 24 hours.",Non-OADS,/arxiv_data1/oa_pdf/02/c9/jbc-16-291.PMC3800725.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.291treated cells transfected with FANCF shRNA were significant ­ ly reduced, to 1.6 and 2.0 μM in the MCF ­7 and MDA ­MB­ 435S cells, respectively (Figure 2), representing a 83.9% and  80% decrease in IC 50 of MMC, respectively.",OADS,/arxiv_data1/oa_pdf/02/c9/jbc-16-291.PMC3800725.pdf
FANCF and Mitomycin C Sensitivity 295 http://dx.doi.org/10.4048/jbc.2013.16.3.291  http://ejbc.krshRNA on the MMC­induced DNA damage.,Non-OADS,/arxiv_data1/oa_pdf/02/c9/jbc-16-291.PMC3800725.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.291 Control shRNA Control shRNA+MMC FANCF shRNA+MMCFL2-H FL2-H FL1-HFL1-H FL1-HFL1-H FL1-HFL1-HFL2-H FL2-H FL2-H FL2-HData.,OADS,/arxiv_data1/oa_pdf/02/c9/jbc-16-291.PMC3800725.pdf
"FANCF and Mitomycin C Sensitivity 297 http://dx.doi.org/10.4048/jbc.2013.16.3.291  http://ejbc.krparts a potent antineoplastic effect on breast cancer cells by  increasing the antiproliferative effect of MMC as well as  through a loss of ΔΨm, ultimately leading to apoptosis.",Non-OADS,/arxiv_data1/oa_pdf/02/c9/jbc-16-291.PMC3800725.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.291to restore genomic integrity through DNA repair.,OADS,/arxiv_data1/oa_pdf/02/c9/jbc-16-291.PMC3800725.pdf
FANCF and Mitomycin C Sensitivity 299 http://dx.doi.org/10.4048/jbc.2013.16.3.291  http://ejbc.kranemia and BRCA pathway and sensitizes head and neck cancer cells  to cisplatin.,Non-OADS,/arxiv_data1/oa_pdf/02/c9/jbc-16-291.PMC3800725.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION The current standard for the treatment of early breast cancer  is breast-conserving surgery, followed by whole-breast irradia - tion and tumor-bed boost irradiation.",Non-OADS,/arxiv_data1/oa_pdf/f8/14/jbc-16-300.PMC3800726.pdf
"Since the lumpectomy cavity volumes Comparison of Electron and X-Ray Beams for Tumor Bed Boost Irradiation in  Breast-Conserving Treatment Shin-Hyung Park, Jae-Chul Kim Department of Radiation Oncology, Kyungpook National University School of Medicine, Daegu, KoreaORIGINAL ARTICLEJ Breast Cancer 2013 September; 16(3): 300-307  http://dx.doi.org/10.4048/jbc.2013.16.3.300 Purpose:  This study aimed to compare the dosimetric profiles of  electron beams (EB) and X-ray beams (XB) for boosting irradia - tion in breast cancer patients who underwent breast-conserving  surgery and postoperative radiotherapy.",Non-OADS,/arxiv_data1/oa_pdf/f8/14/jbc-16-300.PMC3800726.pdf
"Boost Irradiation in Patients with Breast Cancer 301 http://dx.doi.org/10.4048/jbc.2013.16.3.300  http://ejbc.krchanged significantly over the treatment course, additional  CT scans were obtained after completing whole-breast irradi - ation [4,5].",Non-OADS,/arxiv_data1/oa_pdf/f8/14/jbc-16-300.PMC3800726.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.300Radiation pneumonitis was defined as radiographic opacities  within the irradiated volume, including ground-glass opaci - ties or attenuation and consolidation [6,7].",OADS,/arxiv_data1/oa_pdf/f8/14/jbc-16-300.PMC3800726.pdf
Boost Irradiation in Patients with Breast Cancer 303 http://dx.doi.org/10.4048/jbc.2013.16.3.300  http://ejbc.krSparing OAR Table 4 provides the numerical findings from the DVH  analysis of the OAR.,OADS,/arxiv_data1/oa_pdf/f8/14/jbc-16-300.PMC3800726.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.300although irregular target shapes or deep-seated targets pre - cluded the use of EB.,Non-OADS,/arxiv_data1/oa_pdf/f8/14/jbc-16-300.PMC3800726.pdf
"Boost Irradiation in Patients with Breast Cancer 305 http://dx.doi.org/10.4048/jbc.2013.16.3.300  http://ejbc.krpreferred when the tumor bed was located in the inner breast  to avoid irradiating the contralateral breast, or for cases with  left outer lower-quadrant tumors to prevent increased low- dose volumes of the cardiac chambers and coronary arteries.",Non-OADS,/arxiv_data1/oa_pdf/f8/14/jbc-16-300.PMC3800726.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.300at a median interval of 6 weeks after RT completion.,Non-OADS,/arxiv_data1/oa_pdf/f8/14/jbc-16-300.PMC3800726.pdf
Boost Irradiation in Patients with Breast Cancer 307 http://dx.doi.org/10.4048/jbc.2013.16.3.300  http://ejbc.krfindings.,Non-OADS,/arxiv_data1/oa_pdf/f8/14/jbc-16-300.PMC3800726.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION The BRCA1  and BRCA2  genes are involved in DNA repair and recombination, cell-cycle control, and transcription [1].",Non-OADS,/arxiv_data1/oa_pdf/30/1e/jbc-16-308.PMC3800727.pdf
"BRCA1  muta - tion carriers with triple-negative breast cancer also tend to  have tumors with a higher nuclear grade [5].Association between BRCA  Mutation Status, Pathological Findings, and  Magnetic Resonance Imaging Features in Patients with Breast Cancer at Risk  for the Mutation Jae Myoung Noh*, Boo-Kyung Han1,*, Doo Ho Choi, Sun Jung Rhee1, Eun Y oon Cho2, Seung Jae Huh, Won Park,   Hyojung Park, Seok Jin Nam3, Jeong Eon Lee3, Won-Ho Kil3 Departments of Radiation Oncology, 1Radiology, 2Pathology, and 3Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul,  KoreaORIGINAL ARTICLEJ Breast Cancer 2013 September; 16(3): 308-314  http://dx.doi.org/10.4048/jbc.2013.16.3.308 Purpose:  We investigated the relationship between BRCA  muta - tions, pathological findings, and magnetic resonance imaging  (MRI) features in patients with breast cancer at risk for the muta - tion.",Non-OADS,/arxiv_data1/oa_pdf/30/1e/jbc-16-308.PMC3800727.pdf
BRCA  Mutation and MR Imaging Features309 http://dx.doi.org/10.4048/jbc.2013.16.3.308  http://ejbc.krMagnetic resonance imaging (MRI) has been widely used  for screening women at increased risk for breast cancer [8].,Non-OADS,/arxiv_data1/oa_pdf/30/1e/jbc-16-308.PMC3800727.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.308for mass-type lesions.,Non-OADS,/arxiv_data1/oa_pdf/30/1e/jbc-16-308.PMC3800727.pdf
"BRCA  Mutation and MR Imaging Features311 http://dx.doi.org/10.4048/jbc.2013.16.3.308  http://ejbc.krpositive cases, respectively ( p= 0.8888).",Non-OADS,/arxiv_data1/oa_pdf/30/1e/jbc-16-308.PMC3800727.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.308which was increased in patients with the BRCA1  mutation  (17.4%, p= 0.0542), the triple-negative phenotype (22.6%, p<  0.0001), rim enhancement on MRI scans (28.9%, p= 0.0003)  (Figure 2), high nuclear grade (10.6%, p= 0.0500), pathologic  T2-3 disease (12.6%, p= 0.0299), and pathologic N2-3 disease  (12.6%, p= 0.0164).",Non-OADS,/arxiv_data1/oa_pdf/30/1e/jbc-16-308.PMC3800727.pdf
BRCA  Mutation and MR Imaging Features313 http://dx.doi.org/10.4048/jbc.2013.16.3.308  http://ejbc.krrespect to benign morphological features such as round shape  or sharp margin.,Non-OADS,/arxiv_data1/oa_pdf/30/1e/jbc-16-308.PMC3800727.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.30813.,Non-OADS,/arxiv_data1/oa_pdf/30/1e/jbc-16-308.PMC3800727.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Axillary lymph node metastasis (ALNM) is a key factor for  the prognosis of breast cancer and has a major impact on de - cisions regarding treatment modalities; thus, diagnostically  accurate methods for determining ALNM are very important  [1,2].",Non-OADS,/arxiv_data1/oa_pdf/76/33/jbc-16-315.PMC3800728.pdf
"Thus, if ALNM is suspected on AUS, the use of FNAC The Comparative Study of Ultrasonography, Contrast-Enhanced MRI, and  18F-FDG PET/CT for Detecting Axillary Lymph Node Metastasis in T1 Breast  Cancer Seung Ook Hwang, Sang-Woo Lee1, Hye Jung Kim2, Wan Wook Kim, Ho Y ong Park, Jin Hyang Jung Departments of Surgery, 1Nuclear Medicine, and 2Radiology, Kyungpook National University School of Medicine, Daegu, KoreaORIGINAL ARTICLEJ Breast Cancer 2013 September; 16(3): 315-321  http://dx.doi.org/10.4048/jbc.2013.16.3.315 Purpose:  A more noninvasive evaluation of axillary lymph node   in breast cancer is one of the principal challenges of breast can - cer treatment.",Non-OADS,/arxiv_data1/oa_pdf/76/33/jbc-16-315.PMC3800728.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.315or CNB with AUS can accurately determine ALNM.,OADS,/arxiv_data1/oa_pdf/76/33/jbc-16-315.PMC3800728.pdf
"Imaging Modalities and Lymph Node Metastasis in T1 Breast Cancer317 http://dx.doi.org/10.4048/jbc.2013.16.3.315  http://ejbc.krtions rescheduled, and their blood glucose concentration was  managed such that it was < 150 mg/dL in all subjects.",Non-OADS,/arxiv_data1/oa_pdf/76/33/jbc-16-315.PMC3800728.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.315Evaluation of axillary lymph nodes by imaging studies As noted in Table 3, 41.4% (29/70) of patients who were  suspected of having ALNM based on preoperative AUS did not actually show ALNM based on pathological examination.",Non-OADS,/arxiv_data1/oa_pdf/76/33/jbc-16-315.PMC3800728.pdf
"Imaging Modalities and Lymph Node Metastasis in T1 Breast Cancer319 http://dx.doi.org/10.4048/jbc.2013.16.3.315  http://ejbc.krWith regards to the similarity between tests, there was no  significant difference between AUS and cMRI ( p= 0.728);  however, there was a small difference between PET/CT and  AUS ( p= 0.061) and a significant difference between PET/CT  and cMRI ( p= 0.025).",Non-OADS,/arxiv_data1/oa_pdf/76/33/jbc-16-315.PMC3800728.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.315that the accuracies of AUS (sensitivity 57.6%, specificity  95.2%, PPV 85%, NPV 82%, accuracy 83.1%) and PET/CT  (sensitivity 54.2%, specificity 85%, PPV 97%, NPV 82%, accu - racy 84.7%) were similar.",OADS,/arxiv_data1/oa_pdf/76/33/jbc-16-315.PMC3800728.pdf
Imaging Modalities and Lymph Node Metastasis in T1 Breast Cancer321 http://dx.doi.org/10.4048/jbc.2013.16.3.315  http://ejbc.krventional axillary-lymph-node dissection in patients with clinically  node-negative breast cancer: results from the NSABP B-32 randomised  phase III trial.,Non-OADS,/arxiv_data1/oa_pdf/76/33/jbc-16-315.PMC3800728.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Mammography is the gold standard imaging tool for breast  cancer screening and has reduced the mortality by as much as  30% [1-3].",Non-OADS,/arxiv_data1/oa_pdf/ce/fc/jbc-16-322.PMC3800729.pdf
"It is well established that CAD systems have helped to re - duce the rate of false negative interpretations for the detection Detection of Breast Cancer in Asymptomatic and Symptomatic Groups Using  Computer-Aided Detection with Full-Field Digital Mammography Chang Suk Park, Na Y oung Jung1, Kijun Kim, Hyun Seouk Jung, Kyung-Myung Sohn, Se Jeong Oh2 Department of Radiology, Incheon St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Incheon; 1Department of Radiology, Bucheon  St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Bucheon; 2Department of Surgery, Incheon St. Mary’s Hospital, The Catholic  University of Korea College of Medicine, Incheon, KoreaORIGINAL ARTICLEJ Breast Cancer 2013 September; 16(3): 322-328  http://dx.doi.org/10.4048/jbc.2013.16.3.322 Purpose:  We aimed to determine the sensitivity of computer-aid - ed detection (CAD) applied to digital mammography in asymp - tomatic and symptomatic breast cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ce/fc/jbc-16-322.PMC3800729.pdf
Detection of Breast Cancer Using CAD with Full-Field Digital Mammography 323 http://dx.doi.org/10.4048/jbc.2013.16.3.322  http://ejbc.krof masses and calcifications [13].,Non-OADS,/arxiv_data1/oa_pdf/ce/fc/jbc-16-322.PMC3800729.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.322CAD detected 150 of 173 breast cancers (86.7%) in the sym- ptomatic group.,Non-OADS,/arxiv_data1/oa_pdf/ce/fc/jbc-16-322.PMC3800729.pdf
Detection of Breast Cancer Using CAD with Full-Field Digital Mammography 325 http://dx.doi.org/10.4048/jbc.2013.16.3.322  http://ejbc.kr(p= 0.533).,Non-OADS,/arxiv_data1/oa_pdf/ce/fc/jbc-16-322.PMC3800729.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.322digital mammography images, 22 of 28 cancers (78.6%) that  the CAD system missed were identified.",Non-OADS,/arxiv_data1/oa_pdf/ce/fc/jbc-16-322.PMC3800729.pdf
Detection of Breast Cancer Using CAD with Full-Field Digital Mammography 327 http://dx.doi.org/10.4048/jbc.2013.16.3.322  http://ejbc.krsitivity of screening mammography.,Non-OADS,/arxiv_data1/oa_pdf/ce/fc/jbc-16-322.PMC3800729.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.322REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/ce/fc/jbc-16-322.PMC3800729.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION According to imaging studies for patients with breast can - cer, mammography (MMG) and breast ultrasound (US) are  routinely used.",Non-OADS,/arxiv_data1/oa_pdf/32/c2/jbc-16-329.PMC3800730.pdf
"It can be operated by a medical technician or ra -The Clinical Utility of Automated Breast Volume Scanner: A Pilot Study of 139  Cases Y oung Wook Kim1, Seon Kwang Kim1, Hyun Jo Y oun1,2, Eun Jung Choi3, Sung Hoo Jung1,2 1Department of Surgery, Chonbuk National University Medical School, Jeonju; 2Research Institute of Clinical Medicine, Chonbuk National University- Biomedical Research Institute, Chonbuk National University Hospital, Jeonju; 3Department of Radiology, Chonbuk National University Medical School,  Jeonju, KoreaORIGINAL ARTICLEJ Breast Cancer 2013 September; 16(3): 329-334  http://dx.doi.org/10.4048/jbc.2013.16.3.329 Purpose:  The aim of this study is to evaluate the clinical utility of  automated breast volume scanner (ABVS) for detecting and di - agnosing the breast lesions.",Non-OADS,/arxiv_data1/oa_pdf/32/c2/jbc-16-329.PMC3800730.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.329diographer [5].,Non-OADS,/arxiv_data1/oa_pdf/32/c2/jbc-16-329.PMC3800730.pdf
The Clinical Utility of Automated Breast Volume Scanner 331 http://dx.doi.org/10.4048/jbc.2013.16.3.329  http://ejbc.krAmerican College of Radiology Breast Imaging Reporting and  Data System (BI-RADS) final assessment graded from cat- egory 1 (negative) to category 5 (highly suggestive of malig - nancy) [9].,Non-OADS,/arxiv_data1/oa_pdf/32/c2/jbc-16-329.PMC3800730.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.329pared with the HHUS, the lesions of BI-RADS category 2 and  3 had match to those seen on ABVS for 73.5% (61/83) and  85.4% (276/323).",OADS,/arxiv_data1/oa_pdf/32/c2/jbc-16-329.PMC3800730.pdf
"The Clinical Utility of Automated Breast Volume Scanner 333 http://dx.doi.org/10.4048/jbc.2013.16.3.329  http://ejbc.kreach nipple includes a scanning [20], there might be varia - tions in the adjustment of artifacts depending on the examin - ers.",Non-OADS,/arxiv_data1/oa_pdf/32/c2/jbc-16-329.PMC3800730.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.329The present study has several limitations.,Non-OADS,/arxiv_data1/oa_pdf/32/c2/jbc-16-329.PMC3800730.pdf
Epub 2012 Oct 20. http://dx.doi.org/10.1007/s12   282-012-0419-1.,Non-OADS,/arxiv_data1/oa_pdf/32/c2/jbc-16-329.PMC3800730.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Approximately 7% of breast cancer patients are considered  to have genetic predispositions for cancer [1].",Non-OADS,/arxiv_data1/oa_pdf/68/18/jbc-16-335.PMC3800731.pdf
"The lack of awareness of genetic coun - seling as well as a shortage of qualified genetic counselors are The Effects of a Genetic Counseling Educational Program on Hereditary  Breast Cancer for Korean Healthcare Providers Jihyoun Lee, Hyung Jung Cho1, Han-Wook Y oo2, Sue K. Park3, Jae Jeong Y ang4, Sung-Won Kim5, Eunyoung Kang5,   Sei-Hyun Ahn6, Soo-Jung Lee7, Y oung Jin Suh8, Sung Y ong Kim9, Eun-Kyu Kim10, Nan Mo Moon11, Min Hyuk Lee,   The Korean Hereditary Breast Cancer Research Group, Korean Breast Cancer Society Department of Surgery, Soonchunhyang University Seoul Hospital, Seoul; 1Division of The Teacher Training Course, Soonchunhyang University, Asan;  2Departments of Pediatrics and Medical Genetics, Asan Medical Center Children’s Hospital, Seoul; 3Department of Preventive Medicine, Seoul National  University College of Medicine, and Cancer Research Institute, Seoul National University, and Department of Biomedical Sciences, Seoul National  University Graduate School, Seoul; 4Department of Preventive Medicine, Seoul National University College of Medicine, and Cancer Research Institute,  Seoul National University, Seoul; 5Department of Surgery, Seoul National University Bundang Hospital, Seongnam; 6Department of Surgery, Asan Medical  Center, University of Ulsan College of Medicine, Seoul; 7Department of Surgery, Y eungnam University College of Medicine, Daegu; 8Department of Surgery,  St. Vincent’s Hospital, The Catholic University of Korea School of Medicine, Suwon; 9Department of Surgery, Soonchunhyang University Hospital, Cheonan;  10Department of Surgery, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul; 11Department of Surgery, Dongnam  Institute of Radiological and Medical Sciences, Busan, KoreaORIGINAL ARTICLEJ Breast Cancer 2013 September; 16(3): 335-341  http://dx.doi.org/10.4048/jbc.2013.16.3.335 Purpose:  Systematic educational programs and genetic counsel - ing certification courses for hereditary breast/ovarian cancer  (HBOC) have not yet been introduced in Korea.",Non-OADS,/arxiv_data1/oa_pdf/68/18/jbc-16-335.PMC3800731.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.335impediments to effective education of individuals at high risk  of HBOC [7,8].",Non-OADS,/arxiv_data1/oa_pdf/68/18/jbc-16-335.PMC3800731.pdf
Genetic Counseling Education of Hereditary Breast Cancer  337 http://dx.doi.org/10.4048/jbc.2013.16.3.335  http://ejbc.krwere able to describe additional opinions regarding their  overall perception of the educational program.,Non-OADS,/arxiv_data1/oa_pdf/68/18/jbc-16-335.PMC3800731.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.335sociated with hereditary breast cancer; elevated risk of endo - metrial carcinoma in Cowden syndrome; indications of the  BRCA  gene test; definition of “proband”; large genomic rear - rangement; and genetic testing of carrier families.,Non-OADS,/arxiv_data1/oa_pdf/68/18/jbc-16-335.PMC3800731.pdf
Genetic Counseling Education of Hereditary Breast Cancer  339 http://dx.doi.org/10.4048/jbc.2013.16.3.335  http://ejbc.kr(AK) was higher in men ( p= 0.023) and in doctors ( p= 0.002)  before education.,Non-OADS,/arxiv_data1/oa_pdf/68/18/jbc-16-335.PMC3800731.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.335effective for medical education and genetic counseling educa - tion, the lack of realism may be a barrier to improving com - munication skills [15,16].",Non-OADS,/arxiv_data1/oa_pdf/68/18/jbc-16-335.PMC3800731.pdf
Genetic Counseling Education of Hereditary Breast Cancer  341 http://dx.doi.org/10.4048/jbc.2013.16.3.335  http://ejbc.krGenetic Counselors.,Non-OADS,/arxiv_data1/oa_pdf/68/18/jbc-16-335.PMC3800731.pdf
http://www.nccn.org/pro - fessionals/physician_gls/pdf/genetics_screening.pdf.,Non-OADS,/arxiv_data1/oa_pdf/68/18/jbc-16-335.PMC3800731.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.We had previously reported the usefulness of 18F-fluorode - oxyglucose positron emission tomography (FDG-PET) for  predicting the pathological complete response (pCR) of pri - mary breast cancer in the neoadjuvant chemotherapy setting  [1].",Non-OADS,/arxiv_data1/oa_pdf/7f/61/jbc-16-342.PMC3800732.pdf
"[4] reported that among 273 breast cancer patients  who received neoadjuvant chemotherapy, higher baseline  Genomic Profiling Shows Increased Glucose Metabolism in Luminal B Breast  Cancer Shigeto Ueda, Toshiaki Saeki, Hideki Takeuchi, Takashi Shigekawa, Kazuo Matsuura, Noriko Nakamiya, Hiroshi Sano,  Hiroko Shimada, Eiko Hirokawa, Akihiko Osaki Department of Breast Oncology, International Medical Center, Saitama Medical School, Saitama, JapanBRIEF COMMUNICATIONJ Breast Cancer 2013 September; 16(3): 342-344  http://dx.doi.org/10.4048/jbc.2013.16.3.342 We had previously reported a close association between path - ological response and the maximum tumor standardized up - take value (SUVmax) measured by 18F-fluorodeoxyglucose  positron emission tomography prior to chemotherapy in estro - gen receptor (ER)-positive breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/7f/61/jbc-16-342.PMC3800732.pdf
Glucose Metabolism and Luminal Breast Cancer 343 http://dx.doi.org/10.4048/jbc.2013.16.3.342  http://ejbc.krSUVmax of the tumor and ER negativity were independent  indicators of pCR.,OADS,/arxiv_data1/oa_pdf/7f/61/jbc-16-342.PMC3800732.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.342classes with clinical implications.,Non-OADS,/arxiv_data1/oa_pdf/7f/61/jbc-16-342.PMC3800732.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Rhabdomyosarcoma (RMS) is a common soft tissue malig - nancies in pediatric age that accounts for 12% of all solid ma - lignancies [1].",Non-OADS,/arxiv_data1/oa_pdf/3a/aa/jbc-16-345.PMC3800733.pdf
"During follow-up, she had remained in complete re -Breast Metastasis from Rhabdomyosarcoma of the Anus in an Adolescent  Female Seung Pil Jung, Y oon Lee1, Kang Min Han2, Se Kyung Lee3, Sangmin Kim3, Soo Y oun Bae3, Jiyoung Kim3, Minkuk Kim3,  Sinill Kim, Won Ho Kil3, Hong Hoe Koo4, Seok Jin Nam3, Jeoung Won Bae, Jeong Eon Lee3 Division of Breast and Endocrine Surgery, Department of Surgery, and 1Department of Pediatrics, Korea University Anam Hospital, Korea University  College of Medicine, Seoul; 2Department of Pathology, 3Division of Breast and Endocrine Surgery, Department of Surgery, and 4Department of Pediatrics,  Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, KoreaCASE REPORTJ Breast Cancer 2013 September; 16(3): 345-348  http://dx.doi.org/10.4048/jbc.2013.16.3.345 Rhabdomyosarcoma (RMS) of the breast is rare and there is  scant information about the clinical behavior and treatment strat - egies.",Non-OADS,/arxiv_data1/oa_pdf/3a/aa/jbc-16-345.PMC3800733.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.345Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/3a/aa/jbc-16-345.PMC3800733.pdf
Breast Rhabdomyosarcoma Metastasis from the Anus 347 http://dx.doi.org/10.4048/jbc.2013.16.3.345  http://ejbc.krmission state.,Non-OADS,/arxiv_data1/oa_pdf/3a/aa/jbc-16-345.PMC3800733.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.345gest that treatment of ALL would be associated with breast  rhabdomyosarcoma, clinicians should carefully checkup the  patient’s condition with the suspicion of SMN.",Non-OADS,/arxiv_data1/oa_pdf/3a/aa/jbc-16-345.PMC3800733.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Breast carcinoma can produce hormonal products includ - ing human placental lactogen (hPL), adrenocorticotropic hor - mone, and norepinephrine [1-3].",Non-OADS,/arxiv_data1/oa_pdf/2b/86/jbc-16-349.PMC3800734.pdf
"The choriocarcinomatous lesion con -Breast Carcinoma with Choriocarcinomatous Features: A Case Report  Hyun-Jung Sung1,2, Y oung-In Maeng1, Min-Kyung Kim1, Sun-Jae Lee1, Sung-Min Kang3, Jin-Gu Bong4, Hoon-Kyu Oh1 1Department of Pathology, Catholic University of Daegu School of Medicine, Daegu; 2Department of Pathology, Goodsamaritan Hospital, Pohang;  Departments of 3Nuclear Medicine and 4Breast and Thyroid Surgery, Catholic University of Daegu School of Medicine, Daegu, KoreaCASE REPORTJ Breast Cancer 2013 September; 16(3): 349-353  http://dx.doi.org/10.4048/jbc.2013.16.3.349 Nongestational choriocarcinoma differentiation is extremely rare  in breast neoplasms.",Non-OADS,/arxiv_data1/oa_pdf/2b/86/jbc-16-349.PMC3800734.pdf
"http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.349tained highly pleomorphic tumor cells with an increased nu - cleus-cytoplasmic ratio, prominent nucleoli, and syncytio- trophoblast-like multinucleated giant cells.",Non-OADS,/arxiv_data1/oa_pdf/2b/86/jbc-16-349.PMC3800734.pdf
Breast Carcinoma with Choriocarcinomatous Features  351 http://dx.doi.org/10.4048/jbc.2013.16.3.349  http://ejbc.krwhile the 4 sentinel nodes showed no metastatic deposits.,Non-OADS,/arxiv_data1/oa_pdf/2b/86/jbc-16-349.PMC3800734.pdf
http://ejbc.kr  http://dx.doi.org/10.4048/jbc.2013.16.3.349The cytopathological characteristics of choriocarcinomatous  breast cancers are similar to those of choriocarcinomas of the  genital tract.,Non-OADS,/arxiv_data1/oa_pdf/2b/86/jbc-16-349.PMC3800734.pdf
Breast Carcinoma with Choriocarcinomatous Features  353 http://dx.doi.org/10.4048/jbc.2013.16.3.349  http://ejbc.kr465-8.,Non-OADS,/arxiv_data1/oa_pdf/2b/86/jbc-16-349.PMC3800734.pdf
"http://ejbc.kr  |  pISSN 1738-6756    eISSN 2092-9900 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/   licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.To the Editor: We read with great interest the article ‘Usefulness of pre - treatment neutrophil to lymphocyte ratio in predicting dis - ease-specific survival in breast cancer patients’ by Noh et al.",Non-OADS,/arxiv_data1/oa_pdf/d9/5e/jbc-16-354.PMC3800735.pdf
"Further vali - dation work and feasibility study are required before the re -Neutrophil to Lymphocyte Ratio May Predict Mortality in Breast Cancer  Patients Sevket Balta, Sait Demirkol, Ugur Kucuk, Hakan Sarlak1, Omer Kurt1, Zekeriya Arslan  Departments of Cardiology and 1Internal Medicine, Gulhane Medical Academy, Ankara, TurkeyLETTER TO THE EDITORJ Breast Cancer 2013 September; 16(3): 354-355  http://dx.doi.org/10.4048/jbc.2013.16.3.354 Correspondence to:  Sevket Balta  Department of Cardiology, Gulhane School of Medicine, Tevfik Saglam St,  Etlik, Ankara 06018, Turkey Tel: +90-312-3044281, Fax: +90-312-3044250 E-mail: drsevketb@gmail.com Received:  May 16, 2013 Accepted:  September 7, 2013Journal of         BreastCancer",Non-OADS,/arxiv_data1/oa_pdf/d9/5e/jbc-16-354.PMC3800735.pdf
Neutrophil to Lymphocyte Ratio May Predict Mortality in Breast Cancer Patients355 http://dx.doi.org/10.4048/jbc.2013.16.3.354  http://ejbc.krsults of this study can be considered for clinical use.,Non-OADS,/arxiv_data1/oa_pdf/d9/5e/jbc-16-354.PMC3800735.pdf
Epub 2013 Apr 23. http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/d9/5e/jbc-16-354.PMC3800735.pdf
Epub 2012 Nov 26. http://dx.doi.org/10.1177/1076029612467   227.,Non-OADS,/arxiv_data1/oa_pdf/d9/5e/jbc-16-354.PMC3800735.pdf
Epub 2013 Jan 23. http://dx.doi.org/10.1177/107602   9612475023.,Non-OADS,/arxiv_data1/oa_pdf/d9/5e/jbc-16-354.PMC3800735.pdf
Epub 2013 Jan 4. http://dx.doi.org/10.3109/10641963.2012.758734.,Non-OADS,/arxiv_data1/oa_pdf/d9/5e/jbc-16-354.PMC3800735.pdf
"This is an Open Access article distributed unde r the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a7/48/eht371.PMC3800849.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/be/d2/srep03003.PMC3801110.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3003 | DOI: 10.1038/srep03003 10",Non-OADS,/arxiv_data1/oa_pdf/be/d2/srep03003.PMC3801110.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2999 | DOI: 10.1038/srep02999 6",Non-OADS,/arxiv_data1/oa_pdf/03/fe/srep02999.PMC3801111.pdf
"Yeast-2-hybrid assay .A Gal4 based two-hybrid system was used as described by the manufacturer (Clontech, USA; http://www.clontech.com/).",Non-OADS,/arxiv_data1/oa_pdf/09/5d/srep03001.PMC3801112.pdf
Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/09/5d/srep03001.PMC3801112.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3001 | DOI: 10.1038/srep03001 10",Non-OADS,/arxiv_data1/oa_pdf/09/5d/srep03001.PMC3801112.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2991 | DOI: 10.1038/srep02991 9",Non-OADS,/arxiv_data1/oa_pdf/39/3d/srep02991.PMC3801114.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/fd/23/srep02997.PMC3801115.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2997 | DOI: 10.1038/srep02997 6",Non-OADS,/arxiv_data1/oa_pdf/fd/23/srep02997.PMC3801115.pdf
"The figures, and the relevant statistics, have been generated using the online Cyclone eAtlas of the India Meteorological Department ,http://www.rmcchennaieatlas.",OADS,/arxiv_data1/oa_pdf/aa/6b/srep02989.PMC3801124.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/aa/6b/srep02989.PMC3801124.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2989 | DOI: 10.1038/srep02989 8",Non-OADS,/arxiv_data1/oa_pdf/aa/6b/srep02989.PMC3801124.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/65/63/srep02995.PMC3801131.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2995 | DOI: 10.1038/srep02995 5",Non-OADS,/arxiv_data1/oa_pdf/65/63/srep02995.PMC3801131.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/96/70/srep02994.PMC3801133.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2994 | DOI: 10.1038/srep02994 6",Non-OADS,/arxiv_data1/oa_pdf/96/70/srep02994.PMC3801133.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2990 | DOI: 10.1038/srep02990 4",Non-OADS,/arxiv_data1/oa_pdf/09/8c/srep02990.PMC3801134.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2996 | DOI: 10.1038/srep02996 9",Non-OADS,/arxiv_data1/oa_pdf/ee/3b/srep02996.PMC3801138.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The University of Texas M. D. Anderson Cancer Center (UTMDACC) and Rice University, along with their researchers, have filed patents on thetechnology and intellectual property reported here.",Non-OADS,/arxiv_data1/oa_pdf/0d/61/srep03000.PMC3801146.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3000 | DOI: 10.1038/srep03000 8",Non-OADS,/arxiv_data1/oa_pdf/0d/61/srep03000.PMC3801146.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/5b/d5/srep03004.PMC3801147.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3004 | DOI: 10.1038/srep03004 8",Non-OADS,/arxiv_data1/oa_pdf/5b/d5/srep03004.PMC3801147.pdf
"Surgical Neurology International Editor-in-Chief: Nancy E. Epstein, MD Winthrop University Hospital, Mineola, NY, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Spine, a supplement to  Surgical Neurology International   S301A review article on the diagnosis and treatment of cerebrospinal  fluid fistulas and dural tears occurring during spinal surgery Nancy E. Epstein Clinical Professor of Neurological Surgery, Department of Neurosurgery, The Albert Einstein College of Medicine, Bronx, NY , 10461, and Chief of Neurosurgical  Spine and Education, Department of Neurosurgery, Winthrop University Hospital, Mineola, NY , 11501 E‑mail: *Nancy E. Epstein ‑ nancy.epsteinmd@gmail.com   *Corresponding author Received: 11 February 13   Accepted: 25 March 13  Published: 06 May 13 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.111427 Quick Response Code: Abstract Background:  In spinal surgery, cerebrospinal fluid (CSF) fistulas attributed to  deliberate dural opening (e.g., for tumors, shunts, marsupialization of cysts)  or inadvertent/traumatic dural tears (DTs) need to be readily recognized, and  appropriately treated.",Non-OADS,/arxiv_data1/oa_pdf/5d/17/SNI-4-301.PMC3801173.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/3/301/111427 Copyright: © 2013 Epstein NE.,Non-OADS,/arxiv_data1/oa_pdf/5d/17/SNI-4-301.PMC3801173.pdf
Available at: http://www.effectivehealthcare.ahrq.gov/reports/analg  esicsupdate.cfm.,Non-OADS,/arxiv_data1/oa_pdf/8d/98/TOORTHJ-7-473.PMC3802125.pdf
"Available at: http://www.nationalpaincentre.mcmaster.ca/opioid  [6] Gilron I, Bailey JM, Tu D, et al .",OADS,/arxiv_data1/oa_pdf/8d/98/TOORTHJ-7-473.PMC3802125.pdf
REFERENCE 1. http://www.iasp-pain.org.,Non-OADS,/arxiv_data1/oa_pdf/9c/c8/AIM-21-3-170.PMC3804475.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/11/45/ccid-6-245.PMC3804494.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical, Cosmetic and Investigational Dermatology 2013:6 245–256Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  245RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S2424 6Anti-cytotoxic T lymphocyte antigen-4 antibodies  in melanoma Giulio T osti emilia Cocorocchio elisabetta Pennacchioli Divisione Melanomi e Sarcomi,   Istituto europeo di Oncologia,   Milano, Italy Correspondence: elisabetta Pennacchioli   Istituto europeo di Oncologia,   via Ripamonti 435, 20141, Milan, Italy   email elisabetta.pennacchioli@ieo.i tAbstract:  Approaches aimed at enhancement of the tumor specific response have provided  proof for the rationale of immunotherapy in cancer, both in animal models and in humans.",Non-OADS,/arxiv_data1/oa_pdf/11/45/ccid-6-245.PMC3804494.pdf
"Available from: http://www.clinicaltrials.go v. Accessed July 23,  2013.",Non-OADS,/arxiv_data1/oa_pdf/11/45/ccid-6-245.PMC3804494.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/11/45/ccid-6-245.PMC3804494.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/11/45/ccid-6-245.PMC3804494.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e4/af/btt-7-223.PMC3804514.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpBiologics: Targets and Therapy 2013:7 223–229Biologics: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  223Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BTT .S4866 4Efficacy of intensity-modulated radiotherapy  combined with chemotherapy or surgery   in locally advanced squamous cell carcinoma   of the head-and-neck Hua Yang* Li-Qiong Diao* Mei Shi Rui Ma Jian-Hua Wang Jian-Ping Li Feng Xiao Ying Xue Man Xu Bin Zhou Department of Radiotherapy  Oncology, Xijing Hospital, Fourth  Military Medical University, Xi’an,   People’s Republic of China *These authors contributed equally   to this work Correspondence: Mei Shi   Department of Radiotherapy Oncology,  Xijing Hospital, Fourth Military Medical  University, 15 West Changle Road,   Xi’an 710032, People’s Republic of China   Tel +86 29 8477 5425   Fax +86 29 8324 9969   email mshi82@fmmu.edu.c nObjectives:  Long-term locoregional control following intensity-modulated radiotherapy  (IMRT) for locally advanced squamous cell carcinoma of the head-and-neck (SCCHN) remains  challenging.",Non-OADS,/arxiv_data1/oa_pdf/e4/af/btt-7-223.PMC3804514.pdf
"Biologics: Targets & Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/biologics-targets--therapy-journa lBiologics: Targets & Therapy is an international, peer-reviewed journal  focusing on the patho-physiological rationale for and clinical applica - tion of Biologic agents in the management of autoimmune diseases,  cancers or other pathologies where a molecular target can be identified.",Non-OADS,/arxiv_data1/oa_pdf/e4/af/btt-7-223.PMC3804514.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/e4/af/btt-7-223.PMC3804514.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/79/88/cia-8-1405.PMC3804517.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2013:8 1405–1412Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1405OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S4947 8Predicting hemorrhage and obstruction   in the elderly population using  thromboelastographic indices Qiwen Zheng1,* shuhong Fu2,* Dafang Chen1 Xiaoxia li2 Yuru li2 Yanyan li2 Jihong Yu2 Meiliang gong2 Jie Bai2 1Department of epidemiology and  Biostatistics, school of Public health,   Peking University health science  Center, Beijing, People’s republic of  China; 2nanlou Clinical lab, Chinese  PlA general hospital, Beijing,   People’s republic of China *These authors contributed equally   to this work Correspondence: Jie Bai   nanlou Clinical lab,   Chinese PlA general hospital,   no.",Non-OADS,/arxiv_data1/oa_pdf/79/88/cia-8-1405.PMC3804517.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/79/88/cia-8-1405.PMC3804517.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/79/88/cia-8-1405.PMC3804517.pdf
Available from: http://www.sfzg.hr/files/user/isamija/Klinicka_imu - nologija_skripta.doc 4.5.,OADS,/arxiv_data1/oa_pdf/16/2f/AIM-21-3-148.PMC3804522.pdf
Journal title: By the official ac - ronym of the Index Medicus that is available online through PubMed interface at http://www.ncbi.nlm.nih.gov/pubmed/ .,Non-OADS,/arxiv_data1/oa_pdf/16/2f/AIM-21-3-148.PMC3804522.pdf
4. http://www.kb-merkur.hr/attachments/ar-ticle/66/ICMJE-citiranje.pdf.,Non-OADS,/arxiv_data1/oa_pdf/16/2f/AIM-21-3-148.PMC3804522.pdf
"Measures against pla-giarism and related phenomena: A propos- al, CEES Working Papers, ERD 20-01/03-11,  http://ceon.rs/pdf/dopis_mntr_plagijarizam_ eng.pdf .",OADS,/arxiv_data1/oa_pdf/16/2f/AIM-21-3-148.PMC3804522.pdf
"CEES Occasional Pa- per Series,, 2012: 25-26, http://www.ceon.rs/ ops/12122, Accessed June 15th, 2013.",Non-OADS,/arxiv_data1/oa_pdf/16/2f/AIM-21-3-148.PMC3804522.pdf
"Open letter to the Minister of Education, Science, and Tech-nological Development: Please provide nor- mative and ethical integrity of the system of  evaluation of researchers, Belgrade: CEON/ CEES (in Serbian), http://ceon.rs/pdf/peticija.",Non-OADS,/arxiv_data1/oa_pdf/16/2f/AIM-21-3-148.PMC3804522.pdf
"19. International Journal of Collaborative Re-search on Internal Medicine & Public Health (IJCRIMPH),http://www.iomcworld.com/ ijcrimph/, Accessed June 15th, 2013.",Non-OADS,/arxiv_data1/oa_pdf/16/2f/AIM-21-3-148.PMC3804522.pdf
"20. International Journal of Pharmacy Teaching & Practices (IJPTP), http://www.ijptp.iomc- world.com/HOME.html, Accessed June 15th,  2013.",Non-OADS,/arxiv_data1/oa_pdf/16/2f/AIM-21-3-148.PMC3804522.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/20/c9/ijn-8-4007.PMC3804533.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 4007–4013International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4007OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S4369 1effect of selenium nanoparticles with different   sizes in primary cultured intestinal epithelial   cells of crucian carp, Carassius auratus gibelio Yanbo Wang Xuxia Yan linglin Fu Marine resources and Nutrition  Biology research center, Food  Quality and safety Department,   Zhejiang gongshang University,   hangzhou, People’s republic of china correspondence: linglin Fu   Food Quality and safety Department,  Zhejiang gongshang University,   149 Jiaogong road, hangzhou,   310035, Zhejiang Province,   People’s republic of china   Tel +86 571 8807 1024 ext 8595   email fulinglin@mail.zjgsu.edu.c nAbstract:  Nano-selenium (Se), with its high bioavailability and low toxicity, has attracted wide  attention for its potential application in the prevention of oxidative damage in animal tissues.",Non-OADS,/arxiv_data1/oa_pdf/20/c9/ijn-8-4007.PMC3804533.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/20/c9/ijn-8-4007.PMC3804533.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/20/c9/ijn-8-4007.PMC3804533.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d6/20/ppa-7-1061.PMC3804534.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2013:7 1061– 1066Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1061OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S5249 8Validation of the european Organization   for research and Treatment of cancer   cervical cancer module for chinese patients   with cervical cancer cai-hong hua hui-Min guo Xin-lei guan Fan-Jing Kong rui-Jie hou Xue-Ying Zhang shao-ru li Department of gynecology and  Obstetrics, First Affiliated hospital   of Xinxiang Medical University,    Weihui city, henan Province,    People’s republic of china correspondence: cai-hong hua   Department of gynecology and  Obstetrics, First Affiliated Hospital   of Xinxiang Medical University,   Weihui city, henan Province,   453100, People’s republic of china   Tel +86 373 440 4315   Fax +86 373 440 2573   email 13189368@qq.co mPurpose:  The aim of our study was to assess, for the first time, the validity, reliability, and  acceptability of the European Organization for Research and Treatment of Cancer (EORTC)  Quality of Life questionnaire (QLQ) cervical cancer module (CX24) in Chinese cervical cancer  patients.",Non-OADS,/arxiv_data1/oa_pdf/d6/20/ppa-7-1061.PMC3804534.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/d6/20/ppa-7-1061.PMC3804534.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/20/ppa-7-1061.PMC3804534.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a8/88/tcrm-9-395.PMC3804538.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2013:9 395–402Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  395CoMMenT aRyopen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S5229 1eliminating the need for fasting with oral   administration of bisphosphonates Michael Pazianas1 Bo abrahamsen2,3 Serge Ferrari4 R Graham G Russell1,5 1The Botnar Research Center and  oxford University Institute of  Musculoskeletal Sciences, oxford,   UK; 2Department of Medicine F ,   Gentofte Hospital, Hellerup, 3odense  Patient data explorative network  (oPen) Institute of Clinical Research,   University of Southern Denmark,   odense, Denmark; 4Division of  Bone Diseases, Faculty of Medicine,   Geneva University Hospital, Geneva,   Switzerland; 5Mellanby Centre for  Bone Research, University of Sheffield,   Sheffield, UK Correspondence: Michael Pazianas   The Botnar Research Centre and   oxford University Institute of   Musculoskeletal Sciences, Nuffield   Department of orthopaedics,   Rheumatology and Musculoskeletal   Diseases, Nuffield Orthopaedic Centre,  Headington, oxford oX3 7LD, UK   Tel +44 1865 227 335   Fax +44 1865 227 966   email m ichael.",Non-OADS,/arxiv_data1/oa_pdf/a8/88/tcrm-9-395.PMC3804538.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/a8/88/tcrm-9-395.PMC3804538.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a8/88/tcrm-9-395.PMC3804538.pdf
Available from:  http://www.iofbonehealth.org/sites/default/files/PDFs/adherence_gap_ report_2005.pdf .,Non-OADS,/arxiv_data1/oa_pdf/a8/88/tcrm-9-395.PMC3804538.pdf
Available from: http://www.wcrx.com/pdfs/pi/ pi_atelvia.pdf .,Non-OADS,/arxiv_data1/oa_pdf/a8/88/tcrm-9-395.PMC3804538.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a1/c9/cmar-5-337.PMC3804539.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpCancer Management and Research 2013:5 337–347Cancer Management and Research Dove press submit your manuscript | www.dovepress.co m Dove press  337Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CMAR.S3502 9Antiangiogenic treatment in hepatocellular  carcinoma: the balance of efficacy and safety Martin-w alter welker Joerg Trojan Medizinische Klinik 1,   Universitätsklinikum Frankfurt,   Germany Correspondence: Joerg Trojan   Medizinische Klinik 1,  Universitätsklinikum Frankfurt,   Theodor-Stern-Kai 7, Frankfurt   60590, Germany   Tel +49 69 6301 7860   Fax +49 69 6301 6448   email trojan@em.uni-frankfurt.d eAbstract:  Hepatocellular carcinoma (HCC) is a severe complication of advanced liver disease  with a worldwide incidence of more than 600,000 patients per year.",Non-OADS,/arxiv_data1/oa_pdf/a1/c9/cmar-5-337.PMC3804539.pdf
"*press release ( http://www.novartis.com/newsroom/media-releases/en/2013/1721562.shtm l) Abbreviations:  Ang-1/2, angiopoietin-1/2; EGF(R), epidermal growth factor (receptor); ERK, extracellular-signal-regulated kinase; FGF(R), fibroblast growth factor  (receptor); HGF, hepatocyte growth factor; JNK, c-Jun N-terminal kinases; mTOR, mammalian target of rapamycin; NFkB, nuclear factor kappa-light-chain-enhancer of  activated B cells; PDGF(R), platelet-derived growth factor (receptor); PI3K, phosphatidylinositide 3-kinases; RPS6, ribosomal protein S6; TRAIL, TNF-related apoptosis- inducing ligand; veGF(R), vascular endothelial growth factor (receptor).",Non-OADS,/arxiv_data1/oa_pdf/a1/c9/cmar-5-337.PMC3804539.pdf
Cancer Management and Research 2013:5submit your manuscript | www.dovepress.co m Dove press Dove press 343Antiangiogenic agents in HCC in combination with sorafenib in a Phase II trial in advanced  or inoperable HCC ( http://www.clinicaltrials.gov/ct2/show/ NCT0087201 4).,Non-OADS,/arxiv_data1/oa_pdf/a1/c9/cmar-5-337.PMC3804539.pdf
"Further promising drugs that are under development for  advanced HCC are the multiple tyrosine-kinase inhibitor  dovitinib,134 the oral histone-deacetylase inhibitor resmi - nostat ( http://clinicaltrials.gov/show/NCT0094344 9), and  RO5137382 (GC33), a humanized anti-glypican-3 monoclo - nal antibody ( http://www.clinicaltrials.gov/ct2/show/study/  NCT0150716 8).",Non-OADS,/arxiv_data1/oa_pdf/a1/c9/cmar-5-337.PMC3804539.pdf
"Cancer Management and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/cancer-management-and-research-journa lCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of  preventative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/a1/c9/cmar-5-337.PMC3804539.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a1/c9/cmar-5-337.PMC3804539.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a2/3a/ppa-7-1067.PMC3804540.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2013:7 1067–1075Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1067Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S4911 3Factors associated with uptake, adherence,   and efficacy of hepatitis C treatment in people   who inject drugs: a literature review Viktor Mravčík1,2 Lisa Strada3 Josef Štolfa4,5 vladimir Bencko6 T eodora Groshkova7 Jens Reimer3 Bernd Schulte3 1National Monitoring Centre  for Drugs and Drug Addiction,   2Department of Addictology,   First Faculty of Medicine, Charles  University in Prague, Prague, Czech  Republic; 3Centre for Interdisciplinary  Addiction Research, University  of Hamburg, Hamburg, Germany;   4Department of General Practice,   institute for Postgraduate Medical  education in Prague, 5Department  of General Practice, Second Faculty  of Medicine, 6Institute of Hygiene  and Epidemiology, First Faculty of  Medicine, Charles University in  Prague, Prague, Czech Republic;   7European Monitoring Centre for  Drugs and Drug Addiction, Lisbon,   Portugal Correspondence: Viktor Mravčík   National Monitoring Centre for Drugs  and Drug Addiction, Office of the  Government of the Czech Republic,  Nábřeží E Beneše 4, 118 01 Prague 1,  Czech Republic   Tel +420 296 153 354   Fax +420 296 153 264   email mravcik.viktor@vlada.c zIntroduction and methods:  Hepatitis C virus (HCV) infections are highly prevalent amongst  people who inject drugs (PWID).",Non-OADS,/arxiv_data1/oa_pdf/a2/3a/ppa-7-1067.PMC3804540.pdf
Available from: http://www.kirby.unsw.edu.,Non-OADS,/arxiv_data1/oa_pdf/a2/3a/ppa-7-1067.PMC3804540.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/a2/3a/ppa-7-1067.PMC3804540.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a2/3a/ppa-7-1067.PMC3804540.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/24/55/tcrm-9-391.PMC3804541.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2013:9 391–394Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  391Case Repo RTopen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S5216 1Resolution of vitreomacular traction following  intravitreal ranibizumab in cases of ocular  toxoplasmosis with choroidal neovascularization petros petrou1,2 Ilias Georgalas2 Nikolaos Markomichelakis2 Ioannis Vergados2 emanuela Gianakaki2 alexander Rouvas2 1Moorfields eye Hospital, London,   UK; 2ophthalmology Department,   University of athens, athens, Greece Correspondence: petros petrou   ophthalmology Department,   154 Mesogeion avenue,   University of athens, athens, Greece   Tel +30 21 0677 6499   Fax +30 21 0677 6499   email petrospetrou2@yahoo.comPurpose:  To present the occurrence of the resolution of vitreomacular traction following  intravitreal ranibizumab in two patients with inflammatory choroidal neovascular (CNV)  membrane with a background of ocular toxoplasmosis.",Non-OADS,/arxiv_data1/oa_pdf/24/55/tcrm-9-391.PMC3804541.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/24/55/tcrm-9-391.PMC3804541.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/24/55/tcrm-9-391.PMC3804541.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a3/65/ott-6-1453.PMC3804542.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2013:6 1453–1462OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1453Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S3337 4Survivin – biology and potential as a therapeutic  target in oncology Chun Hei Antonio  Cheung1,2 Chien-Chang Huang3 Fang-Ying Tsai4 Jane Ying-Chieh Lee1 Siao Muk Cheng2 Yung-Chieh Chang1 Yi-Chun Huang1 Shang-Hung Chen5 Jang-Yang Chang3,6 1Department of Pharmacology,  College of Medicine, National Cheng  Kung University, Tainan, 2institute  of Basic Medical Sciences, College  of Medicine, National Cheng Kung  University, Tainan, 3National institute  of Cancer Research, National  Health Research institutes, Tainan,  4South east Asian Health education  Center in Taiwan (S eAHeCT),  College of Medicine, National Cheng  Kung University, Tainan, 5Division  of Hematology and Oncology,  Department of internal Medicine,  Chi-Mei Medical Center, Liouying,  Tainan, 6Division of Hematology and  Oncology, Department of internal  Medicine, National Cheng Kung  University Hospital, Tainan, Taiwan,  Republic of China Correspondence: Jang-Yang Chang   National institute of Cancer Research,   National Health Research institutes,   2F, No 367 Shengli Road, Tainan 70456,   Taiwan, Republic of China   email jychang@nhri.org.t wAbstract:  Survivin is a member of the inhibitor-of-apoptosis proteins (IAPs) family; its   overexpression has been widely demonstrated to occur in various types of cancer.",Non-OADS,/arxiv_data1/oa_pdf/a3/65/ott-6-1453.PMC3804542.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/a3/65/ott-6-1453.PMC3804542.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a3/65/ott-6-1453.PMC3804542.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cf/7a/ijwh-5-667.PMC3804543.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2013:5 667–679International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  667OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S4922 0The effects of cigarette smoking on aerobic   and anaerobic capacity and heart rate variability  among female university students chia-lun lee1 Wen-Dien chang2 1Physical education section for  general education, national sun   Yat-sen University, Kaohsiung,  Taiwan; 2Department of sports  Medicine, china Medical University,  Taichung, Taiwan correspondence: chia-lun lee   Physical education section for general  education, national sun Yat-sen  University, 80459 no 70 lien-Hai rd,  Kaohsiung city, Taiwan   Tel +886 7 525 2000 ext 5858   Fax +886 7 719 1435   email karenlee1129@gmail.co mAim:  In this study, the effects of cigarette smoking on maximal aerobic capacity, anaerobic  capacity, and heart rate variability among female university students were investigated.",Non-OADS,/arxiv_data1/oa_pdf/cf/7a/ijwh-5-667.PMC3804543.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/cf/7a/ijwh-5-667.PMC3804543.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cf/7a/ijwh-5-667.PMC3804543.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/58/75/opth-7-2073.PMC3804559.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 2073–2078Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2073Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5075 2Correlation between optical coherence  tomography and multifocal electroretinogram  findings with visual acuity in retinitis pigmentosa Marilita M Moschos irini P Chatziralli george Verriopoulos aristeides Triglianos Dimitrios s ladas Dimitrios Brouzas laboratory of electrophysiology,   First Department of Ophthalmology,   University of athens, athens, greece Correspondence: Marilita M Moschos   laboratory of electrophysiology,  First Department of Ophthalmology,  University of athens, 6 ikarias street,  ekali, 14578, athens, greece   Tel +30 694 488 7319   Fax +30 210 412 2139   email moschosmarilita@yahoo.f rIntroduction:  Our purpose was to study the correlation between the macular morphology and  function in eyes with retinitis pigmentosa (RP).",Non-OADS,/arxiv_data1/oa_pdf/58/75/opth-7-2073.PMC3804559.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/58/75/opth-7-2073.PMC3804559.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/58/75/opth-7-2073.PMC3804559.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6f/b5/ott-6-1437.PMC3804563.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2013:6 1437–1444OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1437Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5199 7Expression and clinical significance of IGF-1,  IGFBP-3, and IGFBP-7 in serum and lung   cancer tissues from patients with non-small   cell lung cancer Zhigang Wang1,3 Zheng Wang1 Zhu liang3 Jikuan liu3 Weicheng shi3 Peiru Bai3 Xialu lin2 ruth Magaye2 Jinshun Zhao2 1Jinan University, Guangzhou,   Guangdong, People’s Republic of  china; 2Public Health Department of  Medical School, Zhejiang Provincial  Key Laboratory of Pathological and  Physiological Technology, Ningbo  University, Zhejiang, People’s Republic  of China; 3The Affiliated Hospital  of Guangdong Medical College,   Zhanjiang, Guangdong, People’s  Republic of China correspondence: Jinshun Zhao   Public Health Department of Medical  School, Zhejiang Provincial Key  Laboratory of Pathological and  Physiological Technology, Ningbo  University, Zhejiang, People’s Republic  of China   Tel +86 574 8760 9591   Fax +86 574 8760 8638   email zhaojinshun@nbu.edu.c nAbstract:  The expression and clinical significance of insulin-like growth factor 1 (IGF-1),  insulin-like growth factor binding protein 3 (IGFBP-3), and insulin-like growth factor bind - ing protein 7 (IGFBP-7) were investigated in serum and lung cancer tissues from 57 patients  with non-small cell lung cancer (NSCLC).",Non-OADS,/arxiv_data1/oa_pdf/6f/b5/ott-6-1437.PMC3804563.pdf
"Available  from: http://globocan.iarc.f r. Accessed August 24, 2013.",Non-OADS,/arxiv_data1/oa_pdf/6f/b5/ott-6-1437.PMC3804563.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/6f/b5/ott-6-1437.PMC3804563.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6f/b5/ott-6-1437.PMC3804563.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d3/14/ijwh-5-681.PMC3804567.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2013:5 681–688International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  681RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S3808 3Crohn’s disease in women Ivana Plavšić1 T ea Štimac2 Goran Hauser3 1Health Center, County of Primorje- Gorski Kotar, Rijeka, Croatia;  2Department of Gynecology,  3Department of Gastroenterology,  Clinical Hospital Center Rijeka,   Rijeka, Croatia Correspondence: Goran Hauser   Clinical Hospital Center Rijeka,  Kresimirova 42, Rijeka, Croatia   Tel +385 51 658 122   Fax +385 51 658 826   email goran.hauser@medri.uniri.h rAbstract:  This article provides an overview of the obstetric and gynecological manifestations  of Crohn’ s disease (CD).",Non-OADS,/arxiv_data1/oa_pdf/d3/14/ijwh-5-681.PMC3804567.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/d3/14/ijwh-5-681.PMC3804567.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d3/14/ijwh-5-681.PMC3804567.pdf
"A vailable at:   http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/   016324s034  s035 lbl.pd f. Accesed May 6, 2013.",Non-OADS,/arxiv_data1/oa_pdf/d3/14/ijwh-5-681.PMC3804567.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a0/d0/opth-7-2063.PMC3804568.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 2063–2068Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2063Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5140 9intracameral anesthesia for cataract surgery:   a population-based study on patient satisfaction  and outcome inger Westborg1,2 eva Mönestam1 1Department of Clinical sciences/ Ophthalmology, Umeå University,   Umeå, sweden; 2eye Clinic, sunderby  hospital, luleå, sweden Correspondence: inger Westborg   Department of Clinical sciences/ Ophthalmology, Umeå University,   Umeå se-901 85, sweden   Tel +46 70 689 8498   Fax +46 90 216 6141   email inger.westborg@nll.s ePurpose:  To evaluate if the standard anesthetic regimen – topical combined with intracameral  anesthesia without sedation – in a population-based cohort of unselected cataract surgery cases  is adequate, optimal, and good practice, or if improvements are necessary.",Non-OADS,/arxiv_data1/oa_pdf/a0/d0/opth-7-2063.PMC3804568.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/a0/d0/opth-7-2063.PMC3804568.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a0/d0/opth-7-2063.PMC3804568.pdf
Available from: http://www.rcophth.ac.uk/core/core_picker/download.,Non-OADS,/arxiv_data1/oa_pdf/a0/d0/opth-7-2063.PMC3804568.pdf
"Available  from: http://one.aao.org/asset.axd?id =8d66318f-ff50-408e-9bb1-   73d277cf14c e. Accessed July 11, 2013 3.",OADS,/arxiv_data1/oa_pdf/a0/d0/opth-7-2063.PMC3804568.pdf
"Available from: http://www.cataractreg.com/ Cataract_ Sve/2Finalårsrapp_2011.pd f. Accessed July 11, 2013.",Non-OADS,/arxiv_data1/oa_pdf/a0/d0/opth-7-2063.PMC3804568.pdf
"Available from: http://www.analeyz.co m. Accessed July 11,  2013.",Non-OADS,/arxiv_data1/oa_pdf/a0/d0/opth-7-2063.PMC3804568.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b4/68/mder-6-163.PMC3804569.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpMedical Devices: Evidence and Research 2013:6 163–167Medical Devices: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  163ORiginal REsEaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/MDER.S5127 0A laminar flow unit for the care of critically ill  newborn infants Jose MR Perez1 sergio g golombek2 carlos Fajardo3 augusto sola4 1stella Maris hospital, international  neurodevelopment neonatal center  (cinn ), sao Paulo, Brazil; 2M Fareri  children’s hospital, Westchester  Medical center, new York Medical  college, Valhalla, nY, Usa; 3University  of Calgary, Calgary, Canada; 4st Jude  Hospital, Fullerton, California, CA,   Usa correspondence: augusto sola   24896 sea crest Dr,   Dana Point, ca, 92629, Usa   Tel +1 949 433 8962   Email augustosolaneo@gmail.co mIntroduction:  Medical and nursing care of newborns is predicated on the delicate control and  balance of several vital parameters.",Non-OADS,/arxiv_data1/oa_pdf/b4/68/mder-6-163.PMC3804569.pdf
Or use: http://dvpr.es/1cHG9u K,Non-OADS,/arxiv_data1/oa_pdf/b4/68/mder-6-163.PMC3804569.pdf
Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa l Medical Devices: Evidence and Research 2013:6submit your manuscript | www.dovepress.co m Dove press Dove press Dove pres s 167Laminar flow unit for care of critically ill newborns of concept study on this topic which will be submitted for  publication in the near future.,Non-OADS,/arxiv_data1/oa_pdf/b4/68/mder-6-163.PMC3804569.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1e/0f/dmso-6-371.PMC3804570.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013:6 371–378Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  371Original reSearchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DMSO.S4442 6Socioeconomic status and obesity   in abia State, South east nigeria innocent ijezie  chukwuonye1 abali chuku2 ikechi gareth Okpechi3 Ugochukwu Uchenna  Onyeonoro4 Okechukwu Ojoemelam  Madukwe5 godwin Oguejiofor  chukwuebuka Okafor6 Okechukwu Samuel Ogah5,7 1Division of renal Medicine,   Department of internal Medicine,   2Department of Ophthalmology,   Federal Medical centre, Umuahia,   nigeria; 3Division of nephrology  and hypertension, groote Schuur  hospital and University of cape  T own, cape T own, South africa;   4Department of community Medicine,   Federal Medical centre, 5Ministry of  health, nnamdi azikiwe Secretariat,   6Department of community Medicine,   Federal Medical centre, Umuahia,   nigeria; 7Division of cardiology,   Department of internal Medicine,   University college hospital, ibadan,   nigeria correspondence: Okechukwu  Samuel Ogah   Ministry of health, nnamdi azikiwe  Secretariat, PMB 7215 Umuahia,   abia State, nigeria   Tel +234 806 774 7121   email osogah56156@yahoo.co mBackground and objectives:  Obesity is a major risk factor for cardiovascular disease in  developed and emerging economies.",Non-OADS,/arxiv_data1/oa_pdf/1e/0f/dmso-6-371.PMC3804570.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/1e/0f/dmso-6-371.PMC3804570.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/1e/0f/dmso-6-371.PMC3804570.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/16/d2/ijn-8-3963.PMC3804571.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 3963–3975International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3963OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S4961 2effects triggered by platinum nanoparticles   on primary keratinocytes Piotr Konieczny1,* anna grazyna goralczyk1,* radoslaw szmyd1,* lukasz skalniak1,* Joanna Koziel2 Francesca larese Filon3 Matteo crosera4 agnieszka cierniak1 ewa K Zuba-surma5 Julia Borowczyk5 eliza laczna5 Justyna Drukala5 elzbieta Pyza6 Danuta semik6 Olga Woznicka6 andrzej Klein1 Jolanta Jura1 1Department of general Biochemistry,   2Department of Microbiology,   Jagiellonian University, Kraków,   Poland; 3Department of Public  health sciences, 4Department  of chemical and Pharmaceutical  sciences, University of Trieste,   Trieste, Italy; 5Department of cell  Biology, 6Department of cell Biology  and Imaging, Jagiellonian University,   Kraków, Poland *These authors equally contributed to  this work correspondence: Jolanta Jura   Department of general Biochemistry,  Faculty of Biochemistry, Biophysics   and Biotechnology, Jagiellonian   University, 7 gronostajowa street,   Kraków 30-387, Poland   Tel +48 12 664 6359   Fax +48 12 664 6902   email jolanta.jura@uj.edu.p lAbstract:  The platinum (Pt)-group elements (PGEs) represent a new kind of environmental  pollutant and a new hazard for human health.",Non-OADS,/arxiv_data1/oa_pdf/16/d2/ijn-8-3963.PMC3804571.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/16/d2/ijn-8-3963.PMC3804571.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/16/d2/ijn-8-3963.PMC3804571.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/80/43/ppa-7-1077.PMC3804572.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2013:7 1077–1090Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1077Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S5156 2Obstructive sleep apnea and endothelial  progenitor cells Qing wang1,* Qi wu2,* Jing Feng3,4 Xin Sun5 1The Second Respiratory Department  of the First People’s Hospital of  Kunming, Yunnan, People’s Republic  of China; 2Tianjin Haihe Hospital,   Tianjin, People’s Republic of China;   3Respiratory Department of Tianjin  Medical University General Hospital,   Tianjin, People’s Republic of China;   4Division of Pulmonary and Critical  Care Medicine, Duke University  Medical Center, Durham, NC, USA;   5Respiratory Department of Tianjin  Haihe Hospital, Tianjin, People’s  Republic of China *These authors contributed equally to  this work Correspondence: Jing Feng   Respiratory Department of Tianjin  Medical University General Hospital,  Tianjin 300052, People’s Republic of China   email zyyhxkfj@126.co m Xin Sun   Respiratory Department of Tianjin  Haihe Hospital, Tianjin 300350,   People’s Republic of China   email sunxin0917@126.co mBackground:  Obstructive sleep apnea (OSA) occurs in 4% of middle-aged men and 2% of  middle-aged women in the general population, and the prevalence is even higher in specific  patient groups.",Non-OADS,/arxiv_data1/oa_pdf/80/43/ppa-7-1077.PMC3804572.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/80/43/ppa-7-1077.PMC3804572.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/80/43/ppa-7-1077.PMC3804572.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e4/ec/ijn-8-3977.PMC3804583.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 3977–3990International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3977OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5205 8Bcl-2-functionalized ultrasmall superparamagnetic  iron oxide nanoparticles coated with amphiphilic  polymer enhance the labeling efficiency of islets  for detection by magnetic resonance imaging Bin Yang1 haolei cai1 Wenjie Qin1 Bo Zhang1 chuanxin Zhai2 Biao Jiang3 Yulian Wu1 1Department of surgery, 2nd affiliated  hospital, school of Medicine,   Zhejiang University, hangzhou,   People’s republic of china; 2state  Key lab of silicon Materials and  Department of Materials science  and engineering, Zhejiang University,   hangzhou, People’s republic of  china; 3Department of radiology,   2nd affiliated hospital, school  of Medicine, Zhejiang University,   hangzhou, People’s republic of china correspondence: Yulian Wu   Department of Surgery, 2nd Affiliated  hospital, school of Medicine,   Zhejiang University, 88 Jiefang road,  Zhejiang Province, hangzhou 310009,  People’s republic of china   Tel +86 571 8778 3602   Fax +86 571 8778 4604   email wuyulian@medmail.com.c nAbstract:  Based on their versatile, biocompatible properties, superparamagnetic iron oxide (SPIO)  or ultrasmall superparamagnetic iron oxide (USPIO) nanoparticles are utilized for detecting and  tracing cells or tumors in vivo.",Non-OADS,/arxiv_data1/oa_pdf/e4/ec/ijn-8-3977.PMC3804583.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/e4/ec/ijn-8-3977.PMC3804583.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e4/ec/ijn-8-3977.PMC3804583.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/84/bf/ndt-9-1591.PMC3804584.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2013:9 1591–1594Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1591Case repor Topen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/NDT .S4926 1selegiline remarkably improved stage 5 treatment- resistant major depressive disorder: a case report Yuji Kitaichi1 Takeshi Inoue1 Nobuyuki Mitsui1 shin Nakagawa1 rie Kameyama1 Y oshiyuki Hayashishita1 T ohru shiga2 Ichiro Kusumi1 Tsukasa Koyama1 1Department of p sychiatry,   Graduate school of Medicine,   Hokkaido University, sapporo, Japan;   2Department of Nuclear Medicine,   Graduate school of Medicine,   Hokkaido University, sapporo, Japan Correspondence: Yuji Kitaichi   Department of psychiatry, Hokkaido  University Graduate school of Medicine,   North 15, West 7, Kita-ku,   sapporo 060-8638, Japan   Tel +81 11 706 5160   Fax +81 11 706 5081   email muenchen-yuji@huhp.hokudai.ac.j pAbstract:  We report a case in which selegiline, an irreversible monoamine oxidase B (MAO-B)  inhibitor, greatly improved depressive symptoms in an adult with stage 5 treatment-resistant  major depressive disorder.",Non-OADS,/arxiv_data1/oa_pdf/84/bf/ndt-9-1591.PMC3804584.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/84/bf/ndt-9-1591.PMC3804584.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/84/bf/ndt-9-1591.PMC3804584.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/45/f1/opth-7-2057.PMC3804590.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 2057–2062Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2057Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5272 6association study of IGF1 polymorphisms   with susceptibility to high myopia in a Japanese  population Masao Y oshida1,* akira Meguro2,* atsushi Y oshino2 naoko nomura2 eiichi Okada3 nobuhisa Mizuki2 1Department of Public health, Kyorin  University school of Medicine,   Mitaka, T okyo, Japan; 2Department  of Ophthalmology and Visual science,   Y okohama City University graduate  school of Medicine, Y okohama,   Kanagawa, Japan; 3Okada eye Clinic,   Y okohama, Kanagawa, Japan *These authors contributed equally to  this work Correspondence: akira Meguro   Department of Ophthalmology and   Visual science, Yokohama City University   graduate school of Medicine,   3-9 Fukuura, Kanazawa-ku, Yokohama,   Kanagawa 236-0004, Japan   Tel +81 457 872 683   Fax +81 457 819 755   email akmeguro@yokohama-cu.ac.j pPurpose:  Polymorphisms in the insulin-like growth factor 1 ( IGF1 ) gene were previously  associated with high or extreme myopia in Caucasian and Chinese populations.",Non-OADS,/arxiv_data1/oa_pdf/45/f1/opth-7-2057.PMC3804590.pdf
These SNPs were selected from  HapMap Japanese data (minor allele  frequency $10%;  pairwise r2 $0.8) ( http://hapmap.ncbi.nlm.nih.gov /) to cap - ture 100% of common IGF1  variants in HapMap.,Non-OADS,/arxiv_data1/oa_pdf/45/f1/opth-7-2057.PMC3804590.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/45/f1/opth-7-2057.PMC3804590.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/45/f1/opth-7-2057.PMC3804590.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8c/05/ott-6-1445.PMC3804591.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2013:6 1445–1451OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1445Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5191 6VegF is a target molecule for peritoneal  metastasis and malignant ascites in gastric cancer:  prognostic significance of VEGF in ascites and  efficacy of anti-VEGF monoclonal antibody sachio Fushida Katsunobu Oyama Jun Kinoshita Yasumichi Yagi Kouichi Okamoto hidehiro Tajima itasu ninomiya Takashi Fujimura T etsuo Ohta Department of gastroenterological  surgery, Kanazawa University  hospital, Kanazawa, Japan correspondence: sachio Fushida   gastroenterological surgery,   Kanazawa University hospital,   Kanazawa 920-8641, Japan   Tel +81 7 6265 2362   Fax +81 7 6234 4260   email fushida@staff.kanazawa-u.ac.j pBackground:  In gastric cancer, poor prognosis is associated with peritoneal dissemination,  which often accompanies malignant ascites.",Non-OADS,/arxiv_data1/oa_pdf/8c/05/ott-6-1445.PMC3804591.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/8c/05/ott-6-1445.PMC3804591.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8c/05/ott-6-1445.PMC3804591.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fa/17/opth-7-2085.PMC3804592.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 2085–2089Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2085Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S4955 2Macular edema in the era of spectral-domain  optical coherence tomography Allan Hunter1 eric K Chin1 David G T elander2 1Department of Ophthalmology,   University of California, Davis,    2Department of Ophthalmology,   Retinal Consultants, Sacramento,    CA, USA Correspondence: Allan Hunter   University of California, Davis,   4860 Y Street, Suite 2400,   Sacramento, CA 95817, USA   Tel +1 916 734 6602   Fax +1 916 734 6074   email hunter.allan.a@gmail.co mAbstract:  The development of spectral-domain optical coherence tomography (OCT) allows  for the highest commercially available resolution of in vivo retinal anatomic details to date.",Non-OADS,/arxiv_data1/oa_pdf/fa/17/opth-7-2085.PMC3804592.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/fa/17/opth-7-2085.PMC3804592.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/fa/17/opth-7-2085.PMC3804592.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4c/b3/dddt-7-1223.PMC3804593.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2013:7 1223–1233Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1223Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S4031 0Daclatasvir: potential role in hepatitis C Choongho Lee College of Pharmacy, Dongguk  University-Seoul, Goyang,    Republic of Korea Correspondence: Choongho Lee   College of Pharmacy Dongguk University  -Seoul, Siksa-dong 814-9, ilsandong-gu  Goyang, Gyeonggi-do, 410-820,   Republic of Korea   Tel +82 31 961 5223   Fax +82 31 961 5206   email choongholee@dongguk.ed uAbstract:  Chronic hepatitis C virus (HCV) infection is responsible for the development of  liver cirrhosis and hepatocellular carcinoma.",Non-OADS,/arxiv_data1/oa_pdf/4c/b3/dddt-7-1223.PMC3804593.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/4c/b3/dddt-7-1223.PMC3804593.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4c/b3/dddt-7-1223.PMC3804593.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0a/5b/cia-8-1393.PMC3804594.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2013:8 1393–1403Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1393OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5049 6effect of aging on airway remodeling   and muscarinic receptors in a murine   acute asthma model Ji Y oung Kang sook Y oung lee Chin Kook rhee seung Joon Kim soon seog Kwon Y oung Kyoon Kim Department of Internal Medicine,   College of Medicine, Catholic  University of Korea, seoul, Korea Correspondence: sook Young lee   Division of respiratory Medicine,  Department of Internal Medicine,  seoul st Mary’s hospital, The Catholic  University of Korea, #505 Banpo-Dong,  seocho-gu, seoul, 137-701, Korea   Tel +82 2 2258 6061   Fax +82 2 596 2158   email sooklee@catholic.ac.k rBackground and objectives:  The influence of aging on the development of asthma has not  been studied thoroughly.",Non-OADS,/arxiv_data1/oa_pdf/0a/5b/cia-8-1393.PMC3804594.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/0a/5b/cia-8-1393.PMC3804594.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0a/5b/cia-8-1393.PMC3804594.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/07/bb/opth-7-2079.PMC3804595.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 2079–2084Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2079Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S4992 7are cataracts associated with osteoporosis?,Non-OADS,/arxiv_data1/oa_pdf/07/bb/opth-7-2079.PMC3804595.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/07/bb/opth-7-2079.PMC3804595.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/07/bb/opth-7-2079.PMC3804595.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a3/a5/ott-6-1463.PMC3804604.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2013:6 1463–1469OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1463Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5198 6Transient elastography-based risk estimation   of hepatitis B virus-related occurrence of  hepatocellular carcinoma: development and  validation of a predictive model Do Y oung Kim1,2,4,* Ki Jun song3,4,* seung Up Kim1,2,4 eun Jin Y oo1 Jun Y ong Park1,2,4 sang hoon ahn1,2,4 Kwang-hyub han1,2,4 1Department of internal Medicine,   2institute of gastroenterology,  3Department of Biostatistics, Yonsei   University college of Medicine,   4liver cirrhosis clinical research   center, seoul, Korea *These authors contributed equally   to this work correspondence: seung Up Kim   Department of internal Medicine,   Yonsei University college of Medicine,   50 Yonsei-ro, seodaemun–gu,   seoul 120-752, south Korea   Tel +82 2 2228 1982   Fax +82 2 393 6884   email ksukorea@yuhs.a cBackground:  The purpose of this study was to develop and validate a novel transient elastog - raphy-based predictive model for occurrence of hepatocellular carcinoma (HCC).",Non-OADS,/arxiv_data1/oa_pdf/a3/a5/ott-6-1463.PMC3804604.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/a3/a5/ott-6-1463.PMC3804604.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a3/a5/ott-6-1463.PMC3804604.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f2/49/opth-7-2069.PMC3804612.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 2069–2072Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2069Case repO rtopen access to scientific and medical research Open access Full text article http: //dx.doi.org/10.2147/OPTH.S5339 7sensory exotropia due to keratoconus   and review of the literature suleyman Ciftci1 ali simsek2 eyup Dogan1 Leyla Ciftci3 1Department of Ophthalmology,   Diyarbakır Training and Research  Hospital, Diyarbakır; 2Department of  Ophthalmology, Faculty of Medicine,   Adıyaman University, Adıyaman;   3Department of Cardiology, Faculty   of Medicine, Dicle University,   Diyarbakır, T urkey Correspondence: suleyman Ciftci   Diyarbakır Eg ˘itim ve Araştırma   Hastanesi Göz Hastalıkları Poliklinig ˘i,  21000 Diyarbakır, Turkey   tel +90 41 22570206   Fax +90 041 22245267   email ciftci1977@hotmail.co mAbstract:  This case report describes a 17-year-old boy with sensory strabismus due to  keratoconus and an ipsilateral nodular lesion of the bulbar conjunctiva.",Non-OADS,/arxiv_data1/oa_pdf/f2/49/opth-7-2069.PMC3804612.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/f2/49/opth-7-2069.PMC3804612.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f2/49/opth-7-2069.PMC3804612.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0a/64/ndt-9-1583.PMC3804613.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2013:9 1583–1589Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1583Shor T repor Topen access to scientific and medical research open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S5021 4Selective cognitive empathy deficit in adolescents  with restrictive anorexia nervosa Sara Calderoni1 pamela Fantozzi1 Sandra Maestro1 elena Brunori1 Antonio Narzisi1 Giulia Balboni2 Filippo Muratori1,3 1Department of Child Neurology  and psychiatry, I rCCS Stella Maris  Foundation, 2Department of Surgery,    Medical, Molecular and Critical   Area pathology, University of pisa,    3Department of Developmental  Medicine, University of pisa, pisa, Italy Correspondence: Filippo Muratori   IrCCS Stella Maris Foundation,   Via dei Giacinti, 2, I-56018 Calambrone,  pisa, Italy   Tel +39 050 886 323   Fax +39 050 886 247   email filippo.muratori@inpe.unipi.i tBackground:  A growing, but conflicting body of literature suggests altered empathic abilities  in subjects with anorexia nervosa-restricting type (AN-R).",Non-OADS,/arxiv_data1/oa_pdf/0a/64/ndt-9-1583.PMC3804613.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/0a/64/ndt-9-1583.PMC3804613.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0a/64/ndt-9-1583.PMC3804613.pdf
"T h i s  i s  a n  O p e n  A c c e s s  a r t i c l e  d i s t r i b u t e d  u n d e r  t h e   terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/li- censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the ori ginal work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a3/ba/jcen-15-131.PMC3804648.pdf
"Keywords Left atrial enlargement, Ischemic stroke, Stroke subtype, Echocardiograph yJournal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2013.15.3.131  Clinical Article INTRODUCTION Stroke is the second leading cause of death in Korea  and is associated with severe disability and mortality.17)  The identification and treatment of stroke risk factors has important consequences on the prognosis of  stroke.",Non-OADS,/arxiv_data1/oa_pdf/a3/ba/jcen-15-131.PMC3804648.pdf
"2013 September;15(3):137-144 Received : 14 June 2013 Revised : 11 July 2013Accepted : 1 August 2013 Correspondence to Chang-Woo Kang Department of Neurosurgery, School of  Medicine, Chungnam National University,  282 Munhwa-ro, Jung-gu, Daejeon 301-721, Korea Tel : 82-42-280-7361 Fax : 82-42-280-7363 E-mail : tbd9900@naver.com T h i s  i s  a n  O p e n  A c c e s s  a r t i c l e  d i s t r i b u t e d  u n d e r  t h e   terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/li- censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the ori ginal work is properly cited.Keywords Basilar artery occlusion, Endovascular mechanical thrombectomy,  Therapeutic time window, RecanalizationJournal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2013.15.3.137  Clinical Article INTRODUCTION The basilar artery (BA) supplies the brain stem, cer- ebellum, thalami, occipital lobes and medial temporal lobes.",Non-OADS,/arxiv_data1/oa_pdf/ac/93/jcen-15-137.PMC3804649.pdf
"2013 September;15(3):145-151 Received : 14 May 2013 Revised : 2 July 2013 Accepted : 31 July 2013 Correspondence to Byung Yon Choi Department of Neurosurgery, College of  Medicine, Yeungnam University, 317-1  Daemyung-dong, Nam-gu, Daegu 705-717, Korea Tel : 82-53-620-3790 Fax : 82-53-620-3770E-mail : bychoi@med.yu.ac.kr T h i s  i s  a n  O p e n  A c c e s s  a r t i c l e  d i s t r i b u t e d  u n d e r  t h e   terms of the Creative Commons Attribution Non-  Commercial License (http://creativecommons.org/li-censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the ori ginal work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/58/e3/jcen-15-145.PMC3804650.pdf
"Keywords Carotid artery, External, Temporal arteriesJournal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2013.15.3.145  Clinical Article INTRODUCTION The superficial temporal artery (STA) is one of the  terminal branches of the external carotid artery  (ECA).",Non-OADS,/arxiv_data1/oa_pdf/58/e3/jcen-15-145.PMC3804650.pdf
"2013 September;15(3):152-157 Received : 15 May 2013 Revised : 1 July 2013 Accepted : 7 August 2013 Correspondence to Cheol Wan Park Department of Neurosurgery, Gil Medical Center, Gachon University of Medical & Science, 1198 Block, Guweol-Dong,Namdong-Gu, Incheon 405-220, Korea Tel : 82-32-460-3304 Fax : 82-32-460-3899E-mail : cwpark@gilhospital.com T h i s  i s  a n  O p e n  A c c e s s  a r t i c l e  d i s t r i b u t e d  u n d e r  t h e   terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/li-censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the ori ginal work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/24/bd/jcen-15-152.PMC3804651.pdf
"Keywords Meteorology, Seasonality, Spontaneous intracerebral hemorrhage, WeatherJournal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2013.15.3.152  Clinical Article INTRODUCTION Spontaneous intracerebral hemorrhage (sICH) ac- counts for 8-13% of all strokes and can result from a wide spectrum of disorders, including hypertension.",Non-OADS,/arxiv_data1/oa_pdf/24/bd/jcen-15-152.PMC3804651.pdf
"2013 September;15(3):158-163 Received : 7 June 2013 Revised : 5 August 2013 Accepted : 2 September 2013 Correspondence to Kil-Sung Chae Department of Neurosurgery, Bongseng Memorial Hospital, Chung-Ang-Daero 401, Dong-gu, Busan 601-723, Korea Tel : 82-51-664-4105 Fax : 82-51-631-8054 E-mail : drkschae@gmail.com  T h i s  i s  a n  O p e n  A c c e s s  a r t i c l e  d i s t r i b u t e d  u n d e r  t h e   terms of the Creative Commons Attribution Non-  Commercial License (http://creativecommons.org/li-censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the ori ginal work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3c/e8/jcen-15-158.PMC3804652.pdf
"Keywords Solitaire stent, Coil embolization, Wide-necked aneurysmJournal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2013.15.3.158  Clinical Article INTRODUCTION The use of self-expanding stents has revolutionized en- dovascular treatment (EVT) of wide-necked aneurysms.11)  These stents provide support to minimize the risk of  coil herniation into the parent vessel, potentially pro-vide a scaffold for orifice endothelialization and per-mit increased packing density of the aneurysm.",Non-OADS,/arxiv_data1/oa_pdf/3c/e8/jcen-15-158.PMC3804652.pdf
"2013 September;15(3):164-170 Received : 5 July 2013 Revised : 5 August 2013 Accepted : 8 August 2013 Correspondence to Seung Young Chung Department of Neurosurgery, Eulji University  Hospital, College of Medicine, Eulji University, 1306 Dunsan-dong, Seo-gu, Daejeon 302-799,  Korea Tel : 82-42-611-3442 Fax : 82-42-611-3444 E-mail : neurocsy@eulji.ac.kr T h i s  i s  a n  O p e n  A c c e s s  a r t i c l e  d i s t r i b u t e d  u n d e r  t h e   terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/li-censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the ori ginal work is properly cited.Keywords Middle cerebral artery, Intracranial aneurysm, Dissecting, Three-dimensional  cerebral angiography Journal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2013.15.3.164  Clinical Article INTRODUCTION There are 3 basic surgical techniques for the dis- section and clipping of mi ddle cerebral artery (MCA)  bifurcation aneurysms.",Non-OADS,/arxiv_data1/oa_pdf/10/2f/jcen-15-164.PMC3804653.pdf
"2013 September;15(3):171-176 Received : 10 July 2013 Revised : 12 August 2013 Accepted : 16 August 2013 Correspondence to Sung-Kon Ha Department of Neurosurgery, Korea University  Ansan Hospital, 516, Gojan-dong, Danwon-gu,  Ansan 425-707, Korea Tel : 82-31-412-5053 Fax : 82-31-412-5054 E-mail : sungkha@yahoo.com T h i s  i s  a n  O p e n  A c c e s s  a r t i c l e  d i s t r i b u t e d  u n d e r  t h e   terms of the Creative Commons Attribution Non-  Commercial License (http://creativecommons.org/li-censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the ori ginal work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/84/db/jcen-15-171.PMC3804654.pdf
"Keywords Adiponectin, Cerebral ischemia, Seco ndary inflammatory reaction, MCAO-RJournal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2013.15.3.171  Clinical Article INTRODUCTION The morbidity and mortality rates of ischemic stroke  are high all over the world.",Non-OADS,/arxiv_data1/oa_pdf/84/db/jcen-15-171.PMC3804654.pdf
"2013 September;15(3):177-183 Received : 10 June 2013 Revised : 11 July 2013 Accepted : 25 August 2013 Correspondence to Tae Sun Kim Department of Neurosurgery, Chonnam National University Hospital, 8 Hak-dong, Dong-gu, Gwangju 501-190, Korea Tel : 82-62-220-6607 Fax : 82-62-224-9865 E-mail : taesun1963@yahoo.co.kr T h i s  i s  a n  O p e n  A c c e s s  a r t i c l e  d i s t r i b u t e d  u n d e r  t h e   terms of the Creative Commons Attribution Non-  Commercial License (http://creativecommons.org/li- censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the ori ginal work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/13/80/jcen-15-177.PMC3804655.pdf
"Keywords Subolfactory, Anterior communicating aneurysm Journal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2013.15.3.177  Clinical Article INTRODUCTION Anterior communicating artery (ACoA) is the most  common site for intracranial aneurysms as revealed by landmark clinical studies.4) Despite the high preva- lence of ACoA aneurysms, surgical clipping of ACoA aneurysm can still be challenge to even experienced neurosurgeons because of variable anatomy of the",Non-OADS,/arxiv_data1/oa_pdf/13/80/jcen-15-177.PMC3804655.pdf
"2013 September;15(3):184-190 Received : 9 August 2013 Revised : 24 August 2013 Accepted : 28 August 2013 Correspondence to Yong Cheol Lim Department of Neurosurgery, Ajou University  School of Medicine, 5 San, Woncheon-Dong,  Yongtong-Ku, Suwon 442-721, Korea Tel : 82-31-219-5232 Fax : 82-31-219-5238 E-mail : nsyclim@gmail.com T h i s  i s  a n  O p e n  A c c e s s  a r t i c l e  d i s t r i b u t e d  u n d e r  t h e   terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/li-censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the ori ginal work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/05/44/jcen-15-184.PMC3804656.pdf
"Keywords Multiple aneurysms, Coil embolization, Single-sessionJournal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2013.15.3.184  Clinical Article INTRODUCTION Detection rate of multiple intracranial aneurysms  has significantly increased with recent advances in  imaging techniques.",Non-OADS,/arxiv_data1/oa_pdf/05/44/jcen-15-184.PMC3804656.pdf
"of Korea, 271, Cheon Bo-ro, Uijongbu 480-717, Korea Tel : 82-31-820-3299 Fax : 82-31-846-3117E-mail : doctorwish@hanmail.co.kr T h i s  i s  a n  O p e n  A c c e s s  a r t i c l e  d i s t r i b u t e d  u n d e r  t h e   terms of the Creative Commons Attribution Non-  Commercial License (http://creativecommons.org/li-censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the ori ginal work is properly cited.Keywords Hemorrhagic moyamoya disease, Revascularization surgery, Intracranial  hemorrhage, Surgical resultsJournal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2013.15.3.191  Clinical Article   INTRODUCTION Moyamoya disease (MMD) is  a rare cerebrovascular  disorder characterized by progressive occlusion of the  bilateral supraclinoid internal carotid artery (ICA),  proximal middle cerebral ar tery (MCA), and anterior  cerebral artery (ACA), and a spontaneously devel-oped collateral vascular network at the base of the brain consisting of the so-called moyamoya vessels.",Non-OADS,/arxiv_data1/oa_pdf/3c/98/jcen-15-191.PMC3804657.pdf
"2013 September;15(3):200-205 Received : 30 July 2013 Revised : 22 August 2013 Accepted : 30 August 2013 Correspondence to Chang-Taek Moon Department of Neurosurgery, Konkuk University Medical Center, 120-1, Neungdong-ro, Gwangjin-gu, Seoul143-729, Korea Tel : 82-2-2030-7357 Fax : 82-2-2030-7359 E-mail : 19900032@kuh.ac.kr T h i s  i s  a n  O p e n  A c c e s s  a r t i c l e  d i s t r i b u t e d  u n d e r  t h e   terms of the Creative Commons Attribution Non-  Commercial License (http://creativecommons.org/li- censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the ori ginal work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d5/e2/jcen-15-200.PMC3804658.pdf
"Keywords Intracerebral hematoma, Cerebral aneurysm, Middle cerebral arter yJournal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2013.15.3.200  Clinical Article INTRODUCTION Intracerebral hematoma (ICH) and intra-sylvian hem- atoma (ISH) occur in 35-55% of patients with sub-arachnoid hemorrhage (SAH) from the ruptured middle  cerebral artery (MCA) aneurysms and that hematomas  are associated with poor outcome.",Non-OADS,/arxiv_data1/oa_pdf/d5/e2/jcen-15-200.PMC3804658.pdf
"2013 September;15(3):206-213 Received : 30 July 2013 Revised : 27 August 2013 Accepted : 4 September 2013 Correspondence to Byung-Moon Cho Department of Neurosurgery, Kandong  Sacred Heart Hospital, Hallym University, 445 Gil-Dong, Kangdong-Gu, Seoul 134-701, Korea  Tel : 82-2-2224-2236  Fax : 82-2-473-7387 E-mail : nschbm@hallym.or.kr T h i s  i s  a n  O p e n  A c c e s s  a r t i c l e  d i s t r i b u t e d  u n d e r  t h e   terms of the Creative Commons Attribution Non-  Commercial License (http://creativecommons.org/li- censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the ori ginal work is properly cited.Keywords Posterior reversible encephalopathy syndrome, Radiological findings,  Clinical featuresJournal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2013.15.3.206  Clinical Article INTRODUCTION Posterior reversible encephalopathy syndrome (PRES)  is a clinico-radiological entity characterized by a vary-ing combination of symptoms and signs that include  impaired consciousness, seizure activity, headache, visual abnormalities, nausea/vomiting, and focal neu-rological deficits.",Non-OADS,/arxiv_data1/oa_pdf/20/5b/jcen-15-206.PMC3804659.pdf
"T h i s  i s  a n  O p e n  A c c e s s  a r t i c l e  d i s t r i b u t e d  u n d e r  t h e   terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/li-censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the ori ginal work is properly cited.Keywords Intracerebral hemorrhage, Outcomes, Prognostic factors, Spontaneous,  Young adultJournal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2013.15.3.214  Clinical Article INTRODUCTION Nontraumatic spontaneous intracranial hemorrhage  (ICH) causes significant morbidity and mortality throughout the world.",Non-OADS,/arxiv_data1/oa_pdf/f4/09/jcen-15-214.PMC3804660.pdf
"2013 September;15(3):221-224 Received : 30 January 2013 Revised : 27 February 2013 Accepted : 3 June 2013 Correspondence to Yeong-Bae Lee Department of Neurology, Gachon University Gil Medical Center, 1198 Guwol-dong, Namdong-Gu, Incheon405-760, Korea Tel : 82-32-460-3346 Fax : 82-32-460-3340E-mail : lyb@gilhospital.com T h i s  i s  a n  O p e n  A c c e s s  a r t i c l e  d i s t r i b u t e d  u n d e r  t h e   terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/li-censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the ori ginal work is properly cited.Keywords Subclavian artery, Protein S deficiency, Thoracic outlet syndrome,  Retrograde cerebral infarctionJournal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2013.15.3.221  Case Report INTRODUCTION Cerebral embolism is an important etiology of stroke  in young adults.",Non-OADS,/arxiv_data1/oa_pdf/2f/fa/jcen-15-221.PMC3804661.pdf
"2013 September;15(3):225-228 Received : 24 February 2013 Revised : 9 April 2013 Accepted : 27 June 2013 Correspondence to Yeong-Bae Lee Department of Neurology, Gachon University Gil Medical Center, 1198 Guwol-dong, Namdong-Gu, Incheon405-760, Korea Tel : 82-32-460-3346 Fax : 82-32-460-3340E-mail : lyb@gilhospital.com T h i s  i s  a n  O p e n  A c c e s s  a r t i c l e  d i s t r i b u t e d  u n d e r  t h e   terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/li- censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the ori ginal work is properly cited.Keywords Vertebro-basilar ischemia, Sensori-neural hearing loss, Cerebral infarction,  Sudden hearing loss, Magnetic resonance imaging, Audiometr yJournal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2013.15.3.225  Case Report INTRODUCTION Most sudden onset sensorineural hearing loss occurs  unilaterally, with an the incidence of bilateral involve- ment of less than 5%.1) Various causes, such as in- fection, vascular event, coagulation disorders, neo- plasm, and demyelinating disease, are related to sud- den sensorineural hearing loss, however in most cases  the causes are idiopathic.2) Although rarely reported,  deafness can also be attributed to vertebrobasilar  ischemia.3) The internal auditory artery (IAA) pro- vides the main blood supply to the cochlear nerve  and cochlea.",Non-OADS,/arxiv_data1/oa_pdf/ce/41/jcen-15-225.PMC3804662.pdf
"327 Sosa-Ro, Bucheon 420-717,  Korea Tel : 82-32-340-2259 Fax : 82-32-340-7391 E-mail : armada1997@naver.com T h i s  i s  a n  O p e n  A c c e s s  a r t i c l e  d i s t r i b u t e d  u n d e r  t h e   terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/li-censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the ori ginal work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ed/2f/jcen-15-229.PMC3804663.pdf
"Keywords Aneurysm, Dissection, Stent angioplasty, Vertebral artery Journal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2013.15.3.229  Case Report INTRODUCTION Intracranial vertebral artery dissecting aneurysms  (VADAs) presenting with subarachnoid hemorrhage (SAH) are rare, however, their risks for morbidity, mortality, and rebleeding are high.",Non-OADS,/arxiv_data1/oa_pdf/ed/2f/jcen-15-229.PMC3804663.pdf
"T h i s  i s  a n  O p e n  A c c e s s  a r t i c l e  d i s t r i b u t e d  u n d e r  t h e   terms of the Creative Commons Attribution Non-  Commercial License (http://creativecommons.org/li-censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the ori ginal work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a1/b9/jcen-15-235.PMC3804664.pdf
"Keywords Mycotic aneurysm, Subdural hematoma, Middle cerebral arter yJournal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2013.15.3.235  Case Report INTRODUCTION Mycotic aneurysms are ra re inflammatory neuro- vascular lesions first described in 1855.6) Mycotic  aneurysms account for approximately 2.5 ~ 4.5% of all  intracranial aneurysms and are unique in their natural history, pathologic findings, location and common multiplicity.",Non-OADS,/arxiv_data1/oa_pdf/a1/b9/jcen-15-235.PMC3804664.pdf
"2013 September;15(3):241-245 Received : 25 June 2013 Revised : 6 August 2013 Accepted : 6 August 2013 Correspondence to Kenneth C. Liu Department of Neurological Surgery, University  of Virginia Health System, Charlottesville,  VA 22908, United States of America Tel : 1-434-924-2735 Fax : 1-434-924-9656 E-mail : kcl3j@hscmail.mcc.virginia.edu T h i s  i s  a n  O p e n  A c c e s s  a r t i c l e  d i s t r i b u t e d  u n d e r  t h e   terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/li-censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the ori ginal work is properly cited.Keywords Endovascular procedures, Intracranial aneurysm, Intraoperative complications,  Stents, StrokeJournal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2013.15.3.241  Case Report INTRODUCTION Giant intracranial aneurysms are exceedingly diffi- cult to successfully  treat by either microsurgical or en- dovascular approaches.3)11) The natural history of  giant aneurysms is significantly more malignant than  that of their smaller counterparts.1)13) The pipeline em- bolization device (PED) is a flow-diverting stent de- veloped for treating giant aneurysms via endovas- cular reconstruction of the parent artery.7) A myriad  of single- and multicenter studies have demonstrated  the relative safety and efficacy of the PED.2)8)9)14) Intraprocedural complications during PED deploy- ment are infrequently reported and complications as- sociated with device malfunction are quite rare.6) We  present a case of a completely deployed, malfunc- tioned PED refractory to en dovascular retrieval that  generated thromboembolic sequelae and required mi- crosurgical extraction.",Non-OADS,/arxiv_data1/oa_pdf/30/be/jcen-15-241.PMC3804665.pdf
"T h i s  i s  a n  O p e n  A c c e s s  a r t i c l e  d i s t r i b u t e d  u n d e r  t h e   terms of the Creative Commons Attribution Non-  Commercial License (http://creativecommons.org/li-censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the ori ginal work is properly cited.Keywords Intraventricular pseudoaneurysm, Intraventricular hemorrhage, Lenticulostriate  arter yJournal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2013.15.3.246  Case Report INTRODUCTION Intraventricular aneurysms (IVA) associated with in- traventricular hemorrhage (IVH) are rare.",Non-OADS,/arxiv_data1/oa_pdf/ab/72/jcen-15-246.PMC3804666.pdf
"2013 September;15(3):251-254 Received : 15 July 2013 Revised : 30 July 2013 Accepted : 16 August 2013 Correspondence to Deok Hee Lee  Department of Radiology, Asan Medical  Center, University of Ulsan College of Medicine, Pungnap-2 dong, Songpa-gu,  Seoul 138-736, Korea Tel : 82-2-3010-5598 Fax : 82-2-476-0090  E-mail : dhlee@amc.seoul.kr T h i s  i s  a n  O p e n  A c c e s s  a r t i c l e  d i s t r i b u t e d  u n d e r  t h e   terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/li-censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the ori ginal work is properly cited.Keywords Arteriovenous malformations, Hemangioma, Primary intraosseous vascular  malformation, Klippel-Trenaunay-Weber syndrome Journal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2013.15.3.251  Case Report INTRODUCTION Intraosseous arteriovenous malformation (AVM) is a  rare form of extracranial AVM.5)6) The location most  frequently involved is the craniofacial region, espe- cially the mandible followed by the maxilla.2) Most le- sions present as excessive, recurrent hemorrhage fol- lowing dental eruption or surgical extraction.2) We en- countered a patient with Klippel-Trenaunay syndrome  (KTS) who presented with insidious onset of ipsi- lateral retroorbital pain, conjunctival injection, propto- sis, and diplopia mimicking cavernous sinus dural ar- teriovenous fistula (CSDAVF) and was found to have  an intraosseous AVM involving the skull base.CASE REPORT A 43-year-old female was referred to our hospital  under the impression of a left CSDAVF.",Non-OADS,/arxiv_data1/oa_pdf/ce/2e/jcen-15-251.PMC3804667.pdf
"2013 September;15(3):255-259 Received : 26 June 2013 Revised : 16 July 2013 Accepted : 22 August 2013 Correspondence to Ki-Young Kwon Department of Neurosurgery, Cheongju  St. Mary's Hospital, 589-5 Jujung-dong,  Sangdang-gu, Cheongju 360-568, Korea  Tel : 82-43-219-8467 Fax : 82-43-211-7925 E-mail : k810a@hanmail.net  T h i s  i s  a n  O p e n  A c c e s s  a r t i c l e  d i s t r i b u t e d  u n d e r  t h e   terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/li-censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the ori ginal work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6b/6b/jcen-15-255.PMC3804668.pdf
"Keywords Cavernous malformation, Giant cystJournal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2013.15.3.255  Case Report INTRODUCTION The cavernous malformation (CM), also known as  cavernous angioma or cavernoma, is a vascular mal-formation characterized by the presence of sinus-oid-like capillary vessels containing blood with poor circulation.",Non-OADS,/arxiv_data1/oa_pdf/6b/6b/jcen-15-255.PMC3804668.pdf
"2013 September;15(3):260-266 Received : 24 May 2013 Revised : 15 July 2013 Accepted : 13 August 2013 Correspondence to Sun-il Lee Department of Neurosurgery, Haeundae  Paik Hospital, Inje University College of  Medicine, 1435, Jwa 4-dong, Haeundae-gu, Busan 612-862, Korea Tel : 82-51-797-3805 Fax : 82-51-797-0841E-mail : nssunlee@inje.ac.kr T h i s  i s  a n  O p e n  A c c e s s  a r t i c l e  d i s t r i b u t e d  u n d e r  t h e   terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/li-censes/by-nc/3.0)  which permits unrestricted non-  commercial use, distribution, and reproduction in any  medium, provided the ori ginal work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/04/b8/jcen-15-260.PMC3804669.pdf
"Keywords Paraclinoid aneurysm, Extradural, Anterior clinoidectomy, Pterional craniotom y Journal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2013.15.3.260  Technical Note INTRODUCTION The anterior clinoid proces s (ACP) is the apex por- tion of the lesser wing of the sphenoid bone.",Non-OADS,/arxiv_data1/oa_pdf/04/b8/jcen-15-260.PMC3804669.pdf
"Key Words:  Stomach neoplasms; Therapeutics; Biological markers; Gene expression; Sequence analysisReview Article J Gastric Cancer 2013;13(3):129-135 y http://dx.doi.org/10.5230/jgc.2013.13.3.129 Correspondence to: Jae Yong Cho Department of Medical Oncology, Gangnam Severance Hospital, Yonsei University College of Medicine, 211 Eonju-ro, Gangnam-gu ,  Seoul 135-720, KoreaTel: +82-2-2019-4363, Fax: +82-2-3463-3882E-mail: chojy@yuhs.acReceived May 15, 2013Revised June 18, 2013Accepted June 18, 2013 Copyrights © 2013 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:/ /creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial us e, distribution, and reproduction in any medium, provided the o riginal work is properly cited.Introduction The personalized cancer therapy target aberrations that drive  tumor growth and survival, by administering the right drug comb i- nation for the right person.",Non-OADS,/arxiv_data1/oa_pdf/2c/f0/jgc-13-129.PMC3804671.pdf
"Key Words:  Robotics; Laparoscopy; Gastrectomy; Stomach neoplasmsOriginal Article J Gastric Cancer 2013;13(3):136-148 y http://dx.doi.org/10.5230/jgc.2013.13.3.136 Correspondence to: Woo Jin Hyung Department of Surgery, Yonsei University College of Medicine, 5 0  Yonsei-ro, Seodaemun-gu, Seoul 120-749, KoreaTel: +82-2-2228-2129, Fax: +82-2-313-8289E-mail: wjhyung@yuhs.acReceived July 24, 2013Revised August 27, 2013Accepted August 27, 2013*These authors contributed equally to this article and are join t first  authors.",Non-OADS,/arxiv_data1/oa_pdf/39/4b/jgc-13-136.PMC3804672.pdf
"Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp/ Accessed 18 June, 2007.",Non-OADS,/arxiv_data1/oa_pdf/39/4b/jgc-13-136.PMC3804672.pdf
"Key Words:  Stomach neoplasms; Neoplasm staging; Technology, radiologicOriginal Article J Gastric Cancer 2013;13(3):149-156 y http://dx.doi.org/10.5230/jgc.2013.13.3.149 Correspondence to: In Ho Jeong Department of Surgery, Jeju National University School of Medic ine,  102 Jejudaehak-ro, Jeju 690-756, KoreaTel: +82-64-723-2240, Fax: +82-64-726-0173E-mail: jeong445@jejunu.ac.krReceived August 7, 2013Revised September 1, 2013Accepted September 3, 2013 Copyrights © 2013 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:/ /creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial us e, distribution, and reproduction in any medium, provided the o riginal work is properly cited.Introduction Although the incidence of gastric cancer has been declining  in most industrialized nations, it remains the most prevalent f orm  of cancer in East Asian countries.1,2 In Korea, the incidence of  early gastric cancer (EGC) has increased due to improvements in  diagnostic methods and changes in the concept of routine health   examinations.2 Early detection has led to the introduction of vari- ous tailored and limited therapies for EGC, enhancing survival outcomes.",Non-OADS,/arxiv_data1/oa_pdf/49/d0/jgc-13-149.PMC3804673.pdf
"Key Words:  Stomach neoplasms; Methylation; Genes, p16Original Article J Gastric Cancer 2013;13(3):157-163 y http://dx.doi.org/10.5230/jgc.2013.13.3.157 Correspondence to: Joong-Min Park Department of Surgery, Chung-Ang University Hospital, 102 Heuks eok- ro, Dongjak-gu, Seoul, 156-755, KoreaTel: +82-2-6299-3124, Fax: +82-2-824-7869E-mail: jmpark@cau.ac.krReceived July 15, 2013Revised September 6, 2013Accepted September 9, 2013 Copyrights © 2013 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:/ /creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial us e, distribution, and reproduction in any medium, provided the o riginal work is properly cited.Introduction The most effective method for treatment of gastric cancer is  surgical resection including radical lymph node dissection and combined resection of the invaded organ.",Non-OADS,/arxiv_data1/oa_pdf/70/9e/jgc-13-157.PMC3804674.pdf
"Trial Registration: NCT01088204 (international), NCCCTS-09-448 (Korea) Key Words:  Gastrectomy; Stomach neoplasms; Lymph node excisionJ Gastric Cancer 2013;13(3):164-171  http://dx.doi.org/10.5230/jgc.2013.13.3.164 Correspondence to: Young-Woo Kim Gastric Cancer Branch, Research Institute & Hospital, National Cancer  Center, 323 Ilsan-ro, Ilsandong-gu, Goyang 410-769, Korea Tel: +82-31-920-1635, Fax: +82-31-920-0696 E-mail: gskim@ncc.re.kr Received August 13, 2013 Revised September 13, 2013 Accepted September 13, 2013 Copyrights © 2013 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Introduction Minimally invasive surgery has become a treatment option for  cancer.",Non-OADS,/arxiv_data1/oa_pdf/36/2e/jgc-13-164.PMC3804675.pdf
Randomization is performed as block randomization  in fixed block sizes in a 1 : 1 allocation ratio using a centralized  web-based randomization system (eVelos [http://eresearch.ncc.,OADS,/arxiv_data1/oa_pdf/36/2e/jgc-13-164.PMC3804675.pdf
Comparable interven- tion groups are achieved by block randomization using a web based  randomization tool (eVelos [http://eresearch.ncc.re.kr/eres/jsp/ ereslogin.jsp]).,OADS,/arxiv_data1/oa_pdf/36/2e/jgc-13-164.PMC3804675.pdf
Documentation and data handling All protocol required information collected during this trial is  entered in the electronic case report form (eCRF) using the web  based eVelos system (http://eresearch.ncc.re.kr/eres/jsp/ereslogin.,OADS,/arxiv_data1/oa_pdf/36/2e/jgc-13-164.PMC3804675.pdf
"Key Words:  Estrogens; Receptors, estrogen; Stomach neoplasms; Cell lineOriginal Article J Gastric Cancer 2013;13(3):172-178 y http://dx.doi.org/10.5230/jgc.2013.13.3.172 Correspondence to: Seong-Heum Park Department of Surgery, Korea University Asan Hospital, 73 Incho n-ro,  Seongbuk-gu, Seoul 136-705, KoreaTel: +82-2-920-6834, Fax: +82-2-928-1631E-mail: pshchw@korea.ac.krReceived June 1, 2013Revised September 13, 2013Accepted September 13, 2013 Copyrights © 2013 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:/ /creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial us e, distribution, and reproduction in any medium, provided the o riginal work is properly cited.Introduction Estrogens regulate the growth, differentiation, and functioning   of diverse target tissues, both within and outside of the repro duc- tive system.1 Although the stomach is not known as a direct target  organ of sex hormones, both epidemiologic and animal stud-ies suggest that gastric cancer may be estrogen-sensitive.",Non-OADS,/arxiv_data1/oa_pdf/98/43/jgc-13-172.PMC3804676.pdf
Primers were de- signed and synthesized by Primer 3 (http://simgene.com/Primer3) .,OADS,/arxiv_data1/oa_pdf/98/43/jgc-13-172.PMC3804676.pdf
"Key Words:  Stomach cancer; Gastrectomy; Pancreatic fistula; Risk factorsOriginal Article J Gastric Cancer 2013;13(3):179-184 y http://dx.doi.org/10.5230/jgc.2013.13.3.179 Correspondence to: Do Joong Park Department of Surgery, Seoul National University Bundang Hospit al,  Seoul National University College of Medicine, 82 Gumi-ro 173be on-gil,  Bundang-gu, Seongnam 463-707, KoreaTel: +82-31-787-7097, Fax: +82-31-787-4078E-mail: djpark@snubh.orgReceived July 21, 2013Revised September 15, 2013Accepted September 16, 2013 Copyrights © 2013 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:/ /creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial us e, distribution, and reproduction in any medium, provided the o riginal work is properly cited.Introduction Gastric cancer is one of the leading causes of cancer death  worldwide, especially in Eastern Asia.1 Despite the recent advances  in chemotherapy and radiotherapy, surgical resection is still i mpor-tant for the treatment of gastric cancer.2 Subtotal or total gastrec- tomy with radical lymph node dissection has been considered as standard surgical treatment for gastric cancer.",Non-OADS,/arxiv_data1/oa_pdf/32/ef/jgc-13-179.PMC3804677.pdf
"Key Words:  Neurofibroma; Stomach neoplasms; Lymphatic metastasisCase Report J Gastric Cancer 2013;13(3):185-187 y http://dx.doi.org/10.5230/jgc.2013.13.3.185 Correspondence to: Sungsoo Kim Department of Surgery, Chosun University College of Medicine, 3 65  Pilmun-daero, Dong-gu, Gwangju 501-717, KoreaTel: +82-62-220-3010, Fax: +82-62-228-3441E-mail: sungsoo73@chosun.ac.krReceived August 9, 2013Revised August 14, 2013Accepted August 18, 2013 Copyrights © 2013 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:/ /creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial us e, distribution, and reproduction in any medium, provided the o riginal work is properly cited.Introduction Compared to advanced gastric cancer, early gastric cancer (EGC)   shows a favorable prognosis, with 5-year survival rates exceedi ng  94%.1  Lymph node (LN) status is the most important prognostic fac- tor.",Non-OADS,/arxiv_data1/oa_pdf/cc/8c/jgc-13-185.PMC3804678.pdf
"Key Words:  Stomach neoplasms; Laparoscopy; Gastrectomy; Intestinal malrotation, familialCase Report J Gastric Cancer 2013;13(3):188-191 y http://dx.doi.org/10.5230/jgc.2013.13.3.188 Correspondence to: Woo Jin Hyung Department of Surgery, Yonsei University College of Medicine, 5 0  Yonsei-ro, Seodaemun-gu, Seoul 120-752, KoreaTel: +82-2-2228-2129, Fax: +82-2-313-8289E-mail: wjhyung@yuhs.acReceived July 30, 2013Revised September 15, 2013Accepted September 16, 2013 Copyrights © 2013 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:/ /creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial us e, distribution, and reproduction in any medium, provided the o riginal work is properly cited.Introduction Intestinal malrotation is a rare congenital anomaly referring t o  incomplete rotation of the primitive midgut around the superior   mesenteric artery (SMA) during fetal development.",Non-OADS,/arxiv_data1/oa_pdf/2a/3e/jgc-13-188.PMC3804679.pdf
"Key Words:  Gastrointestinal stromal tumors; Lymph nodes; Neoplasm metastasisCase Report J Gastric Cancer 2013;13(3):192-195 y http://dx.doi.org/10.5230/jgc.2013.13.3.192 Correspondence to: Woong Lee Department of Surgery, Seonam University College of Medicine, 4 39  Chunhyang-ro, Namwon 590-711, KoreaTel: +82-62-370-7750, Fax: +82-62-371-3092E-mail: dkuma@naver.comReceived July 8, 2013Revised July 23, 2013Accepted August 2, 2013 Copyrights © 2013 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:/ /creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial us e, distribution, and reproduction in any medium, provided the o riginal work is properly cited.Introduction Gastrointestinal stromal tumor (GIST) is very rare tumor arisen   from gastrointestinal tract that constitutes 0.1%~3.0% of gastr oin- testinal malignant tumor.1-5 GISTs may be occurred at the esopha- gus, stomach, small intestine, large intestine, anal canal, mes entery,  greater omentum, and retorperitoneum.6 The small intestine consti- tutes 80% of the length, and 90% of the mucosal surface area of  the  digestive tract.",Non-OADS,/arxiv_data1/oa_pdf/b0/44/jgc-13-192.PMC3804680.pdf
"Neutrophil-to-Lymphocyte Ratio in Prognosis of  Gastric Cancer Sevket Balta, Murat Unlu, Zekeriya Arslan, and Sait Demırkol Department of Cardiology, Gulhane School of Medicine, Ankara, TurkeyLetter to the Editor J Gastric Cancer 2013;13(3):196-197 y http://dx.doi.org/10.5230/jgc.2013.13.3.196 Correspondence to: Sevket Balta Department of Cardiology, Gulhane School of Medicine, Tevfik Sa glam  St., 06018 Etlik-Ankara, TurkeyTel: +90-312-3044281, Fax: +90-312-3044250E-mail: drsevketb@gmail.comReceived July 17, 2013Accepted August 14, 2013 Copyrights © 2013 by The Korean Gastric Cancer Association www .jgc-online.org This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:/ /creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted noncommercial us e, distribution, and reproduction in any medium, provided the o riginal work is properly cited.Dear Editor: We have read with great interest the article ‘Clinical Significance  of Preoperative Inflammatory Parameters in Gastric Cancer Patients’ by Lee  et al.",Non-OADS,/arxiv_data1/oa_pdf/41/d3/jgc-13-196.PMC3804681.pdf
"2013;45(3):155-161 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2013.45.3.155  Yasushi Nagata, MD, PhD  Department of Radiation Oncology,  Hiroshima University, Hiroshima, Japan Stereotactic body radiation therapy (SBRT) is a newly developed technique currently  in clinical use.",Non-OADS,/arxiv_data1/oa_pdf/d5/28/crt-45-155.PMC3804726.pdf
"Key words Radiosurgery, Early stage lung cancer,  Stereotactic body radiation therapy,  Stereotactic ablative radiotherapy,  Stereotactic radiotherapy, Lung neoplasms,  Conformal radiotherapy Review Article Open Access  Stereotactic Body Radiotherapy for Early Stage Lung Cancer  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │155 Copyright ⓒ2013 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d5/28/crt-45-155.PMC3804726.pdf
"2013;45(3):162-171 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2013.45.3.162  Kyu-Won Jung, MS 1 Young-Joo Won, PhD 1 Hyun-Joo Kong, MS 1 Chang-Mo Oh, MD, PhD 1 Aesun Shin, MD, PhD 1,2  Jin-Soo Lee, MD, PhD 1 1The Korea Central Cancer Registry,  Division of Cancer Registration  and Surveillance, National Cancer Center,  2Molecular Epidemiology Branch,  National Cancer Center, Goyang, Korea Original Article Open Access  Survival of Korean Adult Cancer Patients by Stage at Diagnosis,  2006-2010: National Cancer Registry Study  Purpose Although the cancer stage at diagnosis is the most important prognostic factor for  patients’ survival, there are few population-based estimates of stage-specific survival  outcome, especially in Asian countries.",Non-OADS,/arxiv_data1/oa_pdf/ea/f1/crt-45-162.PMC3804727.pdf
"│http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │162 Copyright ⓒ2013 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ea/f1/crt-45-162.PMC3804727.pdf
"2013;45(3):172-177 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2013.45.3.172  Geundoo Jang, MD, PhD 1 Hun Ho Song, MD, PhD 1 Keon Uk Park, MD, PhD 2 Hyeong Su Kim, MD 3 Dae Ro Choi, MD 4 Jung Hye Kwon, MD, PhD 1 Ho Young Kim, MD, PhD 5 Boram Han, MD 5 Jung Han Kim, MD, PhD 3 Joo Young Jung, MD, PhD 6 Hyo Jung Kim, MD, PhD 5 Dae Young Zang, MD, PhD 5 1Department of Internal Medicine,  Hallym University Kangdong Sacred Heart Hospital,  Hallym University College of Medicine, Seoul,  2Department of Internal Medicine,  Keimyung University  Dongsan Medical Center, Keimyung University  School of Medicine, Daegu,  3Department of Internal Medicine,  Hallym University Kangnam Sacred Heart Hospital,  Hallym University College of Medicine, Seoul,  4Department of Internal Medicine,  Hallym University Chuncheon Sacred Heart Hospital,  Hallym University College of Medicine, Chuncheon,  5Department of Internal Medicine,  Hallym University Sacred Heart Hospital,  Hallym University College of Medicine, Anyang,  6Department of Internal Medicine,  Hallym University Dongtan Sacred Heart Hospital,  Hallym University College of Medicine, Dongtan,  Korea Original Article Open Access  A Phase II Study to Evaluate the Efficacy of Ramosetron, Aprepitant,  and Dexamethasone in Preventing Cisplatin-Induced Nausea and  Vomiting in Chemotherapy-Naïve Cancer Patients  Purpose Combination therapy with aprepitant, serotonin receptor antagonist, and steroids  improves the complete response rate of both acute and delayed chemotherapy-  induced nausea and vomiting (CINV).",Non-OADS,/arxiv_data1/oa_pdf/73/43/crt-45-172.PMC3804728.pdf
"│http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │172 Copyright ⓒ2013 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/73/43/crt-45-172.PMC3804728.pdf
"2013;45(3):178-185 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2013.45.3.178  Bhumsuk Keam, MD 1,2  Dong-Wan Kim, MD, PhD 1,2  Jin Hyun Park, MD 1 Jeong-Ok Lee, MD 1 Tae Min Kim, MD, PhD 1,2  Se-Hoon Lee, MD, PhD 1,2  Doo Hyun Chung, MD, PhD 3 Dae Seog Heo, MD, PhD 1,2  1Department of Internal Medicine,  Seoul National University Hospital,  Seoul National University  College of Medicine,  2Cancer Research Institute,  Seoul National University  College of Medicine,  3Department of Pathology,  Seoul National University Hospital,  Seoul National University  College of Medicine, Seoul, Korea Original Article Open Access  How Molecular Understanding Affects to Prescribing Patterns and  Clinical Outcome of Gefitinib in Non-small Cell Lung Cancer?",Non-OADS,/arxiv_data1/oa_pdf/9c/40/crt-45-178.PMC3804729.pdf
"At that time, researchers were aware that the response rate  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │178 Copyright ⓒ2013 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9c/40/crt-45-178.PMC3804729.pdf
"2013;45(3):186-192 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2013.45.3.186  Mi-Joo Chung, MD  Su-Mi Chung, MD  Ji-Yoon Kim, MD  Mi-Ryeong Ryu, MD  Department of Radiation Oncology,  The Catholic University of Korea,  College of Medicine, Seoul, Korea  Correspondence: Mi-Ryeong Ryu, MD  Department of Radiation Oncology,  Uijeongbu St. Mary’s Hospital,  271 Cheonbo-ro, Uijeongbu 480-717, Korea  Tel: 82-31-820-3517  Fax: 82-31-847-3059  E-mail: mrryu@catholic.ac.kr  Received  October 18, 2012  Accepted  November 30, 2012 Purpose The purpose of this retrospective study was to identify factors predictive of survival  in rectal cancer patients who received surgery with curative intent after preoperative  chemoradiotherapy (CRT).",Non-OADS,/arxiv_data1/oa_pdf/0f/57/crt-45-186.PMC3804730.pdf
"These advances have translated into improved rates  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │186 Copyright ⓒ2013 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0f/57/crt-45-186.PMC3804730.pdf
"2013;45(3):193-201 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2013.45.3.193  Hee Seung Kim, MD 1 Taehun Kim, MD 1 Eung Seok Lee, MD 1 Hak Jae Kim, MD, PhD 2 Hyun Hoon Chung, MD, PhD 1 Jae Weon Kim, MD, PhD 1 Yong Sang Song, MD, PhD 1,3,4  Noh Hyun Park, MD, PhD 1 Departments of 1Obstetrics and Gynecology  and 2Radiation Oncology,  Seoul National University  College of Medicine,  3Cancer Research Institute,  Seoul National University  College of Medicine,  4Major in Biomodulation,  World Class University,  Seoul National University, Seoul, Korea Original Article Open Access  Impact of Chemoradiation on Prognosis in Stage IVB Cervical Cancer  with Distant Lymphatic Metastasis  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │Copyright ⓒ2013 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/09/b6/crt-45-193.PMC3804731.pdf
Available from: http://ctep.cancer.gov/protocolDe - velopment/electronic_applications/ctc.htm#ctc_30.,Non-OADS,/arxiv_data1/oa_pdf/09/b6/crt-45-193.PMC3804731.pdf
"2013;45(3):202-209 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2013.45.3.202  Sanghyuk Song, MD 1 Eui Kyu Chie, MD 1,2  Hak Jae Kim, MD 1 Chang-Hyun Kang, MD 3 Young Tae Kim, MD 3 Joo Hyun Kim, MD 3 Charn Il Park, MD 1 1Department of Radiation Oncology,  Seoul National University  College of Medicine,  2Institute of Radiation Medicine,  Medical Research Center,  Seoul National University,  3Department of Thoracic and  Cardiovascular Surgery,  Seoul National University  College of Medicine, Seoul, Korea Original Article Open Access  Role of Postoperative Radiotherapy for Microscopic Margin  Involvement in the Squamous Cell Carcinoma of Esophagus  Purpose The objective of this study was to assess the effect of postoperative radiotherapy on  the outcome of esophageal cancer with microscopically positive resection margin by  comparing the results with those of patients with negative resection margin.",Non-OADS,/arxiv_data1/oa_pdf/07/56/crt-45-202.PMC3804732.pdf
"However, no randomized prospective study validating the  role of PORT for esophageal cancer with MPRM has been  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │202 Copyright ⓒ2013 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/07/56/crt-45-202.PMC3804732.pdf
"2013;45(3):210-219 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2013.45.3.210  Young Ae Cho, PhD, MPH 1 Mi-Kyung Sung, PhD 2 Jee-Young Yeon, PhD 2 Jungsil Ro, MD, PhD 3 Jeongseon Kim, PhD 1 1Molecular Epidemiology Branch,  National Cancer Center, Goyang,  2Department of Food and Nutrition,  Sookmyung Women's University, Seoul,  3Center for Breast Cancer,  National Cancer Center, Goyang, Korea Purpose Inflammation within the tumor microenvironment has been reported to show an  association with poor prognosis in breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/a2/fe/crt-45-210.PMC3804733.pdf
"Many studies and reviews have demonstrated an  association of increased levels of circulating interleukin  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │210 Copyright ⓒ2013 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a2/fe/crt-45-210.PMC3804733.pdf
"2013;45(3):220-225 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2013.45.3.220  Original Article Open Access  Evaluation of Prescribing Medications for Terminal Cancer Patients  near Death: Essential or Futile  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │220 Copyright ⓒ2013 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2a/fe/crt-45-220.PMC3804734.pdf
"2013;45(3):226-233 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2013.45.3.226  Sun Min Lim, MD 1 Hyeon Chang Kim, MD, PhD 2 Soohyeon Lee, MD 1 1Division of Medical Oncology,  Department of Internal Medicine,  2Department of Preventive Medicine,  Yonsei University College of Medicine,  Seoul, Korea Original Article Open Access  Psychosocial Impact of Cancer Patients on Their Family Members  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +   +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  +  + Correspondence: Soohyeon Lee, MD  Division of Medical Oncology,  Department of Internal Medicine,  Yonsei University College of Medicine,  50 Yonsei-ro, Seodaemun-gu,  Seoul 120-752, Korea  Tel: 82-2-2228-8127    Fax: 82-2-393-3653  E-mail: socmed@yuhs.ac  Received  January 25, 2013  Accepted  April 4, 2013 Purpose A population-based study was conducted in order to examine the characteristics of  family members of cancer patients in comparison with the general population and  also to evaluate the psychosocial impact of cancer patients on their family members.",Non-OADS,/arxiv_data1/oa_pdf/ef/5e/crt-45-226.PMC3804735.pdf
"To date, many studies have been conducted for evaluation  of the burden of caregivers in chronic diseases such as stroke  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │226 Copyright ⓒ2013 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ef/5e/crt-45-226.PMC3804735.pdf
"2013;45(3):234-238 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2013.45.3.234  Nuri Karadurmus, MD 1 Selmin Ataergin, MD 1 Gokhan Erdem, MD 1 Mustafa Cakar, MD 2 Ozdes Emer, MD 3 Sukru Ozaydin, MD 1 Mustafa Ozturk, MD 1 Mukerrem Safali, MD 4 Fikret Arpaci, MD 1 Departments of 1Medical Oncology,  2Internal Medicine, 3Nuclear Medicine,  and 4Pathology, Gulhane School of Medicine,  Ankara, Turkey  Correspondence: Nuri Karadurmus, MD  Department of Medical Oncology,  Gulhane School of Medicine, Asagıeglence,  Etlik, Ankara 06018, Turkey  Tel: 90-536-6401020  Fax: 90-312-3044159  E-mail: drnkaradurmus@yahoo.com  Received  August 3, 2012  Accepted  September 24, 2012 The central nervous system (CNS) is an important area of involvement for both high-  grade, aggressive primary and secondary lymphomas.",Non-OADS,/arxiv_data1/oa_pdf/95/e2/crt-45-234.PMC3804736.pdf
"A plain chest radiography revealed  massive bilateral pleural effusion and the thoracentesis fluid  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │234 Copyright ⓒ2013 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/95/e2/crt-45-234.PMC3804736.pdf
"2013;45(3):239-243 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2013.45.3.239  Han-Sang Lee, MD 1 Taewan Kim, MD 1 Jin-Sook Kim, MD 1 Hye Ran Lee, MD 1 Mee Joo, MD 2 Ji Yeon Park, MD 3 Seong Yoon Yi, MD 1 Department of 1Internal Medicine  and 2Pathology, Inje University  Ilsan Paik Hospital, Inje University  College of Medicine, Goyang,  3Department of Radiology,  Kangbuk Samsung Hospital,  Sungkyunkwan University School  of Medicine, Seoul, Korea  Correspondence: Seong Yoon Yi, MD  Departments of Internal Medicine,  Inje University Ilsan Paik Hospital,  Inje University College of Medicine,  170 Juhwa-ro, Ilsanseo-gu,  Goyang 411-706, Korea  Tel: 82-31-910-7200  Fax: 82-31-910-7219  E-mail: Dr-Yi@paik.ac.kr  Received  December 13, 2011  Accepted  February 27, 2012 Angiomatoid fibrous histiocytoma (AFH) is a rare soft tissue tumor, with a low-grade  malignant potential, occurring predominantly in children and young adults.",Non-OADS,/arxiv_data1/oa_pdf/e6/60/crt-45-239.PMC3804737.pdf
"This is a case report on AFH occur - ring as a second tumor in a young adult who underwent  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │239 Copyright ⓒ2013 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e6/60/crt-45-239.PMC3804737.pdf
"2013;45(3):244-249 pISSN 1598-2998, eISSN 2005-9256  http://dx.doi.org/10.4143/crt.2013.45.3.244  Ji-won Yi, MD  Hyo-jeong Kim, MD  Young-jin Choi, MD  Young-mi Seol, MD  Dong-hwahn Kahng, MD  Yu-yi Choi, MD  Eun-kyoung Park, MD  Department of Internal Medicine,  Pusan National University Hospital,  Pusan University College of Medicine,  Busan, Korea  Correspondence: Young-jin Choi, MD  Department of Internal Medicine,  Pusan National University Hospital,  Pusan University College of Medicine,  179 Gudeok-ro, Seo-gu, Busan 602-739, Korea  Tel: 82-51-240-7710  Fax: 82-51-254-3127  E-mail: chyj@pnuh.co.kr  Received  July 16, 2012  Accepted  October 8, 2012 A 37-year-old male presented with a mass measuring 2.5 cm in size in the midbrain  and obstructive hydrocephalus, which had manifested as a headache and dizziness.",Non-OADS,/arxiv_data1/oa_pdf/4b/ce/crt-45-244.PMC3804738.pdf
"Part of the tumor was initially removed through  │http://www.cancerresearchandtreatment.org │ │http://www.e-crt.org │244 Copyright ⓒ2013 by  the Korean Cancer Association  This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/  licenses/by-nc/3.0/)which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4b/ce/crt-45-244.PMC3804738.pdf
"10       http://www.medsci.org  1602  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(12): 1602 -1607.  doi: 10.7150/ ijms.6526   Research Paper   Immunostaining of p16INK4a/Ki-67 and L1 Capsid Protein  on Liquid- based Cytology Specimens Obtained from  ASC- H and LSIL- H Cases   Seung Won Byun1, Ahwon Lee2, Suyeon Kim2, Yeong Jin Choi2, Youn Soo Lee2, Jong Sup Park1   1.",Non-OADS,/arxiv_data1/oa_pdf/6e/43/ijmsv10p1602.PMC3804785.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/6e/43/ijmsv10p1602.PMC3804785.pdf
"10     http://www.medsci.org  1603  cervical cancer have declined dramatically [2].Human  papillomavirus (HPV) infection is necessary for ce r- vical cancer development, but most HPV infections are transient and asymptomatic.",Non-OADS,/arxiv_data1/oa_pdf/6e/43/ijmsv10p1602.PMC3804785.pdf
"10     http://www.medsci.org  1604  Immunocytochemical staining for HPV L1   capsid protein  Immunocytochemistry for the presence of L1  capsid protein was performed using the Cytoactive®  HPV L1 screening set (Cytoimmun Diagnostics  GmbH, Pirmasens, Germany) according to manufa c- turer’s protocols  [9].",Non-OADS,/arxiv_data1/oa_pdf/6e/43/ijmsv10p1602.PMC3804785.pdf
"10     http://www.medsci.org  1605  for 16,18 -HPV.",Non-OADS,/arxiv_data1/oa_pdf/6e/43/ijmsv10p1602.PMC3804785.pdf
10     http://www.medsci.org  1606        Fig 3 .,Non-OADS,/arxiv_data1/oa_pdf/6e/43/ijmsv10p1602.PMC3804785.pdf
"10     http://www.medsci.org  1607  INK4a/Ki-67 and L1 capsid protein (+/ -) result, we  predicted a follow -up CIN2+ with 100% sensitivity  and 100% NPV,  but with low specificity (53.1%) and  low PPV (55.9%).",Non-OADS,/arxiv_data1/oa_pdf/6e/43/ijmsv10p1602.PMC3804785.pdf
"10       http://www.medsci.org  1608  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(12): 1608 -1614.  doi: 10.7150/ ijms.6496  Research Paper   A Comparative Study on Morphochemical Properties  and Osteogenic Cell Differentiation within Bone Graft  and Cora l Graft Culture Systems  Subramaniam Puvaneswary, Hanumantha Rao Balaji Raghavendran, Nurul Syuhada Ibrahim, Malliga  Raman Murali, Azhar Mahmood Merican,  T. Kamarul   Tissue Engineering Group (TEG), Department of Orthopaedic Surgery, NOCERAL, Faculty of Medicine, University of Malaya, Kuala  Lumpur -50603, Malaysia.",Non-OADS,/arxiv_data1/oa_pdf/1d/79/ijmsv10p1608.PMC3804786.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3 .0/).,Non-OADS,/arxiv_data1/oa_pdf/1d/79/ijmsv10p1608.PMC3804786.pdf
10     http://www.medsci.org  1609  ulation of gene expression in CG seeded with human  osteoblast cell line CRL 1543 in vitro  [5].,Non-OADS,/arxiv_data1/oa_pdf/1d/79/ijmsv10p1608.PMC3804786.pdf
"10     http://www.medsci.org  1610  pernatants was isolated using an RNeasy Mini Kit,  according to the manufacturer’s instructions.",Non-OADS,/arxiv_data1/oa_pdf/1d/79/ijmsv10p1608.PMC3804786.pdf
10       http://www.medsci.org  1611    Fig 1.,Non-OADS,/arxiv_data1/oa_pdf/1d/79/ijmsv10p1608.PMC3804786.pdf
10     http://www.medsci.org  1612    Fig 3.,Non-OADS,/arxiv_data1/oa_pdf/1d/79/ijmsv10p1608.PMC3804786.pdf
10     http://www.medsci.org  1613  which CG presented better expression of osteogenic  marker and gene expression [9].,OADS,/arxiv_data1/oa_pdf/1d/79/ijmsv10p1608.PMC3804786.pdf
"10       http://www.medsci.org  1614  Furthermore, the Runx -2 expression was signi f- icantly higher  day 7 in CG when compared to BG   where as the expres sions of other genes were rel a- tively the same between BG and CG [12 -14].In  addi- tion, the results obtained in the present study con- firmed upregulation of integrin in early time point.",Non-OADS,/arxiv_data1/oa_pdf/1d/79/ijmsv10p1608.PMC3804786.pdf
"10       http://www.medsci.org  1615  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(12): 1615 -1624.  doi: 10.7150/ ijms.6635  Research Paper   Interaction of RAS Activation and Lipid Disorders A c- celerates the Progression of Glomerulosclerosis   Kun -Ling Ma1, Jie Ni1, Chang -Xian Wang2, Jing Liu1, Yang Zhang1, Yu Wu1, Lin -Li Lv1, Xiong -Zhong R u- an3, Bi-Cheng Liu1  1.",Non-OADS,/arxiv_data1/oa_pdf/03/a9/ijmsv10p1615.PMC3804787.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/03/a9/ijmsv10p1615.PMC3804787.pdf
"10     http://www.medsci.org  1616  cluding cell survival, for a wide variety of cell types,  such as glomerular mesangial cells (3), suggesting that  the development of glomerulosclerosis may reﬂect the  disruption of ce llular signaling that is secondary to  the altered composition of the ECM.",Non-OADS,/arxiv_data1/oa_pdf/03/a9/ijmsv10p1615.PMC3804787.pdf
10     http://www.medsci.org  1617  Quantitative measurements of intracellular  free cholesterol/cholesterol ester   Quantitat ive measurements of intracellular total  and free cholesterol were analyzed using the method  described by Gamble et al.,OADS,/arxiv_data1/oa_pdf/03/a9/ijmsv10p1615.PMC3804787.pdf
10     http://www.medsci.org  1618  Statistical analysis   All data were expressed as the mean ± the  standard error of the mean (SEM).,OADS,/arxiv_data1/oa_pdf/03/a9/ijmsv10p1615.PMC3804787.pdf
"10       http://www.medsci.org  1619  Ang II disrupted LDLr feedback regulation in  HMCs   To gain further insight into the mechanisms  regulating these phenomena, we studied the effects of  Ang II on the LDLr pathway, which mediates chole s- terol uptake.",Non-OADS,/arxiv_data1/oa_pdf/03/a9/ijmsv10p1615.PMC3804787.pdf
10     http://www.medsci.org  1620    Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/03/a9/ijmsv10p1615.PMC3804787.pdf
10     http://www.medsci.org  1621    Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/03/a9/ijmsv10p1615.PMC3804787.pdf
10     http://www.medsci.org  1622    Figure 5.,Non-OADS,/arxiv_data1/oa_pdf/03/a9/ijmsv10p1615.PMC3804787.pdf
"10       http://www.medsci.org  1623  Discussion   Some studies have reported that RAS activation  combined with dyslipid emia plays an important role  in the development of glomerulosclerosis (11, 12).",Non-OADS,/arxiv_data1/oa_pdf/03/a9/ijmsv10p1615.PMC3804787.pdf
"10     http://www.medsci.org  1624  morphogenesis, migration, cell cycle progression, and  cell growth or death, are common features of glome r- ular diseases.",Non-OADS,/arxiv_data1/oa_pdf/03/a9/ijmsv10p1615.PMC3804787.pdf
"10       http://www.medsci.org  1625  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(12): 1625-1631.  doi: 10.7150/ ijms.6824  Research Paper   Risk Factors for Invasive Pulmonary Aspergillosis and  Hospital Mortality in Acute -On-Chronic Liver Failure  Patients: A Retrospective -Cohort Study   Jiajia Chen, Qing Yang, Jianrong Huang, Lanjuan  Li1, 2,  1.",Non-OADS,/arxiv_data1/oa_pdf/d2/85/ijmsv10p1625.PMC3804788.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/d2/85/ijmsv10p1625.PMC3804788.pdf
10     http://www.medsci.org  1626  tissue disease have a low risk for IPA [1-3].,Non-OADS,/arxiv_data1/oa_pdf/d2/85/ijmsv10p1625.PMC3804788.pdf
10     http://www.medsci.org  1627  survival time for patients with ACLF was defined as  the period from diagnosis of liver failure to death or  the end of the study (30 July 2012).,Non-OADS,/arxiv_data1/oa_pdf/d2/85/ijmsv10p1625.PMC3804788.pdf
"10     http://www.medsci.org  1628  hepatic encephalopathy ( p = 0.001), and s teroid use ( p  = 0.000) were independent risk factors associated with  IPA (Table 2).",Non-OADS,/arxiv_data1/oa_pdf/d2/85/ijmsv10p1625.PMC3804788.pdf
10     http://www.medsci.org  1629  Table 3.,Non-OADS,/arxiv_data1/oa_pdf/d2/85/ijmsv10p1625.PMC3804788.pdf
10     http://www.medsci.org  1630  liver failure [8].,Non-OADS,/arxiv_data1/oa_pdf/d2/85/ijmsv10p1625.PMC3804788.pdf
"10     http://www.medsci.org  1631  IPA, antifungal therapy should be initiated immed i- ately .",Non-OADS,/arxiv_data1/oa_pdf/d2/85/ijmsv10p1625.PMC3804788.pdf
"10       http://www.medsci.org  1632  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(12): 1632 -1638.  doi: 10.7150/ ijms.6710  Research Paper   Incidence, Clinical, Microbiological Features and Ou t- come of Bloodstream Infections in Patients Undergoing  Hemodialysis  Maria  Fysaraki2, George Samonis1, Antonis  Valachis1, Eugenios  Daphnis2, Drosos  E. Karageorgopoulos3,6,7,  Matthew E. Falagas3,4,5, Kostas Stylianou2, Diamantis P. Kofteridis1  1.",Non-OADS,/arxiv_data1/oa_pdf/4d/7b/ijmsv10p1632.PMC3804789.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/4d/7b/ijmsv10p1632.PMC3804789.pdf
"10     http://www.medsci.org  1633  Impaired immunity due to renal failure, como r- bidities, malnourishment that increase the virulence  and the adherence properties of hospital bacteria as  well as the breakdown of the protective anatomical barriers due to repeated intravascular intervention  required for haemodialysis, represent the main rea- sons for the high prevalence of bloodstr eam infection  in those patients [3,6 -8].",Non-OADS,/arxiv_data1/oa_pdf/4d/7b/ijmsv10p1632.PMC3804789.pdf
"10     http://www.medsci.org  1634  eter with or without a positive peripheral blood cu l- ture, in the presence of systemic symptoms of infe c- tion with no other source of infection identified.",Non-OADS,/arxiv_data1/oa_pdf/4d/7b/ijmsv10p1632.PMC3804789.pdf
"10     http://www.medsci.org  1635  Infection rates and comparisons between a c- cess types   Regarding t he type of vascular access, 107 p a- tients (37,5%) had AV fistulas, 32 (11%) AV graft, 104  (36.%) temporary  and 42 (15%) permanent catheter.",Non-OADS,/arxiv_data1/oa_pdf/4d/7b/ijmsv10p1632.PMC3804789.pdf
"10     http://www.medsci.org  1636  The total number of pathogens isolated, inclu d- ing both uni - and polymicrobial episodes was 162.",OADS,/arxiv_data1/oa_pdf/4d/7b/ijmsv10p1632.PMC3804789.pdf
"10     http://www.medsci.org  1637  arteriovenous  fistulas and grafts were associated with  the lowest cumulative rates of infection, followed by  permanent catheters, while temporary central venous  catheters were associated with the highest ones.",Non-OADS,/arxiv_data1/oa_pdf/4d/7b/ijmsv10p1632.PMC3804789.pdf
http://www.usrds.org/20 08/pdf/V2_06_2008.pdf.,Non-OADS,/arxiv_data1/oa_pdf/4d/7b/ijmsv10p1632.PMC3804789.pdf
10     http://www.medsci.org  1638  2.,Non-OADS,/arxiv_data1/oa_pdf/4d/7b/ijmsv10p1632.PMC3804789.pdf
"10       http://www.medsci.org  1649  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(12): 1649 -1657.  doi: 10.7150/ ijms.6395  Review  Mammalian Sperm Fertility Related Proteins   Ali Ashrafzadeh1, Saiful Anuar Karsani2 and Sheila Nathan1  1.",Non-OADS,/arxiv_data1/oa_pdf/b1/e3/ijmsv10p1649.PMC3804790.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/b1/e3/ijmsv10p1649.PMC3804790.pdf
10     http://www.medsci.org  1650  Proteomics approaches are promising in the  identification of proteins associated with sperm ferti l- ity.,Non-OADS,/arxiv_data1/oa_pdf/b1/e3/ijmsv10p1649.PMC3804790.pdf
10     http://www.medsci.org  1651  Table 2.,Non-OADS,/arxiv_data1/oa_pdf/b1/e3/ijmsv10p1649.PMC3804790.pdf
10       http://www.medsci.org  1652  Table 3.,Non-OADS,/arxiv_data1/oa_pdf/b1/e3/ijmsv10p1649.PMC3804790.pdf
10       http://www.medsci.org  1653  Table 5.,Non-OADS,/arxiv_data1/oa_pdf/b1/e3/ijmsv10p1649.PMC3804790.pdf
10     http://www.medsci.org  1654  acrosome reaction.,Non-OADS,/arxiv_data1/oa_pdf/b1/e3/ijmsv10p1649.PMC3804790.pdf
10     http://www.medsci.org  1655  menogelin II and fibronectin are abundant in seminal  plasma and trap the sperm in the gel to protect them  from physical damage .,Non-OADS,/arxiv_data1/oa_pdf/b1/e3/ijmsv10p1649.PMC3804790.pdf
10     http://www.medsci.org  1656  fully accurate measurements of all proteins present as  separation of a complex mixture of protein and pe p- tides still remains one of the most difficult challenges.,Non-OADS,/arxiv_data1/oa_pdf/b1/e3/ijmsv10p1649.PMC3804790.pdf
10     http://www.medsci.org  1657  17.,Non-OADS,/arxiv_data1/oa_pdf/b1/e3/ijmsv10p1649.PMC3804790.pdf
"10       http://www.medsci.org  1658  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(12): 1658 -1664.  doi: 10.7150/ ijms.6415  Research Paper   Dynamic Changes of Clinical Features t hat Predict the  Prognosis of Acute -on-Chronic Hepatitis B Liver Fail- ure: A Retrospective Cohort Study   Yu-Bao Zheng1,2, Zhan Lian Huang1,2, Zhe Bin Wu1,2, Min Zhang1,2, Yu Rong Gu1,2, Yu Jie Su1,2, Chao  Shuang  Lin1,2, Rui Hua Zhu1,2, Bin Liang Lin1,2, Zhi Liang  Gao1,2  1.",Non-OADS,/arxiv_data1/oa_pdf/19/84/ijmsv10p1658.PMC3804791.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/19/84/ijmsv10p1658.PMC3804791.pdf
"10     http://www.medsci.org  1659  extremely variable, in cluding transient self -resolving  acute hepatitis, acute-on-chronic hepatitis B liver  failure (ACHBLF), cirrhosis, or even hepatocellular  carcinoma (HCC) [2].",Non-OADS,/arxiv_data1/oa_pdf/19/84/ijmsv10p1658.PMC3804791.pdf
"10     http://www.medsci.org  1660  General Management of Patients   The 54 patients were given standard medical  treatment[3]  in accordance with the Asia –Pacific con- sensus recommendations including absolute bed rest ,  intravenous antibiotics, high calorie diet (35 –40  cal/kg/day), lactulose, bowel enemas, maintenance   water, electrolyte and acid -base equilibrium, preve n- tion and treatment of complications , and intensive  care monitoring.",Non-OADS,/arxiv_data1/oa_pdf/19/84/ijmsv10p1658.PMC3804791.pdf
10     http://www.medsci.org  1661  age was 45.0±11.8 years old in the death group and  43.5±9.3 years old in the survival group .,Non-OADS,/arxiv_data1/oa_pdf/19/84/ijmsv10p1658.PMC3804791.pdf
10     http://www.medsci.org  1662    Fig 2.,Non-OADS,/arxiv_data1/oa_pdf/19/84/ijmsv10p1658.PMC3804791.pdf
10     http://www.medsci.org  1663  Discussion  Early and accurate prognostic assessment of p a- tients with ACHBLF is critically important for selec t- ing the optimal treatment pathway.,Non-OADS,/arxiv_data1/oa_pdf/19/84/ijmsv10p1658.PMC3804791.pdf
"10     http://www.medsci.org  1664  S2012010009084), the New Teacher Fund of the Mi n- istry of Education  (No.",Non-OADS,/arxiv_data1/oa_pdf/19/84/ijmsv10p1658.PMC3804791.pdf
"10       http://www.medsci.org  1665  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(12): 1665 -1673.  doi: 10.7150/ ijms.6727  Research Paper   Dose Adjustment Strategy of Cyclosporine A in Renal  Transplant Patients: Evaluation of Anthropometric P a- rameters for Dose Adjustment and C0 vs. C2 Mon i- toring i n Japan , 2001 -2010  Takatoshi Kokuhu1, Keizo Fukushima2, Hidetaka  Ushigome3, Norio Yoshimura3, Nobuyuki  Sugioka2  1.",Non-OADS,/arxiv_data1/oa_pdf/44/6e/ijmsv10p1665.PMC3804792.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/44/6e/ijmsv10p1665.PMC3804792.pdf
"10     http://www.medsci.org  1666  bone marrow,2-7 resulting in a significant improv e- ment in clinical outcome.",Non-OADS,/arxiv_data1/oa_pdf/44/6e/ijmsv10p1665.PMC3804792.pdf
"10       http://www.medsci.org  1667  Immunosuppressive Regimen of CyA   The immunosuppressive regimen of CyA d e- veloped by the D epartment of T ransplantation and  Regenerative Surgery, Kyoto Prefectural University of  Medicine, is as follows : for living -related renal tran s- plantation, the initial dosage of CyA (Neoral®, ap- proximately 12 mg/kg/day ; Novartis Pharmaceut i- cals, East Hanover, NJ ) was admi nistered orally for 2  days before transplantation.",Non-OADS,/arxiv_data1/oa_pdf/44/6e/ijmsv10p1665.PMC3804792.pdf
"10     http://www.medsci.org  1668  body weight (TBW), height (HT), body mass index  (BMI), body surface area (BSA), ideal body weight  (IBW), lean body weight (LBW), and fat free mass (FFM).",Non-OADS,/arxiv_data1/oa_pdf/44/6e/ijmsv10p1665.PMC3804792.pdf
10     http://www.medsci.org  1669  Table 5.,Non-OADS,/arxiv_data1/oa_pdf/44/6e/ijmsv10p1665.PMC3804792.pdf
10     http://www.medsci.org  1670    Fig.,Non-OADS,/arxiv_data1/oa_pdf/44/6e/ijmsv10p1665.PMC3804792.pdf
10     http://www.medsci.org  1671  ter-individual variability in CyA absorption.,Non-OADS,/arxiv_data1/oa_pdf/44/6e/ijmsv10p1665.PMC3804792.pdf
"10     http://www.medsci.org  1672  TBW, but not in Vd ss(app,abs)  adjusted for IBW .",Non-OADS,/arxiv_data1/oa_pdf/44/6e/ijmsv10p1665.PMC3804792.pdf
10     http://www.medsci.org  1673  35.,Non-OADS,/arxiv_data1/oa_pdf/44/6e/ijmsv10p1665.PMC3804792.pdf
"10       http://www.medsci.org  1674  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(12): 1674 -1682.  doi: 10.7150/ ijms.6841   Research Paper   The Relation of the Level of  Serum Anti- TF, -Tn and  -Alpha -Gal IgG to Survival in Gastrointestinal Cancer  Patients  Eugeniy Smorodin1, Boris  Sergeyev1, Kersti Klaamas1, Valentin Chuzmarov2, Oleg Kurtenkov1  1.",Non-OADS,/arxiv_data1/oa_pdf/3c/96/ijmsv10p1674.PMC3804793.pdf
"10     http://www.medsci.org  1675  patients with gastrointestinal cancer are scanty, but  may be of clinical significance.",Non-OADS,/arxiv_data1/oa_pdf/3c/96/ijmsv10p1674.PMC3804793.pdf
"10     http://www.medsci.org  1676  disodium salt (1 mg/ml in 0.1 M glycine -buffer, pH  10.3).",Non-OADS,/arxiv_data1/oa_pdf/3c/96/ijmsv10p1674.PMC3804793.pdf
10     http://www.medsci.org  1677  Table 1.,Non-OADS,/arxiv_data1/oa_pdf/3c/96/ijmsv10p1674.PMC3804793.pdf
10     http://www.medsci.org  1678  Table 2.,Non-OADS,/arxiv_data1/oa_pdf/3c/96/ijmsv10p1674.PMC3804793.pdf
10       http://www.medsci.org  1679  Table 3.,Non-OADS,/arxiv_data1/oa_pdf/3c/96/ijmsv10p1674.PMC3804793.pdf
10     http://www.medsci.org  1680  response which is indicative of the switching of  antibodies to the IgG -class.,Non-OADS,/arxiv_data1/oa_pdf/3c/96/ijmsv10p1674.PMC3804793.pdf
"10     http://www.medsci.org  1681  serum samples may compete with anti -TF antibodies  for the binding of TF -conjugate, thereby influencing  the results of determination of anti -TF IgG.",Non-OADS,/arxiv_data1/oa_pdf/3c/96/ijmsv10p1674.PMC3804793.pdf
10     http://www.medsci.org  1682  interpreted data and revised the manuscript.,Non-OADS,/arxiv_data1/oa_pdf/3c/96/ijmsv10p1674.PMC3804793.pdf
"10       http://www.medsci.org  1683  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(12): 1683 -1688.  doi: 10.7150/ ijms.6416  Research Paper   Type and Location of Placenta Previa Affect Preterm  Delivery Risk Related to Antepartum Hemorrhage   Atsuko Sekiguchi, Akihito Nakai, Ikuno Kawabata, M asako Hayashi, Toshiyuki Takeshita   Department  of Obstetrics and Gynecology, Nippon Medical School, Tokyo, Japan .",Non-OADS,/arxiv_data1/oa_pdf/37/1a/ijmsv10p1683.PMC3804794.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/37/1a/ijmsv10p1683.PMC3804794.pdf
10     http://www.medsci.org  1684  previa.,Non-OADS,/arxiv_data1/oa_pdf/37/1a/ijmsv10p1683.PMC3804794.pdf
10     http://www.medsci.org  1685  incomplete p lacenta previa are shown in Table 2.,Non-OADS,/arxiv_data1/oa_pdf/37/1a/ijmsv10p1683.PMC3804794.pdf
"10     http://www.medsci.org  1686  No significant differences were evident in m a- ternal characteristics and treatments such as admi s- sion and tocolytic use, between the anterior and the  posterior groups among women with complete pl a- centa prev ia (Tables 3 and 4).",Non-OADS,/arxiv_data1/oa_pdf/37/1a/ijmsv10p1683.PMC3804794.pdf
"10       http://www.medsci.org  1687  Discussion   Prematurity is a consistent finding in studies  reporting on women with placenta previa 5, 12, 13 .",Non-OADS,/arxiv_data1/oa_pdf/37/1a/ijmsv10p1683.PMC3804794.pdf
10     http://www.medsci.org  1688  interest exists.,Non-OADS,/arxiv_data1/oa_pdf/37/1a/ijmsv10p1683.PMC3804794.pdf
"10       http://www.medsci.org  1698  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(12): 1698 -1701.  doi: 10.7150/ ijms.6315  Research Paper   Immunohistochemical Evaluation of Neuroreceptors in  Healthy and Pathological Temporo -Mandibular Joint   Gianfranco Favia1, Massimo Corsalini2, Daniela  Di Venere2,  Francesco Pettini2, Giorgio Favia3,  Saverio  Capodiferro4,  Eugenio Maiorano5   1.",Non-OADS,/arxiv_data1/oa_pdf/74/79/ijmsv10p1698.PMC3804795.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/74/79/ijmsv10p1698.PMC3804795.pdf
10     http://www.medsci.org  1699  of immunohistochemical investigations in healthy  and pathological TMJ such as arthritis and arthrosis.,Non-OADS,/arxiv_data1/oa_pdf/74/79/ijmsv10p1698.PMC3804795.pdf
10     http://www.medsci.org  1700  only for S -100 protein.,Non-OADS,/arxiv_data1/oa_pdf/74/79/ijmsv10p1698.PMC3804795.pdf
"10     http://www.medsci.org  1701  sues (11); chondrocytes, in fact,  were more numerous  with a rough and thick elongated cytoplasmic pr o- cesses conferring a dendritic- like appearance.",Non-OADS,/arxiv_data1/oa_pdf/74/79/ijmsv10p1698.PMC3804795.pdf
"10       http://www.medsci.org  1715  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(12): 1715 -1719.  doi: 10.7150/ ijms.7087  Research Paper   Incidence and Predictors of Radial Artery Occlusion  Associated Transradial Catheterization  Abdullah Tuncez1, Zeynettin Kaya2, Dursun Aras3, Abdulkadir Yıldız4, Enes Elvin Gül5, Mehmet Teki n- alp6, Mehmet Fatih Karakaş7, Halil Lütfü Kısacık3  1.",Non-OADS,/arxiv_data1/oa_pdf/90/0c/ijmsv10p1715.PMC3804796.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org /  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/90/0c/ijmsv10p1715.PMC3804796.pdf
10     http://www.medsci.org  1716  are less than TFA after thrombolytic therapy.,Non-OADS,/arxiv_data1/oa_pdf/90/0c/ijmsv10p1715.PMC3804796.pdf
"10     http://www.medsci.org  1717    Table 1: Demographic and clinical characteristics of the patients   Demographic features  N=106   Age (years)  58±11   Weight (kg)  80.7±14.6   Height (cm)  170.2±8.6   BMI (kg/m²)  27.4±3.9   Gender, n (%)   Male  46 (43,4)   Female  60 (56.6)   Hypertension, n (%) 86 (81.1)   DM, n (%) 37 (34.9)   Hyperlipidemia, n (%) 90 (85)   Smoking, n (%) 50 (47.2)   Procedural characteristics    Flurosocopy duration    Coronary angiography  2.75±1.5 min   Coronary intervention  8.29±5.1 min   Transient radial spasm, n (%) 8 (7)   RAO, n (%) 10 (9)   Complications    Pseudonaeurysm, n 1  Radial hematoma, n 2  BMI: Body mass index; DM: Diabetes mellitus, RAO: Radial artery occlusion       Table 2: Results of the patients in terms of RAO    RAO (+)  N=10 RAO (−)  N=96 P  Female gender, n (%) 8 (80)  52 (54)  0.02  TRA site, right/left  7/3 55/41  0.69  Low -weight, n (%) 8 (80) 40 (42)  0.01  Smoking, %  60 46 0.75  Antiaggregant use, %      Acetylsalicylic acid  90 81 0.11  Clopidogrel  90 77 0.83  RAO: Radial arterial occlusion, TRA: Transradial approach      DISCUSSION   In this study, comparable with previous studies,  TRA has high procedural success, low complication rates, and presents a low economic burden in exper i- enced hands in the diagnosis and treatment of cor o- nary artery disease.",Non-OADS,/arxiv_data1/oa_pdf/90/0c/ijmsv10p1715.PMC3804796.pdf
10     http://www.medsci.org  1718  into account time of the process .,Non-OADS,/arxiv_data1/oa_pdf/90/0c/ijmsv10p1715.PMC3804796.pdf
10     http://www.medsci.org  1719  25.,Non-OADS,/arxiv_data1/oa_pdf/90/0c/ijmsv10p1715.PMC3804796.pdf
"10       http://www.medsci.org  1720  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(12): 1720 -1726.  doi: 10.7150/ ijms.6651  Research Paper   Prevention of Pleural Adhesions by Bioactive            Polypeptides - A Pilot Study   D. Åkerberg,  M. Posaric -Bauden, K .",Non-OADS,/arxiv_data1/oa_pdf/d4/68/ijmsv10p1720.PMC3804797.pdf
Thi s is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,OADS,/arxiv_data1/oa_pdf/d4/68/ijmsv10p1720.PMC3804797.pdf
10     http://www.medsci.org  1721  tion in the thoracic cavity [11-13].,Non-OADS,/arxiv_data1/oa_pdf/d4/68/ijmsv10p1720.PMC3804797.pdf
10     http://www.medsci.org  1722  [20].,Non-OADS,/arxiv_data1/oa_pdf/d4/68/ijmsv10p1720.PMC3804797.pdf
10       http://www.medsci.org  1723    Fig 2.,Non-OADS,/arxiv_data1/oa_pdf/d4/68/ijmsv10p1720.PMC3804797.pdf
10     http://www.medsci.org  1724    Fig 6.,Non-OADS,/arxiv_data1/oa_pdf/d4/68/ijmsv10p1720.PMC3804797.pdf
10     http://www.medsci.org  1725  than one week after administration [34].,Non-OADS,/arxiv_data1/oa_pdf/d4/68/ijmsv10p1720.PMC3804797.pdf
"10     http://www.medsci.org  1726  [3]  Brokelman WJ, Holmdahl L, Janssen IM, Falk P, Bergstrom M, Klinkenbijl JH,  Reijn en MM: Decreased peritoneal tissue plasminogen activator during  prolonged laparoscopic surgery.",OADS,/arxiv_data1/oa_pdf/d4/68/ijmsv10p1720.PMC3804797.pdf
[21]  [Internet] http://www.avma.org/issues/animal_welfare/euthanasia.pdf .,Non-OADS,/arxiv_data1/oa_pdf/d4/68/ijmsv10p1720.PMC3804797.pdf
"10       http://www.medsci.org  1740  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(12): 1740 -1745.  doi: 10.7150/ ijms.6438  Research Paper   The High Diversity of MRSA Clones Detected in a  University Hospital in Istanbul   Lutfiye Oksuz1, Celine Dupieux2, Anne Tristan2, Michele Bes2, Jerome Etienne2, Nezahat Gurler1   1.",Non-OADS,/arxiv_data1/oa_pdf/45/dd/ijmsv10p1740.PMC3804798.pdf
This is an open- access artic le distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/45/dd/ijmsv10p1740.PMC3804798.pdf
10     http://www.medsci.org  1741  quently contain the genes encoding Panton- Valentine  leukocidin (PVL).,Non-OADS,/arxiv_data1/oa_pdf/45/dd/ijmsv10p1740.PMC3804798.pdf
"10     http://www.medsci.org  1742  ing to the 2012 guidelines of the CA -SFM, the brea k- point for susceptibility to glycopeptides is 2 mg/L.",Non-OADS,/arxiv_data1/oa_pdf/45/dd/ijmsv10p1740.PMC3804798.pdf
10       http://www.medsci.org  1743  Table 1.,Non-OADS,/arxiv_data1/oa_pdf/45/dd/ijmsv10p1740.PMC3804798.pdf
"10     http://www.medsci.org  1744  diversity can be attributed to the demographic and  geographic characteristics of Istanbul, a city of a p- proximately 15 million of inhabitants at a crossroad between Europe and Asia and a center of internation-al touristic and economic exchange.",Non-OADS,/arxiv_data1/oa_pdf/45/dd/ijmsv10p1740.PMC3804798.pdf
"10     http://www.medsci.org  1745  CONCLUSIONS   In summary, this microarray -based study hig h- lights the great diversity of MRSA clones present in  the Istanbul Medical Faculty Hospital.",Non-OADS,/arxiv_data1/oa_pdf/45/dd/ijmsv10p1740.PMC3804798.pdf
"10       http://www.medsci.org  1755  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(12): 1755 -1760.  doi: 10.7150/ ijms.6749  Research Paper   TNF-α -857C>T Genotype is Predictive of Clinical R e- sponse after Treatment with Definitive 5- Fluorouracil/   cisplatin -based Chemoradiotherapy in Japanese Patients  with Esophageal Squamous Cell Carcinoma   Hideaki Omatsu1,2, Akiko Kuwahara1,3, Motohiro Yamamori1,3, Megumi Fujita3, Tatsuya Okuno4, Ikuya  Miki4,5, Takao Tamura4, Kohshi Nishiguchi6, Noboru Okamura3, Tsutomu Nakamura7, Takeshi Azuma4,  Takeshi Hirano1, Koichiro Ozawa2, and Midori Hirai1  1.",Non-OADS,/arxiv_data1/oa_pdf/94/5b/ijmsv10p1755.PMC3804799.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/  licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/94/5b/ijmsv10p1755.PMC3804799.pdf
"10       http://www.medsci.org  1756  Background   Tumor necrosis factor alpha (TNF -α), an i m- portant proinflammatory cytokine, is produced by  activated macrophages and exerts its effects  by bind- ing to its two cognate cell surface receptors,  TNFRSF1A/TNFR1 (p55/60) and TNFRSF1B/TNFR2  (p75/80).",Non-OADS,/arxiv_data1/oa_pdf/94/5b/ijmsv10p1755.PMC3804799.pdf
"10     http://www.medsci.org  1757  days 1 to 5, 8 to 12, and 15 to 19 (a total dose of 60 Gy  in 30 fractions) , with a second course being repeated  after a 2 -week interval [29, 30].",Non-OADS,/arxiv_data1/oa_pdf/94/5b/ijmsv10p1755.PMC3804799.pdf
"10     http://www.medsci.org  1758    The TNF -α and TNFRSF1A  genotypes, and TNF -α  -1031T>C, -863C>A, -857C>T, -308G>A, -238G>A,  TNFRSF1A  -609G>T , and 36A>G genotypes had no  effect on 5 -year  survival (data not shown).",Non-OADS,/arxiv_data1/oa_pdf/94/5b/ijmsv10p1755.PMC3804799.pdf
"10     http://www.medsci.org  1759  due to the therapeutic methods used, surgical trea t- ment, drugs administered, and different types of  cancer .",Non-OADS,/arxiv_data1/oa_pdf/94/5b/ijmsv10p1755.PMC3804799.pdf
10     http://www.medsci.org  1760  8.,Non-OADS,/arxiv_data1/oa_pdf/94/5b/ijmsv10p1755.PMC3804799.pdf
"10       http://www.medsci.org  1761  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(12): 1761 -1770.  doi: 10.7150/ ijms.6294  Research Paper   An Anti-Infection Tissue -Engineered Construct Deliv- ering Vancomycin: its Evaluation i n a Goat Model of  Femur Defect   Zhengqi Chang#,1,2,3,4 , Tianyong Hou#,1,2,3, Xuehui Wu1,2,3,  Fei Luo1,2,3,  Junchao Xing1,2,3,  Zhiqiang Li1,2,3,   Qianbo Chen1,2,3,  Bo Yu1,2,3,  Jianzhong Xu1,2,3, Zhao Xie1,2,3   1.",Non-OADS,/arxiv_data1/oa_pdf/01/41/ijmsv10p1761.PMC3804800.pdf
This is an open- access article dist ributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/01/41/ijmsv10p1761.PMC3804800.pdf
10     http://www.medsci.org  1762  making it an attractive habitat in which bacteria can  live and breed [5].,Non-OADS,/arxiv_data1/oa_pdf/01/41/ijmsv10p1761.PMC3804800.pdf
10     http://www.medsci.org  1763  Passage 3 cells were used in this study.,Non-OADS,/arxiv_data1/oa_pdf/01/41/ijmsv10p1761.PMC3804800.pdf
10     http://www.medsci.org  1764  values were analysed and compared with  pre-operation values for evaluating potential kidney  damage.,Non-OADS,/arxiv_data1/oa_pdf/01/41/ijmsv10p1761.PMC3804800.pdf
10     http://www.medsci.org  1765  zones (Fig.,Non-OADS,/arxiv_data1/oa_pdf/01/41/ijmsv10p1761.PMC3804800.pdf
10     http://www.medsci.org  1766    Fig 2.,Non-OADS,/arxiv_data1/oa_pdf/01/41/ijmsv10p1761.PMC3804800.pdf
10     http://www.medsci.org  1767    Fig 4.,Non-OADS,/arxiv_data1/oa_pdf/01/41/ijmsv10p1761.PMC3804800.pdf
"10       http://www.medsci.org  1768  3.4 Analysis of radionuclide  bone imaging by  SPECT   Blood pool and bone scan images represented  the blood supply of the bone tissue and bone viability,  respectively.",Non-OADS,/arxiv_data1/oa_pdf/01/41/ijmsv10p1761.PMC3804800.pdf
"10       http://www.medsci.org  1769  Discussion   TEC have been widely applied to large bone d e- fects due to their excellent osteogenic effect, but mu l- tiple problems remain.",Non-OADS,/arxiv_data1/oa_pdf/01/41/ijmsv10p1761.PMC3804800.pdf
10     http://www.medsci.org  1770  on the host.,Non-OADS,/arxiv_data1/oa_pdf/01/41/ijmsv10p1761.PMC3804800.pdf
"10       http://www.medsci.org  1771  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013;  10(12): 1771 -1777.  doi: 10.7150/ ijms.7044  Research Paper   Scavenger  Receptor Class B Type 1 Gene rs5888 S ingle  Nucleotide P olymorphism  and the Risk of Coronary  Artery D isease  and I schemic Stroke : A Case -Control  Study   Dong- Feng Wu1, Rui-Xing Yin1, Xiao -Li Cao2, Wu -Xian Chen1, Lynn Htet Htet Aung1, Wei Wang1, Ke-Ke  Huang1, Ping Huang1, Xiao -Na Zeng1, Jian Wu1  1.",Non-OADS,/arxiv_data1/oa_pdf/70/6b/ijmsv10p1771.PMC3804801.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/70/6b/ijmsv10p1771.PMC3804801.pdf
"10     http://www.medsci.org  1772  dyslipidemia and metabolic syndrome [2], and the   common pathophysiology  mechanisms : atherosclero- sis [3].",Non-OADS,/arxiv_data1/oa_pdf/70/6b/ijmsv10p1771.PMC3804801.pdf
10     http://www.medsci.org  1773  trolled hypertension was defined as a systolic blood  pressure of 140 mmHg or higher and a diastolic blood pressure of 90 mmHg or higher.,Non-OADS,/arxiv_data1/oa_pdf/70/6b/ijmsv10p1771.PMC3804801.pdf
10     http://www.medsci.org  1774  Table 2 .,Non-OADS,/arxiv_data1/oa_pdf/70/6b/ijmsv10p1771.PMC3804801.pdf
10       http://www.medsci.org  1775  Table 3 .,Non-OADS,/arxiv_data1/oa_pdf/70/6b/ijmsv10p1771.PMC3804801.pdf
10     http://www.medsci.org  1776  trols.,Non-OADS,/arxiv_data1/oa_pdf/70/6b/ijmsv10p1771.PMC3804801.pdf
10     http://www.medsci.org  1777  22.,Non-OADS,/arxiv_data1/oa_pdf/70/6b/ijmsv10p1771.PMC3804801.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3015 | DOI: 10.1038/srep03015 7",Non-OADS,/arxiv_data1/oa_pdf/42/15/srep03015.PMC3804851.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3014 | DOI: 10.1038/srep03014 9",Non-OADS,/arxiv_data1/oa_pdf/a1/3f/srep03014.PMC3804852.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3010 | DOI: 10.1038/srep03010 6",Non-OADS,/arxiv_data1/oa_pdf/75/97/srep03010.PMC3804854.pdf
"N-terminal transmem-brane domains were predicted for all homologues except P4H2(TMHMM server v.2.0, http://www.cbs.dtu.dk/services/TMHMM/ ).",OADS,/arxiv_data1/oa_pdf/d2/ae/srep03019.PMC3804855.pdf
"One line for each geneticmodification was chosen for further analysis, and stored in theInternational Moss Stock Center (http://www.moss-stock-center.org; Supplementary Table S3 online).",OADS,/arxiv_data1/oa_pdf/d2/ae/srep03019.PMC3804855.pdf
"In silico prediction of intracellular localization .Thein silico predictions for intracellular localization of P. patens P4H homologues were performed with four different programs: TargetP (http://www.cbs.dtu.dk/services/TargetP/), MultiLoc(https://abi.inf.uni-tuebingen.de/Services/MultiLoc), SherLoc (https://abi.inf.uni- tuebingen.de/Services/SherLoc2) and Wolf PSORT (http://wolfpsort.org/).",OADS,/arxiv_data1/oa_pdf/d2/ae/srep03019.PMC3804855.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d2/ae/srep03019.PMC3804855.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3019 | DOI: 10.1038/srep03019 8",Non-OADS,/arxiv_data1/oa_pdf/d2/ae/srep03019.PMC3804855.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/44/c9/srep03012.PMC3804856.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3012 | DOI: 10.1038/srep03012 10",Non-OADS,/arxiv_data1/oa_pdf/44/c9/srep03012.PMC3804856.pdf
"The human gene transgelin TAGLN (ENSG00000149591; Chromosome 11: 117,070,037-117,075,503 forward strand) was analyzed for promoter prediction sites using the Promotor 2.0 prediction server (www.cbs.dtu.dk/services/Promoter/) and SoftBerry NSITE (http://linux1.softberry.com).",OADS,/arxiv_data1/oa_pdf/19/23/srep02178.PMC3804857.pdf
"Primer for bisulfite sequencing PCR that are specific for the modified DNA but do not contain any CpG sites in their sequence were generated around the predicted CpG islands using the program MethPrimer (http://www.urogene.org/methprimer/index1.htm): BC Primer 2(sense) GGGTAGGGTTTTGTTTATAAAAGGT, BC Primer 2 (antisense) CAATAACTCCACACAAACTCCATATT; BC Primer 1 (sense) GGTTAGAGAATAGTGAAGTAGGAGTAGT, BC Primer 1 (antisense) AAACACCAAATTAAAACAATCTACC 56,57.",OADS,/arxiv_data1/oa_pdf/19/23/srep02178.PMC3804857.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/19/23/srep02178.PMC3804857.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2178 | DOI: 10.1038/srep02178 12",Non-OADS,/arxiv_data1/oa_pdf/19/23/srep02178.PMC3804857.pdf
Protein visualization .YASARA (http://www.yasara.org/) was used to predict the structure of the murine (aa540–917) and human (aa542–919) autoinhibited kinasedomain based on the human crystallized structure (PDB ID code 2OGV) reported by Walter and colleagues 12.,OADS,/arxiv_data1/oa_pdf/e5/66/srep03013.PMC3804858.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3013 | DOI: 10.1038/srep03013 5",Non-OADS,/arxiv_data1/oa_pdf/e5/66/srep03013.PMC3804858.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b8/0e/srep03018.PMC3804859.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3018 | DOI: 10.1038/srep03018 9",Non-OADS,/arxiv_data1/oa_pdf/b8/0e/srep03018.PMC3804859.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3016 | DOI: 10.1038/srep03016 6",Non-OADS,/arxiv_data1/oa_pdf/fe/80/srep03016.PMC3804860.pdf
Molecular graphics were cr eated using PyMOL (http://www.pymol.org).,OADS,/arxiv_data1/oa_pdf/58/ea/srep02985.PMC3804861.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/58/ea/srep02985.PMC3804861.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2985 | DOI: 10.1038/srep02985 8",Non-OADS,/arxiv_data1/oa_pdf/58/ea/srep02985.PMC3804861.pdf
"The genomic DNA wasdigested with Sau3A1 and HinP1I enzymes, ligated and used for inverse PCR with primers according to the protocol sited at –http://www.fruitfly.org/about/methods/ inverse.pcr.html, EY.3.F-CCTTTCACTCGCACTTATTG, EY.3.R-GTGAGACAGC GATATGATTGT and Plac1- CACCCAAGGCTCTGCTCCCACAAT, Pwht1-GTA ACGCTAATCACTCCGAACAGGTCACA for 3 9and 59P element respectively.",OADS,/arxiv_data1/oa_pdf/e6/df/srep03011.PMC3804862.pdf
"For calculation of P value significance, we took the raw data of ct values and used the online available tool (http://www.graphpad.com/quickcalcs/ttest1.cfm) to calculate the P value significance.",OADS,/arxiv_data1/oa_pdf/e6/df/srep03011.PMC3804862.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e6/df/srep03011.PMC3804862.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3011 | DOI: 10.1038/srep03011 11",Non-OADS,/arxiv_data1/oa_pdf/e6/df/srep03011.PMC3804862.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3009 | DOI: 10.1038/srep03009 7,Non-OADS,/arxiv_data1/oa_pdf/13/99/srep03009.PMC3804863.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3009 | DOI: 10.1038/srep03009 8",Non-OADS,/arxiv_data1/oa_pdf/13/99/srep03009.PMC3804863.pdf
http://macro.lsu.edu/HowTo/solvents.htm (accessed on 20.,Non-OADS,/arxiv_data1/oa_pdf/4e/85/srep02939.PMC3804864.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/4e/85/srep02939.PMC3804864.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2939 | DOI: 10.1038/srep02939 10",Non-OADS,/arxiv_data1/oa_pdf/4e/85/srep02939.PMC3804864.pdf
"Available from: https://www.nis4.org/DOCS/Nis4Design_Method_Summary.pdf [4]  Ronan KR, Canoy DF, Burke KJ.",OADS,/arxiv_data1/oa_pdf/21/94/CPEMH-9-149.PMC3804885.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/21/94/CPEMH-9-149.PMC3804885.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/be/ed/CPEMH-9-164.PMC3804886.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 2971 | DOI: 10.1038/srep02971 7",Non-OADS,/arxiv_data1/oa_pdf/f6/d0/srep02971.PMC3804889.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ab/7f/CPEMH-9-157.PMC3804926.pdf
"The disorder prediction ofI Nwas performed using PONDR®software with VL-XT al- gorithm (http://www.pondr.com/), and then CDF (cumulativedistribution function) analysis of the output of PONDR ®was performed to provide the distribution of prediction scores and alinear boundary for distinguishing ordered and disordered pro-teins.",OADS,/arxiv_data1/oa_pdf/c2/3b/bsr0320433.PMC3804928.pdf
The intrinsic disorder propensity of INwas further analysed by a neural network-based predictor PONDR® (http://www.pondr.com/) using the VL-XT algorithm with de-fault parameters.,OADS,/arxiv_data1/oa_pdf/c2/3b/bsr0320433.PMC3804928.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/3b/cc/JEM_20130281.PMC3804931.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial– Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0 /).S.",Non-OADS,/arxiv_data1/oa_pdf/3b/cc/JEM_20130281.PMC3804931.pdf
http://dx.doi.org/   10.1111/j.1365-2141.2011.08964.,Non-OADS,/arxiv_data1/oa_pdf/3b/cc/JEM_20130281.PMC3804931.pdf
"54:463– 469. http://dx.doi.org/10.1016/j.ejmech.2012.05.02 9 Filipazzi, P ., V .",OADS,/arxiv_data1/oa_pdf/3b/cc/JEM_20130281.PMC3804931.pdf
"http://dx.doi.org/10   .1007/s00262-011-1028- 0 Gabrilovich, D.I., and S. Nagaraj.",OADS,/arxiv_data1/oa_pdf/3b/cc/JEM_20130281.PMC3804931.pdf
"111:4233– 4244. http://dx.doi.org/10.1182/blood-2007-07-09922 6 Otero, K., I.R.",Non-OADS,/arxiv_data1/oa_pdf/3b/cc/JEM_20130281.PMC3804931.pdf
"http://dx.doi.org/10.1038/ni.174 4 Pan, P .Y ., G.X.",Non-OADS,/arxiv_data1/oa_pdf/3b/cc/JEM_20130281.PMC3804931.pdf
"http://dx.doi.org/10   .1182/blood-2007-04-08683 5 Pham, T.H., C. Benner, M. Lichtinger, L. Schwarzfischer, Y .",Non-OADS,/arxiv_data1/oa_pdf/3b/cc/JEM_20130281.PMC3804931.pdf
"http://dx.doi.org/   10.1182/blood-2012-01-40245 3 Porembka, M.R., J.B. Mitchem, B.A.",Non-OADS,/arxiv_data1/oa_pdf/3b/cc/JEM_20130281.PMC3804931.pdf
"http://dx.doi.org/10.1007/s00262-011-   1178- 0 Roland, C.L., K.D.",Non-OADS,/arxiv_data1/oa_pdf/3b/cc/JEM_20130281.PMC3804931.pdf
"http://dx.doi.org/10.1371/journal   .pone.000766 9 Sawant, A., J. Deshane, J. Jules, C.M.",Non-OADS,/arxiv_data1/oa_pdf/3b/cc/JEM_20130281.PMC3804931.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-12-220 2 Scheller, M., J. Foerster, C.M.",OADS,/arxiv_data1/oa_pdf/3b/cc/JEM_20130281.PMC3804931.pdf
"http://dx.doi.org/10.1038/ni138 7 Schroeder, T., H. Kohlhof, N. Rieber, and U.",OADS,/arxiv_data1/oa_pdf/3b/cc/JEM_20130281.PMC3804931.pdf
"http://dx.doi.org/10.1093/carcin/19.1.17 7 Solito, S., E. Falisi, C.M.",Non-OADS,/arxiv_data1/oa_pdf/3b/cc/JEM_20130281.PMC3804931.pdf
"118:2254– 2265. http://dx.doi.org/10.1182/blood-2010-12-32575 3 Tamura, T., T. Nagamura-Inoue, Z. Shmeltzer, T. Kuwata, and K. Ozato.",OADS,/arxiv_data1/oa_pdf/3b/cc/JEM_20130281.PMC3804931.pdf
"http://dx.doi.org/   10.1016/S1074-7613(00)00016- 9 Wang, D., J. Feng, R. Wen, J.C. Marine, M.Y .",OADS,/arxiv_data1/oa_pdf/3b/cc/JEM_20130281.PMC3804931.pdf
"http://dx.doi.org/10.1016/   S1074-7613(00)00005- 4 Xiang, X., A. Poliakov, C. Liu, Y .",OADS,/arxiv_data1/oa_pdf/3b/cc/JEM_20130281.PMC3804931.pdf
"http://dx.doi.org/10   .1172/JCI2882 8 Greten, T.F ., M.P .",OADS,/arxiv_data1/oa_pdf/3b/cc/JEM_20130281.PMC3804931.pdf
"http://dx.doi.org/10   .1002/stem.56 4 Hashimoto, A., K. Takeda, M. Inaba, M. Sekimata, T. Kaisho, S. Ikehara,  Y. Homma, S. Akira, and T. Kurosaki.",OADS,/arxiv_data1/oa_pdf/3b/cc/JEM_20130281.PMC3804931.pdf
"http://dx.doi   .org/10.1016/S1535-6108(03)00132- 6 Kirstetter, P ., K. Anderson, B.T.",OADS,/arxiv_data1/oa_pdf/3b/cc/JEM_20130281.PMC3804931.pdf
"http://dx.doi.org/10.1038/ni138 1 Kortylewski, M., M. Kujawski, T. Wang, S. Wei, S. Zhang, S. Pilon-Thomas, G.  Niu, H. Kay, J. Mulé, W .G.",Non-OADS,/arxiv_data1/oa_pdf/3b/cc/JEM_20130281.PMC3804931.pdf
"http://dx.doi.org/10.1038/nm132 5 Kusmartsev, S., and D.I.",OADS,/arxiv_data1/oa_pdf/3b/cc/JEM_20130281.PMC3804931.pdf
"http://dx.doi.org/10.1189/jlb.010301 0 Kusmartsev, S., and D.I.",OADS,/arxiv_data1/oa_pdf/3b/cc/JEM_20130281.PMC3804931.pdf
"http://dx.doi   .org/10.1007/s10555-006-9002- 6 Kusmartsev, S., Y .",OADS,/arxiv_data1/oa_pdf/3b/cc/JEM_20130281.PMC3804931.pdf
"9:90. http://dx.doi.org/10.1186/1479-5876-9-9 0 Li, G., G. Wu, G. Zhao, G. Shi, G. Li, G. Zhang, G. Yin, G. Shuai, G.  Wang, and G. Tao.",Non-OADS,/arxiv_data1/oa_pdf/3b/cc/JEM_20130281.PMC3804931.pdf
"http://dx.doi.org/10.1016/j.immuni.2010.05.01 0 Mazzoni, A., V .",OADS,/arxiv_data1/oa_pdf/3b/cc/JEM_20130281.PMC3804931.pdf
"http://dx.doi   .org/10.1002/ijc.2424 9 Y oun, J.I., S. Nagaraj, M. Collazo, and D.I.",Non-OADS,/arxiv_data1/oa_pdf/3b/cc/JEM_20130281.PMC3804931.pdf
"http://dx.doi   .org/10.1016/j.intimp.2011.02.02 1Yu, J., W. Du, F. Yan, Y. Wang, H. Li, S. Cao, W. Yu, C. Shen, J. Liu,  and X. Ren.",OADS,/arxiv_data1/oa_pdf/3b/cc/JEM_20130281.PMC3804931.pdf
"190:3783– 3797. http://dx.doi.org/10.4049/jimmunol.120144 9 Zea, A.H., P .C.",Non-OADS,/arxiv_data1/oa_pdf/3b/cc/JEM_20130281.PMC3804931.pdf
http://dx.doi.org/10.1158/0008-5472.CAN-10-392 2,Non-OADS,/arxiv_data1/oa_pdf/3b/cc/JEM_20130281.PMC3804931.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/e5/9e/JEM_20130443.PMC3804932.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0 /).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/e5/9e/JEM_20130443.PMC3804932.pdf
"http://dx.doi.org/10.1084/jem.2004193 0 Bao, M., and Y .J.",OADS,/arxiv_data1/oa_pdf/e5/9e/JEM_20130443.PMC3804932.pdf
"http://dx.doi.org/10.1007/   s13238-012-2104- 8 Cervantes-Barragan, L., K.L.",Non-OADS,/arxiv_data1/oa_pdf/e5/9e/JEM_20130443.PMC3804932.pdf
"http://dx.doi.org/10   .1016/j.cell.2008.09.01 6 Collins, A., D.R.",OADS,/arxiv_data1/oa_pdf/e5/9e/JEM_20130443.PMC3804932.pdf
"http://dx.doi.org/10.1038/nri248 9 Colonna, M., G. Trinchieri, and Y .J.",Non-OADS,/arxiv_data1/oa_pdf/e5/9e/JEM_20130443.PMC3804932.pdf
"http://dx.doi.org/10 .1038/   ni114 1 Crozat, K., R. Guiton, M. Guilliams, S. Henri, T. Baranek, I. Schwartz-Cornil,  B. Malissen, and M. Dalod.",Non-OADS,/arxiv_data1/oa_pdf/e5/9e/JEM_20130443.PMC3804932.pdf
"http://dx.doi.org/10.1111/j.0105- 2896.2009.00868. x Diacovo, T.G., A.L.",Non-OADS,/arxiv_data1/oa_pdf/e5/9e/JEM_20130443.PMC3804932.pdf
"http://dx.doi.org/10   .1084/jem.2005103 5 Dijkman, R., R. van Doorn, K. Szuhai, R. Willemze, M.H.",Non-OADS,/arxiv_data1/oa_pdf/e5/9e/JEM_20130443.PMC3804932.pdf
"http://dx.doi.org/10.1371/journal   .pone.002392 1 Ghosh, H.S., B. Cisse, A. Bunin, K.L.",Non-OADS,/arxiv_data1/oa_pdf/e5/9e/JEM_20130443.PMC3804932.pdf
"http://dx.doi.org/   10.1016/j.immuni.2010.11.02 3 Jia, T., N.V .",OADS,/arxiv_data1/oa_pdf/e5/9e/JEM_20130443.PMC3804932.pdf
"105:2787– 2792. http://dx.doi.org/10.1182/blood-2004-09-338 8 Li, H.S., A. Gelbard, G.J.",Non-OADS,/arxiv_data1/oa_pdf/e5/9e/JEM_20130443.PMC3804932.pdf
"http://dx.doi.org/10.1182/blood-2011-04-34976 1 Liu, K., and M.C.",OADS,/arxiv_data1/oa_pdf/e5/9e/JEM_20130443.PMC3804932.pdf
"http://dx.doi.org/10.1111/j.0105-2896   .2009.00879. x Long, F .",Non-OADS,/arxiv_data1/oa_pdf/e5/9e/JEM_20130443.PMC3804932.pdf
"http://dx.doi.org/10   .1038/nrm325 4 Mack, M., J. Cihak, C. Simonis, B. Luckow, A.E.",OADS,/arxiv_data1/oa_pdf/e5/9e/JEM_20130443.PMC3804932.pdf
"http://dx.doi.org/10.1038/ni.237 0 Ngo, V .N., R.E.",Non-OADS,/arxiv_data1/oa_pdf/e5/9e/JEM_20130443.PMC3804932.pdf
"http://dx.doi.org/10.1038/nature0468 7 Omatsu, Y ., T. Iyoda, Y .",OADS,/arxiv_data1/oa_pdf/e5/9e/JEM_20130443.PMC3804932.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)80259- 7Reizis, B., A. Bunin, H.S.",OADS,/arxiv_data1/oa_pdf/e5/9e/JEM_20130443.PMC3804932.pdf
"http://dx.doi.org/10.1146/annurev-immunol-031210-   10134 5 Sasaki, I., K. Hoshino, T. Sugiyama, C. Yamazaki, T. Yano, A. Iizuka,  H. Hemmi, T. Tanaka, M. Saito, M. Sugiyama, et al.",OADS,/arxiv_data1/oa_pdf/e5/9e/JEM_20130443.PMC3804932.pdf
"http://dx.doi.org/10.1182/blood-2012-06-43652 7 Satpathy, A.T., K.M.",Non-OADS,/arxiv_data1/oa_pdf/e5/9e/JEM_20130443.PMC3804932.pdf
"http://dx.doi.org/10.1016/j.smim.2011.08.00 9 Schlitzer, A., J. Loschko, K. Mair, R. Vogelmann, L. Henkel, H. Einwächter, M.  Schiemann, J.H.",OADS,/arxiv_data1/oa_pdf/e5/9e/JEM_20130443.PMC3804932.pdf
"http://dx.doi.org/10   .1182/blood-2010-12-32667 8 Seth, S., L. Oberdörfer, R. Hyde, K. Hoff, V. Thies, T. Worbs, S. Schmitz,  and R. Förster.",Non-OADS,/arxiv_data1/oa_pdf/e5/9e/JEM_20130443.PMC3804932.pdf
"http://dx.doi   .org/10.4049/jimmunol.100259 8 Swiecki, M., S. Gilfillan, W. Vermi, Y. Wang, and M. Colonna.",OADS,/arxiv_data1/oa_pdf/e5/9e/JEM_20130443.PMC3804932.pdf
"http://dx.doi.org/10.1016/j.immuni.2010.11.02 0 Tai, L.H., M.L.",OADS,/arxiv_data1/oa_pdf/e5/9e/JEM_20130443.PMC3804932.pdf
"http://dx.doi.org/10.1084/jem.2008071 8 Tsou, C.L., W .",OADS,/arxiv_data1/oa_pdf/e5/9e/JEM_20130443.PMC3804932.pdf
"http://dx.doi.org/10.1172/JCI2991 9 Wendland, M., N. Czeloth, N. Mach, B. Malissen, E. Kremmer, O. Pabst,  and R. Förster.",OADS,/arxiv_data1/oa_pdf/e5/9e/JEM_20130443.PMC3804932.pdf
http://dx.doi.org/10.1016/j.immuni.2012.12.00 1,OADS,/arxiv_data1/oa_pdf/e5/9e/JEM_20130443.PMC3804932.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months after   the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"After six months it is   available under a Creative Commons License (Attribution–Noncommercial–Share   Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/   by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"http://dx.doi.org/10.1016/j.ceb.2003.10.01 3 Arai, F ., A. Hirao, M. Ohmura, H. Sato, S. Matsuoka, K. Takubo, K. Ito, G.Y .",OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"118:149– 161. http://dx.doi.org/10.1016/j.cell.2004.07.00 4 Boggs, D.R., and S.S. Boggs.",OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"http://dx.doi.org/10.1038/nm0797­73 0 Broudy, V .C.",Non-OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"http://dx.doi   .org/10.1038/nm127 4 Castedo, M., J.L.",OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"http://dx.doi.org/10.1038/sj.onc.120752 8 Castedo, M., J.L.",Non-OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"http://dx.doi.org/10.1038/sj.onc.120757 2 Castor, A., L. Nilsson, I. Astrand­Grundström, M. Buitenhuis, C. Ramirez,  K. Anderson, B. Strömbeck, S. Garwicz, A.N.",OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"http://dx.doi.org/   10.1038/nm125 3 Chae, H.D., K.E.",OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"http://dx.doi   .org/10.1182/blood­2007­06­09323 7 Challita, P.M., D. Skelton, A. el­Khoueiry, X.J.",Non-OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"http://dx.doi.org/10.1038/8133 5 Cheng, T., N. Rodrigues, H. Shen, Y .",Non-OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"http://dx.doi.org/10   .1126/science.287.5459.180 4 Domen, J., and I.L.",OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"http://dx.doi.org/10.1016/S1357­4310(99)01464­ 1 Galluzzi, L., and G. Kroemer.",OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"http://dx.doi.org/10.1016/   j.cell.2008.12.00 4 Ganem, N.J., Z. Storchova, and D. Pellman.",OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
http://dx.doi.org/10   .1016/j.gde.2007.02.01 1In vitro viral transduction.,OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"http://dx.doi.org/10.1074/ jbc.C111.22933 6 Min, I.M., G. Pietramaggiori, F.S.",Non-OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"http://dx.doi.org/10.1016/j.stem.2008.01.01 5 Mortensen, M., A.S. Watson, and A.K.",OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"http://dx.doi.org/10.4161/auto.7.9.1588 6 Narumiya, S., T. Ishizaki, and N. Watanabe.",OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"http://dx.doi.org/   10.1016/S0014­5793(97)00317­ 7 Penning, L.C., R.G.",OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"http://dx.doi.org/10   .1006/cyto.1997.031 0 Piekny, A., M. Werner, and M. Glotzer.",OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"http://dx.doi.org/10   .1016/j.tcb.2005.10.00 6 Pleines, I., I. Hagedorn, S. Gupta, F .",OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"http://dx.doi.org/10.1182/blood ­2011­08­37219 3 Randall, T.D., and I.L.",Non-OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"http://dx.doi.org/   10.1093/emboj/17.5.135 0 Shuster, C.B., and D.R.",OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"http://dx.doi.org/10   .1083/jcb.146.5.98 1 Storchova, Z., and D. Pellman.",OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"http://dx.doi.org/10.1101/   gad.11.18.229 5 Vandenabeele, P., L. Galluzzi, T. Vanden Berghe, and G. Kroemer.",Non-OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"http://dx.doi.org/10.1038/nrm297 0 Venezia, T.A., A.A.",Non-OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"http://dx.doi.org/10.1371/journal.pbio.002030 1 Wang, L., and Y. Zheng.",OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"http://dx.doi.org/10.1172/JCI4437 1 Yamashiro, S., G. Totsukawa, Y. Yamakita, Y. Sasaki, P. Madaule, T.  Ishizaki, S. Narumiya, and F. Matsumura.",OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"http://dx.doi.org/10.1091/ mbc.E02­07­042 7 Yang, L., L. Wang, H. Geiger, J.A.",OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"6:455– 460. http://dx.doi.org/10.4161/cc.6.4.383 6 Geh, E., Q. Meng, M. Mongan, J. Wang, A. Takatori, Y .",Non-OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"http://dx.doi.org/10.1073/   pnas.110229710 8 Ghaffari, S. 2008.",Non-OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"http://dx.doi.org/   10.1089/ars.2008.214 2 Ghiaur, G., A. Lee, J. Bailey, J.A.",OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"108:2087– 2094. http://dx.doi.org/10.1182/blood­2006­02­00156 0 Gu, Y ., M.D.",OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"http://dx.doi.org/10.1126/science.108848 5 Hattori, K., B. Heissig, and S. Rafii.",OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"http://dx.doi.org/10.1080/104281902100003798 5 Heasman, S.J., and A.J.",OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"http://dx.doi.org/10.1038/nrm247 6 Jackson, B., K. Peyrollier, E. Pedersen, A. Basse, R. Karlsson, Z. Wang, T. Lefever,  A.M. Ochsenbein, G. Schmidt, K. Aktories, et al.",OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"http://dx.doi   .org/10.1091/mbc.E09­10­085 9 Jaffe, A.B., and A.",OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"http://dx.doi.org/10.1146/annurev   .cellbio.21.020604.15072 1 Janzen, V ., R. Forkert, H.E.",OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"http://dx.doi.org/10.1016/j.cell.2005.05.02 6 Kimura, K., M. Ito, M. Amano, K. Chihara, Y .",OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"http://dx.doi.org/10.1126/science.273.5272.24 5 Knoblich, J.A.",OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"http://dx.doi.org/10.1016/j.cell.2008.02.00 7 Kozar, K., M.A.",OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"http://dx.doi.org/10.1016/j.cell.2004.07.02 5 Kühn, R., F .",OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"http://dx.doi.org/10.1126/   science.766012 5 Lordier, L., A. Jalil, F .",Non-OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"http://dx.doi.org/10.1182/blood ­2008­03­14495 6 Maekawa, M., T. Ishizaki, S. Boku, N. Watanabe, A. Fujita, A. Iwamatsu, T.  Obinata, K. Ohashi, K. Mizuno, and S. Narumiya.",OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"http://dx.doi.org/10.1126/science.285.5429.89 5 Matsumura, F .",OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"http://dx.doi.org/10.1016/   j.tcb.2005.05.00 4 Melendez, J., K. Stengel, X. Zhou, B.K.",OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"110:3853– 3861. http://dx.doi.org/10.1182/blood­2007­03­07958 2 Yilmaz, O.H., R. Valdez, B.K.",Non-OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"http://dx.doi.org/   10.1038/nature0470 3 Yoder, M.C., and D.A.",OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"http://dx.doi.org/10   .1038/nature0474 7 Zhang, S., X. Zhou, R.A. Lang, and F .",OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
"http://dx.doi.org/10.1371/journal.pone   .003377 3 Zou, P ., H. Y oshihara, K. Hosokawa, I. Tai, K. Shinmyozu, F .",OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
http://dx.doi.org/   10.1016/j.stem.2011.07.00 3,OADS,/arxiv_data1/oa_pdf/67/f5/JEM_20122348.PMC3804933.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/ae/17/JEM_20130762.PMC3804934.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial– Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/ae/17/JEM_20130762.PMC3804934.pdf
http://dx.doi.org/10.1158/1078 ­0432.,Non-OADS,/arxiv_data1/oa_pdf/ae/17/JEM_20130762.PMC3804934.pdf
"http://dx.doi.org/10.1038/nm.243 8 Barber, D.L., E.J.",OADS,/arxiv_data1/oa_pdf/ae/17/JEM_20130762.PMC3804934.pdf
"http://dx.doi.org/10.1038/nature0444 4 Brahmer, J.R., S.S. T ykodi, L.Q.",Non-OADS,/arxiv_data1/oa_pdf/ae/17/JEM_20130762.PMC3804934.pdf
"http://dx.doi.org/10.1056/NEJMoa120069 4 Chen, L., and D.B.",OADS,/arxiv_data1/oa_pdf/ae/17/JEM_20130762.PMC3804934.pdf
"http://dx.doi.org/10   .1038/nri340 5 Coussens, L.M., L. Zitvogel, and A.K.",Non-OADS,/arxiv_data1/oa_pdf/ae/17/JEM_20130762.PMC3804934.pdf
"http://dx.doi.org/10.1126/science.123222 7 Curran, M.A., W .",OADS,/arxiv_data1/oa_pdf/ae/17/JEM_20130762.PMC3804934.pdf
"http://dx.doi.org/10.1016/j.ccr.2009   .06.01 8 Drake, C.G.",OADS,/arxiv_data1/oa_pdf/ae/17/JEM_20130762.PMC3804934.pdf
"http://dx.doi.org/10.1093/annonc/mds26 2 Facciabene, A., G.T.",Non-OADS,/arxiv_data1/oa_pdf/ae/17/JEM_20130762.PMC3804934.pdf
"72:2162– 2171. http://dx.doi.org/10.1158/0008­5472.CAN­11­368 7 Formenti, S.C., and S. Demaria.",Non-OADS,/arxiv_data1/oa_pdf/ae/17/JEM_20130762.PMC3804934.pdf
"http://dx.doi.org/10.1016/S1470­2045(09)   70082­ 8 Fransen, M.F., T.C.",OADS,/arxiv_data1/oa_pdf/ae/17/JEM_20130762.PMC3804934.pdf
"http://dx.doi.org/10.1084/jem.2012246 2 Guy, C.T., R.D.",OADS,/arxiv_data1/oa_pdf/ae/17/JEM_20130762.PMC3804934.pdf
"http://dx.doi.org/10.1056/NEJMoa100346 6 Hurwitz, A.A., B.A.",OADS,/arxiv_data1/oa_pdf/ae/17/JEM_20130762.PMC3804934.pdf
"http://dx.doi.org/10.1126/science.120348 6 Selby, M.J., J.J. Engelhardt, M. Quigley, K.A.",OADS,/arxiv_data1/oa_pdf/ae/17/JEM_20130762.PMC3804934.pdf
"http://dx.doi.org/10.1158/   2326­6066.CIR ­13­0013 Shankaran, V., H. Ikeda, A.T. Bruce, J.M.",Non-OADS,/arxiv_data1/oa_pdf/ae/17/JEM_20130762.PMC3804934.pdf
"http://dx.doi.org/10.1038/3507412 2 Simpson, T.R., F. Li, W. Montalvo­Ortiz, M.A.",Non-OADS,/arxiv_data1/oa_pdf/ae/17/JEM_20130762.PMC3804934.pdf
"http://dx.doi.org/10.1084/jem.2013057 9 Strome, S.E., H. Dong, H. Tamura, S.G. Voss, D.B.",OADS,/arxiv_data1/oa_pdf/ae/17/JEM_20130762.PMC3804934.pdf
"http://dx.doi.org/10.1038/nature0970 7 T eng, M.W ., S.F .",OADS,/arxiv_data1/oa_pdf/ae/17/JEM_20130762.PMC3804934.pdf
http://dx.doi.org/10.1158/0008 ­5472.,Non-OADS,/arxiv_data1/oa_pdf/ae/17/JEM_20130762.PMC3804934.pdf
"http://dx.doi.org/10.1016/j.coi.2011.12.00 9 T opalian, S.L., F .S.",OADS,/arxiv_data1/oa_pdf/ae/17/JEM_20130762.PMC3804934.pdf
"http://dx.doi.org/10.1056/NEJMoa120069 0 van Elsas, A., A.A. Hurwitz, and J.P .",OADS,/arxiv_data1/oa_pdf/ae/17/JEM_20130762.PMC3804934.pdf
"http://dx.doi.org/10.1084/jem.190.3.35 5 van Elsas, A., R.P .",Non-OADS,/arxiv_data1/oa_pdf/ae/17/JEM_20130762.PMC3804934.pdf
"http://dx.doi.org/10.1084/jem.194.4.48 1 Waitz, R., S.B.",OADS,/arxiv_data1/oa_pdf/ae/17/JEM_20130762.PMC3804934.pdf
"http://dx.doi.org/10.1158/0008­5472.CAN­11­178 2 Wang, W., R. Lau, D. Yu, W. Zhu, A. Korman, and J. Weber.",OADS,/arxiv_data1/oa_pdf/ae/17/JEM_20130762.PMC3804934.pdf
"http://dx.doi.org/10.1093/intimm/dxp07 2 Willimsky, G., and T. Blankenstein.",OADS,/arxiv_data1/oa_pdf/ae/17/JEM_20130762.PMC3804934.pdf
"http://dx.doi.org/10.1038/nature0395 4 Wing, K., Y. Onishi, P. Prieto­Martin, T. Yamaguchi, M. Miyara, Z.  Fehervari, T. Nomura, and S. Sakaguchi.",OADS,/arxiv_data1/oa_pdf/ae/17/JEM_20130762.PMC3804934.pdf
"http://dx.doi   .org/10.1126/science.116006 2Kaplan, D.H., V .",OADS,/arxiv_data1/oa_pdf/ae/17/JEM_20130762.PMC3804934.pdf
"http://dx.doi.org/10.1038/ni142 8 Kim, J., K. Lahl, S. Hori, C. Loddenkemper, A. Chaudhry, P. deRoos, A.  Rudensky, and T. Sparwasser.",Non-OADS,/arxiv_data1/oa_pdf/ae/17/JEM_20130762.PMC3804934.pdf
"http://dx.doi.org/10.4049/jimmunol.080430 8 Klages, K., C.T.",OADS,/arxiv_data1/oa_pdf/ae/17/JEM_20130762.PMC3804934.pdf
"http://dx.doi   .org/10.1158/0008 ­5472.CAN ­10­1736 Komatsu, N., and S. Hori.",OADS,/arxiv_data1/oa_pdf/ae/17/JEM_20130762.PMC3804934.pdf
"http://dx.doi.org/10.1073/   pnas.070200410 4 Li, X., E. Kostareli, J. Suffner, N. Garbi, and G.J.",OADS,/arxiv_data1/oa_pdf/ae/17/JEM_20130762.PMC3804934.pdf
"http://dx.doi.org/10.1002/eji.20104109 3 Lin, E.Y., J.G.",OADS,/arxiv_data1/oa_pdf/ae/17/JEM_20130762.PMC3804934.pdf
"http://dx.doi.org/10.1016/S0002 ­  9440(10)63568 ­7 Lucas, J.A., J. Menke, W.A.",OADS,/arxiv_data1/oa_pdf/ae/17/JEM_20130762.PMC3804934.pdf
"http://dx.doi.org/10.1038/nrc323 9 Peggs, K.S., S.A. Quezada, C.A.",Non-OADS,/arxiv_data1/oa_pdf/ae/17/JEM_20130762.PMC3804934.pdf
"http://dx.doi.org/10.1084/jem.2008249 2 Podsypanina, K., K. Politi, L.J.",Non-OADS,/arxiv_data1/oa_pdf/ae/17/JEM_20130762.PMC3804934.pdf
"http://dx.doi.org/ 10.1097/   PPO.0b013e318250c00 1 Quezada, S.A., K.S.",Non-OADS,/arxiv_data1/oa_pdf/ae/17/JEM_20130762.PMC3804934.pdf
"116:1935– 1945. http://dx.doi.org/10.1172/JCI2774 5 Quezada, S.A., T.R.",Non-OADS,/arxiv_data1/oa_pdf/ae/17/JEM_20130762.PMC3804934.pdf
http://dx.doi.org/10.1084/jem.2009191 8,Non-OADS,/arxiv_data1/oa_pdf/ae/17/JEM_20130762.PMC3804934.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/6a/4d/JEM_20130056.PMC3804935.pdf
"After six months it is   available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).circulating neutrophils (neutropenia) can lead  to chronic or even life threatening infections The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/6a/4d/JEM_20130056.PMC3804935.pdf
Online supplemental material is available at  http://www.jem.org/cgi/content/full/jem.20130056/DC1.,Non-OADS,/arxiv_data1/oa_pdf/6a/4d/JEM_20130056.PMC3804935.pdf
"http://dx.doi.org/   10.1038/ng114 9 Hoeffel, G., Y .",OADS,/arxiv_data1/oa_pdf/6a/4d/JEM_20130056.PMC3804935.pdf
"http://dx.doi   .org/10.1128/MCB.20.11.4106-4114.200 0 Kim, H.K., M. De La Luz Sierra, C.K.",Non-OADS,/arxiv_data1/oa_pdf/6a/4d/JEM_20130056.PMC3804935.pdf
"http://dx.doi.org/10.1182/blood-2005-10-416 2 Köhler, A., H. Geiger, and M. Gunzer.",Non-OADS,/arxiv_data1/oa_pdf/6a/4d/JEM_20130056.PMC3804935.pdf
"750:215– 224. http://dx.doi.org/10.1007/978-1-61779-145-1_1 5 Köhler, A., K. De Filippo, M. Hasenberg, C. van den Brandt, E. Nye, M.P .",Non-OADS,/arxiv_data1/oa_pdf/6a/4d/JEM_20130056.PMC3804935.pdf
"http://dx.doi.org/10.1182/blood-2010-09-30838 7 Kreisel, D., R.G.",Non-OADS,/arxiv_data1/oa_pdf/6a/4d/JEM_20130056.PMC3804935.pdf
"http://dx.doi   .org/10.1182/blood-2003-05-158 9 Li, J.L., C.C.",Non-OADS,/arxiv_data1/oa_pdf/6a/4d/JEM_20130056.PMC3804935.pdf
"http://dx.doi.org/10.1038/nprot.2011.43 8 Lien, D.C., W .W .",OADS,/arxiv_data1/oa_pdf/6a/4d/JEM_20130056.PMC3804935.pdf
"http://dx.doi.org/10.1056/NEJM19920702327010 6 Lieschke, G.J., and A.W .",OADS,/arxiv_data1/oa_pdf/6a/4d/JEM_20130056.PMC3804935.pdf
"http://dx.doi.org/10.1056/NEJM19920709327020 7 Lo Celso, C., C.P .",OADS,/arxiv_data1/oa_pdf/6a/4d/JEM_20130056.PMC3804935.pdf
"http://dx.doi.org/10.1038/nprot.2010.16 8 Looney, M.R., E.E.",OADS,/arxiv_data1/oa_pdf/6a/4d/JEM_20130056.PMC3804935.pdf
"http://dx.doi.org/10.1038/nmeth   .1543 Løvås, K., E. Knudsen, P.O.",OADS,/arxiv_data1/oa_pdf/6a/4d/JEM_20130056.PMC3804935.pdf
http://dx.doi   .org/10.1111/j.1600-0609.1996.tb01933.,Non-OADS,/arxiv_data1/oa_pdf/6a/4d/JEM_20130056.PMC3804935.pdf
http://dx.doi   .org/10.1016/S0002-9440(10)62562- Xto thank Prof. Thomas Graf for providing LysM-GFP mice.,Non-OADS,/arxiv_data1/oa_pdf/6a/4d/JEM_20130056.PMC3804935.pdf
"http://dx.doi.org/10.1016/S1074-7613(03)00201- 2 Balabanian, K., E. Brotin, V .",OADS,/arxiv_data1/oa_pdf/6a/4d/JEM_20130056.PMC3804935.pdf
"201:1307– 1318. http://dx.doi.org/10.1084/jem.2004138 5 Chtanova, T., M. Schaeffer, S.-J.",OADS,/arxiv_data1/oa_pdf/6a/4d/JEM_20130056.PMC3804935.pdf
"http://dx.doi.org/10.1016/j.immuni.2008.07.01 2 Dale, D.C., A.A. Bolyard, M.L.",OADS,/arxiv_data1/oa_pdf/6a/4d/JEM_20130056.PMC3804935.pdf
"118:4963– 4966. http://dx.doi.org/10.1182/blood-2011-06-36058 6 Dock, D.S., W.L.",Non-OADS,/arxiv_data1/oa_pdf/6a/4d/JEM_20130056.PMC3804935.pdf
"http://dx.doi.org/10.1172/JCI10425 9 Doerschuk, C.M., M.F.",OADS,/arxiv_data1/oa_pdf/6a/4d/JEM_20130056.PMC3804935.pdf
"http://dx.doi.org/10.1172/JCI11918 9 Duyverman, A.M.M.J., M. Kohno, S. Roberge, D. Fukumura, D.G.",Non-OADS,/arxiv_data1/oa_pdf/6a/4d/JEM_20130056.PMC3804935.pdf
"http://dx.doi.org/10.1038/nprot.2012.03 0 Eash, K.J., J.M.",OADS,/arxiv_data1/oa_pdf/6a/4d/JEM_20130056.PMC3804935.pdf
"http://dx.doi   .org/10.1182/blood-2008-09-17728 7 Eash, K.J., A.M. Greenbaum, P.K.",Non-OADS,/arxiv_data1/oa_pdf/6a/4d/JEM_20130056.PMC3804935.pdf
"http://dx.doi.org/10   .1172/JCI4164 9 Faust, N., F .",Non-OADS,/arxiv_data1/oa_pdf/6a/4d/JEM_20130056.PMC3804935.pdf
"http://dx.doi.org/10.1038/nri302 4 Martin, C., P.C.E.",OADS,/arxiv_data1/oa_pdf/6a/4d/JEM_20130056.PMC3804935.pdf
"http://dx.doi   .org/10.1016/S1074-7613(03)00263- 2 Mazo, I.B., J.C. Gutierrez-Ramos, P.S.",OADS,/arxiv_data1/oa_pdf/6a/4d/JEM_20130056.PMC3804935.pdf
"http://dx.doi.org/10.1084/jem.188.3.46 5 McDermott, D.H., Q. Liu, J. Ulrick, N. Kwatemaa, S. Anaya-O’Brien, S.R.",Non-OADS,/arxiv_data1/oa_pdf/6a/4d/JEM_20130056.PMC3804935.pdf
"http://dx.doi.org/10.1182/   blood-2011-07-36808 4 Mei, J., Y .",Non-OADS,/arxiv_data1/oa_pdf/6a/4d/JEM_20130056.PMC3804935.pdf
"http://dx.doi.org/10.1172/ JCI6058 8 Mieno, S., M. Boodhwani, B. Ramlawi, J. Li, J. Feng, C. Bianchi, R.J.  Laham, J. Li, and F.W.",Non-OADS,/arxiv_data1/oa_pdf/6a/4d/JEM_20130056.PMC3804935.pdf
"http://dx.doi.org/10.1371/journal.ppat   .100022 2 Ng, L.G., J.S.",OADS,/arxiv_data1/oa_pdf/6a/4d/JEM_20130056.PMC3804935.pdf
"http://dx.doi.org/10.1038/jid.2011.17 9 Peled, A., O. Kollet, T. Ponomaryov, I. Petit, S. Franitza, V. Grabovsky,  M.M.",Non-OADS,/arxiv_data1/oa_pdf/6a/4d/JEM_20130056.PMC3804935.pdf
"http://dx.doi.org/10.1126/   science.115919 4 Petty, J.M., C.C.",OADS,/arxiv_data1/oa_pdf/6a/4d/JEM_20130056.PMC3804935.pdf
"http://dx.doi.org/   10.1172/JCI5799 0 Ponomaryov, T., A. Peled, I. Petit, R.S.",Non-OADS,/arxiv_data1/oa_pdf/6a/4d/JEM_20130056.PMC3804935.pdf
"11:153– 161. http://dx.doi.org/10.1016/S1074-7613(00)80090- 4 Semerad, C.L., F. Liu, A.D. Gregory, K. Stumpf, and D.C. Link.",OADS,/arxiv_data1/oa_pdf/6a/4d/JEM_20130056.PMC3804935.pdf
"http://dx.doi.org/10.1016/   S1074-7613(02)00424- 7 Shirozu, M., T. Nakano, J. Inazawa, K. Tashiro, H. Tada, T. Shinohara, and T.  Honjo.",OADS,/arxiv_data1/oa_pdf/6a/4d/JEM_20130056.PMC3804935.pdf
"http://dx.doi.org/10.1182/blood-2003-10-363 8 Ulich, T.R., J. del Castillo, and L. Souza.",Non-OADS,/arxiv_data1/oa_pdf/6a/4d/JEM_20130056.PMC3804935.pdf
http://dx.doi.org/10.1038/nm.284 7,Non-OADS,/arxiv_data1/oa_pdf/6a/4d/JEM_20130056.PMC3804935.pdf
This article is distributed under the terms of an   Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six  months after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"After six   months it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
Online supplemental material is avail - able at http://www.jem.org/cgi/content/full/jem.20122019/DC1.,Non-OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"28:1487– 1497. http://dx.doi.org/10.1002/stem.47 2 Akala, O.O., I.-K. Park, D. Qian, M. Pihalja, M.W.",Non-OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/10.1038/nature0686 9 Bassler, J., M. Kallas, B. Pertschy, C. Ulbrich, M. Thoms, and E. Hurt.",OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/10.1016/j.molcel.2010.05.02 4 Bigas, A., and L. Espinosa.",OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/10.1182/blood-2011-   10-35582 6 Chantha, S.-C., and D.P.",Non-OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/10.1007/s12298-010-0005- y Chen, J., F.M.",Non-OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/10.1016/j.exphem.2008.04.01 2 Cormier, S., S. Le Bras, C. Souilhol, S. Vandormael-Pournin, B. Durand, C.  Babinet, P. Baldacci, and M. Cohen-Tannoudji.",OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/10.1128/MCB.26.9.3541-3549.200 6 Danilova, N., K.M.",Non-OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/10.1111/j.1365-2141   .2010.08396. xde la Cruz, J., E. Sanz-Martínez, and M. Remacha.",OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/10.1093/nar/gki88 7 Dutt, S., A. Narla, K. Lin, A. Mullally, N. Abayasekara, C. Megerdichian,  F.H.",Non-OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/10.1182/blood-2010-07-29523 8 Fichelson, P., C. Moch, K. Ivanovitch, C. Martin, C.M.",Non-OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/10.1038/ncb187 4 Fromont-Racine, M., B. Senger, C. Saveanu, and F. Fasiolo.",Non-OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/   10.1016/S0378-1119(03)00629- 2 Fumagalli, S., A.",OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/10.1038/   ncb185 8 Gan, B., J. Hu, S. Jiang, Y. Liu, E. Sahin, L. Zhuang, E. Fletcher-Sananikone,  S. Colla, Y.A.",OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/10.1038/nature0959 5 Ganapathi, K.A., and A. Shimamura.",Non-OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
http://dx.doi.org/   10.1111/j.1365-2141.2008.07095.,Non-OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"9:249. http://dx.doi.org/10.1186/   1471-2148-9-24 9 Gilbert, W.V.",Non-OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/10.1016/j.tibs.2010.12.00 2 Gurumurthy, S., S.Z.",OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/10.1038/nature0957 2 Hall, L.E., S.J.",OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/10.1017/S001667230400673 1 Hameyer, D., A. Loonstra, L. Eshkind, S. Schmitt, C. Antunes, A. Groen, E.  Bindels, J. Jonkers, P. Krimpenfort, R. Meuwissen, et al.",OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/10.1152/physiolgenomics   .00019.200 7 Higashi, A.Y., T. Ikawa, M. Muramatsu, A.N.",OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/10.4049/jimmunol.080241 3 Hock, H., M.J. Hamblen, H.M. Rooke, J.W.",OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/10.1038/nature0299 4 Horos, R., H. Ijspeert, D. Pospisilova, R. Sendtner, C. Andrieu-Soler, E.  Taskesen, A. Nieradka, R. Cmejla, M. Sendtner, I.P.",OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/10.1182/   blood-2011-06-35820 0 Inomata, K., T. Aoto, N.T.",Non-OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/10.1016/   j.cell.2009.03.03 7 Insinga, A., A. Cicalese, M. Faretta, B. Gallo, L. Albano, S. Ronzoni, L. Furia, A.  Viale, and P .G.",Non-OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/10.1016/S0960-9822   (00)00002- 6 Ji, H., G. Wu, X. Zhan, A. Nolan, C. Koh, A.",OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/10.1371/journal   .pone.002605 7 Jude, C.D., L. Climer, D. Xu, E. Artinger, J.K. Fisher, and P. Ernst.",Non-OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/10.1016/   j.stem.2007.05.01 9 Kai, T., D. Williams, and A.C. Spradling.",OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/10.1016/j.cell.2005.05.026 Komili, S., N.G.",OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/10.1016/j.cell.2007.08.03 7 Kondrashov, N., A. Pusic, C.R.",OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/10.1016/j.cell.2011.03.02 8 Kranc, K.R., H. Schepers, N.P.",OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/   10.1016/j.stem.2009.11.00 1 Kress, C., S. Vandormael-Pournin, P .",OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/10.1007/s00335990091 4 Laurenti, E., B. Varnum-Finney, A. Wilson, I. Ferrero, W.E.",Non-OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/10.1016/j.stem.2008.09.00 5 Leung, C.G., Y. Xu, B. Mularski, H. Liu, S. Gurbuxani, and J.D.",OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"46:30– 42. http://dx.doi.org/10.1016/j.molcel.2012.01.02 0 Maillard, I., U. Koch, A. Dumortier, O. Shestova, L. Xu, H. Sai, S.E.",OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi   .org/10.1016/j.stem.2008.02.01 1 Mohrin, M., E. Bourke, D. Alexander, M.R.",OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/10.1016/j.stem   .2010.06.01 4 Mourikis, P., R.J. Lake, C.B.",OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"10:107. http://dx.doi.org/10.1186/1471-213X-10-10 7Naiche, L.A., and V.E.",Non-OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/10.1002/dvg.2035 3 Nakada, D., T.L.",OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/10.1038/nature0957 1 Nal, B., E. Mohr, M.-I.D.",OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/10.1006/geno   .2001.668 2 Narla, A., and B.L.",OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/10.1182/   blood-2009-10-17812 9 Neumüller, R.A., C. Richter, A. Fischer, M. Novatchkova, K.G.",Non-OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/10.1016/j.stem.2011.02.02 2 Nybakken, K., S.A. Vokes, T.-Y.",OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/10.1038/ng168 2 O’Donohue, M.F., V. Choesmel, M. Faubladier, G. Fichant, and P.-E.  Gleizes.",Non-OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"190:853– 866. http://dx.doi.org/10.1083/jcb.20100511 7 Okabe, M., M. Ikawa, K. Kominami, T. Nakanishi, and Y. Nishimune.",OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/10.1016/S0014-5793(97)00313- X Opferman, J.T., H. Iwasaki, C.C.",OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/10.1016/   j.cell.2008.01.02 5 Pajerowski, A.G., M.J. Shapiro, K. Gwin, R. Sundsbak, M. Nelson-Holte,  K. Medina, and V.S.",OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/10.1182/blood-2010-02-26839 1 Passegué, E., A.J.",Non-OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/10.1084/jem.2005096 7 Qian, Z., L. Chen, A.A. Fernald, B.O.",OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/10.1084/jem.2008057 8 Randall, T.D., and I.L.",OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/10.1093/nar/25.6.131 7 Royet, J., T. Bouwmeester, and S.M.",OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/10.1093/emboj/17.24.735 1 Schultz, J.",OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/10.1128/MCB.00226-1 0 Tothova, Z., R. Kollipara, B.J.",Non-OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi   .org/10.1016/j.cell.2007.01.00 3 Turner, A.J., A.A. Knox, J.-L. Prieto, B. McStay, and N.J. Watkins.",OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"29:3007– 3017. http://dx.doi.org/10.1128/MCB.00029-0 9 Ulbrich, C., M. Diepholz, J. Bassler, D. Kressler, B. Pertschy, K. Galani, B.  Böttcher, and E. Hurt.",Non-OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"138:911– 922. http://dx.doi.org/10.1016/j.cell.2009.06.04 5 van Riggelen, J., A. Yetil, and D.W. Felsher.",OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"10:301– 309. http://dx.doi.org/10.1038/nrc281 9 Voutev, R., D.J.",Non-OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/10.1016/j.ydbio   .2006.06.01 1Wang, J., Q.",OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/10.1016/j.cell.2012.01.04 0 Xue, S., and M. Barna.",OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"13:355– 369. http://dx.doi.org/10.1038/nrm335 9 Zhang, Y ., and H. Lu.",OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
"http://dx.doi.org/10.1016/j.ccr.2009.09.02 4 Zhu, H.H., K. Ji, N. Alderson, Z.",OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
http://dx.doi.org/10.1182/blood-2011-01-33347 6,Non-OADS,/arxiv_data1/oa_pdf/de/76/JEM_20122019.PMC3804936.pdf
This article is distributed under the terms of an   Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six  months after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/   by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
http://dx.doi.org/10.1038/   nri118 4 Anonymous.,Non-OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
"http://dx.doi.org/10.1126/science.122482 0 Attarwala, H. 2010.",Non-OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
"http://dx.doi.org/10.4103/0975­1483.6681 0 Balkwill, F .",Non-OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
"http://dx.doi.org/10.1038/nrc262 8 Berger, C., M. Berger, R.C.",OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
"http://dx.doi   .org/10.1182/blood­2008­12­18926 6 Blay, J.Y ., S. Negrier, V .",Non-OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
"http://dx.doi.org/10.1002/msj.2027 8 Brüünsgaard, H., and B.K.",OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
"http://dx.doi.org/10.1073/   pnas.72.9.366 6 Chen, X., R. Das, R. Komorowski, A. Beres, M.J. Hessner, M. Mihara, and W .R.",Non-OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
"http://dx.doi.org/10.1182/blood­2009­   01­19717 8 Chung, H.Y ., M. Cesari, S. Anton, E. Marzetti, S. Giovannini, A.Y .",Non-OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
"8:18– 30. http://dx.doi.org/10.1016/j.arr.2008.07.00 2 Cressman, D.E., L.E.",OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
"http://dx.doi.org/10   .1089/cbr.2008.060 7 Munford, R.S.",Non-OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
"http://dx.doi.org/10.1146/ annurev.pathol.1.110304.10020 0 Murphy, W.J., L. Welniak, T. Back, J. Hixon, J. Subleski, N. Seki, J.M.",Non-OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
"http://dx.doi.org/   10.1016/j.yexmp.2011.02.00 3 Paludan, S.R.",OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
"http://dx.doi.org/10.1016/S1470­2045(02)00730­ 1 Rosas, G.O., S.J.",OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
"http://dx.doi   .org/10.1006/jmcc.2001.144 8 Rotter Sopasakis, V ., B.M.",OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
"47:1879– 1887. http://dx.doi.org/10.1007/s00125­004­1544­ y Schett, G., L.C.",Non-OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
"http://dx.doi   .org/10.1074/jbc.M21068920 0 Sethi, G., B.",Non-OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
"http://dx.doi.org/   10.2741/306 6 Shalaby, M.R., A. Waage, L. Aarden, and T. Espevik.",OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
"http://dx.doi   .org/10.1016/0090­1229(89)90010­ X Sheron, N., J.N.",OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
82:427– 428. http://dx.doi.org/10.1111/j.1365­2249.1990.tb05465.,Non-OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
"http://dx.doi.org/10.1056/NEJMoa06384 2 Surguladze, D., D. Deevi, N. Claros, E. Corcoran, S. Wang, M.J. Plym, Y .",OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
"http://dx.doi.org/10.1158/0008 ­5472.CAN ­09­048 7 Taylor, P.C.",Non-OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
10:308– 315. http://dx.doi.org/10.1016/j.coph.2010.01.00 5Oncol.,OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
"http://dx.doi.org/10.1053/j.seminoncol.2010.09   .007 Dougan, M., and G. Dranoff.",OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
"http://dx.doi.org/10.1182/   blood­2004­07­259 9 Franceschi, C. 2007.",Non-OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
"http://dx.doi   .org/10.1301/nr.2007.dec.S173­S17 6 Franceschi, C., M. Bonafè, S. Valensin, F .",Non-OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
http://dx.doi.org/10.1111/j.1749­6632.2000.tb06651.,Non-OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
"http://dx.doi.org/10   .1056/NEJMcibr121234 1 Gantner, F ., M. Leist, A.W .",OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
"http://dx.doi.org/10.1007/s00441­005­1102­ z Hack, C.E., E.R.",Non-OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
"http://dx.doi.org/10.1016/j.nmd.2006.06.01 1 Hooper, L.V ., D.R.",OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
http://dx.doi.org/10.1111/j.1365­2249.2007.03509.,Non-OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
"http://dx.doi   .org/10.1002/hep.2108 7 Kamada, N., S.U.",OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
"http://dx.doi.org/10.1038/nri343 0 Kawa, K., H. Tsutsui, R. Uchiyama, J. Kato, K. Matsui, Y .",OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
"http://dx.doi.org/   10.1093/intimm/dxp12 2 Korngold, R., J.C. Marini, M.E.",OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
"http://dx.doi.org/10.1016/S1083­8791(03)00087­ 9 Krüttgen, A., and S. Rose­John.",OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
"http://dx.doi   .org/10.1089/jir.2011.006 2 Leon, L.R., A.A. White, and M.J. Kluger.",OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
"http://dx.doi.org/10.1038/nm0297­18 9 Minor, D.R., K. Chin, and M. Kashani ­Sabet.",Non-OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
"5:578– 582. http://dx.doi.org/10.1038/nrrheum.2009.18 1 Tietze, J.K., D.E.",Non-OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
"http://dx.doi.org/10.1182/blood­2011­07­36973 6 van Horssen, R., T.L.",Non-OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
"http://dx.doi.org/10.1634/theoncologist   .11­4­39 7 Vonderheide, R.H., K.T.",Non-OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
"http://dx.doi.org/10.1200/JCO.2006.08.331 1 Waldmann, T.A.",OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
"http://dx.doi.org/10.1038/nri190 1Weber, J.S., K.C.",OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
"http://dx.doi.org/10.1200/JCO.2012.41.675 0 Wigginton, J.M., K.L.",OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
"http://dx.doi.org/10.1093/jnci/   88.1.3 8 Wigginton, J.M., E. Gruys, L. Geiselhart, J. Subleski, K.L.",Non-OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
Chapter 14:1.  http://dx.doi.org/10.1002/0471142735.im1401s8 3,Non-OADS,/arxiv_data1/oa_pdf/7a/3d/JEM_20131219.PMC3804937.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/ad/3a/JEM_20122490.PMC3804938.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/ad/3a/JEM_20122490.PMC3804938.pdf
"http://dx.doi.org/   10.1182/blood-2009-11-25469 8 Kawaguchi, M., M. Nanno, Y. Umesaki, S. Matsumoto, Y. Okada, Z.  Cai, T. Shimamura, Y. Matsuoka, M. Ohwaki, and H. Ishikawa.",OADS,/arxiv_data1/oa_pdf/ad/3a/JEM_20122490.PMC3804938.pdf
"http://dx.doi.org/10.1038/416194 a Kobayashi, K.S., M. Chamaillard, Y. Ogura, O. Henegariu, N. Inohara,  G. Nuñez, and R.A. Flavell.",Non-OADS,/arxiv_data1/oa_pdf/ad/3a/JEM_20122490.PMC3804938.pdf
"http://dx.doi.org/10.1126/science.110491 1 Lee, H.B., J.H.",OADS,/arxiv_data1/oa_pdf/ad/3a/JEM_20122490.PMC3804938.pdf
"http://dx.doi.org/10.1016/j.cell.2011.09.02 5 Marks, D.J., M.W.",OADS,/arxiv_data1/oa_pdf/ad/3a/JEM_20122490.PMC3804938.pdf
"http://dx.doi.org/10.1016/S0140-6736(06)68265- 2 Meylan, E., J. Tschopp, and M. Karin.",OADS,/arxiv_data1/oa_pdf/ad/3a/JEM_20122490.PMC3804938.pdf
"http://dx.doi   .org/10.1038/nature0494 6 Ninomiya, T., H. Takimoto, G. Matsuzaki, S. Hamano, H. Yoshida, Y.  Yoshikai, G. Kimura, and K. Nomoto.",OADS,/arxiv_data1/oa_pdf/ad/3a/JEM_20122490.PMC3804938.pdf
http://dx.doi.org/10.1046/j.1365-2567.2000.00938.,Non-OADS,/arxiv_data1/oa_pdf/ad/3a/JEM_20122490.PMC3804938.pdf
"http://dx.doi.org/10.1038/3507911 4 Olivares-Villagómez, D., Y.V.",Non-OADS,/arxiv_data1/oa_pdf/ad/3a/JEM_20122490.PMC3804938.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ad/3a/JEM_20122490.PMC3804938.pdf
"http://dx.doi.org/10.1056/NEJMra02083 1 Rakoff-Nahoum, S., J. Paglino, F. Eslami-Varzaneh, S. Edberg, and R.  Medzhitov.",Non-OADS,/arxiv_data1/oa_pdf/ad/3a/JEM_20122490.PMC3804938.pdf
"http://dx.doi.org/10.1016/j.cell.2004.07.00 2 Reikvam, D.H., A. Erofeev, A. Sandvik, V. Grcic, F.L.",OADS,/arxiv_data1/oa_pdf/ad/3a/JEM_20122490.PMC3804938.pdf
"http://dx.doi.org/   10.1371/journal.pone.001799 6 Scheiffele, F., and I.J.",Non-OADS,/arxiv_data1/oa_pdf/ad/3a/JEM_20122490.PMC3804938.pdf
"http://dx.doi.org/10.1097/MOG   .0b013e328331b6b 4 Adachi, O., T. Kawai, K. Takeda, M. Matsumoto, H. Tsutsui, M. Sakagami,  K. Nakanishi, and S. Akira.",OADS,/arxiv_data1/oa_pdf/ad/3a/JEM_20122490.PMC3804938.pdf
"http://dx.doi.org/10.1016/S1074-7613(00)80596- 8 Barreau, F., U. Meinzer, F. Chareyre, D. Berrebi, M. Niwa-Kawakita,  M. Dussaillant, B. Foligne, V. Ollendorff, M. Heyman, S. Bonacorsi,  et al.",OADS,/arxiv_data1/oa_pdf/ad/3a/JEM_20122490.PMC3804938.pdf
"http://dx.doi.org/10.1371/journal   .pone.000052 3 Cao, X., E.W.",OADS,/arxiv_data1/oa_pdf/ad/3a/JEM_20122490.PMC3804938.pdf
"http://dx.doi   .org/10.1016/1074-7613(95)90047- 0 Chen, Y., K. Chou, E. Fuchs, W.L.",OADS,/arxiv_data1/oa_pdf/ad/3a/JEM_20122490.PMC3804938.pdf
"http://dx.doi.org/10.1073/   pnas.21229049 9 Cheroutre, H. 2004.",Non-OADS,/arxiv_data1/oa_pdf/ad/3a/JEM_20122490.PMC3804938.pdf
"http://dx.doi   .org/10.1146/annurev.immunol.22.012703.10452 2 Cheroutre, H., and F. Lambolez.",Non-OADS,/arxiv_data1/oa_pdf/ad/3a/JEM_20122490.PMC3804938.pdf
"20:185– 191. http://dx.doi.org/10.1016/j.coi.2008.03.00 9 Comalada, M., and M.P.",OADS,/arxiv_data1/oa_pdf/ad/3a/JEM_20122490.PMC3804938.pdf
"http://dx.doi   .org/10.1016/j.molmed.2006.07.00 5 Elinav, E., T. Strowig, J. Henao-Mejia, and R.A. Flavell.",OADS,/arxiv_data1/oa_pdf/ad/3a/JEM_20122490.PMC3804938.pdf
"http://dx.doi.org/10.1016/j.immuni.2011.05.00 7 Fukushima, K., T. Masuda, H. Ohtani, I. Sasaki, Y. Funayama, S. Matsuno,  and H. Nagura.",OADS,/arxiv_data1/oa_pdf/ad/3a/JEM_20122490.PMC3804938.pdf
"http://dx.doi.org/10.1016/j.immuni.2006.08.01 8 Guy-Grand, D., N. Cerf-Bensussan, B. Malissen, M. Malassis-Seris, C.  Briottet, and P. Vassalli.",OADS,/arxiv_data1/oa_pdf/ad/3a/JEM_20122490.PMC3804938.pdf
"http://dx.doi.org/10.1136/gut.48.4.48 9 Honda, K., and D.R.",OADS,/arxiv_data1/oa_pdf/ad/3a/JEM_20122490.PMC3804938.pdf
"http://dx.doi.org/   10.1146/annurev-immunol-020711-07493 7 Hugot, J.P., M. Chamaillard, H. Zouali, S. Lesage, J.P. Cézard, J. Belaiche,  S. Almer, C. Tysk, C.A.",Non-OADS,/arxiv_data1/oa_pdf/ad/3a/JEM_20122490.PMC3804938.pdf
"http://dx.doi.org/10.1038/3507910 7 Ismail, A.S., K.M.",Non-OADS,/arxiv_data1/oa_pdf/ad/3a/JEM_20122490.PMC3804938.pdf
"http://dx.doi.org/   10.1073/pnas.101957410 8 Janeway, C.A.",Non-OADS,/arxiv_data1/oa_pdf/ad/3a/JEM_20122490.PMC3804938.pdf
http://dx.doi.org/10.1146/annurev   .immunol.20.083001.08435 9,Non-OADS,/arxiv_data1/oa_pdf/ad/3a/JEM_20122490.PMC3804938.pdf
"http://dx.doi.org/10.1136/gut.2007.14258 8 Sonnenburg, J.L., C.T.",Non-OADS,/arxiv_data1/oa_pdf/ad/3a/JEM_20122490.PMC3804938.pdf
"http://dx.doi.org/10.1371/journal.pbio   .004041 3 Suzuki, H., K.I.",OADS,/arxiv_data1/oa_pdf/ad/3a/JEM_20122490.PMC3804938.pdf
"http://dx.doi.org/10   .1007/s00251005039 3 W ehkamp, J., N.H. Salzman, E. Porter, S. Nuding, M. W eichenthal, R.E.",Non-OADS,/arxiv_data1/oa_pdf/ad/3a/JEM_20122490.PMC3804938.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/d9/8c/JEM_20130150.PMC3804939.pdf
"After six months it is   available under a Creative Commons License (Attribution–Noncommercial–Share   Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/   by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/d9/8c/JEM_20130150.PMC3804939.pdf
"http://dx.doi.org/10.1242/jcs.0096 8 Chaineau, M., L. Danglot, and T. Galli.",Non-OADS,/arxiv_data1/oa_pdf/d9/8c/JEM_20130150.PMC3804939.pdf
"http://dx.doi.org/10.1016/j.febslet.2009.10.02 6 Colvin, R.A., T.K.",OADS,/arxiv_data1/oa_pdf/d9/8c/JEM_20130150.PMC3804939.pdf
"http://dx.doi.org/10.1038/ni.187 8 Das, V., B. Nal, A. Dujeancourt, M.I.",OADS,/arxiv_data1/oa_pdf/d9/8c/JEM_20130150.PMC3804939.pdf
"http://dx.doi   .org/10.1016/S1074-7613(04)00106- 2 de Saint Basile, G., G. Ménasché, and A. Fischer.",Non-OADS,/arxiv_data1/oa_pdf/d9/8c/JEM_20130150.PMC3804939.pdf
"http://dx.doi.org/10.1038/nri280 3 Douglass, A.D., and R.D.",OADS,/arxiv_data1/oa_pdf/d9/8c/JEM_20130150.PMC3804939.pdf
"http://dx.doi.org/10.1016/j.cell.2005.04.00 9 Dustin, M.L., and D. Depoil.",OADS,/arxiv_data1/oa_pdf/d9/8c/JEM_20130150.PMC3804939.pdf
"17:809– 822. http://dx.doi.org/10.1016/S1074-7613(02)00481- 8 Finetti, F., S.R.",Non-OADS,/arxiv_data1/oa_pdf/d9/8c/JEM_20130150.PMC3804939.pdf
"http://dx.doi.org/10   .1038/ncb197 7 Frank, E., M. Hall, L. Trigg, G. Holmes, and I.H.",OADS,/arxiv_data1/oa_pdf/d9/8c/JEM_20130150.PMC3804939.pdf
"http://dx.doi.org/10.1007/   s00018-008-8351- 4 Heilemann, M., S. van de Linde, M. Schüttpelz, R. Kasper, B. Seefeldt,  A. Mukherjee, P. Tinnefeld, and M. Sauer.",Non-OADS,/arxiv_data1/oa_pdf/d9/8c/JEM_20130150.PMC3804939.pdf
"http://dx.doi.org/10.1002/   anie.20080237 6 Henriques, R., M. Lelek, E.F. Fornasiero, F. Valtorta, C. Zimmer, and  M.M.",Non-OADS,/arxiv_data1/oa_pdf/d9/8c/JEM_20130150.PMC3804939.pdf
"http://dx.doi.org/10.1038/nmeth0411-27 9 Houtman, J.C., H. Yamaguchi, M. Barda-Saad, A. Braiman, B. Bowden,  E. Appella, P. Schuck, and L.E.",Non-OADS,/arxiv_data1/oa_pdf/d9/8c/JEM_20130150.PMC3804939.pdf
"http://dx.doi.org/10.1038/   nsmb113 3 Huse, M., B.F. Lillemeier, M.S.",OADS,/arxiv_data1/oa_pdf/d9/8c/JEM_20130150.PMC3804939.pdf
"http://dx.doi.org/10.1038/ni130 4 Kusumi, A., Y.M.",OADS,/arxiv_data1/oa_pdf/d9/8c/JEM_20130150.PMC3804939.pdf
"http://dx.doi.org/10.1016/j.febslet   .2010.02.04 7 Larghi, P., D.J.",OADS,/arxiv_data1/oa_pdf/d9/8c/JEM_20130150.PMC3804939.pdf
Online supplemental material is  available at http://www.jem.org/cgi/content/full/jem.20130150/DC1.,Non-OADS,/arxiv_data1/oa_pdf/d9/8c/JEM_20130150.PMC3804939.pdf
"http://dx.doi.org/10.1038/nri239 7 Alcover, A., and M.I.",OADS,/arxiv_data1/oa_pdf/d9/8c/JEM_20130150.PMC3804939.pdf
"http://dx.doi.org/10.1007/978-   3-642-03858-7_1 0 Antón, O., A. Batista, J. Millán, L. Andrés-Delgado, R. Puertollano, I.  Correas, and M.A.",Non-OADS,/arxiv_data1/oa_pdf/d9/8c/JEM_20130150.PMC3804939.pdf
"http://dx.doi.org/10.1084/jem.2008055 2 Balagopalan, L., V.A.",Non-OADS,/arxiv_data1/oa_pdf/d9/8c/JEM_20130150.PMC3804939.pdf
"http://dx.doi.org/10.4049/jimmunol.120276 0 Bates, M., B. Huang, G.T.",OADS,/arxiv_data1/oa_pdf/d9/8c/JEM_20130150.PMC3804939.pdf
"http://dx.doi.org/10.1126/science.114659 8 Bonello, G., N. Blanchard, M.C.",OADS,/arxiv_data1/oa_pdf/d9/8c/JEM_20130150.PMC3804939.pdf
"14:723– 731. http://dx.doi.org/10.1038/ni.260 9 Lasserre, R., and A. Alcover.",OADS,/arxiv_data1/oa_pdf/d9/8c/JEM_20130150.PMC3804939.pdf
"http://dx.doi.org/10.1038/ni.183 2 Marcet-Palacios, M., S.O.",Non-OADS,/arxiv_data1/oa_pdf/d9/8c/JEM_20130150.PMC3804939.pdf
"http://dx.doi.org/10.1016/j.bbrc.2007.11.07 9 Ménager, M.M., G. Ménasché, M. Romao, P. Knapnougel, C.H.",OADS,/arxiv_data1/oa_pdf/d9/8c/JEM_20130150.PMC3804939.pdf
"http://dx.doi.org/10.1038/ni143 1 Nika, K., C. Soldani, M. Salek, W. Paster, A.",Non-OADS,/arxiv_data1/oa_pdf/d9/8c/JEM_20130150.PMC3804939.pdf
"http://dx.doi.org/10.1016/j.immuni.2010.05.01 1 Pang, Z.P., and T.C.",OADS,/arxiv_data1/oa_pdf/d9/8c/JEM_20130150.PMC3804939.pdf
"http://dx.doi.org/10.1016/j.ceb   .2010.05.00 1 Purbhoo, M.A., H. Liu, S. Oddos, D.M.",OADS,/arxiv_data1/oa_pdf/d9/8c/JEM_20130150.PMC3804939.pdf
"http://dx.doi.org/10.1126/scisignal.200064 5 Rao, S.K., C. Huynh, V. Proux-Gillardeaux, T. Galli, and N.W.",OADS,/arxiv_data1/oa_pdf/d9/8c/JEM_20130150.PMC3804939.pdf
"http://dx.doi.org/   10.1074/jbc.M40079820 0 Schindelin, J., I. Arganda-Carreras, E. Frise, V. Kaynig, M. Longair, T.  Pietzsch, S. Preibisch, C. Rueden, S. Saalfeld, B. Schmid, et al.",Non-OADS,/arxiv_data1/oa_pdf/d9/8c/JEM_20130150.PMC3804939.pdf
"http://dx.doi.org/10.1038/nmeth.201 9 Sengupta, P., T. Jovanovic-Talisman, D. Skoko, M. Renz, S.L.",OADS,/arxiv_data1/oa_pdf/d9/8c/JEM_20130150.PMC3804939.pdf
"http://dx.doi.org/10.1038/nmeth.170 4 Sherman, E., V. Barr, S. Manley, G. Patterson, L. Balagopalan, I. Akpan,  C.K.",Non-OADS,/arxiv_data1/oa_pdf/d9/8c/JEM_20130150.PMC3804939.pdf
"http://dx.doi.org/10.1016/j.immuni.2011.10.00 4 Simonson, P.D., E. Rothenberg, and P.R.",OADS,/arxiv_data1/oa_pdf/d9/8c/JEM_20130150.PMC3804939.pdf
"http://dx.doi.org/10.1021/nl203560 r Stinchcombe, J.C., D.C. Barral, E.H. Mules, S. Booth, A.N.",Non-OADS,/arxiv_data1/oa_pdf/d9/8c/JEM_20130150.PMC3804939.pdf
"http://dx.doi.org/10.1083/jcb.152.4.82 5 Stojilkovic, S.S. 2005.",OADS,/arxiv_data1/oa_pdf/d9/8c/JEM_20130150.PMC3804939.pdf
"http://dx.doi.org/10.1016/j.tem   .2005.02.00 2 Sugawara, K., T. Shibasaki, A. Mizoguchi, T. Saito, and S. Seino.",OADS,/arxiv_data1/oa_pdf/d9/8c/JEM_20130150.PMC3804939.pdf
"http://dx.doi.org/10.1111/j.1365- 2443.2009.01285. x Wei, C., X. Wang, M. Chen, K. Ouyang, L.S.",OADS,/arxiv_data1/oa_pdf/d9/8c/JEM_20130150.PMC3804939.pdf
12:655– 662. http://dx.doi.org/10.1038/ni.204 9[ID]VID1[/ID],OADS,/arxiv_data1/oa_pdf/d9/8c/JEM_20130150.PMC3804939.pdf
This article is distributed under the terms of an   Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six  months after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/   by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"http://dx.doi.org/10.1194/jlr.M00165 1 Bates, S.R., J.Q.",OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"http://dx.doi   .org/10.1152/ajplung.00234.200 5 Blanchard, P.G., W.T.",OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"http://dx.doi.org/10.1194/jlr.M02148 5 Bonfield, T.L., C.F.",Non-OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"http://dx.doi.org/10.1165/rcmb.2003-0148O C Borie, R., C. Danel, M.P.",OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"http://dx.doi.org/10.1183/09059180.0000131 1 Brügger, B., G. Erben, R. Sandhoff, F.T.",Non-OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"http://dx.doi.org/10.1378/chest.55.4.27 4 Cao, S., J. Liu, M. Chesi, P.L.",OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"http://dx.doi.org/   10.1016/S1097-2765(01)00164- 2 Cordonnier, C., J. Fleury-Feith, E. Escudier, K. Atassi, and J.F.",OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"http://dx.doi.org/10.1164/ajrccm.149.3.811865 1 Corti, M., A.R.",Non-OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"http://dx.doi.org/10.1165/ajrcmb.14.4.860093 3 Dirksen, U., R. Nishinakamura, P. Groneck, U. Hattenhorst, L. Nogee, R.  Murray, and S. Burdach.",Non-OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"http://dx.doi.org/   10.1172/JCI11975 8 Dohi, Y., T. Ikura, Y. Hoshikawa, Y. Katoh, K. Ota, A. Nakanome, A.  Muto, S. Omura, T. Ohta, A. Ito, et al.",OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"http://dx.doi.org/10   .1038/nsmb.151 6 Dranoff, G., A.D. Crawford, M. Sadelain, B. Ream, A. Rashid, R.T.  Bronson, G.R.",Non-OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"http://dx.doi   .org/10.1126/science.817132 4 Fleetwood, A.J., T. Lawrence, J.A.",Non-OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"http://dx.doi.org/10.1038/nri97 8 Gunasekara, L., W .M.",Non-OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
http://dx.doi.org/10.1016/j.bbamem.2007.10.02 7Mouse Fc block antibody (BD).,OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
Online supplemental material  is available at http://www.jem.org/cgi/content/full/jem.20130028/DC1.,Non-OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"http://dx.doi.org/10.1016/S0165-4608(02)00652- 0 Baker, A.D., A. Malur, B.P.",OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"http://dx.doi.org/10.1038/nature0259 6 Muto, A., K. Ochiai, Y. Kimura, A. Itoh-Nakadai, K.L.",OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"http://dx.doi.org/10.1038/emboj.2010.25 7 Nelson, S.M., X. Lei, and K.S.",OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"http://dx.doi.org/10.3945/jn.111   .14117 6 Nogee, L.M., D.E.",OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"http://dx.doi.org/   10.1056/NEJM19930211328060 6 Nogee, L.M., A.E.",OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"http://dx.doi.org/10.1056/NEJM20010222344080 5 Ochiai, K., Y. Katoh, T. Ikura, Y. Hoshikawa, T. Noda, H. Karasuyama, S.  Tashiro, A. Muto, and K. Igarashi.",OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"281:38226– 38234. http://dx.doi.org/10.1074/jbc.M60759220 0 Odegaard, J.I., R.R.",OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"http://dx.doi.org/10.1038/nature0589 4 Oyake, T., K. Itoh, H. Motohashi, N. Hayashi, H. Hoshino, M. Nishizawa,  M. Yamamoto, and K. Igarashi.",OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"25:132– 141. http://dx.doi.org/10.1152/physiol.00006.201 0 Postle, A.D., L.W.",Non-OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"http://dx.doi.org/10.1194/ jlr.M600054-JLR20 0 Rauh, M.J., V. Ho, C. Pereira, A. Sham, L.M.",Non-OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"http://dx.doi.org/10.1016/j.immuni.2005.09.00 3 Ricote, M., A.F.",OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"http://dx.doi.org/10.1161/01.ATV.0000103951   .67680.B 1 Roychoudhuri, R., K. Hirahara, K. Mousavi, D. Clever, C.A.",Non-OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"http://dx.doi.org/10.1038/nature1219 9 Ruben, F.L., and T.S.",Non-OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"http://dx.doi.org/10.1016/0002-   9343(86)90683- 2 Saigusa, D., K. Shiba, A. Inoue, K. Hama, M. Okutani, N. Iida, M. Saito, K.  Suzuki, T. Kaneko, N. Suzuki, et al.",OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"http://dx.doi.org/10.1007/s00216-012-   6004- 9Harris, J.O.",Non-OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"http://dx.doi.org/10   .1378/chest.76.2.15 6 Homer, R.J., T. Zheng, G. Chupp, S. He, Z. Zhu, Q. Chen, B. Ma, R.D.",Non-OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"http://dx.doi.org/10.1093/jb/mvm10 6 Ikegami, M., J.A.",OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"http://dx.doi.org/10   .1164/rccm.200708-1271O C Ishii, H., R. Tazawa, C. Kaneko, T. Saraya, Y. Inoue, E. Hamano, Y. Kogure,  K. Tomii, M. Terada, T. Takada, et al.",OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"http://dx.doi.org/10.1183/09031936.0009291 0 Iyonaga, K., M. Suga, T. Yamamoto, H. Ichiyasu, H. Miyakawa, and M.  Ando.",OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
http://dx.doi.org/10.1034/j.1399-3003.1999.14b24.,Non-OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"http://dx.doi.org/10.1016/j.cmet.2008.04.00 2 Keller, C.A., A.",OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"http://dx.doi.org/10.1378/chest.108.1.27 7 Kitamura, T., N. Tanaka, J. Watanabe, S. Uchida, S. Kanegasaki, Y .",OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"http://dx.doi   .org/10.1084/jem.190.6.87 5 Kohyama, M., W. Ise, B.T.",OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"http://dx.doi.org/10.1038/nature0747 2 Kuroki, Y., H. Takahashi, H. Chiba, and T. Akino.",OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"http://dx.doi.org/10.1016/S0925-4439(98)00079- 9 Ladeb, S., J. Fleury-Feith, E. Escudier, J. Tran Van Nhieu, J.F.",OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"http://dx.doi.org/10.1007/   BF0188063 9 Lawrence, T., and G. Natoli.",Non-OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"http://dx.doi.org/10.1038/nri308 8 Martinez, F.O.",Non-OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"http://dx.doi.org/10.1002/eji.20114167 0 Matute-Bello, G., J.S.",Non-OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"http://dx.doi.org/10.1016/j.jim.2004.05.01 0 Mosser, D.M., and J.P. Edwards.",OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"http://dx.doi   .org/10.1038/nri244 8 Muto, A., H. Hoshino, L. Madisen, N. Yanai, M. Obinata, H. Karasuyama,  N. Hayashi, H. Nakauchi, M. Yamamoto, M. Groudine, and K. Igarashi.",OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
http://dx.doi.org/10.1093/   emboj/17.19.573 4,Non-OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"http://dx.doi.org/10.1038/   nature1193 0 Sciammas, R., A.L.",OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"http://dx.doi.org/10.1016/j.immuni.2006.07.00 9 Shapiro-Shelef, M., K.I.",OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"http://dx.doi.org/10.1016/   S1074-7613(03)00267- X Shibata, Y., P.Y.",OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"http://dx.doi.org/10.1016/S1074-7613(01)00218- 7 Takeda, K., T. Tanaka, W. Shi, M. Matsumoto, M. Minami, S. Kashiwamura,  K. Nakanishi, N. Yoshida, T. Kishimoto, and S. Akira.",OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"http://dx.doi   .org/10.1038/380627a 0 Thomassen, M.J., B.P.",OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"48:2762– 2768. http://dx.doi.org/10.1194/jlr.P700022-JLR20 0 Trapnell, B.C., J.A.",Non-OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"http://dx.doi.org/10.1056/   NEJMra02322 6 Trapnell, B.C., B.C.",OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
"40:2296– 2307. http://dx.doi.org/10.1002/eji.20094028 8 Yoshida, M., M. Ikegami, J.A.",OADS,/arxiv_data1/oa_pdf/11/1d/JEM_20130028.PMC3804940.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
Online supplemental material is avail - able at http://www.jem.org/cgi/content/full/jem.20122709/DC1.,Non-OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi   .org/10.1159/00018752 1 Asberg, A., A. Hartmann, E. Fjeldså, S. Bergan, and H. Holdaas.",OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
http://dx.doi.org/10.1034/j.1600-6143.2001.10415.,Non-OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
http://dx.doi.org/10.1002/eji.20073759 4RNA integrity was checked with an RNA 6000 Nano LabChip kit (Agilent  Technologies) on a 2100 Bioanalyzer (Agilent Technologies).,OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi.org/10.1002/sim.287 1 Goldberg, R., and D. Roth.",OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi.org/10.1097/   00007890-199612150-0000 5 Grip, O., and S. Janciauskiene.",OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi.org/10.1371/journal.pone.000526 3 Guillén, D., F. Cofán, E. Ros, O. Millán, M. Cofán, and M. Brunet.",Non-OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi.org/10.1007/BF0325639 3 Halloran, P.F.",Non-OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi.org/10.1056/   NEJMra03354 0 Hartl, M., A. Nist, M.I.",OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi   .org/10.1073/pnas.081210110 6 Holdaas, H., A.G. Jardine, D.C. Wheeler, I.B.",OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
http://dx.doi.org/10.1046/ j.1523-1755.2001.00010.,Non-OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi.org/10.1093/nar/gng01 5 Irizarry, R.A., B. Hobbs, F. Collin, Y.D.",OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi.org/10.1093/biostatistics/4.2.24 9 Karason, K., M. Jernås, D.A.",OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"6:29. http://dx.doi.org/10   .1186/1471-2261-6-2 9 Kasiske, B.L., K.L.",Non-OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi.org/10.1097/   00007890-199605270-0001 0 Khatri, P., S. Draghici, A.L.",OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
http://dx.doi.org/   10.1111/j.1365-2567.2010.03269.,Non-OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi   .org/10.1097/TP.0b013e318195262 3 Kobashigawa, J.A., S. Katznelson, H. Laks, J.A.",OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi.org/10.1056/NEJM19950907333100 3 Kondo, T., K. Morita, Y. Watarai, M.B.",OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi   .org/10.1097/00007890-200003150-0005 1Blake, S.J., A. Bruce Lyons, C.K.",Non-OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi.org/10.1182/blood-2008-02-13870 1 Butte, A.J.",Non-OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi.org/10.1197/jamia.M282 4 Campana, C., I. Iacona, M.B.",Non-OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"273:16177– 16183. http://dx.doi.org/10.1074/jbc.273.26.1617 7 Chen, R., T.K.",Non-OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi.org/10   .1101/gr.620260 7 Drayton, D.L., S. Liao, R.H. Mounzer, and N.H. Ruddle.",Non-OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi.org/10.1038/ni133 0 Dudley, J.T., E. Schadt, M. Sirota, A.J.",Non-OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi.org/10.1007/s12265-   010-9214- 6 Einecke, G., J. Reeve, B. Sis, M. Mengel, L. Hidalgo, K.S.",Non-OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi.org/10.1172/   JCI4178 9 Ellis, S.L., V. Gysbers, P.M. Manders, W. Li, M.J. Hofer, M. Müller, and  I.L.",OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi.org/10.4049/jimmunol.100090 0 Ferreira, G.A., A.L.",Non-OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi   .org/10.1177/096120331036440 0 Fischbein, M.P., A. Ardehali, J. Yun, S. Schoenberger, H. Laks, Y. Irie, P.  Dempsey, G. Cheng, M.C.",Non-OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi.org/10.1016/S0009-9236(97)90034- 5 Ramasamy, A., A. Mondry, C.C.",Non-OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi.org/10.1371/journal.pmed.005018 4 Reeve, J., J. Sellarés, M. Mengel, B. Sis, A. Skene, L. Hidalgo, D.G.",Non-OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi.org/10.1111/ajt.1207 9 Regazzi, M.B., I. Iacona, C. Campana, V. Raddato, C. Lesi, G. Perani,  A. Gavazzi, and M. Viganò.",Non-OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi.org/10.1093/ndt/16.1.14 1 Robertson, G., M. Hirst, M. Bainbridge, M. Bilenky, Y. Zhao, T. Zeng, G.  Euskirchen, B. Bernier, R. Varhol, A. Delaney, et al.",Non-OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi.org/10.1038/nmeth106 8 Sakaeda, Y., M. Hiroi, T. Shimojima, M. Iguchi, H. Kanegae, and Y. Ohmori.",OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi.org/10.1016/j.bbrc.2006.09.05 8 Sarwal, M., M.-S. Chua, N. Kambham, S.-C. Hsieh, T. Satterwhite, M.  Masek, and O.J.",OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi.org/10.1056/NEJMoa03558 8 Schade, A.E., G.L.",OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi.org/10.1182/blood-2007-04-08481 4 Shah, N.P., H.M. Kantarjian, D.W. Kim, D. Réa, P.E.",Non-OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi.org/10.1200/JCO.2007.14.926 0 Sharif, M.N., I. Tassiulas, Y. Hu, I. Mecklenbräuker, A. Tarakhovsky, and  L.B.",Non-OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi.org/10.1111/1467-9868.0034 6 Su, A.I., T. Wiltshire, S. Batalov, H. Lapp, K.A.",Non-OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi   .org/10.1093/bioinformatics/btn57 7 Vajdic, C.M., S.P .",OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi.org/10.1001/jama.296.23.282 3Kuo, P.C., J.M.",OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi.org/10.1016/0002-9149(89)90492- X Kuznetsov, V.A.",OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi.org/10.1007/978-1-60761-175-2_ 2 Kwak, B., F. Mulhaupt, S. Myit, and F. Mach.",Non-OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi.org/10.1038/nm125 1 Lee, K.C., I. Ouwehand, A.L.",OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi.org/10.1038/   leu.2010.1 1 Li, L., P. Khatri, T.K.",OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
12:2710– 2718. http://dx.doi.org/10.1111/j.1600-6143.2012.04253.,Non-OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi.org/10.1016/   S0735-1097(02)02340- 9 Morgun, A., N. Shulzhenko, A. Perez-Diez, R.V.Z.",Non-OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi.org/10.1161/01.RES.0000228714   .15691.8 a Mück, W., I. Mai, L. Fritsche, K. Ochmann, G. Rohde, S. Unger, A. Johne,  S. Bauer, K. Budde, I.",Non-OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi.org/10.1681/ASN.200811114 5 Naesens, M., P. Khatri, L. Li, T.K.",Non-OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi.org/10.1038/   ki.2011.24 5 Navaneethan, S.D., V .",Non-OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
http://dx.doi.org/10.1046/j.1365-2249.2003.02021.,Non-OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi.org/10.1056/NEJMoa120173 5 Obara, H., K. Nagasaki, C.L.",OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
http://dx.doi.org/10.1111/j.1600-6143.2005.00995.,Non-OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi.org/   10.1097/00007890-200006150-0003 3 Olbricht, C., C. Wanner, T. Eisenhauer, V. Kliem, R. Doll, M. Boddaert,  P. O’Grady, M. Krekler, B. Mangold, and U. Christians.",Non-OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi.org/10.1016/j.atherosclerosis.2010   .01.04 3 Walsh, R.C., J.J. Everly, P. Brailey, A.H. Rike, L.J.",OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi.org/10.1097/   TP.0b013e3181c6ff8 d Wang, E., A. Worschech, and F.M.",Non-OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi.org/   10.1016/j.it.2008.03.00 2Xu, F., Z.H.",OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
"http://dx.doi.org/10.1097/01.ASN.0000054496.68498.1 3 Zhao, D.X.-M., Y. Hu, G.G.",Non-OADS,/arxiv_data1/oa_pdf/7a/ed/JEM_20122709.PMC3804941.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
eValues from Molprobity server (http://molprobity.biochem.duke.edu/).,OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"http://dx.doi.org/10.1002/pros.2073 6 Banerjee, S., A. Friggeri, G. Liu, and E. Abraham.",Non-OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"http://dx.doi.org/10.1189/jlb.051026 2 Barton, G.M., J.C. Kagan, and R. Medzhitov.",OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"http://dx.doi.org/10   .1038/ni128 0 Bierhaus, A., S. Schiekofer, M. Schwaninger, M. Andrassy, P .M.",Non-OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"http://dx.doi.org/10.2337/diabetes   .50.12.279 2 Blasius, A.L., C.N.",Non-OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"2010:917108.   http://dx.doi.org/10.1155/2010/91710 8 Chen, V .B., W .B.",OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"http://dx.doi.org/   10.1107/S090744490904207 3 Chuang, T.H., and R.J. Ulevitch.",Non-OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"http://dx.doi.org/10.1093/hmg/ddp29 3 Dapi ć, V., V. Abdomerovi ć, R. Marrington, J. Peberdy, A. Rodger, J.O.",Non-OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"31:2097– 2107. http://dx.doi.org/10.1093/nar/gkg31 6 Dattilo, B.M., G. Fritz, E. Leclerc, C.W.",Non-OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"http://dx.doi.org/10.1021/bi700373 5 Demling, N., C. Ehrhardt, M. Kasper, M. Laue, L. Knels, and E.P.",OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"http://dx.doi   .org/10.1007/s00441-005-0069- 0 Dumitriu, I.E., M.E.",Non-OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"http://dx.doi   .org/10.1189/jlb.030617 1 Emsley, P ., and K. Cowtan.",OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"http://dx.doi.org/10.1016/j.gene.2003.08.02 2 Ewald, S.E., B.L.",OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
http://dx.doi   .org/10.1038/nature0740 537°C and imaged.,OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
Online supplemental material is available at http://www.jem   .org/cgi/content/full/jem.20120201/DC1.,Non-OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"http://dx.doi.org/10.1038/nature0711 5 Li, J., and A.M. Schmidt.",OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"http://dx.doi.org/10.1074/jbc.272.26.1649 8 McCoy, A.J., R.W .",Non-OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"http://dx.doi.org/10.1107/S002188980702120 6 Miller, A.L., G.P .",Non-OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"http://dx.doi.org/10.1093/infdis/jir82 6 Moser, B., D.D.",OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"http://dx.doi.org/10.1038/   76032 Ostendorp, T., E. Leclerc, A. Galichet, M. Koch, N. Demling, B. Weigle,   C.W .",OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"http://dx.doi.org/10.1038/sj.emboj.760180 5 Otwinowski, Z., and W. Minor.",Non-OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"http://dx.doi.org/10.1107/   S090744490600527 0 Park, H., F.G. Adsit, and J.C. Boyington.",Non-OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"http://dx.doi.org/10.1074/jbc.M110   .16927 6 Park, B., M.M.",OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"9:1407– 1414. http://dx.doi.org/10.1038/ni.166 9 Potterton, E., P .",Non-OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"http://dx.doi.org/10.1107/S090744490300812 6 Ramasamy, R., S.F .",Non-OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"http://dx.doi.org/10.1189/jlb.040923 0 Ranjan, P ., J.B. Bowzard, J.W .",OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"http://dx.doi.org/10.1016/j   .molmed.2009.06.00 3 Ruan, B.H., X. Li, A.R.",OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"http://dx.doi.org/10   .4049/jimmunol.100086 3 Sárkány, Z., T.P.",OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"286:37525– 37534. http://dx.doi.org/10.1074/jbc.M111.22343 8 Sasai, M., M.M.",OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"http://dx.doi.org/10.1084/jem.2010068 2 Gregorio, J., S. Meller, C. Conrad, A.",Non-OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"http://dx.doi.org/10.1084/jem.2010110 2 Haas, T., J. Metzger, F .",OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"http://dx.doi.org/10.1016/j   .immuni.2008.01.01 3 Hartmann, G., R.D.",OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"http://dx.doi   .org/10.1038/3504712 3 Hofmann, M.A., S. Drury, C. Fu, W .",Non-OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"http://dx.doi.org/10.1016/   S0092-8674(00)80801- 6 Honda, K., Y .",OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"http://dx.doi.org/10.1038/nature0354 7 Honig, B., and A. Nicholls.",OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"http://dx.doi.org/10.1126/science.776182 9 Hornung, V., and E. Latz.",OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"http://dx.doi.org/10.1038/nri269 0 Hornung, V ., F .",OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"http://dx.doi.org/10.1038/ni.163 1 Horton, C.G., Z.J.",OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"http://dx.doi.org/10.1074/jbc.M80146520 0 Huttunen, H.J., C. Fages, and H. Rauvala.",OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"274:19919– 19924. http://dx.doi.org/10.1074/jbc.274.28.1991 9 Kabsch, W .",Non-OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"http://dx.doi   .org/10.1096/fj.08-11773 9 Kawane, K., H. Tanaka, Y .",OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"http://dx.doi.org/10.1016/j.str.2010.05.01 7 Krieg, A.M. 2007.",OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"8:475– 477.http://dx.doi.org/10.1038/ni0507-47 5 Lakshiminarayanan, A.V ., and V .",Non-OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
http://dx.doi.org/10.1016/0005-2787(70)90489- 2,OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"http://dx.doi.org/10.1016/j.immuni.2009.05.00 8 Sims, G.P ., D.C. Rowe, S.T.",OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"http://dx.doi.org/10.1146/annurev.immunol.021908.13260 3 Srikrishna, G., J. Nayak, B. Weigle, A. T emme, D. Foell, L. Hazelwood, A.  Olsson, N. Volkmann, D. Hanein, and H.H.",Non-OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"http://dx.doi.org/10.1002/jcb.2257 5 Szentesi, G., G. Horváth, I. Bori, G. Vámosi, J. Szöllosi, R. Gáspár, S.  Damjanovich, A. Jenei, and L. Mátyus.",Non-OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"http://dx.doi.org/10.1016/j.cmpb.2004.02.00 4 Takeda, K., T. Kaisho, and S. Akira.",OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"http://dx.doi.org/10.1146/annurev.immunol.21   .120601.14112 6 Tian, J., A.M. Avalos, S.Y .",Non-OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"http://dx.doi   .org/10.1038/ni145 7 Vollmer, J., R. Weeratna, P .",OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"http://dx.doi.org/   10.1002/eji.20032403 2 Xu, D., J.H.",OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"41:408– 422.http://dx.doi.org/10.1080/0785389090280657 6 Y anai, H., T .",Non-OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"http://dx.doi.org/10.1038/nature0851 2 Yang, H., V. Guranovic, S. Dutta, Z. Feng, H.M. Berman, and J.D.",Non-OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
"http://dx.doi.org/10.1107/S090744490401941 9 Zong, H., A. Madden, M. Ward, M.H.",Non-OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
http://dx.doi.org/10.1074/jbc.M110   .13382 7,Non-OADS,/arxiv_data1/oa_pdf/fc/98/JEM_20120201.PMC3804942.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/e6/03/JEM_20130731.PMC3804943.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial– Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0 /).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/e6/03/JEM_20130731.PMC3804943.pdf
"http://dx.doi.org/10.1038/   ng.97 5 Bagavant, H., U.S. Deshmukh, H. Wang, T. Ly, and S.M.",OADS,/arxiv_data1/oa_pdf/e6/03/JEM_20130731.PMC3804943.pdf
"http://dx.doi.org/10.4049/jimmunol.100301 0 Bjorndahl, J.M., S.­S.J.",OADS,/arxiv_data1/oa_pdf/e6/03/JEM_20130731.PMC3804943.pdf
"http://dx.doi.org/   10.1002/eji.183019051 5 Clynes, R., C. Dumitru, and J.V .",Non-OADS,/arxiv_data1/oa_pdf/e6/03/JEM_20130731.PMC3804943.pdf
"http://dx.doi.org/10.1126/science.279   .5353.105 2 Dooley, M.A.",Non-OADS,/arxiv_data1/oa_pdf/e6/03/JEM_20130731.PMC3804943.pdf
"http://dx.doi.org/10   .1002/acr.2166 4 Hochberg, M.C.",OADS,/arxiv_data1/oa_pdf/e6/03/JEM_20130731.PMC3804943.pdf
"40:1725. http://dx.doi.org/10.1002/art.178040092 8 Holdsworth, S.R., and P .G.",Non-OADS,/arxiv_data1/oa_pdf/e6/03/JEM_20130731.PMC3804943.pdf
"http://dx.doi.org/10.1007/   s00281­007­0097­ 9 Jacob, C.O., L. Pricop, C. Putterman, M.N.",Non-OADS,/arxiv_data1/oa_pdf/e6/03/JEM_20130731.PMC3804943.pdf
"http://dx.doi.org/10.1038/sj.ki.500198 8 Kumar, K.R., L. Li, M. Yan, M. Bhaskarabhatla, A.B.",Non-OADS,/arxiv_data1/oa_pdf/e6/03/JEM_20130731.PMC3804943.pdf
"http://dx.doi.org/10.1126/science.112589 3 Lawson, B.R., S.I.",OADS,/arxiv_data1/oa_pdf/e6/03/JEM_20130731.PMC3804943.pdf
"http://dx.doi.org/10.1016/   B978­0­12­394299­9.00004­ 7 Morel, L., U.H.",OADS,/arxiv_data1/oa_pdf/e6/03/JEM_20130731.PMC3804943.pdf
"http://dx.doi.org/10.1016/   1074­7613(94)90100­ 7 Morel, L., B.P .",OADS,/arxiv_data1/oa_pdf/e6/03/JEM_20130731.PMC3804943.pdf
"http://dx.doi.org/10.1056/NEJMra07129 7 Satoh, M., E.K.",OADS,/arxiv_data1/oa_pdf/e6/03/JEM_20130731.PMC3804943.pdf
"http://dx.doi.org/10.1002/art.3438 0 Schiffer, L., R. Bethunaickan, M. Ramanujam, W .",Non-OADS,/arxiv_data1/oa_pdf/e6/03/JEM_20130731.PMC3804943.pdf
"http://dx.doi.org/10.1002/art.178025110 1Theofilopoulos, A.N., and F.J. Dixon.",Non-OADS,/arxiv_data1/oa_pdf/e6/03/JEM_20130731.PMC3804943.pdf
"http://dx.doi.org/   10.1016/S0065­2776(08)60342­ 9 Tipping, P.G., and S.R.",OADS,/arxiv_data1/oa_pdf/e6/03/JEM_20130731.PMC3804943.pdf
"http://dx.doi.org/10.1007/   s00281­003­0121­ 7 Tsokos, G.C.",Non-OADS,/arxiv_data1/oa_pdf/e6/03/JEM_20130731.PMC3804943.pdf
"http://dx.doi.org/10.1056/NEJMra110035 9 Ward, M.M.",OADS,/arxiv_data1/oa_pdf/e6/03/JEM_20130731.PMC3804943.pdf
"199:255– 264. http://dx.doi.org/10.1084/jem.2003151 9 Wofsy, D., and W.E.",OADS,/arxiv_data1/oa_pdf/e6/03/JEM_20130731.PMC3804943.pdf
"http://dx.doi.org/10.1084/jem.161.2.37 8 Xie, C., X.J.",Non-OADS,/arxiv_data1/oa_pdf/e6/03/JEM_20130731.PMC3804943.pdf
"http://dx.doi.org/10.1002/art.1088 7 Xie, C., Y.",Non-OADS,/arxiv_data1/oa_pdf/e6/03/JEM_20130731.PMC3804943.pdf
http://dx.doi   .org/10.1038/gene.2012.5 7,OADS,/arxiv_data1/oa_pdf/e6/03/JEM_20130731.PMC3804943.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/06/00/JEM_20130497.PMC3804944.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial–   Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/06/00/JEM_20130497.PMC3804944.pdf
Online sup - plemental material is available at http://www.jem.org/cgi/content/full/   jem.20130497/DC1.,Non-OADS,/arxiv_data1/oa_pdf/06/00/JEM_20130497.PMC3804944.pdf
"http://dx.doi.org/10.1182/blood-2003-07-238 8 Chaki, M., R. Airik, A.K.",Non-OADS,/arxiv_data1/oa_pdf/06/00/JEM_20130497.PMC3804944.pdf
"http://dx.doi   .org/10.1016/j.cell.2012.06.02 8 Cheng, L.E., and R.R.",OADS,/arxiv_data1/oa_pdf/06/00/JEM_20130497.PMC3804944.pdf
"http://dx.doi.org/10.1016/j.ydbio   .2007.04.00 5 Davidsson, J., H. Lilljebjörn, A. Andersson, S. Veerla, J. Heldrup, M. Behrendtz,  T. Fioretos, and B. Johansson.",OADS,/arxiv_data1/oa_pdf/06/00/JEM_20130497.PMC3804944.pdf
"http://dx.doi.org/10.1038/sj.onc.120565 1 Escherich, G., M.A.",Non-OADS,/arxiv_data1/oa_pdf/06/00/JEM_20130497.PMC3804944.pdf
"http://dx.doi.org/10.1038/   leu.2009.24 9 Feinberg, A.P ., and B. T ycko.",OADS,/arxiv_data1/oa_pdf/06/00/JEM_20130497.PMC3804944.pdf
"http://dx.doi.org/10.1038/nrc127 9 Gronemeyer, H., and A. Zelent.",OADS,/arxiv_data1/oa_pdf/06/00/JEM_20130497.PMC3804944.pdf
"http://dx.doi.org/10.1016/j.ccr.2009.03.01 2 Hata, A., J. Seoane, G. Lagna, E. Montalvo, A. Hemmati-Brivanlou, and J.  Massagué.",OADS,/arxiv_data1/oa_pdf/06/00/JEM_20130497.PMC3804944.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)81561- 5 Huang, S., J. Laoukili, M.T.",OADS,/arxiv_data1/oa_pdf/06/00/JEM_20130497.PMC3804944.pdf
"http://dx.doi.org/10.1016/0092-8674(92)90293- L Klug, M., and M. Rehli.",OADS,/arxiv_data1/oa_pdf/06/00/JEM_20130497.PMC3804944.pdf
"http://dx.doi.org/10.4161/epi.1.3.332 7 Lauberth, S.M., and M. Rauchman.",OADS,/arxiv_data1/oa_pdf/06/00/JEM_20130497.PMC3804944.pdf
"http://dx.doi.org/10.1074/ jbc.M51346120 0 Lee, K.S., H.J.",OADS,/arxiv_data1/oa_pdf/06/00/JEM_20130497.PMC3804944.pdf
"http://dx.doi   .org/10.1128/MCB.20.23.8783-8792.200 0 Lewin, J., A.O.",OADS,/arxiv_data1/oa_pdf/06/00/JEM_20130497.PMC3804944.pdf
"20:3005– 3012. http://dx.doi.org/10.1093/bioinformatics/bth34 6 Lin, A.C., A.E.",OADS,/arxiv_data1/oa_pdf/06/00/JEM_20130497.PMC3804944.pdf
"http://dx.doi.org/10.1074/jbc.M41124020 0 Miyazaki, K., N. Yamasaki, H. Oda, T. Kuwata, Y .",OADS,/arxiv_data1/oa_pdf/06/00/JEM_20130497.PMC3804944.pdf
"113:4702– 4710. http://dx.doi.org/10.1182/blood-2007-05-08872 4 Mullighan, C.G., S. Goorha, I. Radtke, C.B.",Non-OADS,/arxiv_data1/oa_pdf/06/00/JEM_20130497.PMC3804944.pdf
"http://dx.doi.org/10.1038/nature0569 0 Mullighan, C.G., X. Su, J. Zhang, I. Radtke, L.A. Phillips, C.B.",OADS,/arxiv_data1/oa_pdf/06/00/JEM_20130497.PMC3804944.pdf
"http://dx.doi.org/10.1056/   NEJMoa080825 3 Mundt, C., S. Licence, T. Shimizu, F .",OADS,/arxiv_data1/oa_pdf/06/00/JEM_20130497.PMC3804944.pdf
"http://dx.doi   .org/10.1084/jem.193.4.43 5 Niebuhr, B., N. Kriebitzsch, M. Fischer, K. Behrens, T. Günther, M. Alawi,  U. Bergholz, U. Müller, S. Roscher, M. Ziegler, et al.",Non-OADS,/arxiv_data1/oa_pdf/06/00/JEM_20130497.PMC3804944.pdf
"http://dx.doi.org/10.1182/blood-2013-01-48024 4 Nutt, S.L., A.M. Morrison, P .",Non-OADS,/arxiv_data1/oa_pdf/06/00/JEM_20130497.PMC3804944.pdf
"http://dx.doi.org/10.1056/   NEJMra02300 1 Shultz, L.D., B.L.",OADS,/arxiv_data1/oa_pdf/06/00/JEM_20130497.PMC3804944.pdf
"http://dx.doi.org/10.1016/j.mrrev.2008.02.00 4 Warming, S., T. Suzuki, T.P .",OADS,/arxiv_data1/oa_pdf/06/00/JEM_20130497.PMC3804944.pdf
"http://dx.doi.org/10.1038/sj.onc.120745 2 Zelent, A., M. Greaves, and T. Enver.",Non-OADS,/arxiv_data1/oa_pdf/06/00/JEM_20130497.PMC3804944.pdf
"http://dx.doi.org/10.1038/sj.onc.120767 2 Zhang, J., C.G.",OADS,/arxiv_data1/oa_pdf/06/00/JEM_20130497.PMC3804944.pdf
http://dx.doi.org/10.1182/blood-2011-03-34141 2,Non-OADS,/arxiv_data1/oa_pdf/06/00/JEM_20130497.PMC3804944.pdf
"Despite these advances, long-term graft  survival has remained modest, with  graft half-life hovering around 10 yr   on average (http://optn.transplant.hrsa   .gov).",Non-OADS,/arxiv_data1/oa_pdf/42/4b/JEM_20131810.PMC3804945.pdf
Billar: billiartr@upmc.eduMolecular analysis of transplant rejection:   marching onward Fadi G. Lakkis and Timothy R. Billiar © 2013 Lakkis and Billiar  This article is distributed under the  terms of an Attribution–Noncommercial–Share Alike–No Mirror  Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/42/4b/JEM_20131810.PMC3804945.pdf
"http://dx.doi   .org/10.1097/00007890-200109150-0003 4 Brenner, S. 2010.",Non-OADS,/arxiv_data1/oa_pdf/42/4b/JEM_20131810.PMC3804945.pdf
"365:207–   212. http://dx.doi.org/10.1098/rstb.2009   .0221 de Freitas, D.G., J. Sellarés, M. Mengel, J. Chang,  L.G.",Non-OADS,/arxiv_data1/oa_pdf/42/4b/JEM_20131810.PMC3804945.pdf
http://dx.doi   .org/10.1111/j.1600-6143.2011.03784.,Non-OADS,/arxiv_data1/oa_pdf/42/4b/JEM_20131810.PMC3804945.pdf
"http://dx.doi.org/10.1038/nrd190 1 Khatri, P., S. Roedder, N. Kimura, K. De  Vusser, A. Morgan, Y. Gong, M. Fischbein,  R. Robbins, M. Naesens, A. Butte, and  M. Sarwal.",Non-OADS,/arxiv_data1/oa_pdf/42/4b/JEM_20131810.PMC3804945.pdf
"http://dx.doi.org/   10.1093/ndt/gfh38 5 Li, B., C. Hartono, R. Ding, V.K.",OADS,/arxiv_data1/oa_pdf/42/4b/JEM_20131810.PMC3804945.pdf
"http://dx.doi.org/   10.1056/NEJM20010329344130 1 Schade, A.E., G.L.",OADS,/arxiv_data1/oa_pdf/42/4b/JEM_20131810.PMC3804945.pdf
"http://dx.doi.org/10.1182/blood-2007-   04-08481 4 Strehlau, J., M. Pavlakis, M. Lipman, M. Shapiro,  L. Vasconcellos, W. Harmon, and T.B.",Non-OADS,/arxiv_data1/oa_pdf/42/4b/JEM_20131810.PMC3804945.pdf
"http://dx.doi.org/10   .1073/pnas.94.2.69 5 Suthanthiran, M., J.E.",OADS,/arxiv_data1/oa_pdf/42/4b/JEM_20131810.PMC3804945.pdf
"http://dx.doi.org/10.1056/NEJMoa121555 5 Tarantola, A.",OADS,/arxiv_data1/oa_pdf/42/4b/JEM_20131810.PMC3804945.pdf
"24:1643–1659, quiz :1655.  http://dx.doi.org/10.1007/s00467-008-   0808- z",Non-OADS,/arxiv_data1/oa_pdf/42/4b/JEM_20131810.PMC3804945.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months  after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"After six months  it is available under a Creative Commons License (Attribution–Noncommercial– Share Alike 3.0 Unported license, as described at http://creativecommons.org/   licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"For functional  analysis, we used GSEA v2.0 algorithm ( http://www.broadinstitute.org/ gsea)  using the computed t-statistic from limma as preranking.",OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
Online supplemental material is avail - able at http://www.jem.org/cgi/content/full/jem.20130706/DC1.,Non-OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10.1371/journal.pone.001318 6 Aberle, H., A. Bauer, J. Stappert, A. Kispert, and R. Kemler.",OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"16:3797– 3804. http://dx.doi.org/10.1093/emboj/16.13.379 7 Abrahamsson, A.E., I. Geron, J. Gotlib, K.H.",Non-OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/   10.1073/pnas.090018910 6 Baba, Y ., K.P .",Non-OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10   .1016/j.immuni.2005.10.00 9 Bartram, C.R., A. de Klein, A. Hagemeijer, T. van Agthoven, A. Geurts  van Kessel, D. Bootsma, G. Grosveld, M.A.",OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"Sequences were aligned using mVISTA, a set of pro - grams for comparing DNA sequences from two or more species, available at  http://genome.lbl.gov/vista/index.shtml.",OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10.1084/jem.190.3.41 1 Golebiewska, A., N.H. Brons, R. Bjerkvig, and S.P .",OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10.1016/   j.stem.2011.01.00 7 Gorre, M.E., M. Mohammed, K. Ellwood, N. Hsu, R. Paquette, P.N.",OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"293:876– 880. http://dx.doi.org/10.1126/science.106253 8 Gurevich, R.M., P.M. Rosten, M. Schwieger, C. Stocking, and R.K.  Humphries.",OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
"http://dx.doi.org/10.1016/j.exphem   .2006.04.02 0 Hao, S.X., and R. Ren.",OADS,/arxiv_data1/oa_pdf/e1/70/JEM_20130706.PMC3804946.pdf
